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Abstract
A conventional approach in the construction of complex molecules is to use existing substrate stereochemistry
to direct the introduction of new stereogenic centers. Since Cram's original studies 1952, the Felkin–Anh,
Cornforth–Evans, and Cram-chelation models were developed and have been widely utilized to predict
stereochemical outcomes in nucleophilic additions to aldehydes and ketones bearing a proximal chiral center.
Specifically, nucleophilic additions to protected α- and β-hydroxy aldehydes and ketones is protecting group
dependent. Small protecting groups such as methyl or benzyl undergo carbonyl addition via a chelation-
controlled mechanism. In contrast, sterically encumbered silyl protecting groups preclude chelation and
furnish Felkin/Cornforth addition products with few exceptions. One major drawback to this approach is that
the overall synthetic approach is, including the choice of protecting group, is governed by the stereochemical
outcome desired for the carbonyl addition step.
We have identified alkyl zinc halide Lewis acids capable of promoting chelation-controlled additions to α-
silyloxy aldehydes and ketones, thus overriding the expected Felkin selectivity. A variety of organozinc
reagents, including dialkylzincs, functionalized dialkylzinc reagents, and add to α- and β-silyloxy aldehydes
and ketones with high selectivity for the chelation-controlled products in the presence of achiral alkyl zinc
halides (RZnX) and triflates (RZnOTf). This method constitutes an alternate approach to employing
enantioenriched stoichiometric auxiliaries, chiral catalysts, and optically active stoichiometric additives that
have to be first synthesized and later separated from the product. Moreover, this method challenges the well-
established paradigm used to understand and predict diastereoselectivity in these reactions.
Organohalides are known to coordinate to electron-poor metal complexes. However, there are few examples
of chelation-controlled additions to α-halogenated carbonyl and imine derivatives. All of these examples
involve hydride addition. We have achieved highly diastereoselective additions to N-Ts α-chloro aldimines,
which represents the first diastereoselective halide directed C–C bond forming reaction. Alkyl and vinylzinc
reagents undergo chelation-controlled additions to in situ generated α-chloro aldimines with good to excellent
selectivity. Computational studies provide additional evidence for our proposed chelation transition state. The
functionalized syn β-chloroamine products can be utilized in further multi-step and tandem reactions.
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ABSTRACT 
REVERSING DIASTEREOSELECTIVITY: CHELATION-CONTROLLED 
ADDITION OF ORGANOZINCS TO CHIRAL CARBONYL DERIVATIVES 
 
Gretchen R. Stanton 
 
Professor Patrick J. Walsh 
 
A conventional approach in the construction of complex molecules is to use 
existing substrate stereochemistry to direct the introduction of new stereogenic centers.  
Since Cram’s original studies 1952, the Felkin!Anh, Cornforth!Evans, and Cram-
chelation models were developed and have been widely utilized to predict stereochemical 
outcomes in nucleophilic additions to aldehydes and ketones bearing a proximal chiral 
center.  Specifically, nucleophilic additions to protected "- and #-hydroxy aldehydes and 
ketones is protecting group dependent.  Small protecting groups such as methyl or benzyl 
undergo carbonyl addition via a chelation-controlled mechanism.  In contrast, sterically 
encumbered silyl protecting groups preclude chelation and furnish Felkin/Cornforth 
addition products with few exceptions.  One major drawback to this approach is that the 
overall synthetic approach is, including the choice of protecting group, is governed by the 
stereochemical outcome desired for the carbonyl addition step.  The following chapters 
describe our development of general methods to reverse the diastereoselecivity of 
reactions predicted by the aforementioned models using achiral reagents. 
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We have identified alkyl zinc halide Lewis acids capable of promoting chelation-
controlled additions to "-silyloxy aldehydes and ketones, thus overriding the expected 
Felkin selectivity.  A variety of organozinc reagents, including dialkylzincs, 
functionalized dialkylzinc reagents, and add to "- and #-silyloxy aldehydes and ketones 
with high selectivity for the chelation-controlled products in the presence of achiral alkyl 
zinc halides (RZnX) and triflates (RZnOTf) (eq. 1 and 2).  This method constitutes an 
alternate approach to employing enantioenriched stoichiometric auxiliaries, chiral 
catalysts, and optically active stoichiometric additives that have to be first synthesized 
and later separated from the product.  Moreover, this method challenges the well-
established paradigm used to understand and predict diastereoselectivity in these 
reactions.  
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Organohalides are known to coordinate to electron-poor metal complexes.  
However, there are few examples of chelation-controlled additions to "-halogenated 
carbonyl and imine derivatives.  All of these examples involve hydride addition.  We 
have achieved highly diastereoselective additions to N-Ts "-chloro aldimines, which 
represents the first diastereoselective halide directed C!C bond forming reaction (eq. 3).  
Alkyl and vinylzinc reagents undergo chelation-controlled additions to in situ generated 
"-chloro aldimines with good to excellent selectivity.  Computational studies provide 
additional evidence for our proposed chelation transition state.  The functionalized syn #-
chloroamine products can be utilized in further multi-step and tandem reactions.     
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Chapter 1. The Evolution of Stereoinduction Models  
1.1 Introduction 
          The conventional approach to complex molecule synthesis is to utilize the existing 
stereochemistry of the substrate to direct the reaction of achiral reagents to form new 
stereogenic centers.  The seminal work of of Cram and Elhafez in 1952 introduced key 
concepts for predicting and controlling diastereoselectivity in nucleophilic additions to 
C=O bonds containing an adjacent stereogenic center.1  Since these early studies, key 
contributions from several groups have formed the foundation for the current paradigm 
comprised of the Felkin#Anh#Eisenstein, Cram-chelation, and Cornforth#Evans 
stereoinduction models.2  
           These models predict that diastereoselectivity in nucleophilic additions to 
protected !-and "-hydroxy carbonyl derivatives is depedent on the size of the protecting 
group.  There have been few exceptions to this paradigm.3  In cases when the protecting 
group needed for the overall protecting group strategy does not provide the desired 
stereochemistry in the addition step, chemists have relied on reagent control to override 
the inherant selecitvity.  Thus, chiral reagents such as optically active stoichiometric 
additives,4 chiral catalysts,5 and enantioenriched stoichiometric axuiliaries have been 
employed to negate substrate control.  While this approach has proven useful in complex 
molecule synthesis, it has several limitations.  The stoichiometric additives require 
additional synthetic steps to prepare and have to be separated from the product.  
           An improved approach would be to reverse the expected diastereselectivity of the 
reaction by proper of choice achiral reagent.  In recent years, general methods employing 
organozinc reagents have emerged as a viable route to achieve reversed selectivity in 
! "!
these additions.#!!Thus, by proper choice of reagents, either diastereomeric product can be 
accessed from a common starting material.  Moreover, this approach builds on the current 
models that have been widely accepted for quite some time.  Although these models have 
been refined over the last 60 years, the basic concepts are still relevant.   
 
1.2 Early Studies of Stereoinduction Models 
           One of the earliest examples of using substrate stereochemistry to control the 
configuration of new stereogenic centers was reported by Emil Fischer and co-workers in 
1889.7  In these pioneering studies, they determined that the homologation of D-(+)-
mannose with HCN led to a single diastereomer (Scheme 1.1).  Interestingly, the first 
model to rationalize stereochemical outcomes of additions to !-chiral carbonyl 
derivatives was reported by Cram and Elhafez over 60 years later.1  These studies 
focused on the correlation between the effective steric bulk of the substiutents at the !-
chiral center and the preference for the approach of the incoming nucleophile from the  
 
 
 
 
 
                Scheme 1.1 Diastereoselective homologation of D-mannose by Fischer 
 
 least hindered face of the carbonyl.  According to the “rule of steric control in 
asymmetric induction,” the carbonyl is flanked by the two least sterically encumbered 
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groups, RS and RM (Scheme 1.2).  It is worth noting that Cram alluded to several factors 
such as electronic effects of the substituents at the !-position, and an altenative model for 
substrates bearing a !-heteroatom capable of coordinating to the metal center.8  These 
incisive speculations were later studied and confirmed by other groups.3b,9    
 
 
 
           
          Scheme 1.2 Cram’s rule of steric control in asymmetric induction 
 
          In 1958, Cram described two distinct models for predicting diastereoselectivity in 
nucleophilic additions to !-chiral carbonyl derivatives: the open-chain and cyclic models 
(Scheme 1.3).  The open chain model was described previously.1  In the cyclic model, RM 
was a hydroxy or an amino group that could coordinate to the metal.  However, both 
models predicted the same stereochemical outcome.  Around the same time, Cornforth 
and co-workers began to investigate nucleophilic additions to !-chlorinated aldehydes 
and ketones.10  They presented a third model based on minimizing dipole interactions 
between the C=O and C"X bonds, which became known as the “dipolar model.”  In this 
model, it was predicted that the antiparallel conformation of the carbonyl and C#X bonds 
was most favorable in the transition state, despite its minimal contribution to the 
rotational equilibrium in solution.  The three models are outlined in Scheme 1.3.    
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              Scheme 1.3 Open chain, cyclic, and dipolar stereoinduction models 
 
              Following these preliminary studies, which established three distinct 
stereoinduction models, several groups investigated the specific factors that contributed 
to diastereoselecivity in additions to !-chiral carbonyl derivatives.  In 1966, Karabatsos 
and coworkers reassessed the models and reported some inconsistencies with 
experimental trends.11  They concluded that the steric interaction between the metal-
bound carbonyl oxygen and the substituents, RM or RL, at the !-position was the most 
important interaction contributing to stereoselectivity (Scheme 1.4).  Conversely, Felkin 
and coworkers found flaws in both the studies performed by Karabatsos and Cram.12  
Felkin proposed that the dominant factor that contributed to diastereoselectivty was the 
interaction of the incoming nucleophile, R2, and the R1 substituent of the !-carbon as 
shown in Scheme 1.4. Moreover, the importance of staggered transition states was noted, 
which is still included in current stereoinduction models.  The stabilization of the 
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transition state via an antiperiplanar approach of the nucleophile to the electronegative !-
substituent was another premise of this model. 
 
 
  
 
 
       
 
           
 
Scheme 1.4 Proposed interactions in transition states leading to stereoselectivity by 
Cram, Karabatsos, and Felkin (representative structures by Felkin12) 
 
            In 1976, Anh and Eisenstein performed a pivotal computational study comparing 
the Cram, Felkin, Cornforth, and Karabatsos models.9  A few factors were excluded in 
their ab initio calulations, such as solvent effects, counterion effects, and cation 
complexation effect, because they were shown to not significantly modify the geometries 
of the favored transition states.  In both cases, with and without solvent or counterion 
effects, they determined that the Felkin transition state was nearly 2.7 kcal/mol lower in 
energy than the transition states proposed by Cram and Karabatsos.  Additionally, Anh 
and Eisenstein explored the role of the Bürgi#Dunitz angle13 in intermolecular orbital 
overlap between the nucleophile and the carbonyl group.  As illustrated in Figure 1.1, the 
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predominant interaction is between the C=O LUMO (!*) and the HOMO of the 
nucleophile (Nu).  Anything that lowers the !* of C=O, in turn, strengthens this 
interaction.  When the "* of the adjacent C#RL bond is antiperiplanar to the incoming 
nucleophile in the transition state, !* is stabilized and lower in energy.  This stabilization 
is more pronounced when RL is an electron accepting group and the nucleophile 
approaches from the Bürgi-Dunitz trajectory of 110°, resulting in a favorable 
hyperconjugation effect.  It is notable that these contributions confirmed the importance 
of electronic effects in addition to steric factors.   
 
 
 
        
                 Figure 1.1 Anh and Eisenstein´s “antiperiplanar effect” 
 
1.3 Role of Protecting Groups in Stereoindution Models 
                Shortly after Cram’s initial paper,1 many groups adopted the cyclic chelate 
model to rationalize stereochemical outcomes in additions to $-hydroxy or amino 
carbonyl derivatives.14! !   However, a systematic survey of reaction conditions, such as 
solvent, temperature, and carbon nucleophile, in addition to the hydroxyl protecting 
group, were carried out some time later by Still and coworkers.15  This concept involving 
the size of the protecting group later became the basis for the current Felkin!Anh and 
Cram chelation models.  Still and coworkers found that the diasteroselectivity of 
reactions of protected $-hydroxy ketones with carbon nucleophiles could be improved 
OR1
RMRS
RL
Nu!
"#C-R L
$#C-O
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using Grignard reagents in highly coordinating solvent as shown in Scheme 1.5.  In 
general, employing Grignard reagents resulted in better selectivity than the corresponding 
organolithiums.  The reaction of MEM-protected 3-hydroxydecan-2-one with n-BuMgBr 
yields chelation product 1.1 with > 20:1 dr in THF solvent (dr = 9:1 in Et2O).  
  
 
 
 
 
 
 
 
Scheme 1.5 Screen of protecting groups and reaction conditions by Still and coworkers15a 
 
 
Still and coworkers also demonstrated that aldehydes, which are significatly more 
reactive than ketones, also undergo highly selective chelation-controlled additions using a 
milder organocopper nucleophile.15b  Moreover, Still attributed the substantial erosion of 
diastereoselectivity using a tetrahydropyranyl protecting group to steric effects, which 
disfavors chelation (Scheme 1.5).  They observed a similar trend to employing 
tetrahydropyranyl protecting group in nucleophilic additions to !-hydroxy aldehydes 
bearing a sterically encumbered trityl (Tr) group, which has modest selectivity for the 
other diastereomer (Scheme 1.6).15b  
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Scheme 1.6 Survey of protecting groups in addition of organocopper reagents to 
protected !-hydroxy aldehydes by Still and coworkers 
 
        A few years after Still’s investigation,15 Reetz and coworkers reported another 
detailed study, assessing selectivity for chelation or Felkin addition products by proper 
choice of organometallic reagent.16  Based on their previous work,16a  the Reetz group 
explored the correlation between Lewis acidity of organotitanium reagents and the 
selectivity for the chelation product in additions to !-benzyloxy aldehydes.  As depicted 
in Scheme 1.7, the reaction of aldehyde 1.5 with highly Lewis acidic 
methyltitaniumtrichloride affords the chelation product with 11.5:1 dr.  In contrast, 
employing less Lewis acidic methyltitaniumtriisopropoxide in the reaction gives equal 
levels of diastereoselecivity, but precludes chelation to give the opposite diastereomer.  In 
both cases, the diastereoselectivity of the reaction is improved over the reactions using 
the analogous Grignard or organolithium reagents.  Other carbon nucleophiles, such as 
allylsilanes, dialkylzincs, and silyl enol ether, could be used in the reaction with titanium 
tetrachloride.  Although a more detailed mechanism of addition using organotitanium 
reagents was not elucidated until later, Reetz performed the first studies to provide 
preliminary spectroscopic evidence for chelation.17  
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Scheme 1.7  Survey of organotitanium reagents of different Lewis acidity by Reetz 
 
 
             Until this point, studies on the effect of protecting groups focused primarily on 
groups that promote chelation in nucleophilic additions, such as Bn and BOM.  In 1984, 
Keck reported using sterically encumbered silyl protecting groups to preclude chelation 
to furnish Felkin additions products with moderate to excellent dr depending on the 
Lewis acid employed in the reaction.18   As illustrated in Scheme 1.8, the reaction of 
benzyl-protected aldehyde 1.8 with tributylallyltin in the presence of magnesium bromide 
Lewis acid furnishes the chelation product 1.9 with  > 20:1 dr.  Conversely, the reaction 
of tributylallyltin with bulky tert-butyldimethylsilyl (TBS)-protected 1.8 employing 
BF3•OEt2, a monodentate Lewis acid, gave Felkin product 1.10 with 19:1 dr.  This 
investigation was one of the first systematic methods to access both diastereomers with 
synthetically useful diastereomeric ratios.  Two years later, Reetz and coworks reported 
an analogous study on nucleophilic additions of organotitanium reagents to protected !-
hydroxy ketones to generate Felkin products.3g  They deteremined that the 
diastereoselectivity of the reaction could be controlled using the proper protecting 
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Scheme 1.8 A systematic approach to diastereoselectivity by Keck19 
 
group/Lewis acid combination.  These findings were also corroborated by other groups.20 
 
 
1.4 Early Spectroscopic Evidence for Chelation versus Non-Chelation 
              After demonstrating a rational approach to access chelation and non-chelation 
addition products, many groups turned their efforts to providing further evidence for 
chelation.  In 1986, Keck and coworkers reported the first detailed NMR experiments on 
the chelating ability of protected !-hydroxy !- and !-substituted aldehydes with titanium 
tetrachloride.21  They elucidated key information about the conformation of the six-
membered chelate of "-hydroxy aldehydes with titanium tetrachloride (Scheme 1.9).  
When aldehyde 1.5 was mixed with TiCl4, complex 1.12 formed.  By analysis of the 
coupling constants, they concluded that the !-methyl substituent occupies the equatorial 
(or pseudo-equatorial) position (1.12).  On the other hand, when aldehyde 1.11 is 
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employed, the !-methyl substituent in complex 1.13 preferably occupies the axial (or 
pseudo-axial position). 
  
 
 
 
 
 
 
 
 
Scheme 1.9  Proposed structure of !-benzyloxy  aldehydes with TiCl4 by Keck  
 
The high levels of diasteroselectivity previously seen in reactions with these aldehydes 
was attributed to this conformation, which effectively blocks one face of the aldehyde.  In 
a related NMR study, Keck investigated the chelating ability of "-substituted Bn and TBS 
protected !-hydroxy aldehydes.22  In the presence of two equivalents of tin tetrachloride, 
benzyloxy aldehyde 1.5 was shown to have a larger downfield shift of the ! protons than 
the " proton in the 1H NMR spectrum owing to chelation (Figure 1.2).  The absence of 
chelation in the corresponding silyloxy aldehydes was confirmed using aldehyde 1.14.  In 
this case, the downfield shift of the !-proton was significantly less than the "-proton.   
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 Figure 1.2  Binding studies of protected !-hydroxy aldehydes by Keck 
       
      The first spectroscopic evidence for a Cram chelate intermediate in additions of 
MeTiCl3 to !-benyzloxy ketones was reported in 1987 by Reetz and coworkers using 
variable temperature NMR.23  Although substantial evidence for chelation of !- and "- 
benzyloxy aldehydes and ketones to Lewis acids was previously reported, including a 
crystal structure,24 no studies had been performed to elucidate the mechanism for delivery 
of the nucleophile.  As outlined above, only binding studies had been reported, and, no 
intermediates had been observed.22  Reetz showed that upon addition of MeTiCl3 to 
benzyloxy ketone 1.15, two diastereomeric titanium complexes (1.17 and 1.18) formed as 
ascertained the 13C NMR spectrum at "45 °C (Scheme 1.10).23  Similarly, titanium 
complexes 1.19 and 1.20 are formed when CD3TiCl3 is added to ketone 1.16.  To 
determine if the methyl group is delivered to the ketone via an intramolecular or 
intermolecular process, complexes 1.17"1.20 were combined.  Interestingly, nearly a 
statistical mixture of diols 1.21, 1.22, 1.23, and 1.24 were furnished.  Moreover, kinetic 
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experiments show that the reaction is second order with respect to the titanium complex.  
These results, collectively, suggests that methyl addition occurs by an intermolecular 
mechanism. 
 
 
 
 
 
  
 
 
 
Scheme 1.10 Mechanistic studies on delivery of nucleophile by Reetz and coworkers 
 
        In 1992, Eliel and Frye performed a series of refined kinetic experiments that 
support the proposed intermediacy of chelates.3b They carried out kinetic experiments for 
the reaction of dimethylmagnesium (MgMe2) with various silyl-protected hydroxy 
ketones under pseudo first-order conditions (Table 1.1).  This was achieved using a large 
excess of the ketone.  In contrast to Reetz’s prior kinetic studies, these conditions 
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substantiate the assumption that the chelate formed is an intemediate in product formation 
and not an intermediate of a non-productive equilibrium.25  As illustrated in Scheme 1.12,  
 
Table 1.1 Pseudo first order reaction kinetic studies by Eliel and Frye 
 
 
 
!
 
 
  
 
 
the methylation of ketone 1.25 bearing a small protecting group such as TMS affords the 
chelation product with excellent selectivity.  As the size of the protecting group is 
increased, the dr steadily decreases and the reaction rate is significantly lower.  The rate 
acceleration observed for the TMS-protected substrate is nearly two orders of magnitude 
faster than the TIPS-protected substrate and propiophenone.  These results confirmed that 
chelation must lower the activation energy of the reaction.  Furthermore, they perfomed 
NMR binding studies of 1.25 with MgBr2 in CD2Cl2.  They observed that the !-proton of 
TBS-protected 1.25 exhibits a downfield shift intermediate between Me and TIPS-
protected 1.25.  Interestingly, this suggests an equilibrium between the chelated and non-
PG Relative rate dr (1.26: 1.27)
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chelated complex for TBS-protected 1.25 and is consistent with the modest selectivity for 
the chelation product (Table 1.1, entry 3). 
 
1.5 Recent Contributions: Relevance of  the Cornforth Model 
              After Anh and Eisenstein’s theoretical investigation comparing the Cram, 
Felkin, Cornforth, and Karabatsos models, much focus was centered around the 
Felkin$Anh and Cram-chelate transition states.9b!!Although the Felkin transition state was 
shown to be lower in energy in this study, several groups have observed inconsistencies 
between the proposed Felkin transition state and their experimental results.26  In these 
cases, the Cornforth transition state better rationalized the trends in diastereofacial 
selectivity.   
       In 2003, Evans and coworkers performed a study to reevaluate the relevance of the 
Cornforth model.27  Since the polar Felkin!Anh and Cornforth transtion states lead to the 
same product, it was neccesary to determine a reliable approach to distinguish between 
the two.  They proposed that the polar Felkin!Anh model and the Cornforth models 
could be differentiated using carbonyl additions reaction in which the nucleophile 
imposes a conformational constraint on the "-stereogenic center of the electrophile.  The 
aldol reaction of (E)- and (Z)-enolates with protected "-hydroxy aldehdyes fit this 
requirement and was used as a model system to investigate the conformational preference 
in the transition state.  As depicted in Scheme 1.11, aldol reactions between a chiral 
aldehyde and (E)- and (Z)-boron enolates generate two diastereomers, each owing to a 
strong correlation between the enolate configuration and the product stereochemistry 
(2,3-relationship).  The enolate configuration also strongly influences the aldehyde facial 
! "#!
selectivity (3,4-relationship).  This is attributed to unfavorable syn-pentane interactions 
with the enolate substituent and the !-substituent of the carbonyl (Scheme 1.12).   
 
 
 
 
 
 
 
 
Scheme 1.11 Additions of (E)- and (Z)-enolates to chiral aldehydes 
   
      The transition states for the aldol reaction of (E)- and (Z)-enolates with aldehydes 
containing an !-heteroatom are shown in Scheme 1.14.  Transition states 1.28 and 1.29 
correspond to the polar Felkin"Anh model, while 1.30 and 1.31 correspond to the 
Cornforth model.  Since the enolate substituent provides an additional conformational 
constraint, it can be used to probe the relationship between enolate configuration and 
aldehyde diastereofacial selectivity.  The polar Felkin"Anh model predicts that (Z)-
enolate induces a syn-pentane interaction in structure 1.28.  In contrast, the (E)-enolate 
has no destablilizing interactions (structure 1.29) and, therefore, (E)-enolates are 
expected to give higher 3,4-selectivity.  On the other hand, the Cornforth model predicts 
that (E)-enolate substituents causes a syn-pentane interation in structure 1.30, while the 
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(Z)-enolate does not (1.31).  The Cornforth model is predicted to afford high 3,4-
selectivity employing (Z)-enolates.  
    
 
 
 
 
 
 
 
     
Scheme 1.12 Comparison of aldol reaction transition states employing (E)- or (Z)-enolate 
leading to Cornforth or Felkin!Anh product 
 
     As illustrated in Scheme 1.14, the reaction of a (Z)-boron enolate with protected "-
hydroxy aldehydes affords 3,4-anti product 1.32 with high selectivity (! 10:1).  Both the 
hydroxy protecting group and the "-substituent on the aldehyde can be varied, while 
maintaining high diastereoselectivity of the reaction.  These results parralel the expected 
diastereofacial selecitity based on the Cornforth transition states in Scheme 1.12, giving 
product with higher dr when the (Z)-enolate is used.  The same reaction employing the 
(E)-boron enolate displays strikingly different results.  Namely, the 3,4-diastereofacial 
selectivity is poor, and even favors diastereomer 1.35 in some cases.  These findings are 
contradictory to the premise that the reaction of  (E)-enolates with "-heteroatom  
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 Scheme 1.13 Aldol reaction of (Z)-enolates with protected !-hydroxy aldehydes 
 
Scheme 1.14 Aldol reaction of (E)-enolates with protected !-hydroxy aldehydes 
 
substituted carbonyl derivatives  give high 3,4-selectivity via a Felkin"Anh transition 
state.  These analyses, collectively, effectively distinguish between the Cornforth and 
Felkin$Anh transition states.  Furthermore, it validates the relevance of the Cornforth 
transition state.  A few years later, Evans and coworkers published a computational study 
that supports their experimental results.28  It is worth noting that Evans also proposes that 
it is likely that this concept can be extended to non-sp2 nucleophiles. 
i-Pr
OM
Me
M = 9-BBN
O
H
R
OPG
+
O
i-Pr
Me
OH
R
OPG
O
i-Pr
Me
OH
R
OPG
+
1.32 1.33
PG R 2,3-syn:2,3-anti 1.32 :1.33
TBS
TBS
95 :05
95 :05
93 :07
94 :06
89 :11
98 :02
98 :02
98 :02
Me
i-Pr
Me
i-Pr
Bn
Bn
i-Pr
OM
M = (Cy)2B
O
H
R
OPG
+
O
i-Pr
Me
OH
R
OPG
O
i-Pr
Me
OH
R
OPG
+
1.34 1.35
PG R 2,3-syn:2,3-anti 1.34 :1.35
TBS
TBS
>99 :01
>99 :01
>99 :01
>99 :01
33 :67
67 :33
21 :79
43 :57
Me
Me
i-Pr
Me
i-Pr
Bn
Bn
! "#!
1.6 Summary of Current Stereoinduction Models 
     Over the past 60 years, key investigations by many groups have elucidated important 
factors that govern diastereofacial selectivity in nucleophilic additions to !- and "-chiral 
carbonyl derivatives.2  One important factor for predicting stereochemical outcome in 
these additions is the size of the protecting group.  Scheme 1.15 illustrates the preferred 
facial attack of the nucleophile for protected !-substituted !-hydroxy aldehydes and 
ketones.  Sterically encumbered silyl protecting groups disfavor chelation and furnish 
Felkin addition products (1.39).  According to the Felkin#Anh model, the nucleophile 
approaches the carbonyl from the Bürgi#Dunitz trajectory antiperiplanar to X, which is 
either the largest !-substituent or the substituent with the  lowest C#X $* (structure 
1.37).  However, recent studies by Evans and coworkers have reaffirmed the relevance of 
Cornforth transition state 1.38, which also yields product 1.39.  In this case, the polar 
substituent, X, is antiperiplanar to the C=O bond to minimize dipole interactions.  When 
X is a group capable of coordinating to the metal, the Felkin#Anh model does not apply.  
!-Hydroxy aldehydes and ketones containing small protecting groups, such as Bn, 
MOM, or Me, favor chelation transition state 1.41.  The nucleophile attacks the carbonyl 
from the opposite diastereotopic face to afford syn diol product 1.42 as predicted by the 
Cram chelate model.  To date, there are few exceptions to this paradigm.3d,3g,29  
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Scheme 1.15 Stereoinduction models for additions to !-substituted protected !-
hydroxy carbonyl derivatives 
 
            In the case of !-substituted, "-hydroxy aldehydes and ketones, the desired  
stereochemistry of the product can also be achieved by proper choice of the protecting 
group employed.  As previously described, key contributions from Still, Keck, and Reetz 
elucidated the mode of nuclephilic attack for "-hydroxy aldehydes under chelation 
conditions.3d,21,30  As shown in Scheme 1.16, two possible transition states were validated 
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for !-hydroxy carbonyls bearing a small protecting group.  Transition state 1.44, in which 
the "-substituent R1 adopts a pseudo equitorial conformation to afford 1,2-anti product 
1.47.  Transition state 1.45 was also shown to be plausible for chelation control.  
Additionally, a cationic boat tranision state has been proposed by Evans to give product 
1.47.3d  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.16 Stereoinduction models for additions to "-substituted, protected !-
hydroxy carbonyl derivatives 
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     If chelation is prevented, the addition occurs as depicted in transition state 1.46.  The 
nucleophile attacks carbonyl 1.43 from the opposite diastereotopic face to give 1,2-syn 
product 1.48. 
     For nucleophilic additions to !-hydroxy carbonyl derivatives bearing a !-substituent, 
it has been shown that the product possesses a 1,3-anti relationship, regardless of the 
protecting group employed.  The proposed transition states for chelation and non-
chelation conditions are outlined in Scheme 1.17.  Keck and coworkers reported good to 
excellent dr, favoring the 1,3-anti product under non-chelation conditions.22  Moreover, 
Evans and coworkers proposed transition state 1.50, in which the carbonyl and the !-  
 
 
Scheme 1.17 Stereoinduction models for additions to !-substituted protected !-
hydroxy carbonyl derivatives 
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silyloxy substituent have an anti relationship to minimize dipole interactions.31  Keck has 
also shown that good levels of selectivity for diastereomer 1.52 under chelating 
conditions.  The high selectivity seen is rationalized by transition state 1.51 based on 
variable temperature NMR experiments.21,32 
 
1.7 Representative Applications in Complex Molecule Synthesis: Past and Present 
      Cram´s first paper1 exploring the concept of substrate control prompted many 
research groups to adopt a rational approach to incorporate diastereoselective reactions 
into complex molecule synthesis.  Interestingly, although the stereoinduction models 
have been refined over the last 60 years, many of the findings in Cram’s original paper 
are still relevant. To date, Cram’s orginial paper has been cited nearly one thousand 
times.  Substrate control in nucleophilic additions of organometallic reagents to carbonyls 
continues to be a practical method for the stereoselecitive construction of C!C, C!O, and 
C!N bonds. It is impressive that the same fundamental concepts in these stereoinduction 
models used in the 1960’s and 70’s are widely used in synthetic design today. 
          One early example that demonstrates the efficiency of diasteroselective reactions is 
Kishi´s second generation synthesis of lasalocid A in 1978.33  As outlined in Scheme 
1.18, this approach takes advantage of the close proximity of the tetrahydofuranyl group 
in ketone 1.53 to engage in a five-membered ring chelate 1.54 in the transition state.  The 
addition of ethyl magnesium bromide to ketone 1.53 yields alcohol 1.55 as a single 
diastereomer.    
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  Scheme 1.18 Kishi´s second generation synthesis of lasalocid A 
 
          A more recent example of substrate control is highlighted in Fürstner and 
coworker´s syntheses of 4 members of the amiphidinolide family of natural products 
from a common intermediate (Scheme 1.19).34  In the critical step in the synthesis of the 
intermediate, the diastereofacial approach of the hydride nucleophile to ketone 1.60 can 
be carefully controlled by proper choice of reducing agent.  Employing L-selectride 
affords diastereomer 1.61 with excellent dr, whereas using lithium aluminum hydride in 
the presence of lithium iodide reverses the selectivity to give diol 1.62.  The change in 
stereochemical bias can be explained by the difference in size of the reducing agent.  
Employing sterically encumbered L-selectride disfavors chelation and furnished product 
1.61 via Felkin transition state 1.58.   On the other hand, when the reaction was 
performed with lithiumaluminum hyride, lithium formed a five-membered ring chelate 
(1.59) via coordination to the MOM-protected !-hydroxy group to afford product 1.62.  
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Alternatively, lithium can participate in a six-membered chelate with the oxygen of the 
tetrahydrofuranyl group, which also results in the formation of 1.62.  Both diastereomer 
1.61 and 1.62 were used to access the common scaffolds for the amphidinolide T natural  
products (structures 1.63 and 1.64).  As shown in Scheme 1.20, 4 members of the 
amphidinolide T family can be synthesized from 1.63 and 1.64.  
      
 
Scheme 1.19 Key step in Fürstner´s synthesis of amphidinolide T family 
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Scheme 1.20 Amphidinolide natural products synthesized from a common 
intermdiate by Fürstner and coworkers 
 
1.8 Goal of Research 
          Chemists continue to pursue efficient synthetic routes to access molecules with 
increased molecular complexity.  In turn, novel synthetic methods are also an ongoing 
target.  The overall goal of the research described in the subsequent chapters is to build 
on the existing stereoinduction models.  Specifically, the aim is to explore alternative  
approaches to reverse the diastereoselectivity in nucleophilic additions to !- and "-chiral 
carbonyl derivatives using solely substrate control.  Although there are some exceptions 
to the current stereoinductions models, general methods to reverse the inherent 
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diastereofacial selectivity are lacking.  Establishing general methods to furnish either 
diastereomeric product from a common starting material, especially independent of the 
protecting group employed, constitutes an important advancement for applications in 
total synthesis.    
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Chapter 2. Chelation-controlled Addition of Organozincs to !- and "-Silyloxy 
Aldehydes 
 
2.1 Introduction 
          The Felkin#Anh, Cornforth#Evans, and Cram-chelation models for predicting 
diastereofacial selectivity in nucleophilic additions to chiral carbonyl derivatives are 
widely utilized in synthesis.  Specifically, stereoinduction in additions of organometallic 
reagents to protected !-and "-hydroxy aldehydes is based on the size of the protecting 
group.1  As outlined in Figure 1, sterically encumbered silyl protecting groups will 
preclude chelation and furnish Felkin/Cornforth addition products.  On the other hand, 
smaller protecting groups such as alkyl and benzyl allow chelation and give the opposite 
diastereomeric product.  This chapter describes our contributions to the to the  
 
Figure  2.1 Summary of stereoinduction models for nucleophlic additions to 
chiral protected !-hydroxy aldehydes.  MLn = metal-Lewis acid complex 
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development of general methods to access chelation-controlled products from !- and "-
silyloxy aldehydes using organozinc reagents. 
 
2.2 Previous Examples of Chelation-Controlled in Additions to Chiral Silyloxy 
Aldehydes  
       To date, exceptions to the Felkin/Cornforth stereoinduction models are limited.  In 
these cases, nucleophilic additions to chiral !- and "-silyloxy aldehydes provide the 
unexpected chelation product.  In 2001, Evans and coworkers reported an impressive 
example of reversing the diastereofacial selectivity in additions to silyloxy aldehdyes.  
They demonstrated that ClAlMe2 and Cl2AlMe Lewis acids can chelate "-silyloxy 
aldehydes.2  However, these aluminum-based Lewis acids are monodentate like BF3 and 
are, therefore, not expected to participate in bidentate coordination.  As illustrated in 
Scheme 2.1, the Mukayama aldol reaction of TBS-protected aldehyde 2.1 was performed 
with different amounts of Me2AlCl.  Chelation product 2.3 was furnished in excellent dr 
when two or more equivalents of Me2AlCl was employed in the reaction (dr # 91:9).  
Evans proposed that extraction of an aluminum chloride by another equivalent of the 
Lewis acid generates a cationic aluminum species, 2.2, which can form a six-membered 
chelate with "-silyloxy aldehydes.  Moreover, en route to the synthesis of mycolactone 
polyketide derivatives, Burkart and coworkers recently reported a highly selective 
allylation of aldehyde 2.5 using allyltrichlorostannane, which afforded chelation product 
2.6 with > 19:1 dr (Scheme 2.2).3          
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Scheme 2.1 Chelation-controlled reaction of !-silyloxy aldehydes by Evans  
 
 
 
 
 
Scheme 2.2 Chelation-controlled allylation by Burkart and coworkers 
 
  Our group has also observed reversed selectivity in additions to silyloxy 
aldehydes in efforts toward a general protocol for the one-pot generation of stereodefined 
(Z)-disubstituted allylic alcohols.4 The (Z)-vinylzinc reagents were generated as needed 
from 1-bromoalkynes.  As illustrated in Scheme 2.3, hydroboration with 
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dicylcohexylborane provided vinyl borane 2.7.  Subsequent addition of a nucleophile, 
such as a hydride source from t-BuLi, resulted in a rearrangement and generated (Z)-
vinylborane intermediate 2.9.  Using the procedure reported by Srebnik5 and Oppolzer,6 
treatment of vinylborane 2.9 with diethylzinc generated a more nucleophilic vinylzinc 
species.  Surprisingly, upon addition to aldehyde 2.10 in the presence of 2 equiv 
BF3•OEt, chelation product 2.11 was furnished with 8:1 dr.  As shown in Scheme 2.4, !-          
 
 
 
 
 
 
 
 
 
Scheme 2.3 One-pot generation of (Z)-disubstituted allylic alcohols via chelation  
  
 
 
 
 
Scheme 2.4 Generation of (Z)-disubstituted diols from !-silyloxy aldehydes 
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silyloxy aldehydes could also be employed and gave comparable levels of  
diastereoselectivity, favoring the chelation product when 2 equiv ZnBr2 Lewis acid were 
employed. 
 Further insight about the reversed diastereoselectivity of these reactions was 
realized when the corresponding (Z)-trisubstituted vinylzinc reagents were added to !-
silyloxy aldehydes.7  In this case, a dialkylzinc reagent was added to vinylborane 
intermediate 2.13 instead of a hydride source (t-BuLi in Scheme 2.3) to promote the 1,2-
metallate rearrangement.  An excess of the dialkylzinc was used to carry out the 
transmetallation step to generate the (Z)-trisubstituted vinylzinc intermediates (Scheme  
 
Scheme 2.5 Generation of (Z)-trisubstituted allylic alcohols with high diastereoselectivity 
 
2.5).8  The addition of this vinylzinc intermediate to both TBS and TIPS-protected !-
silyloxy aldehydes afforded chelation product 2.18 with excellent distereoselectivity (dr > 
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20:1).  It is important to note that no BF3•OEt2 or ZnX2 Lewis acids were added to these 
reactions.  As depicted in Scheme 2.5, EtZnBr was generated during the transmetallation 
step.  Although the alkyl zinc halide, RZnX, has two open coordination sites and is 
capable of coordinating a bidentate substrate, it seemed rather unlikely that such mild 
Lewis acids could promote chelation.  With this in mind, we set out to investigate 
whether EtZnBr was responsible for unexpected diastereofacial selectivities observed in 
additions to silyloxy aldehydes. 
 
2.4 Results and Discussion: Chelation-Controlled Addition of Organozincs to !-
Silyloxy Aldehydes 
2.4.1 Addition of dialkylzincs to !-Silyloxy Aldehydes 
 Initially, we investigated the reaction of commercially available diethylzinc with 
TBS and TES-protected !-hydroxy aldehyde 2.19.9  The reactions of diethylzinc with the 
silyloxy aldehydes in the absence of a Lewis acid were slow and furnished a 1:1 mixture 
of chelation:Felkin products (Table 2.1, entries 1 and 10).  In stark contrast, when 1.5 
equiv of EtZnCl was employed in the reaction, the chelation product was generated with 
28:1 dr, as ascertained by GC analysis of the TMS-protected derivative (entry 2).  The 
relative configuration of the product was confirmed by modified Mosher ester analysis.10 
The RZnX Lewis acids were prepared in non-coordinating solvent by conproportionation 
of ZnR2 and ZnX2 at 70 °C for 3 days and subsequent filtration and concentration 
(Scheme 2.6).11  Importantly, non-coordinating solvents were also used in the addition 
reactions since coordinating solvents compete with the RZnX Lewis acids for binding of 
the substrate.   
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The reactions were then performed in the presence of varying amounts of EtZnCl 
or EtZnBr Lewis acids (0.1!1.0 equiv, entries 3!5 and 7!9).  As shown in Table 2.1, 
1.0!1.5 equiv EtZnCl or EtZnBr effectively promote chelation in additions to TBS and 
TES-protected 2.19 (entries 2, 3, 6, 7, 11, and 12).  Employing substoichiometric   
 
Table 2.1 Diastereoselective ethyl addition to silyl-protected 2.19 
 
 
 
 
 
Et2Zn
EtZnX
toluene
0 °C to rt
O
Me
OPG
H
OH
Me
OPG
OH
Me
OPG
+
Felkinchelation
entry PG EtZnX mol %a yield (%) drb
1 TBS EtZnCl 0 77 1:1
2 150 90 28:1c
3 100 93 31:1c
4 50 94 14:1
5 25 91 6.7:1
6 TBS EtZnBr 150 92 22:1
7 100 94 20:1
8 25 89 13:1
9 10 81 6:1
10 TES EtZnCl 0 69 1:1
150 77 > 20:1
100 85 > 20:1
50 60 1:2
11
12
13
14 TIPS EtZnCl 0 60 1:2
15 150 80 > 20:1d
2.19
product
2.20
2.20
2.21
2.22
a mol% EtZnX relative to aldehyde.  b dr (chelation:Felkin) determined by 1H NMR of unpurified products. 
 c dr (chelation:Felkin) determined by GC analysis of TMS-protected derivative.  d Reaction conducted at !50 °C.
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Scheme 2.6 Synthesis of alkyl zinc halide Lewis acids 
 
amounts of EtZnX also furnished chelation products, albeit with decreased dr.  It is likely 
that the alkoxide product of the addition traps EtZnX, rendering it unavailable to bind the 
substrate.  The addition of an additive to trap the resulting zinc alkoxide may be an 
approach to a Lewis acid catalyzed variant of this reaction.  The addition of diethylzinc to 
sterically encumbered TIPS-protected aldehyde 2.19 in the absence of added Lewis acid 
marginally favored the expected Felkin product with 2:1 dr.  Performing the same 
reaction in the presence of 1.5 equiv EtZnCl at low temperature provided the chelation 
product with > 20:1 dr in 80% yield (Table 2.1, entry 15).  Notably, the reaction of TBS-
protected 2.19 with diethylzinc at !50 °C with no added Lewis acid gives no conversion 
after 8 h.  On the other hand, the reaction in the presence of 1.5 equiv EtZnCl at !50 °C 
gave 65% conversion in 16 min.  This substantial increase in reaction rate provides 
further evidence for a chelate intermediate.12 
 We next turned out attention to the substrate scope with respect to the dialkylzinc 
reagent.  It was important that the R group on RZnX and R2Zn be identical due to the 
rapid alkyl exchange between alkylzinc species to prevent formation of a mixture of 
products.13  As illustrated in Table 2.2, the addition of commercially available Me2Zn and  
n-Bu2Zn to 2.10 in the presence of MeZnCl and n-BuZnCl, respectively, yielded 
chelation products with excellent diastereoselectivity (! 18:1 dr, entries 1 and 2).  We  
ZnR2    +     ZnX2 2 RZnX
toluene
70 °C, 3d
80!90% yield
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Table 2.2 Determination of scope with respect to dialkylzinc reagent  
  
 
Zn(R2)2 (1.2 equiv)
R2ZnX (1.5 equiv)
O
R1
OTBS
H
OH
R1
OTBS
R2
OH
R1
OTBS
R2
O
Me
OTBS
H
OH
Me
OTBS
Me
OH
Me
OTBS
n-Bu
OH
Me
OTBS
Cl(CH2)4
OH
Me
OTBS
TBSO(CH2)4
O
i-Pr
OTBS
H
OH
i-Pr
OTBS
OH
i-Pr
OTBS
Cl(CH2)4
OH
i-Pr
OTBS
TBSO(CH2)4
O
Ph
OTBS
H
OH
Ph
OTBS
+
ZnMe2
Zn(n-Bu)2
Zn((CH2)4Cl)2
Zn((CH2)4OTBS)2
ZnEt2
Zn((CH2)4Cl)2
Zn((CH2)4OTBS)2
ZnEt2
1
2
3
4
5
6
7
8
91 18: 1
87 > 20: 1
50 16: 1
47 20: 1
82 > 20: 1
52 20: 1
58 > 20: 1
93 > 20: 1
entry aldehyde Zn(R2)2 yield (%) dr
a major product
chelation product Felkin product
2.10
2.23
2.24
2.25
2.26
2.27
2.29
2.30
2.32
2.28
2.31
a dr (chelation:Felkin) determined by 1H NMR of unpurified products.
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next explored the addition of more functionalized dialkylzinc reagent, which were 
prepared by the method of Knochel.14  For these reactions, alkylzinc triflates, RZnOTf, 
were employed and generated in situ by reaction of 2.7 equiv R2Zn with 1.5 equiv triflic 
acid (Table 2.2, entries 3, 4, 6, and 7)s.15  This provided 1.5 equiv RZnOTf  Lewis acid 
and 1.2 equiv R2Zn nucleophile.  As shown in entries 3 and 4 (Table 2.2), the chelation 
products were furnished with ! 16:1 dr, but the yields are slightly diminished.  The 
reduced yields were due to the formation of reduction side-products, which likely form 
via a  !-hydride transfer mechanism.16 
 Having demonstrated the ability to access chelation controlled products from "-
silyloxy aldehydes using a variety of dialkylzincs nucleophiles, we further explored the 
substrate scope with respect to the aldehyde.  We anticipated that a larger substituent on 
the "-carbon  would improve the diasteroselectivity of the reaction by more effectively  
impeding the Felkin pathway.  Moreover, an electron-withdrawing group at the "-carbon 
would stabilize the chelate transition state due to improved hyperconjugation.  For this 
reason, substrates 2.28 and 2.31 were chosen for these studies.  As shown in Table 2.2, 
high diastereoselectivities favoring the chelation product were obtained employing these 
substrates (entries 5#8).  Additionally, the larger isopropyl substituent does lead to 
improved diastereoselectivity (entry 3 vs 6), supporting the chelation-controlled model. 
 
2.3.2 Addition of Vinylzincs to "-Silyloxy Aldehydes 
 With the goal of developing a general method, we turned our attention to 
exploring other organozinc nucleophiles.  Allylic alcohols are common structural motifs 
and intermediates in synthesis and in natural products.17  Owing to their importance in  
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Table 2.3 Diastereoselective generation of (E)-di and trisubstituted allylic alcohols 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+
R1
i. Et2BH, 0 °C to rt
ii. Me2Zn, !78 °C
OH
R1
OH
Me
OTBS
n-Bu
OPG
MeZnMe
R1
EtZnCl 
(1.5 equiv)
 !30 °C
R2
Hn-Bu
H
OH
Me
Met-Bu
OH
Me
OTBS
t-Bu
Me
R2 R2
H
OH
Me
OTBS
HTBDPSO(CH2)2
HCl(CH2)4
OH
Me
OTBS
Cl(CH2)4
Met-Bu
OH
Me
OTES
t-Bu
Me
OH
Me
OTBS
PhHPh
O
Me
OPG
H
OH
Me
OTBS
PhHPh
OH
Me
OTBSOTBDPS
entry PG alkyne yield (%) dra major productb
1
2
3
4
5
6
7
8
9
TBS
TES
20 1: 1.5c
82 > 20: 1
54 17: 1
82 11: 1
72 > 20:1
92 10:1
70 > 20:1
85 > 20: 1
93 > 20:1
OTBS
2.33
2.34
2.35
2.36
2.37
2.38
2.39
2.40
2.41
a dr determined by 1H NMR of the unpurified product and refers to the ratio of chelation:Felkin 
addition products.  b Absolute configuration of alcohols were determined by modified Mosher ester
analysis. c The yield and dr correspond to the reaction without EtZnCl.
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synthesis, new routes to control both the double bond geometry and the facial selectivity 
of the newly formed stereocenter of allylic alcohols is an important target for chemists. 
Consequently, we next applied our approach using vinylzinc reagents.  Oppolzer’s 
procedure6,18 was applied to generate the (E)-vinylzinc intermediates.  As illustrated in 
Table 2.3, alkyne hydroboration with Et2BH and transmetallation with Me2Zn provided 
the (E)-vinylzinc intermediates, which were then added to the silyloxy aldehydes.  It is 
well precedented that vinylzinc reagents add to aldehydes substantially faster than 
alkylzinc reagents.19  In the absence of an RZnX Lewis acid, the diol product is obtained 
with essentially no diastereoselectivity (Table 2.3, entry 1).  After an extensive screen of 
reaction conditions we found that !30 °C for the addition step was an optimal balance 
between minimizing the background reaction without overly compromising the EtZnCl 
solubility.   Both terminal and internal alkynes were successfully employed to afford (E)-
di and (E)-trisubstituted allylic alcohols with ! 10:1 dr.  The chelation product formed in 
all cases using the TBS or TES protecting groups.  Finally, it is important to demonstrate  
 
 
 
 
 
 
 
Scheme 2.7 Diastereoselective (Z)-vinylation of "-silyloxy aldehydes employing 
EtZnCl 
Br
R1 i. Et2BH, 0 °C to rt
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2.42
90% yield, dr > 20:1
2.43
80% yield, dr > 20:1
2.28
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scalability for any useful method.  When the reaction was conducted using 
phenylacetylene on 5 mmol scale, allylic alcohol 2.34 was obtain with > 20:1 dr in 82% 
yield (Table 2.3, entry 2). 
A method for the generation of chelation products in the addition of (Z)-
disubstituted vinylzinc reagents was developed previously in our group using either 
BF3•OEt or ZnBr2 Lewis acids.4  The diastereoselectivites, however, did not exceed 8:1.  
In this study we set out to determine if alkylzinc halide Lewis acids could improve the 
diastereoselectivity of the reaction.  In our previous reports, the one-pot (Z)-vinylzinc 
formation/addition was carried out in THF or TBME solvent to stabilize the polar borate 
intermediate (Scheme 2.3).  Since these solvents are not compatible with the RZnX 
Lewis acids, because they can compete with the substrate for binding, it was important to 
switch solvents before the addition step.  Thus, the hydroboration and addition of t-BuLi 
were performed in THF solvent (Scheme 2.7).  The volatiles were then removed under 
reduced pressure, toluene was added, and the volatiles were removed again to eliminate 
any residual THF.  After adding toluene again, transmetallation gave the (Z)-vinylzinc 
intermediates, followed by adding EtZnCl and aldehyde 2.28 at !30 °C  afforded 
chelation products 2.42 and 2.43 with > 20:1 dr. 
 
2.4 Results and Discussion: Chelation-Controlled Additions of Organozincs to "-
Silyloxy Aldehydes 
 Given the generality and excellent levels of diastereoselectiviy observed in the 
addition of organozinc reagents to  #-silyloxy aldehydes in the presence of alkyl zinc 
halide Lewis acids, we set out to determine whether highly diastereoselective chelation-
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controlled additions to !-silyloxy aldehydes could also be achieved.  In general, "-
chelation is more favorable than !-chelation and generally yields product with higher 
dr.20  For this reason, we perceived chelation controlled-additions to !-silyloxy aldehydes 
to be more difficult. Meara Kauffman, a former graduate student, performed most of the 
optimization studies shown in Tables 2.4 and 2.5 and Scheme 2.7.  My contribution to 
this project was further screening of zinc-based Lewis acids and optimization of the 
vinylzinc additions as discussed in later sections. 
 
2.4.1 Addition of dialkylzincs to !-Silyloxy Aldehydes 
 Initially, the reaction of aldehyde ent-2.5 with diethylzinc was investigated as 
shown in Table 2.4.21  Notably, in the absence of an EtZnX Lewis acid, chelation product 
2.44 predominated, albeit with 3.5:1 dr in < 10% yield after 48 h at 0 °C (Table 2.4, 
entry1).  The absolute stereochemistry of the major product was confirmed by 
comparison to literature data22 and by modified Mosher ester analysis.10a,10c,23  In the 
presence of  25#150 mol% EtZnCl, the additions afforded the chelation product with only 
slightly improved dr (! 7.4:1, entries 2#5).  Lowering the reaction temperature was 
ineffective in increasing the diasteroselectivity of the reaction (entries 6 and 7).  In 
contrast, increasing the  concentration proved beneficial for the diastereoselectivity of the 
reaction and generated chelation product 2.44 with 8.9:1 dr in 89% yield (entry 8).  Next, 
we screened several other EtZnX Lewis acids (entries 9#12).  Employing more Lewis 
acidic EtZnOTf15 or EtZnONf produced 2.44 with 15.5:1 and 10:1 dr, respectively (Table 
2.4, entries 10 and 11).  
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Table 2.4 Optimization of diethylzinc addition to ent-2.5  
 
 
 Encouraged by these results, the addition of other commercially available 
dialkylzincs were conducted using the optimized reaction conditions (Table 2.4, entry 
10).  As stated before, it is important for the R groups on the Lewis acid and dialkylzinc 
reagent to be the same to obviate a mixture of addition products.13  As shown in Scheme  
entry temp (°C) concentration (M)a LA (mol %)b drc
1 0 0.2 0 3.5: 1
3 0 0.2 EtZnCl (50) 5.7: 1
4 0 0.2 EtZnCl (100) 7.4:1
5 0 0.2 EtZnCl (150) 6.5: 1
6 !15 0.2 EtZnCl (150) 6.9: 1
7 !30 0.2 EtZnCl (150) 5.2: 1
8 0 0.5 EtZnCl (150) 8.9: 1
9 0 0.5 EtZnBr (150) 7.9: 1
10 0 0.5 EtZnOTf (150) 15.5: 1
11 0 0.5 EtZnONf (150) 10: 1
O
Me
Et2Zn 
(1.2 equiv)
EtZnX
OH
Me
OTBS OH
Me
OTBSOTBS
+
2.44
chelation product
2.45
Felkin product
H
2 0 0.2 EtZnCl (25) 5.7: 1
yield (%)d
< 10
61
77
83
83
61
89
85
87
50
78
ent-2.5
a Concentration is with respect to the aldehyde.  b mol % of Lewis acid is with respect to the 
aldehyde.  c dr determined by 1H NMR of the unpurified product or by GC analysis of the TMS-protected 
product derivatives and refers to the ratio of chelation:Felkin addition products. d Refers to yield of isolated, 
purified product.
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Scheme 2.8 Chelation-controlled addition of dialkylzincs to ent-2.5 
 
2.8, the addition of dimethylzinc furnished chelation product 2.46 with significantly 
lower dr (5:1).  This diminished dr can be attributed to both the limited solubility of 
MeZnOTf in dichloromethane and the smaller size of the nucleophile, resulting in a 
smaller difference in energy of the transition states corresponding to the chelation and 
Felkin products.  The diastereoselectivity of the reaction employing di-n-butylzinc was 
comparable to diethylzinc and yielded product 2.47 with 16:1 dr in 73% yield.  A large 
excess of di-n-butylzinc was necessary to preclude the formation of reduction side 
products.16 
 
2.4.2 Addition of Vinylzincs to !-Silyloxy Aldehydes 
 We next set out to broaden the substrate scope with respect to the organozinc 
nucleophile.  Specifically, we explored the addition of (E)-vinylzinc reagents to !-
silyloxy aldehydes.  The Srebnik/Oppolzer18,24 procedure was utilized to generate the (E)-  
O
Me
R2Zn (1.2 equiv)
RZnOTf (1.5 equiv)
0 °C, CH2Cl2, 0.5 M
4!10 h
OH
Me
R
OTBS OH
Me
R
OTBSOTBS
+
chelation product Felkin product
OH
Me
OTBSOH
Me
OTBS OH
Me
n-Bu
OTBS
2.46
62% yield, dr = 5:1
2.44
78% yield, dr = 15.5:1
2.47
73% yield, dr = 16:1
(3 equiv n-Bu2Zn)
H
ent-2.5
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Table 2.5  Generation of (E)-di and -trisubstituted allylic alcohols 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i. Cy2BH, 0 °C to rt
   CH2Cl2:toluene 
   (1:1),  0.5 M
ii. Et2Zn, –78 °C
ZnEt
R1
O
Me
H
EtZnX (1.5 equiv)
!15 °C, 14!18 h
1.2 equivR2
R2
R1
OPG
OH
Me
OPG
R2
R1
chelation product
t-Bu
t-Bu Me
i-Pr Me
n-Bu 11:1 (65%)
9:1 (78%)
18:1 (71%)
> 20:1 (76%)
10:1 (70%)
5.8:1 (66%)
20:1 (80%)
17:1 (78%)5b
TES
entry PG alkyne dra, EtZnONf (yield) major product
1 TBS n-Bu 10:1 (61%) OH
Me
OTBS
n-Bu
2 OH
Me
OTBS
3 OH
Me
OTBS
t-Bu
4 OH
Me
OTBS
t-Bu
Me
OH
Me
OTBS
i-Pr
Me
6 OH
Me
OTES
n-Bu
7 OH
Me
OTES
8 t-Bu OH
Me
OTES
t-Bu
t-Bu Me9 OH
Me
OTES
t-Bu
Me
H
H
H
H
H
iii.
H
7.8:1 (84%)
4.6:1 (67%)
10:1 (45%)
17.5:1 (76%)
3.6:1 (78%)
2.3:1 (50%)
11:1 (77%)
7.8:1 (77%)
dra, EtZnOTf (yield)
4.8:1 (83%) 2.48
2.49
2.50
2.51
2.52
2.53
2.54
2.55
2.56
a dr determined by 1H NMR of the unpurified product and refers to the ratio of chelation:Felkin addition
 products. b The relative stereochemistry was determined by modified Mosher ester analysis (see 
Supporting Information).
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vinylzinc intermediates as described previously.  As illustrated in Table 2.5, using a 1:1 
mixture of toluene to dichloromethane solvent at !15 °C gave the optimal yields and 
diastereoselectivities.  Although EtZnOTf was the most effective Lewis acid in the 
dialkylzinc additions, EtZnONf (Nf = perfluorobutanesulfonyl) gave superior 
diastereoselectivies in the vinylzinc additions.  For example, the dr of product 2.49 is 
doubled when EtZnONf was employed in comparison to the reaction employing 
EtZnOTf (dr = 10:1 vs 4.8, entry 1).  It is likely that the increased diastereoselectivity is a 
result of the improved solubility of EtZnONf in dichloromethane at !15 °C.  A variety of 
terminal and internal alkynes can be employed in the reaction with both TBS and TES-
protected "-silyloxy aldehydes (Table 2.5). The (E)-di and trisubstituted allylic alcohol 
products were afforded with # 5.8:1 dr and # 10:1 dr for most substrates in 60!80% 
yield.  In general, the reaction employing TES- protected 3-hydroxy-2-methylpropanol 
furnished product of higher dr owing to a more favorable chelate formation. 
 
2.5 Conclusions 
 In summary, chelation-controlled addition of organozinc reagents to silyl-
protected $- and "-hydroxy aldehydes was achieved uing mild alkylzinc halide (RZnX) 
and sulfonate (RZnO3SRF) Lewis acids.  The generality of this approach constitutes a 
promising outlook for applications in complex molecule synthesis.  Importantly, both 
diastereomeric addition products can be accessed from a common silyloxy aldehyde 
starting material, which can potentially have an important impact on synthetic design of 
biologically active small molecules and natural products.   From a fundamental 
standpoint, this method contributes to changing a long-standing paradigm.    
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2.6 Experimental Section  
General Methods: All reactions were performed under N2 atmosphere using flame-dried 
glassware and standard Schlenk and vacuum line techniques. The progress of reactions 
were monitored by thin-layer chromatography (TLC) using Whatman precoated silica gel 
60 F-254 plates and visualized by staining with ceric ammonium molybdate or 4-
dinitrophenylhydrazine stains or ultra-violet light. Toluene and dichloromethane were 
passed through alumina columns and degassed before use. Alkyl zinc halides and 
dicyclohexyl borane were prepared using literature procedures.11a,15  Chiral !-silyloxy 
aldehydes were prepared by literature "#$%&'(! )*++,-%./&#+,01! &2,'*$,&0! &3! $%#!
+#45,6,$#!7+,"*+8!*9:&%&9!;*6!7#+3&+"#'!<56$!7+,&+!$&!:*+=&089!*'',$,&0!+#*:$,&06.25  
The "-silyloxy aldehydes were prepared within one day of use or stored at –16 °C under 
nitrogen atmosphere.26 >50:$,&0*9,?#'!&+1*0&?,0:! +#*1#0$6!;#+#!7+#7*+#'! 3+&"! $%#!
:&++#67&0',01! *9-89! ,&','#! &+! 3+&"! $%#! *9-#0#! @,*! %8'+&=&+*$,&0! =8! 9,$#+*$5+#!
"#$%&'6ABC*D=DEF The 1H NMR and 13C{1H} NMR spectra were obtained using a Bruker 
AM-500 Fourier transform NMR spectrometer at 500 and 125 MHz, respectively. 1H 
NMR were referenced to tetramethylsilane in CDCl3, and 13C{1H} NMR spectra were 
referenced to residual solvent. Coupling constants are reported in hertz. The infrared 
spectra were obtained using a Perkin-Elmer 1600 series spectrometer. The optical 
rotations were recorded using a JASCO DIP-370. Silica gel (230-400 mesh, Silicycle) 
was used for flash chromatography. Reagents were obtained from TCI America, Acros, 
Sigma-Aldrich, or GFS Chemicals and used without further purification. Analysis of 
diastereomeric ratios was performed by gas chromatography using a Hewlett-Packard 
6890 GC with a Beta-Dex Column or by 1H NMR of the crude or purified reaction 
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products. High resolution mass spectra were measured using a Waters LCTOF- Xe 
Premier ESI mass spectrometer. Relative stereochemistry was confirmed by modified 
Mosher ester analysis.10a,10c 
 
General Procedure A: dialkylzinc addition to !-silyloxy aldehydes. A dry 10 mL 
Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) three times, 
was charged with the alkyl zinc chloride (0.35 mmol, neat solid), chiral aldehyde (0.35 
mmol, neat), and toluene (1 mL).  The flask was then cooled to 0 °C and dialkylzinc 
(0.42 mmol) was added dropwise.  The reaction mixture was gradually warmed to room 
temperature and monitored by TLC until completion (usually 30 min).  The reaction 
mixture was quenched with saturated aq. NH4Cl (2 mL) followed by addition of 2N HCl 
(1 mL) and Et2O (5 mL). The organic layer was separated and the aqueous solution 
extracted with EtOAc (3 " 10 mL).  The combined organic layers were successively 
washed with NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was 
concentrated in vacuo and purified by column chromatography on silica gel. 
 
General Procedure B: dialkylzinc addition to !-silyloxy aldehydes. A dry 10 mL 
Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) three times, 
was charged with the alkyl zinc chloride (0.35 mmol, neat solid), dialkylzinc (0.42 
mmol), and toluene (1 mL). The flask was then cooled to #50 °C followed by slow 
addition of aldehyde solution (0.35 mmol, in 0.5 mL toluene).  The reaction was 
monitored by TLC until completion (usually 30 min).  The reaction mixture was 
quenched with saturated aq. NH4Cl (2 mL) followed by addition of 2N HCl (1 mL) and 
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Et2O (5 mL). The organic layer was separated and the aqueous solution extracted with 
EtOAc (3 ! 10 mL).  The combined organic layers were successively washed with 
NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was concentrated in 
vacuo and purified by column chromatography on silica gel.  
 
General Procedure C: functionalized dialkylzinc addition to "-silyloxy aldehydes. A 
dry 10 mL Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) 
three times, was charged with the functionalized dialkylzinc reagent (0.94 mL, 1M in 
degassed CH2Cl2).  The flask was cooled to #78 °C and trifluoromethanesulfonic acid (50 
µL, 0.52mmol) was added dropwise.15  The flask was slowly warmed to room 
temperature and stirred for 45 minutes.   The flask was the cooled to 0 °C and the 
aldehyde solution (0.35 mmol, in 0.3 mL degassed CH2Cl2) was added dropwise. The 
reaction was monitored by TLC until completion.  The reaction mixture was quenched 
with saturated aq. NH4Cl (2 mL) followed by addition of 2N HCl (1 mL) and Et2O (5 
mL).  The organic layer was separated and the aqueous solution extracted with Et2O (3 ! 
10 mL).  The combined organic layers were successively washed with NaHCO3 and 
brine, dried over MgSO4, and filtered.  The filtrate was concentrated in vacuo and 
purified by column chromatography on silica gel.  
 
 
 (2S,3S)-2-(tert-butyldimethylsilyloxy)pentan-3-ol (2.20).28  General 
Procedure A was applied to Et2Zn (0.262 mL, 2M in toluene), EtZnCl 
(45 mg, 0.35 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal (66 mg, 0.35 mmol).  
OH
OTBS
Me
(+)
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The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to yield the title compound (69 mg, 90% yield, dr 31:1) as an oil.  
The diastereomeric ratio was determined by GC analysis.  The major diastereomer was 
characterized.  = 14 (c = 0.613, CHCl3). 1H NMR (CDCl3, 500 MHz): ! 0.08 (s, 
3H), 0.09 (s, 3H), 0.90 (s, 9H), 0.98 (t, J = 7.0 Hz, 3H), 1.15 (d, J = 6.0 Hz, 3H), 1.40 (m, 
1H), 1.48 (m, 1H), 2.33 (d, J = 5.0 Hz, 1H), 3.20 (m, 1H), 3.64 (dq, J = 6.0 Hz, J = 6.0 
Hz, 1H).  13C{1H} (CDCl3, 125 MHz): !  "4.6, "3.7, 10.4, 18.2, 20.5, 26.0, 26.7, 71.6, 
77.0.  IR (neat) 3468, 2958, 1676, 1463, 1375, 1256, 1092, 836 cm"1.  HMRS calcd for 
C11H27O2Si (MH)+: 219.1780, found 219.1789. GC conditions: Supelco #-Dex 120 fused 
silica capillary column 60 m x 0.25 m x 0.25 µm film thickness, t1 = 11.5 min, t2 = 14.1 
min (oven: 100 °C, 2 mL/min).    
 
 (2S,3S)-2-(triethylsilyloxy)pentan-3-ol (2.21).  General Procedure A 
was applied to Et2Zn (0.262 mL, 2M in toluene), EtZnCl (45 mg, 0.35 
mmol), and (S)-2-(triethylsilyloxy)propanal (66 mg, 0.35 mmol).  The crude product was 
purified by column chromatography on silica gel (hexanes:EtOAc, 95:5) to yield the title 
compound (71 mg, 94% yield, dr 20:1) as an oil.    = 10 (c = 0.667, CHCl3). 
1H 
NMR (CDCl3, 500 MHz): ! 0.62 (q, J = 7.5 Hz, 6H), 0.95"0.99 (m, 12H), 1.16 (d, J = 
6.5 Hz, 3H), 1.34"1.43 (m, 1H), 1.46"1.54 (m, 1H), 2.43 (d, J = 5.0 Hz, 1H), 3.17"3.22 
(m, 1H), 3.66 (q, J = 6.0 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.3, 7.0, 10.4, 20.5, 
26.6, 71.7, 77.0.  IR (neat): 3428, 2960, 2102, 1644, 1093 cm"1. HMRS calcd for 
C11H27O2Si (MH)+: 219.1780, found 219.1776. 
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 (2S,3S)-2-(triisopropylsilyloxy)pentan-3-ol (2.22). General 
Procedure B was applied to Et2Zn (0.262 mL, 2M in toluene), EtZnCl 
(68 mg, 0.525 mmol), and (S)-2-(triisopropylsilyloxy)propanal (80 mg, 
0.35 mmol).  The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to yield the title compound (91 mg, 80% yield, dr > 20:1) as an 
oil.   = 10 (c = 0.667, CHCl3). 1H NMR (CDCl3, 500 MHz): ! 1.00 (t, J = 7.5 Hz, 
3H), 1.08 (m, 21H), 1.20 (d, J = 6.0 Hz, 3H), 1.36"1.44 (m, 1H), 1.50"1.58 (m, 1H), 2.48 
(d, J = 4.5 Hz, 1H), 3.21"3.26 (m, 1H), 3.81 (q, J = 6.0 Hz, 1H).  13C{1H} (CDCl3, 125 
MHz): ! 10.5, 12.9, 18.3, 18.4, 20.5, 26.4, 72.1, 77.8 ppm. IR (neat): 3464, 2943, 1464, 
1383, 1246, 1115, 1013, 957 cm"1.  HMRS calcd for C14H26O2SiNa (M+Na)+: 283.2070, 
found 283.2070. 
      
  (2S,3S)-3-(tert-butyldimethylsilyloxy)butan-2-ol (2.23).  General 
Procedure A was applied to Me2Zn (0.262 mL, 2M in toluene), MeZnCl 
(45 mg, 0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal (66 
mg, 0.35 mmol).  The crude product was purified by column chromatography on silica 
gel (hexanes:EtOAc, 95:5) to yield the title compound with the minor diastereomer (65 
mg, 91% yield, dr 18:1) as an oil.  The major diastereomer was separated from the minor 
and characterized.   = 17 (c = 0.505, CHCl3).  1H NMR (CDCl3, 500 MHz): ! 0.09 
(s, 6H), 0.91 (s, 9H), 1.12"1.14 (m, 6H), 2.44 (d, J = 4.15 Hz, 1H), 3.44"3.50 (m, 1H), 
3.55 (q, J = 6.0 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! "4.0, "3.9, 18.3, 19.2, 20.3, 
72.31, 73.6.  IR (neat): 3427, 2931, 1463, 1255, 1090, 1037, 949 cm"1. HMRS calcd for 
C11H23O2Si (M"H)": 203.1468, found 203.1457. 
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(2S,3S)-2-(tert-butyldimethylsilyloxy)heptan-3-ol (2.24).  
General Procedure A was applied to Bu2Zn (0.42 mL, 1M in 
heptane), BuZnCl (83 mg, 0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal 
(66 mg, 0.35 mmol).  The crude product was purified by column chromatography on 
silica gel (hexane:EtOAc, 95:5) to yield the title compound with the minor diastereomer 
(86 mg, 87% yield, dr >20:1) as an oil.  = 8 (c = 0.9, CHCl3). 1H NMR (CDCl3, 500 
MHz): ! 0.08 (s, 3H), 0.09 (s, 3H), 0.90 (s, 9H), 1.15 (d, J = 6.0 Hz, 3H), 1.28-1.48 (m, 
6H), 2.36 (d, J = 5.0 Hz, 1H), 3.27 (m, 1H), 3.63 (q, J = 6.5 Hz, 1H). 13C{1H} (CDCl3, 
125 MHz): ! "4.6, "3.9, 14.3, 18.2, 20.5, 23.0, 26.0, 28.2, 33.4, 72.0, 76.0. IR (neat): 
3438, 2890, 1457, 1278, 1063 cm"1. HMRS calcd for C13H29OSi (M"OH): 229.1988, 
found 229.1985. 
 
(2S,3S)-2-(tert-butyldimethylsilyloxy)-7-chloroheptan-3-ol 
(2.25). General Procedure C was applied to Zn((CH2)4Cl)2  
(0.94 mL, 1M in degassed CH2Cl2), trifluoromethanesulfonic 
acid (50 µL, 0.52 mmol), and (S)-2-(triethylsilyloxy)propanal (66 mg, 0.35 mmol).  The 
crude product was purified by column chromatography on silica gel (hexanes:EtOAc, 
95:5) to yield the title compound (49 mg, 50% yield, dr 16:1) as an oil.   = 5 (c = 
1.0, CHCl3). 1H NMR (CDCl3, 360 MHz): ! 0.08 (S, 3H), 0.09 (s, 3H), 0.9 (S, 9H), 1.15 
(d, J = 6.2 Hz, 3H), 1.36"1.48 (m, 2H), 1.50"1.68 (m, 2H), 1.76"1.86 (m, 2H), 2.34 (d, J 
= 5.2 Hz, 1H), 3.25"3.31 (m, 1H), 3.54 (t, J = 6.8 Hz, 2H), 3.63 (q, J = 5.3 Hz, 1H).  
13C{1H} (CDCl3, 125 MHz): ! "4.6, "3.9, 18.2, 20.5, 23.5, 26.0, 32.9, 33.0, 45.2, 72.0, 
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75.8. IR (neat): 3465, 2955, 2852, 1757, 1462, 1376, 1255, 1073 cm!1.  HMRS calcd for 
C13H29ClO2SiNa (M+Na)+: 303.1525, found 303.1521. 
 
 (5S,6S)-2,2,3,3,5,12,12,13,13-nonamethyl-4,11-dioxa-
3,12-disilatetradecan-6-ol (2.26).  General Procedure C 
was applied to Zn((CH2)4OTBS)2 (0.94 mL, 1M in degassed CH2Cl2), 
trifluoromethanesulfonic acid (50 µL, 0.52 mmol), and (S)-2-(triethylsilyloxy)propanal 
(66 mg, 0.35 mmol).  The crude product was purified by column chromatography on 
silica gel (hexanes:EtOAc, 95:5) to yield the title compound (62 mg, 47% yield, dr 
>20:1) as an oil.   = 7 (c = 1.0, CHCl3).  1H NMR (CDCl3, 500 MHz): " 0.05 (S, 
6H), 0.08 (s, 3H), 0.09 (S, 3H), 0.89 (s, 9H), 0.90 (s, 9H), 1.15 (d, J = 6.2 Hz, 3H), 
1.37!1.57 (m, 6H), 2.36 (d, J = 5.2 Hz, 3H),  3.25!3.30 (m, 1H), 3.60!3.65 (m, 3H).  
13C{1H} (CDCl3, 125 MHz): " !5.0, !4.6, !3.9, 18.2, 18.6, 20.5, 22.4, 26.0, 33.1, 33.6, 
63.6, 71.9, 76.0. IR (neat): 3500, 2956, 2859, 1472, 1389, 1254, 1101, 939 cm!1.  HMRS 
calcd for C19H44O3Si2Na (M+Na)+: 399.2729, found 399.2746. 
 
 (3S,4S)-4-(tert-butyldimethylsilyloxy)-5-methylhexan-3-ol (2.27).  
General Procedure A was applied to Et2Zn (0.262 mL, 2M in 
toluene), EtZnCl (45 mg, 0.35 mmol), and (S)-2-(tert-
butyldimethylsilyloxy)-3-methylbutanal (76 mg, 0.35 mmol).  The crude product was 
purified by column chromatography on silica gel (DCM:hexanes, 20:80) to yield the title 
compound (71 mg, 82% yield, dr >20:1) as an oil.  The major diastereomer was 
characterized.  = 3.5 (c = 0.680, CHCl3). 1H NMR (CDCl3, 500 MHz): " 0.09 (s, 
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3H), 0.10 (s, 3H), 0.88 (d, J =7.0 Hz, 3H), 0.93 (s, 9H), 0.94!0.97 (m, 6H), 1.35!1.49 
(m, 2H), 1.76!1.84 (m, 1H), 2.33 (d, J =7.0 Hz, 1H), 3.33!3.35 (m, 1H), 3.39!3.44 (m, 
1H).  13C{1H} (CDCl3, 125 MHz): "  !4.0, !3.7, 10.5, 18.2, 18.6, 19.0, 26.3, 28.8, 32.5, 
72.5, 79.0.  IR (neat) 3489, 2958, 2858, 1471, 1388, 1254, 1059, 973cm!1.  HMRS calcd 
for C13H31O2Si (MH)+: 247.2023, found 247.2083. 
 
 (3S,4S)-3-(tert-butyldimethylsilyloxy)-8-chloro-2-
methyloctan-4-ol (2.29).  General Procedure C was applied 
to Zn((CH2)4Cl)2  (0.94 mL, 1M in degassed CH2Cl2), trifluoromethanesulfonic acid (50 
µL, 0.52 mmol), and (S)-2-(tert-butyldimethylsilyloxy)-3-methylbutanal (76 mg, 0.35 
mmol).The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to yield the title compound (56 mg, 52% yield, dr >20:1) as an 
oil.   = !2 (c = 0.92, CHCl3).  1H NMR (CDCl3, 360 MHz): " 0.10 (S, 3H), 0.11 (s, 
3H), 0.89 (d, J = 6.9 Hz, 3H), 0.94 (s, 9H), 0.96 (d, J = 6.9 Hz, 3H), 1.34!1.68 (m, 4H), 
1.77!1.86 (m, 3H), 2.35 (d, J = 7.1 Hz, 1H), 3.33 (t, J = 4.01 Hz, 1H), 3.49!3.58 (m, 
1H), 3.54 (t, J = 6.7 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): " !4.0, !3.7, 18.1, 18.6, 19.0, 
26.3, 32.4, 32.9, 35.2, 45.2, 70.8, 79.4. IR (neat): 3487, 2956, 2859, 1471, 1389, 1368, 
1254, 1062, 1006, 960 cm!1.  HMRS calcd for C15H33ClO2SiNa (M+Na)+: 331.1838, 
found 331.1820. 
 
 (5S,6S)-5-isopropyl-2,2,3,3,12,12,13,13-octamethyl-
4,11-dioxa-3,12-disilatetradecan-6-ol (2.30).  General 
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Procedure C was applied to Zn((CH2)4OTBS)2 (0.94 mL, 1M in degassed CH2Cl2), 
trifluoromethanesulfonic acid (50 µL, 0.52 mmol), and (S)-2-(tert-
butyldimethylsilyloxy)-3-methylbutanal (76 mg, 0.35 mmol).The crude product was 
purified by column chromatography on silica gel (hexanes:EtOAc, 95:5) to yield the title 
compound (82 mg, 58% yield, dr >20:1) as an oil.   = !3 (c = 0.92, CHCl3).  1H 
NMR (CDCl3, 500 MHz): " 0.04 (S, 6H), 0.09 (s, 3H), 0.10 (s, 3H), 0.88 (d, J = 6.9 Hz, 
3H), 0.89 (s, 9H), 0.93 (s, 9H), 0.95 (d, J = 6.9 Hz, 3H)  1.34!1.57 (m, 6H), 1.77!1.83 
(m, 1H), 2.32 (d, J = 7.1 Hz, 1H), 3.32 (t, J = 4.01 Hz, 1H), 3.48!3.52 (m, 1H), 3.61 (t, J 
= 6.5 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): " !5.0, !3.9, !3.7 18.1, 18.5, 18.6, 19.0, 
22.4, 26.3, 32.4, 33.1, 35.7, 63.4, 71.0, 79.3. IR (neat): 3488, 2956, 2932, 2859, 1472, 
1389, 1254, 1062, 938 cm!1.  HMRS calcd for C21H48O3Si2Na (M+Na)+: 427.3042, found 
427.3058. 
 
 (1S,2S)-1-(tert-butyldimethylsilyloxy)-1-phenylbutan-2-ol (2.32).  
General Procedure A was applied to Et2Zn (0.262 mL, 2M in toluene), 
EtZnCl (45 mg, 0.35 mmol), and (S)-2-(tert-butyldimethylsilyloxy)-2-
phenylacetaldehyde (88 mg, 0.35 mmol).  The crude product was purified by column 
chromatography on silica gel (hexanes:EtOAc, 97:3) to yield the title compound (91 mg, 
93% yield, dr >20:1) as an oil.  The major diastereomer was characterized.  = 65 (c 
= 0.81, CHCl3). 1H NMR (CDCl3, 500 MHz): " !0.22 (s, 3H), 0.03 (s, 3H), 0.88 (s, 9H), 
0.92 (t, J =7.5 Hz, 3H), 2.75 (d, J =3.5 Hz, 1H), 3.46!3.50 (m, 1H), 4.36 (d, J = 7.0 Hz, 
1H), 7.26!7.32 (m, 5H).  13C{1H} (CDCl3, 125 MHz): "  !4.9, !4.2, 10.4, 18.4, 25.4, 
26.0, 78.0, 79.5, 127.4, 128.0, 128.4, 142.0.  IR (neat) 3579, 3487, 3064, 2858, 1471, 
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1390, 1253, 1082, 976 cm!1.  HMRS calcd for C16H28O2SiNa (M+Na)+: 303.1757, found 
303.1744. 
 
General Procedure D: (E)-vinylzinc addition to "-silyloxy aldehydes. A dry 10 mL 
Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) three times, 
was charged with diethylborane (Et2BH) (1 mL, 1 M in toluene) and dichloromethane (1 
mL).  The solution was cooled to 0 °C followed by slow addition of alkyne (1 mmol).  
After 5 min the reaction was warmed to room temperature and stirred for an additional 15 
min.  The solution was cool to !78 °C and dimethylzinc (Me2Zn) (0.6 mL, 2M in 
toluene) was added.  After stirring at !78 °C for 30 minutes, the reaction flask was 
warmed to !30 °C and EtZnCl (1.25 mmol) was added under a steady flow of N2 (g).  
Immediately there after, the aldehyde (0.833 mmol) was added neat.  The reaction 
mixture stirred at !30 °C and was monitored by TLC until completion (usually 1 h).  The 
reaction mixture was quenched with saturated aq. NH4Cl (2 mL) and 2N HCL (1 mL) and 
5 mL Et2O was added.  The organic layer was separated and the aqueous layer was 
extracted successively with Et2O (2 # 5 mL).  The combined organic layers were 
successively washed with NaHCO3 and brine, dried over MgSO4, and filtered.  The 
filtrate was concentrated in vacuo and purified column chromatography on silica gel. 
 
General Procedure E: (E)-vinylzinc addition to "-silyloxy aldehydes. In the 
glovebox, dicyclohexylborane (Cy2BH) (1 mmol) was added to a dry 10 mL Schlenk 
flask with a stir bar and the flask was fitted with a rubber septum before removal from the 
glovebox.   The Schlenk flask was attached to vacuum line with vacuum tubing and the 
 60!
hose was evacuated and back filled with N2 three times.  The flask was charged with 
dichloromethane (1 mL) and alkyne (1 mmol) at 0 °C.  The reaction was stirred for 5 
min, warmed to room temperature, and stirred for an additional 15 min after which the 
white solid Cy2BH had dissolved to form a clear solution. The solution was cool to !78 
°C and dimethylzinc (0.6 mL, 2M in toluene) was added.  After stirring at !78 °C for 30 
minutes, the reaction flask was warmed to !30 °C and EtZnCl (1.25 mmol) was added 
under a steady flow of N2 (g).  Immediately afterwards, the aldehyde (0.833 mmol) was 
added neat.  The reaction mixture stirred at !30 °C and was monitored by TLC until 
completion (usually 1 h).  The reaction mixture was quenched with saturated aq. NH4Cl 
(2 mL) and 2N HCL (1 mL) and 5 mL Et2O was added.  The organic layer was separated 
and the aqueous layer was extracted successively with Et2O (2 " 5 mL).  The combined 
organic layers were successively washed with NaHCO3 and brine, dried over MgSO4, and 
filtered.  The filtrate was concentrated in vacuo and purified column chromatography on 
silica gel. 
 
 (3S,4S,E)-4-(tert-butyldimethylsilyloxy)-1-phenylpent-1-en-3-
ol (2.34). General Procedure D was applied to Et2BH (6.0 mL, 
1M in toluene), phenylacetylene (0.659 mL, 6 mmol), Me2Zn (3.0 mL, 2M in toluene), 
EtZnCl (970 mg, 6 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal (942 mg, 5 
mmol). The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to yield the title compound (1.2 g, 82% yield, dr >20:1) as an oil.  
 = 23 (c = 0.133, CHCl3). 1H NMR (CDCl3, 500 MHz): # 0.09 (s, 3H), 0.10 (s, 3H), 
0.92 (s, 9H), 1.21 (d, J = 6.0 Hz, 3H), 2.69 (d, J = 4.5 Hz, 1H), 3.77 (q, J = 6.0 Hz, 1H), 
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3.99 (m, 1H), 6.17 (dd, J = 16.0 Hz, J = 6.5 Hz, 1H), 6.66 (d, J = 16.0 Hz, 1H), 7.23 (t, J 
= 7.5 Hz, 1H), 7.31 (t, J = 7.5 Hz, 2H), 7.37 (d, J = 7.5 Hz, 2H).  13C{1H} (CDCl3, 125 
MHz): ! "4.5, "4.0, 18.3, 20.7, 26.1, 72.4, 77.3, 126.7, 127.8, 128.8, 129.3, 132.1, 137.1.  
IR (neat): 3440, 3027, 1599, 1472, 1374, 1255, 1136, 1071, 966 cm"1. HMRS calcd for 
C17H28O2SiNa (M+Na)+: 315.1757, found 315.1750. 
 
 (2S,3S,E)-2-(tert-butyldimethylsilyloxy)non-4-en-3-ol (2.35).29  
General Procedure D was applied to Et2BH (0.42 mL, 1M in 
toluene), 1-hexyne (41 µL, 0.42 mmol), Me2Zn (0.21 mL, 2M in 
toluene), EtZnCl (68 mg, 0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal 
(66 mg, 0.35 mmol).  The crude product was purified by column chromatography on 
silica gel (hexanes:EtOAc, 95:5) to yield the title compound (52 mg, 54% yield, dr 17:1) 
as an oil.  The title product was separated from the minor diastereomer and 
charatcterized.   = 25 (c = 0.585, CHCl3).  1H NMR (CDCl3, 500 MHz): ! 0.09 (s, 
6H), 0.90 (t, J = 6.5 Hz, 3H), 0.92 (s, 9H), 1.13 (d, J = 7.0 Hz, 3H), 1.29"1.40 (m, 4H), 
2.02"2.07 (m, 2H), 2.58 (d, J = 4.0 Hz, 1H), 3.64 (q, J = 6.0 Hz, 1H), 3.75 (m, 1H), 5.40 
(ddt, J = 15.0 Hz, J = 8.5 Hz, J = 1.5 Hz, 1H), 5.73 (dt, J = 15.0 Hz, J = 7.0 Hz, 1H).  
13C{1H} (CDCl3, 125 MHz): ! "4.6, "4.0, 14.1, 18.3, 20.2, 22.4, 26.0, 31.4, 32.3, 72.4, 
77.6, 129.4, 134.456.  IR (neat): 3448, 2929, 2858, 1637, 1092, 968, 835 cm"1. HMRS 
calcd for  C15H32O2SiNa (M+Na)+: 295.2070, found 295.2061. 
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 (3S,4S,E)-4-(tert-butyldimethylsilyloxy)-1-cyclopropylpent-1-
en-3-ol (2.36).  General Procedure D was applied to Et2BH (0.42 
mL, 1M in toluene), cyclopropylacetylene (36 µL, 0.42 mmol), 
Me2Zn (0.21 mL, 2M in toluene), EtZnCl (68 mg, 0.525 mmol), and (S)-2-(tert-
butyldimethylsilyloxy)propanal (66 mg, 0.35 mmol).  The crude product was purified by 
column chromatography on silica gel (hexanes:EtOAc, 95:5) to yield the title compound 
(74 mg, 82% yield, dr 11:1) as an oil.  The title product was separated from the minor 
diastereomer and charatcterized.   = 15 (c = 0.64, CHCl3).  1H NMR (CDCl3, 500 
MHz): ! 0.09 (s, 6H), 0.36"0.40 (m, 2H), 0.68"0.72 (m, 2H), 0.90 (s, 9H), 1.13 (d, J = 
6.0 Hz, 3H), 1.35"1.42 (m, 1H), 2.56 (d, J =  4.0 Hz, 1H), 3.63 (q, J = 6.0 Hz, 1H), 
3.71"3.75 (m, 1H), 5.24"5.30 (m, 1H), 5.48 (dd, J = 15.0 Hz, J = 7.0 Hz, 1H).  13C{1H} 
(CDCl3, 125 MHz): ! "4.6, "4.0, 6.9, 7.0, 13.8, 18.3, 20.2, 26.0, 72.5, 77.3, 127.0, 137.7 
ppm.  IR (neat): 3460, 12955, 1669, 1463, 1361, 1255, 1133, 1094, 1020 cm"1.  HMRS 
calcd for  C14H28O2SiNa (M+Na)+: 279.1757, found 279.1765.  
 
 (5S,6S,E)-2,2,3,3,5,13,13-heptamethyl-12,12-diphenyl-
4,11-dioxa-3,12-disilatetradec-7-en-6-ol (2.37).  General 
Procedure E was applied to Cy2BH (75 mg, 0.42 mmol), 
(but-3-ynyloxy)(tert-butyl)diphenylsilane (130 µL, 0.42 mmol), Me2Zn (0.21 mL, 2M in 
toluene), EtZnCl (68 mg, 0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal 
(66 mg, 0.35 mmol). The crude product was purified by column chromatography on silica 
gel (hexanes:EtOAc, 95:5) to yield the title compound (126 mg, 82% yield, dr >20:1) as 
an oil.    = 10 (c = 0.37, CHCl3).  
1H NMR (CDCl3, 500 MHz): ! 0.06 (s, 3H), 0.08 
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(s, 3H), 0.89 (s, 9H), 1.04 (s, 9H), 1.12 (d, J = 6.0 Hz, 3H), 2.31 (q, J = 6.5 Hz, 2H), 2.54 
(d, 4.0 Hz, 1H), 3.61 (q, J = 6.50 Hz, 1H), 3.70 (t, J = 6.5 Hz, 2H), 3.70!3.75 (m, 1H), 
5.45 (ddt, J = 15.5 Hz, J = 7.0 Hz, J = 1.5 Hz, 1H), 5.74 (dt, J = 16.0 Hz, J = 7.0 Hz, 1H), 
7.36!7.43 (m, 6H), 7.64!7.67 (m, 4H).  13C{1H} (CDCl3, 125 MHz): " !4.559, !3.907, 
18.255, 19.428, 20.215, 26.038, 27.066, 36.034, 63.715, 72.331, 77.447, 127.825, 
129.777, 130.476, 131.469, 134.135, 135.781.  IR (neat): 3469, 3049, 2955, 1428, 1361, 
1254, 1111, 969 cm!1.  HMRS calcd for  C29H46O3SiNa (M+Na)+: 521.2883, found 
521.2899.  
 
 (2S,3S,E)-2-(tert-butyldimethylsilyloxy)-9-
chloronon-4-en-3-ol (2.38). General Procedure D 
was applied to Et2BH (0.42 mL, 1M in toluene), 6-
chloro-1-hexyne (51 µL, 0.42 mmol), Me2Zn (0.21 mL, 2M in toluene), EtZnCl (68 mg, 
0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal (66 mg, 0.35 mmol). The 
crude product was purified by column chromatography on silica gel (hexanes:EtOAc, 
95:5) to yield the title compound (99 mg, 82% yield, dr 10:1) as an oil.  The title product 
was separated from the minor diastereomer and charatcterized.      = 17 (c = 0.89, 
CHCl3).  1H NMR (CDCl3, 500 MHz): " 0.09 (s, 6H), 0.90 (s, 9H), 1.12 (d, J = 6.0 Hz, 
3H), 1.52!1.57 (m, 2H), 1.789 (q, J = 5.0 Hz, 2H), 2.06!2.12 (m, 2H), 2.57 (d, J = 4.0 
Hz, 1H), 3.53 (t, J = 6.5 Hz, 1H), 3.63 (q, J = 6.0 Hz, 1H), 3.73!3.77 (m, 1H), 5.42 (ddt, 
J = 15.5 Hz, 7.0 Hz, J = 1.5 Hz, 1H), 5.72 (dt, J = 15.5 Hz, J = 6.5 Hz, 1H).  13C{1H} 
(CDCl3, 125 MHz): " !4.6, !4.0, 18.3, 20.3, 26.0, 26.5, 31.8, 32.2, 45.1, 72.4, 77.4, 
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130.2, 133.3.  IR (neat): 3467, 2930, 2886, 1962, 1361, 1254, 1088 cm!1. HMRS calcd for  
C15H31ClO2SiNa (M+Na)+: 329.1680, found 329.1672.  
 
 (3S,4S,E)-4-(tert-butyldimethylsilyloxy)-1-
cyclohexenylpent-1-en-3-ol (2.39).  General Procedure D 
was applied to Et2BH (0.42 mL, 1M in PhMe), 1-
ethynylcyclohexene (41 µL, 0.42 mmol), Me2Zn (0.21 mL, 2M in toluene), EtZnCl (68 
mg, 0.525 mmol), and (S)-2-(tert-butyldimethylsilyloxy)propanal (66 mg, 0.35 mmol). 
The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to yield the title compound (72.6 mg, 70% yield, dr >20:1) as an 
oil.    = 13 (c = 0.9, CHCl3).  
1H NMR (CDCl3, 500 MHz): " 0.09 (s, 6H), 0.91 (s, 
9H), 1.14 (d, J = 6.0 Hz, 3H), 1.57!1.68 (m, 4H), 2.12 (m, 4H), 2.61 (d, J = 4.0, 1H), 
3.66 (q, J = 6.0 Hz, 1H), 3.83 (m, 1H), 5.48 (dd, J = 16.0 Hz, J = 7.0 Hz, 1H), 5.76 (m, 
1H), 6.27 (d, J = 16.0 Hz, 1H).  13C{1H} (CDCl3, 125 MHz): !4.6, !4.0, 18.3, 20.3, 22.7, 
22.7, 24.7, 26.0, 26.1, 72.6, 77.7, 124.8, 130.2, 135.3, 136.2.  IR (neat): 3467, 2929, 
1462, 1254, 1095, 965 cm!1.  HMRS calcd for  C17H32O2SiNa (M+Na)+: 319.2070, found 
319.2077. 
 
 (2S,3S,E)-2-(tert-butyldimethylsilyloxy)-4,6,6-trimethylhept-
4-en-3-ol (2.40).  General Procedure D was applied to Et2BH 
(0.42 mL, 1M in toluene), 4,4-dimethyl-2-pentyne (56 µL, 0.42 mmol), Me2Zn (0.21 mL, 
2M in toluene), EtZnCl (85 mg, 0.525 mmol), and (S)-2-(tert-
butyldimethylsilyloxy)propanal (66 mg, 0.35 mmol). The crude product was purified by 
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column chromatography on silica gel (hexanes:EtOAc, 97:3) to yield the title compound 
(72.6 mg, 85% yield, dr >20:1) as an oil.   = 21 (c = 1.0, CHCl3).  1H NMR (CDCl3, 
500 MHz): ! 0.10 (s, 6H), 0.91 (s, 9H), 1.07 (d, J = 6.0 Hz, 3H), 1.12 (s, 9H), 1.70 (s, 
3H), 2.70 (d, J = 2.50 Hz, 1H), 3.55 (dd, J = 7.0 Hz, J = 3.0 Hz, 1H), 3.74 (q, J = 6.5 Hz, 
1H), 5.43 (s, 1H).  13C{1H} (CDCl3, 125 MHz): "4.6, "3.8, 12.9, 18.3, 20.6, 26.1, 31.0, 
32.5, 70.6, 83.9, 132.4, 139.4.  IR (neat): 3569, 3483, 2956, 1663, 1463, 1362, 1254, 
1088, 1013, 964 cm"1.  HMRS calcd for  C17H32O2SiNa (M+Na)+: 309.2226, found 
309.2238. 
 
 (2S,3S,E)-4,6,6-trimethyl-2-(triethylsilyloxy)hept-4-en-3-ol 
(2.41). General Procedure D was applied to Et2BH (0.42 mL, 1M 
in toluene), 4,4-dimethyl-2-pentyne (56 µL, 0.42 mmol), Me2Zn 
(0.21 mL, 2M in toluene), EtZnCl (85 mg, 0.525 mmol), and (S)-2-
(triethylsilyloxy)propanal (66 mg, 0.35 mmol). The crude product was purified by 
column chromatography on silica gel (hexanes:EtOAc, 97:3) to yield the title compound 
(93 mg, 93% yield, dr >20:1) as an oil.    = 21 (c = 1.0, CHCl3).  
1H NMR (CDCl3, 
500 MHz): ! 0.64 (q, J = 8.0 Hz, 6H), 0.98 (t, J = 7.5 Hz, 9H), 1.07 (d, J = 6.0 Hz, 3H), 
1.11 (s, 9H), 2.77 (d, J = 2.5 Hz, 1H), 3.54"3.56 (m, 1H), 3.74 (q, J = 6.5 Hz, 1H), 5.43 
(s, 1H).  13C{1H} (CDCl3, 125 MHz): ! 5.3, 7.0, 12.8, 20.6, 31.0, 32.5, 70.6, 84.2, 132.4, 
139.7.  IR (neat): 3515, 2956, 1463, 1363, 1237, 1133, 1062, 1011 cm"1.  HMRS calcd for  
C16H34O2SiNa (M+Na)+: 309.2226, found 309.2231.   
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General Procedure F: (Z)-vinylzinc addition to !-silyloxy aldehydes. A dry 10 mL 
Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) three times, 
was charged with diethylborane (0.42 mL, 1M toluene) and 1 mL dry THF.  After 
cooling the flask to 0 °C, the bromoalkyne (0.42 mmol) was added dropwise and the flask 
was stirred at room temperature for 20 minutes.  t"BuLi  (0.25 mL, 1.7 M in pentanes) 
was added to the flask at "78 °C and stirred for 35 minutes, warmed to room temperature 
and stirred for an additional 40 minutes.  The volatiles were then removed under vacuum 
over 30 minutes and the residue redissolved in toluene (1 mL).  Dimethylzinc was slowly 
added to the reaction mixture at "78 °C and stirred for 30 minutes.  The EtZnCl (67 mg, 
0.52 mmol) was then added followed by the aldehyde solution (0.35 mmol, in 0.2 mL 
toluene). The reaction mixture stirred at "30 °C and was monitored by TLC until 
completion.  The reaction mixture was quenched with saturated aq. NH4Cl (2 mL) and 
2N HCl (1 mL) and 5 mL Et2O was added.  The organic layer was separated and the 
aqueous layer was extracted successively with Et2O (2 # 5 mL).  The combined organic 
layers were successively washed with NaHCO3 and brine, dried over MgSO4, and 
filtered.  The filtrate was concentrated in vacuo and purified column chromatography on 
silica gel. 
 
 (5S,6S,Z)-5-isopropyl-2,2,3,3,13,13-hexamethyl-12,12-
diphenyl-4,11-dioxa-3,12-disilatetradec-7-en-6-ol 
(2.42). General Procedure F was applied to Et2BH (0.42 
mL, 1M in toluene), (4-bromobut-3-ynyloxy)(tert-butyl)diphenylsilane (162 mg, 0.42 
mmol), Me2Zn (0.21 mL, 2M in toluene), EtZnCl (85 mg, 0.525 mmol), and (S)-2-(tert-
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butyldimethylsilyloxy)-3-methylbutanal (76 mg, 0.35 mmol).  The crude product was 
purified by column chromatography on silica gel (hexanes:EtOAc, 97:3) to yield the title 
compound (87 mg, 80% yield, dr 20:1) as an oil.    = 13 (c = 1.0, CHCl3).  
1H NMR 
(CDCl3, 500 MHz): ! 0.08 (s, 3H), 0.10 (s, 3H), 0.85 (d, J = 7.0 Hz, 3H), 0.93 (s, 9H), 
0.93 (d, J = 6.5 Hz, 3H), 1.05 (s, 9H), 1.68"1.78 (m, 1H), 2.32"2.46 (m, 2H), 2.37 (d, J = 
5.0 Hz, 1H), 3.34"3.36 (m, 1H), 3.69 (t, J = 8.0 Hz, 3H), 4.27 (dt, J = 9.0 Hz, J = 8.0 
Hz), 5.43"5.48 (m, 1H), 5.54"5.60 (m, 1H), 7.35"7.43 (m, 6H), 7.65"7.67 (m, 4H).  
13C{1H} (CDCl3, 125 MHz): ! "3.9, "3.8, 14.4, 17.4, 18.7, 19.4, 19.9, 22.9, 25.5, 26.3, 
27.1, 31.5, 31.6, 31.8, 63.6, 68.2, 80.6, 100.1, 129.1, 127.8, 129.8, 132.5, 134.0, 135.8.  
IR (neat): 3473, 3014, 2858, 1472, 1253, 1064, 937, 854cm"1.  HMRS calcd for  
C31H50O3Si2Na (M+Na)+: 549.3198, found 549.3191. 
 
 (3S,4S,Z)-3-(tert-butyldimethylsilyloxy)-9-chloro-2- 
methylnon-5-en-4-ol (2.43).  General Procedure F was applied 
to Et2BH (0.42 mL, 1M in toluene), 1-bromo-5-chloropent-1-
yne (76 mg, 0.42 mmol), Me2Zn (0.21 mL, 2M in toluene), EtZnCl (85 mg, 0.525 mmol), 
and (S)-2-(tert-butyldimethylsilyloxy)-3-methylbutanal (76 mg, 0.35 mmol).  The crude 
product was purified by column chromatography on silica gel (hexanes:EtOAc, 95:5) to 
yield the title compound (101 mg, 90% yield, dr >20:1) as an oil.    = 23 (c = 1.0, 
CHCl3).  1H NMR (CDCl3, 500 MHz): ! 0.10 (s, 3H), 0.11 (s, 3H), 0.89 (d, J = 7.0 Hz, 
3H), 0.94 (s, 9H), 0.96 (d, J = 6.5 Hz, 3H), 1.75"1.81 (m, 1H), 2.21"2.34 (m, 2H), 2.44 
(d, J = 5.5 Hz, 1H), 3.36"3.38 (m, 1H), 3.59 (t, J = 7.5 Hz, 3H), 4.33"4.37 (m, 1H), 
5.43"5.50 (m, 2H).  13C{1H} (CDCl3, 125 MHz): ! "3.9, "3.8, 17.6, 18.6, 19.7, 25.2, 
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26.3, 31.7, 32.4, 44.6, 67.9, 80.6, 130.8, 132.5.  IR (neat): 3468, 2931, 2858, 1472, 1253, 
1138, 1062, 961 cm!1.  HMRS calcd for  C16H33ClO2SiNa (M+Na)+: 343.1838, found 
343.1830. 
General Procedure G: Synthesis of O-Mosher Ester.10b,23  A solution of 1,2-diol or 
allylic alcohol (0.02 mmol) and 4-dimethylamino-pyridine (DMAP) (12.3 mg, 0.1 mmol) 
in 1 mL of dichloromethane was treated with (R)-(!)-"-methoxy-"-
(trifluoromethyl)phenylacetyl chloride ((R)-MTPA-Cl) (19 µL, 0.1 mmol) at 0 °C.  The 
mixture was warmed to room temperature and stirred for 1 h.  After removal of solvent 
by rotary evaporation, the crude product was purified by column chromatography on 
silica gel (hexanes:EtOAc, 97/3) to yield the (S)-O-Mosher ester.  The same procedure 
was used with (S)-(+)-"-methoxy-"-(trifluoromethyl)phenylacetyl chloride ((S)-MTPA-
Cl) in preparation of the analogous (R)-O-Mosher ester.  
 
Preparation of (S)-O-Mosher Ester of (2S,3S)-2-(tert-
butyldimethylsilyloxy)pentan-3-ol (2.57).  General Procedure G was 
applied to (2S,3S)-2-(tert-butyldimethylsilyloxy)pentan-3-ol (4.4 mg, 
0.02 mmol), DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 
0.1 mmol).  The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 97:3) to give the title compound as an oil.  1H NMR (CDCl3, 500 
MHz): # 0.07 (s, 3H), 0.08 (s, 3H), 0.82 (t, J = 7.5 Hz, 3H), 0.88 (s, 9H), 1.08 (d, J = 6.5 
Hz, 3H), 1.56-1.65 (m, 1H), 1.68-1.77 (m, 1H), 3.57 (s, 3H), 3.96-4.00 (m, 1H), 4.86-
4.89 (m, 1H), 7.39!7.41 (m, 3H), 7.58!7.59 (m, 2H).  HMRS calcd for  C21H33F3O4SiNa 
(M+Na)+: 457.1998, found 457.1993. 
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Preparation of (R)-O-Mosher Ester of  (2S,3S)-2-(tert-
butyldimethylsilyloxy)pentan-3-ol (2.58).  General Procedure G was 
applied to (2S,3S)-2-(tert-butyldimethylsilyloxy)pentan-3-ol (4.4 mg, 
0.02 mmol), DMAP (12.5 mg, 0.1mmol), and (S)-MTPA-Cl (19 µL, 
0.1 mmol).  The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 97:3) to give the title compound as an oil.  1H NMR (CDCl3, 500 
MHz): ! 0.05 (s, 3H), 0.06 (s, 3H), 0.87 (s, 9H), 0.93 (t, J = 7.5 Hz, 3H), 0.96 (d, J = 6.5 
Hz, 3H), 1.57"1.66 (m, 1H), 1.76"1.84 (m, 1H), 3.56 (s, 3H), 3.92"3.97 (m, 1H), 
4.83"4.86 (m, 1H), 7.38"7.41 (m, 3H), 7.55"7.57 (m, 2H).  HMRS calcd for  
C21H33F3O4SiNa (M+Na)+: 457.1998, found 457.1984. 
 
Preparation of (S)-O-Mosher Ester of (3S,4S)-4-(tert-
butyldimethylsilyloxy)-5-methylhexan-3-ol (2.59).  General 
Procedure G was applied to (3S,4S)-4-(tert-butyldimethylsilyloxy)-5-
methylhexan-3-ol (4.49 mg, 0.02 mmol), DMAP (12.5 mg, 0.1mmol), 
and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product was purified by column 
chromatography on silica gel (DCM:hexanes, 20:80) to give the title compound as an oil.  
1H NMR (CDCl3, 500 MHz): ! 0.07 (s, 3H), 0.08 (s, 3H), 0.81 (d, J = 7.0 Hz, 3H), 0.85 
(t, J = 7.5 Hz, 3H), 0.90 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 1.57"1.66 (m, 1H), 1.70"1.78 
(m, 2H), 3.41 (dd, J = 7.0 Hz, J = 7.0 Hz, 1H), 3.52 (s, 3H), 4.98"5.01 (m, 1H), 
7.38"7.40 (m, 3H), 7.56"7.58 (m, 2H).    HMRS calcd for  C23H37F3O4SiNa (M+Na)+: 
485.2311, found 485.2309. 
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Preparation of (R)-O-Mosher Ester of (3S,4S)-4-(tert-
butyldimethylsilyloxy)-5-methylhexan-3-ol (2.60).  General 
Procedure G was applied to (3S,4S)-4-(tert-butyldimethylsilyloxy)-5-
methylhexan-3-ol (4.49 mg, 0.02 mmol), DMAP (12.5 mg, 0.1mmol), 
and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product was purified by column 
chromatography on silica gel (DCM:hexanes, 20:80) to give the title compound as an oil.  
1H NMR (CDCl3, 500 MHz): ! 0.06 (s, 3H), 0.13 (s, 3H), 0.63 (d, J = 7.0 Hz, 3H), 0.82 
(d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.93 (t, J = 7.5 Hz, 3H), 1.58"1.68 (m, 2H), 1.79"1.86 
(m, 1H), 3.44 (dd, J = 6.5 Hz, J = 6.5 Hz, 1H), 3.58 (s, 3H), 4.93"4.96 (m, 1H), 
7.38"7.40 (m, 3H), 7.54"7.56 (m, 2H).  HMRS calcd for  C23H37F3O4SiNa (M+Na)+: 
485.2311, found 485.2325. 
 
 Preparation of (S)-O-Mosher Ester of (1S,2S)-1-(tert-
butyldimethylsilyloxy)-1-phenylbutan-2-ol (2.61).  General 
Procedure G was applied to (1S,2S)-1-(tert-butyldimethylsilyloxy)-1-
phenylbutan-2-ol (5.6 mg, 0.02 mmol), DMAP (12.5 mg, 0.1mmol), 
and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product was purified by column 
chromatography on silica gel (DCM:hexanes, 20:80) to give the title compound as an oil.  
1H NMR (CDCl3, 500 MHz): ! "0.18 (s, 3H), 0.05 (s, 3H), 0.82 (t, J = 7.5 Hz, 3H), 0.89 
(s, 9H), 1.35"1.43 (m, 1H), 1.66"1.75 (m, 1H), 3.44 (s, 3H). 4.83 (d, J = 4.0 Hz, 1H), 
5.11 (dt, J = 8.0 Hz, J = 8.5 Hz, 1H), 7.22"7.26 (m, 5H), 7.34"7.42 (m, 5H). HMRS 
calcd for C26H35F3O4SiNa (M+Na)+: 519.2155, found 519.2159. 
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Preparation of (R)-O-Mosher Ester of (1S,2S)-1-(tert-
butyldimethylsilyloxy)-1-phenylbutan-2-ol (2.62).  General 
Procedure G was applied to (1S,2S)-1-(tert-butyldimethylsilyloxy)-1-
phenylbutan-2-ol (5.6 mg, 0.02 mmol), DMAP (12.5 mg, 0.1mmol), 
and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product was purified by column 
chromatography on silica gel (DCM:hexanes, 20:80) to give the title compound as an oil.  
1H NMR (CDCl3, 500 MHz): ! "0.16 (s, 3H), 0.04 (s, 3H), 0.88 (s, 9H),  0.90 (t, J = 7.5 
Hz, 3H), 1.35"1.43 (m, 1H), 1.68"1.76 (m, 1H), 3.49 (s, 3H). 4.74 (d, J = 4.0 Hz, 1H), 
5.11 (dt, J = 8.5 Hz, J = 8.0 Hz, 1H), 7.04"7.06 (m, 2H), 7.14"7.20 (m, 3H), 7.35"7.42 
(m, 3H), 7.47 (d, J = 7.0 Hz, 2H) . HMRS calcd for  C21H33F3O4SiNa (M+Na)+: 
519.2155, found 519.2156. 
 
Preparation of (S)-O-Mosher Ester of (2S,3S)-2-(tert-
butyldimethylsilyloxy)-7-chloroheptan-3-ol (2.63).  
General Procedure G was applied to (2S,3S)-2-(tert-
butyldimethylsilyloxy)-7-chloroheptan-3-ol (5.6 mg, 0.02 
mmol), DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude 
product was purified by column chromatography on silica gel (DCM:hexanes, 20:80) to 
give the title compound as an oil.  1H NMR (CDCl3, 500 MHz): ! 0.07 (s, 3H), 0.08 (s, 
3H), 0.88 (s, 9H), 1.09 (d, J = 6.4 Hz, 3H), 1.31 (q, J = 7.7 Hz, 2H), 1.56"1.78 (m, 4H), 
3.42 (td, J = 6.6 Hz, J = 2.4 Hz, 2H), 3.56 (s, 3H), 3.96"4.00 (m, 1H), 4.94 (dt, J = 9.3 
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Hz, J = 3.5 Hz, 1H), 7.40!7.41 (m, 3H), 7.56!7.58 (m, 2H). HMRS calcd for 
C23H36ClF3O4SiNa (M+Na)+: 519.1923, found 519.1917. 
 
Preparation of (R)-O-Mosher Ester of (2S,3S)-2-(tert-
butyldimethylsilyloxy)-7-chloroheptan-3-ol (2.64).  
General Procedure G was applied to (2S,3S)-2-(tert-
butyldimethylsilyloxy)-7-chloroheptan-3-ol (5.6 mg, 0.02 
mmol), DMAP (12.5 mg, 0.1mmol), and (S)-MTPA-Cl (19 µL, 0.1 mmol).  The crude 
product was purified by column chromatography on silica gel (DCM:hexanes, 20:80) to 
give the title compound as an oil.  1H NMR (CDCl3, 500 MHz): " 0.06 (s, 3H), 0.07 (s, 
3H), 0.87 (s, 9H), 0.96 (d, J = 6.3 Hz, 3H), 1.39!1.52 (m, 2H), 1.58!1.65 (m, 2H), 
1.70!1.84 (m, 4H), 3.49 (t, J = 6.5 Hz, 2H), 3.54 (s, 3H), 3.92!3.96 (m, 1H), 4.94 (dt, J = 
9.0 Hz, J = 8.9 Hz, 1H), 7.40!7.41 (m, 3H), 7.54!7.55 (m, 2H). HMRS calcd for 
C23H36ClF3O4Si (M + Na)+: 519.1923, found 519.1904. 
 
Preparation of (S)-O-Mosher Ester of  (2S,3S,E)-2-(tert-
butyldimethylsilyloxy)non-4-en-3-ol (2.65).  General 
Procedure G was applied to (2S,3S,E)-2-(tert-
butyldimethylsilyloxy)non-4-en-3-ol (5.5 mg, 0.02 mmol), 
DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product 
was purified by column chromatography on silica gel (hexanes:EtOAc, 97:3) to give the 
title compound as an oil.  1H NMR (CDCl3, 500 MHz): " 0.05 (s, 3H), 0.06 (s, 3H), 0.88 
(s, 9H), 0.89 (t, J = 7.5 Hz, 3H), 1.12 (d, J = 6.0 Hz, 3H), 1.27!1.35 (m, 4H), 2.04 (q, J = 
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7.0 Hz, 2H), 3.55 (s, 3H), 3.92!3.97 (m, 1H), 5.29!5.32 (m, 1H), 5.40 (ddt, J = 15.6 Hz, 
J = 7.5 Hz, J = 1.5 Hz, 1H), 5.74 (dt, J = 15.5 Hz, J = 6.5 Hz,1H), 7.36!7.41 (m, 3H), 
7.52 (d, J = 9.0 Hz, 2H).  HMRS calcd for  C25H39F3O4Si (M + Na)+: 511.2468, found 
511.2457. 
 
Preparation of  (R)-O-Mosher Ester of  (2S,3S,E)-2-(tert-
butyldimethylsilyloxy)non-4-en-3-ol (2.66).  General 
Procedure G was applied to (2S,3S,E)-2-(tert-
butyldimethylsilyloxy)non-4-en-3-ol (5.5 mg, 0.02 mmol), 
DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product 
was purified by column chromatography on silica gel (hexanes:EtOAc, 97:3) to give the 
title compound as an oil.  1H NMR (CDCl3, 500 MHz): " !0.06 (s, 3H), 0.03 (s, 3H), 0.85 
(s, 9H), 0.88 (t, J = 7.0 Hz, 3H), 1.02 (d, J = 6.0 Hz, 3H), 1.22!1.38 (m, 4H), 2.07 (q, J = 
7.0 Hz, 2H), 3.55 (s, 3H), 3.89!3.93 (m, 1H), 5.29!5.31 (m, 1H), 5.50 (ddt, J = 15.5 Hz, 
J = 7.5 Hz, J = 1.0 Hz, 1H), 5.82 (dt, J = 15.5 Hz, J = 8.0 Hz, J = 1.0 Hz, 1H), 7.35!7.39 
(m, 3H), 7.54 (d, J = 8.0 Hz, 2H).  HMRS calcd for  C25H39F3O4SiNa (M+Na)+: 
511.2468, found 511.2463. 
 
Preparation of (S)-O-Mosher Ester of (3S,4S,E)-4-(tert-
butyldimethylsilyloxy)-1-phenylpent-1-en-3-ol (2.67).  
General Procedure G was applied to (3S,4S,E)-4-(tert-
butyldimethylsilyloxy)-1-phenylpent-1-en-3-ol (5.8 mg, 0.02 
mmol), DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude 
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product was purified by column chromatography on silica gel (hexanes:EtOAc, 97:3) to 
give the title compound as an oil.  1H NMR (CDCl3, 500 MHz): ! 0.07 (s, 3H), 0.07 (s, 
3H), 0.89 (s, 9H), 1.16 (d, J = 6.0 Hz, 3H), 3.57 (s, 3H), 4.02"4.07 (m, 1H), 5.52 (t, J = 
6.5 Hz, 1H), 6.15 (dd, J = 16.0 Hz, J = 6.5 Hz, 1H), 6.53 (d, J = 16.0 Hz, 1H), 7.29"7.33 
(m, 4H), 7.35"7.42 (m, 4H), 7.55 (d, J = 7.0 Hz, 2H).  HMRS calcd for  C27H35F3O4SiNa 
(M+Na)+:  531.2155, found 531.2150. 
 
Preparation of (R)-O-Mosher Ester of (3S,4S,E)-4-(tert-
butyldimethylsilyloxy)-1-phenylpent-1-en-3-ol (2.68).  
General Procedure G was applied to (3S,4S,E)-4-(tert-
butyldimethylsilyloxy)-1-phenylpent-1-en-3-ol (5.8 mg, 0.02 
mmol), DMAP (12.5 mg, 0.1 mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude 
product was purified by column chromatography on silica gel (hexanes:EtOAc, 97:3) to 
give the title compound as an oil.  1H NMR (CDCl3, 500 MHz): ! 0.05 (s, 3H), 0.07 (s, 
3H), 0.89 (s, 9H), 1.07 (d, J = 6.0 Hz, 3H), 3.57 (s, 3H), 4.02"4.06 (m, 1H), 5.53"5.56 
(m, 1H), 6.26 (dd, J = 15.5 Hz, J = 7.0 Hz, 1H), 6.66 (d, J = 15.5 Hz, 1H), 7.32"7.41 (m, 
8H), 7.57 (d, J = 7.0 Hz, 1H).  HMRS calcd for  C27H35F3O4SiNa (M+Na)+:  531.2155, 
found 531.2146. 
 
Preparation of (S)-O-Mosher Ester of (3S,4S,E)-3-(tert-
butyldimethylsilyloxy)-2,5,7,7-tetramethyloct-5-en-4-ol 
(2.69).  General Procedure G was applied to (3S,4S,E)-3-(tert-
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butyldimethylsilyloxy)-2,5,7,7-tetramethyloct-5-en-4-ol (6.8 mg, 0.02 mmol), DMAP 
(12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The crude product was 
purified by column chromatography on silica gel (DCM:hexanes, 20:80) to give the title 
compound as an oil.  1H NMR (CDCl3, 500 MHz): ! 0.06 (s, 6H), 0.89 (d, J = 6.5 Hz, 
3H), 0.90 (s, 9H), 0.93 (d, J = 7.0 Hz, 3H), 1.09 (s, 9H), 1.66 (d, J = 1.0 Hz, 3H), 
1.70"1.77 (m, 1H), 3.51 (s, 3H), 3.67 (dd, J = 5.5 Hz, J = 5.5 Hz, 1H), 5.28 (d, J = 5.5 
Hz, 1H), 5.51 (s, 1H), 7.36"7.40 (m, 3H), 7.50 (d, J = 6.5 Hz, 2H). HMRS calcd for  
C21H33F3O4SiNa (M+Na)+: 553.2937, found 553.2911. 
 
Preparation of (R)-O-Mosher Ester of (3S,4S,E)-3-(tert-
butyldimethylsilyloxy)-2,5,7,7-tetramethyloct-5-en-4-ol 
(2.70).  General Procedure G was applied to (3S,4S,E)-3-(tert-
butyldimethylsilyloxy)-2,5,7,7-tetramethyloct-5-en-4-ol (6.8 
mg, 0.02 mmol), DMAP (12.5 mg, 0.1mmol), and (R)-MTPA-Cl (19 µL, 0.1 mmol).  The 
crude product was purified by column chromatography on silica gel (DCM:hexanes, 
20:80) to give the title compound as an oil.  1H NMR (CDCl3, 500 MHz): ! "0.17 (s, 
3H), 0.05 (s, 3H), 0.84"0.86 (m, 12), 0.86 (d, J = 3.0 Hz, 3H), 1.11 (s, 9H), 1.68"1.73 
(m, 1H), 1.79 (d, J = 1.0 Hz, 3H), 3.57 (s, 3H), 3.63 (dd, J = 6.0 Hz, J = 6.0 Hz, 1H), 5.24 
(d, J = 6.0 Hz, 1H), 5.57 (s, 1H), 7.36"7.40 (m, 3H), 7.52"7.53 (m, 2H).  HMRS calcd 
for  C21H33F3O4SiNa (M+Na)+: 553.2937, found 553.2912. 
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Schlenk equipped with magnetic stirrer and septum was flame-dried under vacuum and 
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back-filled with N2. To the flask was added R2Zn (0.670 mmol, neat) and CH2Cl2 (0.3 
mL). The flask was cooled to –78 °C in a dry ice/acetone bath. Triflic acid (33 !L, 0.371 
mmol) was added dropwise, and the reaction was allowed to stir at –78 °C for 5 min. The 
reaction was then stirred at rt for 45 min to 1 h and then cooled to 0 °C. A solution of 
aldehyde (0.247 mmol) in dichloromethane (0.19 mL) was added dropwise and the 
reaction was allowed to slowly warm to rt.  After 16 h, the reaction was quenched with a 
saturated solution of NH4Cl (15 mL) and extracted with diethyl ether (3 x 10 mL). The 
combined organic layers were washed with brine, dried over MgSO4, and filtered. The 
crude products were concentrated in vacuo and added to a silica gel column. 
 
(2R,3S)-1-((tert-Butyldimethylsilyl)oxy)-2-methylpentan-3-ol 
(2.44).22 Procedure H was applied to Et2Zn (0.67 mL, 1.34 mmol, 2M 
in CH2Cl2), triflic acid (66 !L, 0.75 mmol), and  (R)-3-((tert-
butyldimethylsilyl)oxy)-2-methylpropanal (98.0 mg, 0.484 mmol, in 0.3 mL CH2Cl2). 
The crude products were concentrated in vacuo and added to a silica gel column.  The 
crude product was purified by flash chromatography (EtOAc:hexanes, 1:49 to 1:24) to 
afford the title compound as a clear oil (87.5 mg, 78% yield, dr 15.4:1).  The major 
diastereomer was separated and characterized.   = –20.6 (c = 1.15, CHCl3). 1H NMR 
(CDCl3, 500 MHz): " 0.08 (s, 3H), 0.85 (d, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.97 (t, J = 7.5 
Hz, 3H), 1.44 (m, 1H), 1.58, (m, 1H), 1.71 (m, 1H), 3.45 (m, 1H), 3.58 (dd, J = 7.5 Hz, 
10.0 Hz, 1H), 3.68 (bs, 1H), 3.79 (dd, J = 4.1 Hz, 10.0 Hz, 1H). 13C{1H} (CDCl3, 125 
MHz): " !5.46, !5.53, 9.8, 13.8, 18.3, 26.0, 28.0, 39.4, 68.6, 78.0. IR (neat): 3445, 2958, 
2930, 2858, 1471, 1463, 1256, 1084, 850 cm-1. HRMS calcd for C12H29O2Si (MH)+: 
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233.1937, found 233.1943.  GC condition for TMS-protected 2: Supelco Beta Dex 120 
fused silica capillary column 60 m x 0.25 m x 0.25 µm film thickness, t = 30.3 min, t = 
33.7 min (oven: 98 °C, 1.4 mL/min). 
 
!(2S,3R)-4-((tert-Butyldimethylsilyl)oxy)-3-methylbutan-2-ol (2.46).30 
General Procedure H was applied to Me2Zn (88 !L, 0.670 mmol, neat), 
triflic acid (33 !L, 0.371 mmol), and  (R)-3-((tert-butyldimethylsilyl)oxy)-2-
methylpropanal (50.0 mg, 0.247 mmol, in 0.19 mL CH2Cl2). The crude products were 
concentrated in vacuo and added to a silica gel column.  The crude product was purified 
by flash chromatography (EtOAc:hexanes, 1:49) to afford the title compound as a clear 
oil (33.3 mg, 62% yield, dr 5:1). The product was characterized as a 5:1 mixture of 
diastereomers. 1H NMR (CDCl3, 500 MHz) major: " 0.08 (s, 6H), 0.81 (d, J = 7.0 Hz, 
3H), 0.90 (s, 9H), 1.18 (d, J = 6.30 Hz, 3H), 1.65 (m, 1H), 3.55 (dd, J = 8.5 Hz, 10.0 Hz, 
1H), 3.69 (m, 1H), 3.78 (dd, J = 4.1 Hz, 10.2 Hz, 1H), 3.98 (d, J = 2.3 Hz, 1H). 13C{1H} 
(CDCl3, 125 MHz) major: " !5.5, !5.4, 13.5, 18.3, 21.5, 26.0, 41.6, 69.2, 73.4. IR (neat): 
3435, 2958, 2930, 2859, 1472, 1463, 1256, 1079, 836, 776 cm-1. HRMS calcd for 
C7H17O2Si (M–C4H9) +: 161.0998, found 161.0997. 
 
(2R,3S)-1-((tert-Butyldimethylsilyl)oxy)-2-methylheptan-3-ol 
(2.47).  A 10 mL Schlenk equipped with magnetic stirrer and 
septum was flame-dried under vacuum and back-filled with N2. 
To the flask was added n-Bu2Zn (1.11 mL, 1.11 mmol, 1M in heptane). The septum was 
replaced with a glass stopper, and the flask was evacuated for 3 min and back-filled with 
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N2 3 times. The glass stopper was replaced with a septum, and CH2Cl2 (0.25 mL) was 
added.  The rest of the procedure is the same as General Procedure A employing triflic 
acid (33 !L, 0.371 mmol) and (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal 
(50.0 mg, 0.247 mmol, in 0.25 mL CH2Cl2).  The crude products were concentrated in 
vacuo and added to a silica gel column.  The crude product was purified by flash 
chromatography (EtOAc:hexanes, 1:49 to 1:24) to afford the title compound as a clear oil 
(46.7 mg, 73% yield, dr 16:1).  The major diastereomer was separated and characterized.  
 = –24.2 (c = 1.03, CHCl3). 1H NMR (CDCl3, 500 MHz): " 0.08 (s, 6H), 0.85 (d, J = 
7.0 Hz, 3H), 0.90 (m, 12H), 1.42 (m, 6H), 1.7 (m, 1H), 3.52 (m, 1H), 3.57 (dd, J = 7.7 
Hz, 10.0 Hz, 1H), 3.80 (dd, J = 4.0 Hz, 10.0 Hz, 1H), 3.84 (d, J = 3.2 Hz, 1H). 13C{1H} 
(CDCl3, 125 MHz): " !5.5, !5.4, 13.8, 14.3, 18.3, 23.1, 26.0, 27.7, 35.1, 40.0, 68.8. IR 
(neat): 3446, 2931, 2859, 1471, 1464, 1255. 1090, 837, 777 cm-1. HRMS calcd for 
C14H33O2Si (MH) +: 261.2250, found 261.2244. 
 
Genaral Procedure I: preparation of EtZnOTf and EtZnONf. To a flame-dried 25 
mL Schlenk flask equipped with magnetic stirrer and septum was added Et2Zn (0.2 mL, 
0.4 mmol, 2 M in CH2Cl2). The solution was cooled to –78 °C in a dry ice/acetone bath, 
and triflic acid or nonafluorobutane-1-sulfonic acid (0.371 mmol) was added dropwise. 
The reaction was allowed to stir and –78 °C for 5 min and was then warmed to rt and 
stirred for 1 h. The septum was replaced with a glass stopper, and the solvent was 
removed under reduced pressure. 
!
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General Procedure J: (E)-vinylzinc addition to !-silyloxy aldehydes. A 10 mL 
Schlenk flask equipped with magnetic stirrer and septum was flame-dried under vacuum 
and back-filled with N2. To the flask was added HBCy2 (43 mg, 0.24 mmol) and CH2Cl2. 
The flask was cooled to 0 °C, and the alkyne (0.24 mmol) was added dropwise. The 
reaction mixture was allowed to stir at 0 °C for 5 min and then stirred at rt for 15 min. 
The flask was cooled to –78 °C, Et2Zn (.12 mL, 2M in toluene) was added dropwise, and 
the reaction mixture was allowed to stir at –78 °C for 30 min.  EtZnONf (118 mg, 0.3 
mmol) was added at –78 °C, and the flask was transferred to a cooling bath at –15 °C. 
The aldehyde (0.2 mmol) was added dropwise as a solution in toluene, and the reaction 
was allowed to stir at –15 °C for 14"18 h. The reaction was quenched with a saturated 
solution of NH4Cl (15 mL) and extracted with diethyl ether (3 x 10 mL). The combined 
organic layers were washed with brine, dried over MgSO4, and filtered. The crude 
products were concentrated in vacuo and purified by flash-chromatography on silica gel.  
 
General Procedure K: The procedure follows General Procedure C, except EtZnOTf (73 
mg, 0.3 mmol) is employed.  
!
(2R,3S,E)-1-((tert-Butyldimethylsilyl)oxy)-2-methylnon-4-en-
3-ol (2.48).31 General Procedure I was applied to HBCy2 (2.7 
mg, 0.296 mmol), CH2Cl2 (0.41 mL), 1-hexyne (34 !L, 0.296 mmol), Et2Zn (0.15 mL, 
0.30 mmol), EtZnONf (146 mg, 0.371 mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-
methylpropanal (50.0 mg, 0.247 mmol), and toluene (0.26 mL).  The crude product was 
purified by flash chromatography (EtOAc:hexanes, 1:50 to 1:25) to afford the title 
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compound as a clear oil (43.2 mg, 64% yield, dr 10:1). The product was characterized as 
a 10:1 mixture of diastereomers. 1H NMR (CDCl3, 500 MHz) major: ! 0.08 (s, 6H), 0.81 
(d, J = 7.1 Hz, 3H), 0.89 (t, J = 7.0 Hz, 3H), 0.90 (s, 9H), 1.34 (m, 4H), 1.74 (m, 1H), 
2.05 (m, 2H), 3.57 (dd, J = 7.7 Hz, 9.9 Hz, 1 H), 3.74 (d, J = 3.0 Hz, 1H), 3.78 (dd, J = 
4.3 Hz, 10.1 Hz, 1H), 3.95 (m, 1H), 5.44 (dd, J = 7.2 Hz, 15.3 Hz, 1H), 5.66 (m, 
1H).13C{1H} (CDCl3, 125 MHz) major: –5.4, 13.7, 14.1, 18.3, 22.5, 26.0, 31.6, 32.1, 
40.3, 68.4, 78.4, 131.7, 133.1. ! IR (neat): 3432, 2957, 2929, 2858, 1670, 1471, 1255, 
1095, 1006, 970, 836, 776 cm-1. HRMS calcd for C16H33OSi (M!OH) +: 269.2301, found 
269.2290. 
 
General Procedure J was applied to HBCy2 (2.7 mg, 0.296 mmol), CH2Cl2 (0.41 mL), 1-
hexyne (34 "L, 0.296 mmol), Et2Zn (0.15 mL, 0.30 mmol), EtZnOTf (90 mg, 0.371 
mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal (50.0 mg, 0.247 mmol), 
and toluene (0.26 mL).  The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (56.0 mg, 79% 
yield, dr 4:1). 
 
(3S,4R,E)-5-((tert-Butyldimethylsilyl)oxy)-1-(cyclohex-1-en-
1-yl)-4-methylpent-1-en-3-ol (2.49).  General Procedure I was 
applied to HBCy2 (93.4 mg, 0.524 mmol), CH2Cl2 (0.71 mL), 1-ethynylcyclohexene (62 
"L, 0.524 mmol), Et2Zn (0.26 mL, 0.52 mmol), EtZnONf (258 mg, 0.656 mmol), (R)-3-
((tert-butyldimethylsilyl)oxy)-2-methylpropanal (88.5 mg, 0.437 mmol), and toluene 
(0.47 mL).  The crude product was purified by flash chromatography (EtOAc:hexanes, 
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1:50 to 1:25) to afford the title compound as a clear oil (90 mg, 66% yield, dr 5.8:1).  The 
product was characterized as a 5.8:1 mixture of diastereomers. 1H NMR (CDCl3, 500 
MHz) major: ! 0.08 (s, 1H), 0.83 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 1.64 (m, 4H), 1.78 (m, 
1H), 2.13 (bs, 4H), 3.58 (dd, J = 7.4 Hz, 10.0 Hz, 1H), 3.73 (d, J = 3.1 Hz, 1H), 3.79 (dd, 
J = 4.2 Hz, 10.1 Hz, 1H), 4.04 (m, 1H), 5.53 (dd, J = 7.6 Hz, 16.0 Hz, 1H), 5.74 (bs, 1H), 
6.21 (d, J = 15.5 Hz, 1H). 13C{1H} (CDCl3, 125 MHz) major: ! –5.36, –5.44, 11.6, 13.8, 
18.3, 22.7, 22.8, 24.8, 26.0, 40.6, 68.3, 78.4, 127.2, 129.7, 135.1, 135.4. IR (neat): 3429, 
2929, 2857, 1651, 1625, 1471, 1463, 1255, 1092, 1006, 965, 814, 776, 667 cm-1. HRMS 
calcd for C18H35O2Si (MH)+: 311.2406, found 311.2412. 
 
General Procedure J was applied to HBCy2 (93.4 mg, 0.524 mmol), CH2Cl2 (0.71 mL), 1-
ethynylcyclohexene (62 "L, 0.524 mmol), Et2Zn (0.26 mL, 0.52 mmol), EtZnOTf (160 
mg, 0.656 mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal (88.5 mg, 0.437 
mmol), and toluene (0.47 mL).  The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (68.3 mg, 50% 
yield, dr 2.3:1). 
 
(2R,3S,E)-1-((tert-Butyldimethylsilyl)oxy)-2,6,6-trimethylhept-
4-en-3-ol (2.50).  General Procedure I was applied to HBCy2 
(97.1 mg, 0.545 mmol), CH2Cl2 (0.76 mL), 3,3-dimethyl butyne (67 "L, 0.545 mmol), 
Et2Zn (0.27 mL, 0.545 mmol), EtZnONf (268 mg, 0.681 mmol), (R)-3-((tert-
butyldimethylsilyl)oxy)-2-methylpropanal (91.9 mg, 0.454 mmol), and toluene (0.49 
mL). The crude product was purified by flash chromatography (EtOAc:hexanes, 1:50 to 
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1:25) to afford the title compound as a clear oil (86.0 mg, 70% yield, dr 10:1). The 
product was characterized as a 10:1 mixture of diastereomers.  1H NMR (CDCl3, 500 
MHz) major: ! 0.08 (s, 6H), 0.79 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 1.02 (s, 9H), 1.75 (m, 
1H), 3.56 (dd, J = 7.9 Hz, 9.7 Hz, 1H), 3.79 (dd, J = 4.0 Hz, 9.9 Hz, 1H), 3.82 (d, J = 2.7 
Hz, 1 H), 3.95 (m, 1H), 5.34 (dd, J = 7.4 Hz, 15.8 Hz, 1H), 5.68 (d, J = 15.6 Hz, 1H). 
13C{1H} (CDCl3, 125 MHz) major: ! –5.5, –5.4, 13.7, 18.3, 26.0, 29.8, 33.0, 40.3, 68.5, 
78.7, 126.4, 143.9. IR (neat): 3438, 2859, 1662, 1472, 1463, 1362, 1256, 1095, 1024, 
1006, 974, 836, 776 cm-1.  HRMS calcd for C16H33OSi (M–OH)+: 269.2301, found 
269.2312. 
 
General Procedure J was applied to HBCy2 (97.1 mg, 0.545 mmol), CH2Cl2 (0.76 mL), 
3,3-dimethyl butyne (67 "L, 0.545 mmol), Et2Zn (0.27 mL, 0.545 mmol), EtZnOTf (166 
mg, 0.681 mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal (91.9 mg, 0.454 
mmol), and toluene (0.49 mL).  The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (86.0 mg, 70% 
yield, dr 3.6:1). 
 
(2R,3R,E)-1-((tert-Butyldimethylsilyl)oxy)-2,4,6,6-
tetramethylhept-4-en-3-ol (2.51).  General Procedure I was 
applied to HBCy2 (52.7 mg, 0.296 mmol), CH2Cl2 (0.41 mL), 4,4-dimethyl-2-pentyne (40 
"L, 0.30 mmol), Et2Zn (0.15 mL, 0.30 mmol), EtZnOTf (90.2 mg, 0.371 mmol), (R)-3-
((tert-butyldimethylsilyl)oxy)-2-methylpropanal (50.0 mg, 0.247 mmol), and toluene 
(0.26 mL). The crude product was purified by flash chromatography (EtOAc:hexanes, 
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1:50 to 1:25) to afford the title compound as a clear oil (59 mg, 80% yield, dr > 20:1).  
 = –29.7 (c = 1.03, CHCl3). 1H NMR (CDCl3, 500 MHz): ! 0.09 (s, 6H), 0.69 (d, J = 
6.9 Hz, 3H), 0.91 (s, 9H), 1.12 (s, 9H), 1.71 (s, 3H), 1.84 (m, 1H), 3.58 (t, J = 8.4 Hz, 
1H), 3.74 (d, J = 8.7 Hz, 1H), 3.79 (dd, J = 4.0 Hz, 9.9 Hz, 1H), 4.02 (bs, 1H), 5.39 (s, 
1H). 13C{1H} (CDCl3, 125 MHz): ! -5.5, -5.4, 12.1, 13.8, 18.3, 26.0, 31.0, 32.4, 37.5, 
69.2, 85.8, 134.4, 138.5. IR (neat): 3445, 2931, 2859, 1660, 1471, 1464, 1254, 1091, 
1006, 836, 777 cm-1. HRMS calcd for C17H36O2NaSi (M + Na) +: 323.2382, found 
323.2379. 
 
General Procedure J was applied to HBCy2 (52.7 mg, 0.296 mmol), CH2Cl2 (0.41 mL), 
4,4-dimethyl-2-pentyne (40 "L, 0.30 mmol), Et2Zn (0.15 mL, 0.30 mmol), EtZnOTf 
(90.2 mg, 0.371 mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal (50.0 mg, 
0.247 mmol), and toluene (0.26 mL).  The crude product was purified by flash 
chromatography (EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil 
(56.9 mg, 79% yield, dr 11:1). 
 
(2R,3R,E)-1-((tert-Butyldimethylsilyl)oxy)-2,4,6-trimethylhept-
4-en-3-ol (2.52). General Procedure I was applied to HBCy2 (88 
mg, 0.494 mmol), CH2Cl2 (0.41 mL), 4-methyl-2-pentyne (57 "L, 0.494 mmol), Et2Zn 
(0.25 mL, 0.50 mmol), EtZnONf (146 mg, 0.371 mmol), (R)-3-((tert-
butyldimethylsilyl)oxy)-2-methylpropanal (50.0 mg, 0.247 mmol), and toluene (0.16 
mL).  The crude product was purified by flash chromatography (EtOAc:hexanes, 1:50 to 
1:25) to afford the title compound as a clear oil (55 mg, 78% yield, dr 17:1).  The major 
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diastereomer was separated and characterized.  = –23.0 (c = 0.847, CHCl3). 1H 
NMR (CDCl3, 500 MHz): ! 0.09 (s, 6H), 0.70 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.93 (d, J 
= 6.6 Hz, 3H), 0.97 (d, J = 6.6 Hz, 3H), 1.61 (d, J = 1.2 Hz, 3H), 1.85 (m, 1H), 2.55 (m, 
1H), 3.58 (dd, J = 8.1 Hz, 9.8 Hz, 1H), 3.79 (m, 2H), 3.98 (d, J = 2.2 Hz, 1H), 5.20 (d, J 
= 9.3 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! –5.5, –5.4, 11.2, 13.8, 18.3, 23.1, 23.1, 
26.0, 27.0, 37.5, 69.0, 84.2, 133.4, 136.0. IR (neat): 3452, 2930, 2859, 1669, 1464, 1254, 
1089, 1006, 836, 777 cm-1. HRMS calcd for C16H33OSi (M – OH)+: 269.2301, found 
269.2300. 
 
General Procedure J was applied to HBCy2 (88 mg, 0.494 mmol), CH2Cl2 (0.41 mL), 4-
methyl-2-pentyne (57 "L, 0.494 mmol), Et2Zn (0.25 mL, 0.50 mmol), EtZnOTf (90.3 
mg, 0.371 mmol), (R)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanal (50.0 mg, 0.247 
mmol), and toluene (0.16 mL).  The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (54.6 mg, 77% 
yield, dr 7.7:1). 
 
(2R,3S,E)-1-((Triethylsilyl)oxy)-2-methylnon-4-en-3-ol (2.53). 
General Procedure I was applied to HBCy2 (71.2 mg, 0.400 
mmol), CH2Cl2 (0.55 mL), 1-hexyne (46 "L, 0.400 mmol), Et2Zn (0.20 mL, 0.40 mmol), 
EtZnONf (197 mg, 0.500 mmol), (R)-3-((triethylsilyl)oxy)-2-methylpropanal (67.1 mg, 
0.332 mmol), and toluene (0.35 mL). The crude product was purified by flash 
chromatography (EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil 
(62 mg, 66% yield, dr 11:1).  The product was characterized as a 6.2:1 mixture of 
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diastereomers. 1H NMR (CDCl3, 500 MHz) major: ! 0.62 (q, 6H), 0.81 (d, J = 7.0 Hz, 
3H), 0.89 (t, J = 7.1 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 1.34 (m, 4H), 1.77 (m, 1H), 2.05 
(m, 2H), 3.58 (dd, J = 7.9 Hz, J = 10.0 Hz, 1H), 3.78 (dd, J = 4.2 Hz, J = 10.0 Hz, 1H), 
3.88 (d, J = 2.8 Hz, 1H), 3.94 (m, 1H), 5.44 (dd, J = 7.5 Hz, J = 15.4 Hz, 1H), 5.66 (m, 
1H).  13C{1H} (CDCl3, 125 MHz) major: ! 4.4, 6.9, 13.7, 14.1, 22.4, 31.6, 32.1, 40.3, 
68.2, 78.6, 131.7, 133.1. IR (neat): 3435, 2915, 2876, 1670, 1458, 1415, 1239, 1093, 
1008, 970, 804, 745 cm-1. HRMS calcd for C16H34O2NaSi (M + Na)+: 309.2226, found 
309.2238. 
 
Procedure J was applied to HBCy2 (71.2 mg, 0.400 mmol), CH2Cl2 (0.55 mL), 1-hexyne 
(46 "L, 0.400 mmol), Et2Zn (0.20 mL, 0.40 mmol), EtZnOTf (122 mg, 0.500 mmol), (R)-
3-((triethylsilyl)oxy)-2-methylpropanal (67.1 mg, 0.332 mmol), and toluene (0.35 mL).  
The crude product was purified by flash chromatography (EtOAc:hexanes, 1:50 to 1:25) 
to afford the title compound as a clear oil (57.3 mg, 60% yield, dr 6.2:1). 
 
(3S,4R,E)-5-((Triethylsilyl)oxy)-1-(cyclohex-1-en-1-yl)-4-
methylpent-1-en-3-ol (2.54).  General Procedure I was applied 
to HBCy2 (102 mg, 0.572 mmol), CH2Cl2 (0.80 mL), 1-ethynylcyclohexene (65 "L, 
0.572 mmol), Et2Zn (0.29 mL, 0.58 mmol), EtZnONf (282 mg, 0.716 mmol), (R)-3-
((triethylsilyl)oxy)-2-methylpropanal (96.5 mg, 0.477 mmol), and toluene (0.51 mL). The 
crude product was purified by flash chromatography (EtOAc:hexanes, 1:50 to 1:25) to 
afford the title compound as a clear oil (116 mg, 78% yield, dr 9:1).  The product was 
characterized as a 9:1 mixture of diastereomers. 1H NMR (CDCl3, 500 MHz) major: ! 
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0.62 (q, 6H), 0.82 (d, J = 6.9 Hz, 3H), 0.97 (t, J = 8.1 Hz, 9H), 1.63 (m, 4H), 1.78 (m, 
1H), 2.12 (m, 4H), 3.59 (dd, J = 7.9 Hz, J = 10.0 Hz, 1H), 3.79 (dd, J = 4.2 Hz, J = 9.9 
Hz, 1H), 3.88 (d, J = 2.9 Hz, 1H), 4.04 (m, 1H), 5.53 (dd, J = 7.4 Hz, J = 15.8 Hz, 1H), 
5.74 (bs, 1H), 6.21 (d, J = 15.7 Hz, 1H). 13C{1H} (CDCl3, 125 MHz) major: ! 4.4, 6.9, 
13.8, 22.7, 22.7, 24.8, 26.1, 40.6, 68.2, 78.6, 127.2, 129.7, 135.1, 135.4. IR (neat): 3428, 
2876, 1650, 1625, 1458, 1414, 1240, 1092, 1011, 965, 803, 744 cm-1. HRMS calcd for 
C18H34N6NaSi (M + Na) +: 333.2226, found 333.2215. 
 
General Procedure J was applied to HBCy2 (102 mg, 0.572 mmol), CH2Cl2 (0.80 mL), 1-
ethynylcyclohexene (65 "L, 0.572 mmol), Et2Zn (0.29 mL, 0.58 mmol), EtZnOTf (174 
mg, 0.716 mmol), (R)-3-((triethylsilyl)oxy)-2-methylpropanal (96.5 mg, 0.477 mmol), 
and toluene (0.51 mL). The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (99.8 mg, 67% 
yield, dr 4.6:1). 
 
(2R,3S,E)-1-((Triethylsilyl)oxy)-2,6,6-trimethylhept-4-en-3-ol 
(2.55). General Procedure I was applied to HBCy2 (99.8 mg, 
0.560 mmol), CH2Cl2 (0.78 mL), 3,3-dimethyl butyne (70 "L, 
0.70 mmol), Et2Zn (0.28 mL, 0.56 mmol), EtZnONf (275 mg, 0.700 mmol), (R)-3-
((triethylsilyl)oxy)-2-methylpropanal (99.5 mg, 0.467 mmol), and toluene (0.50 mL). The 
crude product was purified by flash chromatography (EtOAc:hexanes, 1:50 to 1:25) to 
afford the title compound as a clear oil (95 mg, 71% yield, dr 18:1). The major 
diastereomer was characterized as a 18:1 mixture of diastereomers. 1H NMR (CDCl3, 500 
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MHz) major: ! 0.62 (q, 6H), 0.79 (d, J = 7.0 Hz, 3H), 0.97 (t, J = 8.1 Hz, 9H) 1.02 (s, 
9H), 1.75 (m, 1H), 3.58 (dd, J = 8.1 Hz, J =10.0 Hz, 1H), 3.79 (dd, J = 4.2 Hz, J = 10.0 
Hz, 1H), 3.94 (dd, J = 2.7 Hz, 7.5 Hz, 1H), 3.96 (d, J = 2.5 Hz, 1H), 5.35 (dd, J = 7.2 Hz, 
J = 15.6 Hz, 1H), 5.68 (dd, J = 0.74 Hz, J = 15.6 Hz, 1H). 13C{1H} (CDCl3, 125 MHz) 
major: ! 4.4, 6.9, 13.7, 29.8, 33.0, 40.3, 68.3, 78.9, 126.5, 143.9. IR (neat): 3436, 2910, 
2877, 1661, 1460, 1415, 1363, 1239, 1094, 1010, 974, 805, 744 cm-1. HRMS calcd for 
C16H34O2NaSi (M + Na)+: 309.2226, found 309.2236. 
 
General Procedure J was applied to HBCy2 (99.8 mg, 0.560 mmol), CH2Cl2 (0.78 mL), 
3,3-dimethyl butyne (70 "L, 0.70 mmol), Et2Zn (0.28 mL, 0.56 mmol), EtZnOTf (171 
mg, 0.700 mmol), (R)-3-((triethylsilyl)oxy)-2-methylpropanal (99.5 mg, 0.467 mmol), 
and toluene (0.50 mL). The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (60.8 mg, 45% 
yield, dr 10:1). 
 
(2R,3R,E)-1-((Triethylsilyl)oxy)-2,4,6,6-tetramethylhept-4-en-
3-ol (2.56).  General Procedure I was applied to HBCy2 (64.8 mg, 
0.364 mmol), CH2Cl2 (0.51 mL), 4,4-dimethyl-2-pentyne (49 "L, 0.364 mmol), Et2Zn 
(0.18 mL, 0.364 mmol), EtZnONf (179 mg, 0.455 mmol), (R)-3-((triethylsilyl)oxy)-2-
methylpropanal (61.3 mg, 0.303 mmol), and toluene (0.33 mL).  The crude product was 
purified by flash chromatography (EtOAc:hexanes, 1:50 to 1:25) to afford the title 
compound as a clear oil (68.8 mg, 76% yield, dr > 20:1).   = –21.2 (c = 0.920 
CHCl3). 1H NMR (CDCl3, 500 MHz): ! 0.63 (q, 6H), 0.68 (d, J = 7.0 Hz, 3H), 0.97 (t, J 
Me
OTESOH
t-Bu
Me
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= 8.0 Hz, 9H), 1.12 (s, 9H), 1.72 (d, J = 1.2 Hz, 3H), 1.85 (m, 1H), 3.58 (dd, J = 8.6 Hz, J 
= 9.8 Hz, 1H), 3.74 (dd, J = 1.4 Hz, J = 8.5 Hz, 1H), 3.78 (dd, J = 4.16 Hz, J = 10.0 Hz, 
1H), 4.16 (d, J = 1.7 Hz, 1H), 5.39 (s, 1H). 13C{1H} (CDCl3, 125 MHz): ! 4.4, 6.9, 12.0, 
13.8, 31.1, 32.4, 37.6, 69.1, 86.1, 134.4, 138.6. IR (neat): 3486, 2911, 2877, 1659, 1460, 
1364, 1237, 1091, 1006, 838, 797, 745 cm-1. HRMS calcd for C17H36O2NaSi (M + Na) +: 
323.2382, found 323.2394. 
 
General Procedure J was applied to HBCy2 (64.8 mg, 0.364 mmol), CH2Cl2 (0.51 mL), 
4,4-dimethyl-2-pentyne (49 "L, 0.364 mmol), Et2Zn (0.18 mL, 0.364 mmol), EtZnOTf 
(111 mg, 0.455 mmol), (R)-3-((triethylsilyl)oxy)-2-methylpropanal (61.3 mg, 0.303 
mmol), and toluene (0.33 mL).  The crude product was purified by flash chromatography 
(EtOAc:hexanes, 1:50 to 1:25) to afford the title compound as a clear oil (68.8 mg, 76% 
yield, dr 17.5:1). 
 
Preparation of the (S)-O-Mosher Ester of (2R,3S)-1-((tert-
Butyldimethylsilyl)oxy)-2-methylpentan-3-ol (2.71). General 
Procedure G was applied to (2R,3S)-1-((tert-butyldimethylsilyl)oxy)-
2-methylpentan-3-ol (10.7 mg, 0.046 mmol) and (R)-MTPA-Cl (15 "L, 0.082 mmol). 
The reaction stirred for 3 h. The crude product was purified by column chromatography 
on silica gel (2% EtOAc in hexanes to 5% EtOAc in hexanes) to give the desired product 
as a clear oil. 1H NMR (CDCl3, 500 MHz): ! 0.02 (s, 3H), 0.02 (s, 3H), 0.81 (t, J = 7.4 
Hz, 3H), 0.89 (s, 9H), 0.91 (d, J = 7.1 Hz, 3H), 1.60 (m, 1H), 1.68 (m, 1H), 2.03 (m, 1H), 
3.46 (dd, J = 6.4 Hz, 10.3 Hz, 1H), 3.54 (s, 3H), 3.55 (dd, J = 5.5 Hz, 10.3 Hz, 1H), 5.12 
Me
OTBSOO
F3C PhOMe
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(m, 1H), 7.50 (m, 3H), 7.55 (m, 2H). HRMS calcd for C22H36O4F3Si (MH)+: 449.2335, 
found 449.2348. 
 
Preparation of the (R)-O-Mosher Ester of (2R,3S)-1-((tert-
Butyldimethylsilyl)oxy)-2-methylpentan-3-ol (2.72). General 
Procedure G was applied to (2R,3S)-1-((tert-butyldimethylsilyl)oxy)-
2-methylpentan-3-ol (10.4 mg, 0.045 mmol) and (S)-MTPA-Cl (15 
!L, 0.082 mmol). The reaction stirred for 3 h. The crude product was purified by column 
chromatography on silica gel (2% EtOAc in hexanes to 5% EtOAc in hexanes) to give 
the desired product as a clear oil. 1H NMR (CDCl3, 500 MHz): " 0.00 (s, 3H), 0.00 (s, 
3H), 0.83 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.92 (t, J = 7.4 Hz, 3 H), 1.66 (m, 1H), 1.74 
(m, 1H), 2.01 (m, 1H), 3.38 (dd, J = 6.5 Hz, 10.0 Hz, 1H), 3.51 (dd, J = 5.7 Hz, 10.1 Hz, 
1H), 3.56 (d, J = 1.1 Hz, 1H), 5.11 (m, 1H), 7.40 (m, 3H), 7.56 (m, 2H). HRMS calcd for 
C22H35O4NaSiF3 (M + Na)+: 471.2154, found 471.2149 
 
Preparation of the (S)-O-Mosher Ester of (2R,3S)-1-((tert-
Butyldimethylsilyl)oxy)-2-methylheptan-3-ol (2.73). General 
Procedure G was applied to (2R,3S)-1-((tert-
butyldimethylsilyl)oxy)-2-methylheptan-3-ol (10.5 mg, 0.040 mmol) and (R)-MTPA-Cl 
(14 !L, 0.077 mmol). The reaction stirred for 18 h. The crude product was purified by 
column chromatography on silica gel (2% EtOAc in hexanes) to give the desired product 
as a clear oil. 1H NMR (CDCl3, 500 MHz): " 0.03 (s, 3H) 0.03 (s, 3H), 0.83 (t, J = 7.2 
Hz, 3H), 0.90 (s, 9H), 0.91 (d, J = 7.0 Hz, 3H), 1.20 (m, 4H), 1.58 (m, 2H), 2.04 (m, 1H), 
Me
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3.47 (dd, J = 6.2 Hz, 10.0 Hz, 1H), 3.56 (m, 4H), 5.20 (m, 1H), 7.41 (m, 3H), 7.56 (m, 
2H). HRMS calcd for C24H39O4F3NaSi (M + Na)+: 499.2467, found 499.2483. 
 
Preparation of the (R)-O-Mosher Ester of (2R,3S)-1-((tert-
Butyldimethylsilyl)oxy)-2-methylheptan-3-ol (2.74). General 
Procedure G was applied to (2R,3S)-1-((tert-
butyldimethylsilyl)oxy)-2-methylheptan-3-ol (9.3 mg, 0.035 mmol) and (S)-MTPA-Cl 
(14 !L, 0.077 mmol). The reaction stirred for 18 h. The crude product was purified by 
column chromatography on silica gel (2% EtOAc in hexanes) to give the desired product 
as a clear oil. 1H NMR (CDCl3, 500 MHz): " 0.01 (s, 3H), 0.01 (s, 3H), 0.83 (t, J = 6.9 
Hz, 3H), 0.89 (m, 12H), 1.29 (m, 4H), 1.65 (m, 2H), 2.01 (m, 1H), 3.39 (dd, J = 6.5 Hz, 
10.1 Hz, 1H), 3.51 (dd, J = 6.0 Hz, 10.1 Hz, 1H), 3.56 (s, 3H), 5.19 (m, 1H), 7.41 (m, 
3H), 7.56 (m, 2H). HRMS calcd for C24H39O4NaF3Si (M + Na)+: 499.2467, found 
499.2461. 
 
Preparation of the (S)-O-Mosher Ester of (2R,3R,E)-1-((tert-
Butyldimethylsilyl)oxy)-2,4,6,6-tetramethylhept-4-en-3-ol 
(2.75). General Procedure G was applied to (2R,3R,E)-1-((tert-
Butyldimethylsilyl)oxy)-2,4,6,6-tetramethylhept-4-en-3-ol (10.7 mg, 0.036 mmol) and 
(R)-MTPA-Cl (13 !L, 0.068 mmol). The reaction stirred for 18 h. The crude product was 
purified by column chromatography on silica gel (2% EtOAc in hexanes) to give the 
desired product as a clear oil. 1H NMR (CDCl3, 500 MHz): " 0.03 (s, 6H), 0.84 (d, J = 
7.0 Hz, 3H), 0.90 (s, 9H), 1.12 (s, 9H), 1.48 (s, J = 1.2 Hz, 3H), 1.97 (m, 1H) 3.56 (m, 
Me
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4H), 3.58 (dd, J = 3.1 Hz, 8.4 Hz, 1H), 5.13 (d, J = 10.2 Hz, 1H), 5.60 (J = 1.4 Hz, 1H), 
7.39 (m, 3H), 7.49 (m, 2H). HRMS calcd for C27H43O4F3NaSi (M + Na)+: 539.2780, 
found 539.2796. 
 
Preparation of the (R)-O-Mosher Ester of (2R,3R,E)-1-((tert-
Butyldimethylsilyl)oxy)-2,4,6,6-tetramethylhept-4-en-3-ol 
(2.76). General Procedure G was applied to (2R,3R,E)-1-((tert-
Butyldimethylsilyl)oxy)-2,4,6,6-tetramethylhept-4-en-3-ol (10.3 mg, 0.034 mmol) and 
(S)-MTPA-Cl (13 !L, 0.068 mmol). The reaction stirred for 18 h. The crude product was 
purified by column chromatography on silica gel (2% EtOAc in hexanes) to give the 
desired product as a clear oil. 1H NMR (CDCl3, 500 MHz): " 0.00 (s, 6H), 0.89 (d, J  = 
6.9 Hz, 3H), 0.89 (s, 9H), 1.14 (s, 9H), 1.69 (d, J = 1.1 Hz, 3H), 1.97 (m, 1H), 3.38 (dd, 
(J = 6.2 Hz, 9.7 Hz, 1H), 3.50 (dd, J = 3.1 Hz, 9.7 Hz, 1H), 3.53 (s, 3H), 5.20 (d, J = 10.2 
Hz, 1H), 5.65 (s, 1H), 7.38 (m, 3H), 7.48 (m, 2H). HRMS calcd for C27H43O4F3NaSi (M 
+ Na)+: 539.2780, found 539.2802. 
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!"#$%&'()*(Chelation-Controlled Addition of Organozincs to !-Silyloxy Ketones 
 
3.1 Introduction 
 The construction of quaternary stereogenic centers bearing an alcohol moiety 
remains an important aim in organic methodology.  One common approach to access this 
structural motif involves asymmetric addition of organometallic reagents to ketones.  
Despite many advances in this field, several drawbacks make these additions more 
challenging than their aldehyde counterparts.  Specifically, ketones are considerably less 
reactive than aldeydes.1 Furthermore, competitive enolization and reduction often result 
in lower yields.  Within this conceptual framework, vicinal diols containing one 
secondary and one tertiary carbinol are common scaffolds in found in natural products 
such as fostriecin2 (Figure 3.1).  Based on our previous studies3 involving chelation-
controlled additions to !-silyloxy aldehdyes, we set out to develop a complementary 
method to access syn 1,2-diols bearing a quaternary stereocenter via nucleophilic addition 
of organozinc reagents to chiral !-silyloxy ketones.  These additions are known to 
proceed via a non-chelation pathway to give anti diol products (Felkin model).4  
 
  
 
 
 
 
 
 
 
Figure 3.1 Structure of Fostriecin 
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In 1986, Reetz and coworkers demonstrated that MeTiCl3 could undergo 
additions to TBS-protected ketone 3.1 to afford chelation product 3.2 with modest dr of 
85:15 (Scheme 3.1).5 Similar diastereoselectivity was observed in the same reaction  
 
 
 
 
 
 
 
 
Scheme 3.1 Chelation-controlled methyl additions to !-silyloxy ketones by Reetz 
 
Table 3.1 Addition of dimethylmagnesium to !-silyloxy ketones by Frye and 
Eliel 
 
 
 
 
 
 
 
employing TMS-protected ketone 3.1.  Around the same time, Eliel and Frye performed a 
series of rate studies and also observed selectivity for the chelation product in additions 
of dimethylmagnesium to silyloxy ketone 3.4.6 As shown in Table 3.1, ketones bearing a 
MeTiCl3
Et2O, !10 °C
O
Me
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Et Me
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EtHO OHEt
chelation product Felkin product
Si(t-Bu)Me2
SiMe3
85 : 15
81 : 19
+
3.1 3.2 3.3
PG dr (3.5: 3.6)
99 : 1
96 : 4
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SiEt3
SiMe3
entry
1
3
2
O
Ph
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MgMe2
THF, !70 °C Me
OPG OPG
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3.4 3.5 3.6
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chelation Felkin
Si(t-Bu)Me2
PhHO Ph OH
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smaller silyl protecting group, such as TMS, gave very high diastereoselectivity (99:1 dr), 
favoring the chelation product.  As expected, the diastereoselectivity decreased as the size 
of the silyl protecting group increased.  Although both of these examples represent useful 
tools for application in synthesis, the scope with respect to ketone substrate and 
nucleophile were not explored.  With this in mind, we aimed to develop a general 
approach to promote chelation in additions of organozinc reagents to !-silyloxy ketones.     
 
3.2 Results and Discussion 
3.2.1 Addition of Dialkylzincs to !-Silyloxy Ketones 
 We first explored the reaction of diethylzinc with TBS-protected ketone 3.7.7  We 
perceived this reaction to be potentially more difficult than the reaction employing mixed 
vinylzinc reagents due to the significantly lower reactivity of dialkylzincs.  Gamze Koz, a 
former visiting student, optimized the reaction conditions for the dialkylzinc additions.   
As illustrated in Table 3.2, only a trace amount of product was formed in the absence of 
an EtZnX Lewis acid (entry 1).  Moreover, no diastereoselectivity was observed (dr = 
1:1).  When 2 equiv EtZnCl were added to the reaction, 77% conversion to chelation 
product 3.8 was achieved in excellent dr in 24 h at room temperature (dr > 20:1, entry 2).   
However, a considerable amount of ketone 3.7  (18%)  was converted to aldol side 
products.  Lowering the reaction temperature to 0 °C did not preclude the formation of 
aldol side products (Table 3.2, entry 4).  Reducing the reaction temperature to "15 °C 
resulted in less aldol side product formation (entry 4 vs 5).  Other zinc-based Lewis acids 
such as EtZnBr and EtZnOTf did not improve the yield or dr of the product (entries 6 and 
7).  Ultimately, when the amount of Lewis acid was increased to 3.5 equiv, excellent 
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diastereoselectivity was achieved and conversion to product 3.8 increased to 97%.  The 
relative stereochemistry of the product was ascertained by comparison of the 1H NMR 
spectrum to literature data8 and by comparison of the major product to that of the 
corresponding EtMgBr addition, which is know to favor the Felkin diastereomer 3.9.4 
   
 Table 3.2 Optimization of diethylzinc addition to ketone 3.7 
 
 Using the optimized reaction conditions (Table 3.2, entry 9), the addition of 
commercially available diethylzinc and di-n-butyl zinc were performed using a variety of 
TBS and TES protected ketones (Table 3.3).  Entry 1 is included for comparison.  When 
ZnEt2
EtZnX
O
Me
OTBS
Me
OTBS
Me
OTBS
MeHO OHMe
3.8
chelation product
3.9
Felkin product
+
entry X
3.7
3.7: EtZnX: Et2Zn solvent temp (°C) time (h) dr (3.8:3.9) 3.7 aldol 3.8 + 3.9
1
2
3
4
5
6
7
8
9
!
Cl
Cl
Cl
Cl
Br
OTf
Cl
Cl
1.0: 0: 1.5
1.0: 2.0: 1.5
1.0: 2.0: 1.5
1.0: 2.0: 1.5
1.0: 2.0: 1.5
1.0: 2.0: 1.5
1.0: 2.0: 1.5
1.0: 3.0: 1.5
1.0: 3.5: 1.5
toluene
toluene
CH2Cl2
toluene
toluene
toluene
toluene
toluene
toluene
!15
rt
0
0
!15
!15
!15
!15
!15
72
24
24
24
24
24
24
48
48
1:1
> 20: 1
> 20: 1
> 20: 1
> 20: 1
> 20: 1
> 20: 1
> 20: 1
6:1
> 95
5
3
3
13
24
93
5
1
!
18
30
16
4
10
!
2
2
< 5
77
67
81
83
65
7
93
97
a Remaining starting material, conversion, and dr (chelation:Felkin addition) based on GC analysis.
b Conversion of 2 mol of starting ketone to 1 mol of aldol side product, as by GC analysis.
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di-n-butylzinc was reacted with ketone 3.7, the reaction required 3.5 equiv of the 
nucleophile to achieve good yield of product 3.10 (86% yield, > 20:1 dr).  
 
Table 3.3 Diasteroselective alkyl addition to silyl-protected !-silyloxy ketones 
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entry ketone ZnR2b yield (%) drc product
3.7
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3.11
3.12
3.13
3.14
3.15
3.16
3.17
3.18
3.19
3.20
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a Equiv RZnX relative to ketone.  b 1.5 equiv ZnEt2 or 3.5 equiv Zn(n-Bu)2 were used.
c dr (Cram-chelation:Felkin) determined by 1H NMR or GC analysis of unpurified products.  Relative 
stereochemistry was determined by comparison to corresponding Grignard or organolithium addition.
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The addition of both Et2Zn and n-Bu2Zn to TES-protected analogue 3.11 furnished 
products 3.12 and 3.13, respectively, with excellent dr and good yields (Table 3.3, entries 
3 and 4). 
 Next, we explored the impact of changing the substituent at the 3-position of the 
ketone.  To this end, additions to ketones 3.14, 3.17, and 3.20 were performed.  As shown 
in Table 3.3, the reaction of TBS and TES-substituted phenyl ketones with Et2Zn and n-
Bu2Zn proceeded to furnish products with ! 20:1 dr in moderate to good yields (entries 
5"8).  Importantly, no erosion of ee was observed is these reactions (Table 3.3, entry 5, 
see Appendix A2).  Additionally, the reaction of benzyl-substituted ketone 3.20 with 
diethylzinc furnished diol 3.21 in 68% yield with > 20:1 dr.  In this case, the reaction was 
more sluggish than those employing ketones 3.11 and 3.17.  To confirm the relative 
stereochemistry of the major product for these reactions, the addition with the 
corresponding Grignard or organolithium reagent was performed for comparison.  In each 
case, the major product had a diastereomeric relationship with the major product obtained 
from the organozinc addition.   
 To further probe substrate scope with respect to the ketone, the #’-methyl 
substituent was replaced with n-butyl (Table 3.4).  The reaction of n-butyl ketone 3.22 
with diethylzinc gave less than 50% of addition product, even at room temperature.  This 
significant change in reactivity can be attributed to more steric hindrance of the n-butyl 
substituent and slightly lower electrophilicity of ketone 3.22.  After screening several 
reaction temperatures, we determined that performing the addition at 50 °C allowed full 
consumption of the ketone.  Surprisingly, the increased reaction temperature had no 
detrimental effect on the diastereoselectivity of the reaction and yielded 3.23 with > 20:1 
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dr, albeit in modest yield due to a considerable amount of aldol side product formation 
(Table 3.4, entry 1).  Additionally, when ketone 3.22 was reacted with dimethylzinc 
excellent diastereoselectivity was observed, favoring chelation product 3.24 with an 
improved yield of 81% with > 20:1 dr.  Notably, dimethylzinc reacts with carbonyl 
derivatives significantly slower than diethylzinc, but is still an effective nucleophile in 
this reaction.  It is also important to note that no erosion of enantiopurity was observed in 
this reaction, even at 50 °C.  
 
Table 3.4 Diastereoselective alkyl additions to n-butyl-substituted ketones 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
n-Bu
OPG
R2
ZnR2 (4 equiv)a
RZnCl (3.5 equiv)a
toluene, 50 °C
12!24 h
R
OPG
R2
O
n-Bu
OTBS
Me
O
n-Bu
OTES
Me
2
3
ZnEt2
ZnMe2
4
5
6
ZnEt2
ZnMe2
> 20: 1
> 20: 1
> 20: 1
O
n-Bu
OTBS
Ph
ZnEt2
ZnMe2
> 20: 1
> 20: 1
> 20: 1
chelation-control
(major product)
1
n-BuHO
54
81
51
86
56
77
entry ketone yield (%) drb product
3.22
3.23
3.24
3.25
3.26
3.27
3.28
3.29
3.30
ZnR2
a Equiv relative to ketone.  b  dr (chelation:Felkin) determined by  1H NMR or GC analysis of 
unpurified products.  Relative stereochemistry was  determined by comparison to 
corresponding Grignard or organolithium addition products.
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TES-protected ketone 3.25 underwent additions with Et2Zn and n-Bu2Zn to furnish 
chelation products 3.26 and 3.27, respectively, with > 20:1 dr in comparable yields to the 
TBS-protected ketone (entries 3 and 4).  Phenyl-substituted ketone 3.28 could also be 
employed in the reaction and similar yields and diastereoselectivity were observed (Table 
3.4, entries 5 and 6). 
 
3.2.2 Addition of Vinylzincs to !-Silyloxy Ketones 
 Tertiary allylic alcohols are common scaffolds of natural products and important 
intermediates in synthesis.9 Therefore, we turned our attention to developing a highly 
diasteroselective method for the addition of vinylzinc reagents to !-silyloxy ketones.  
The optimization and additions in Table 3.5 (entries 1"5) were perfromed by Gamze 
Koz.  My contribution to this part of the project was further optimization of the reaction 
and to explore the substrate scope with respect to the ketone substrate and vinylzinc 
reagent (Table 3.5 entries 6"10, Table 3.6 , and Scheme 3.2).  The vinylzinc reagents 
were generated in situ using the Oppolzer/Srebnik10 method as described for the additions 
to !- and #-silyloxy aldehydes.  Alkyne hydroboration with CyBH was followed by B to 
Zn transmetallation with Me2Zn and subsequent addition of the RZnX Lewis acid and 
ketone substrate.  
 After performing an extensive screen of solvents, temperatures, and amount of 
Lewis acid, we found that good diastereoselectivity and yields were obtained at "30 °C 
for the addition step in toluene employing 3 equiv EtZnCl.  As shown in Table 3.5, both 
TBS and TES-protected 3-hydroxybutanone underwent addition with a variety of (E)-di- 
   
 103!
Table 3.5 Diastereoselective generation of (E)-di and trisubstituted allylic alcohols 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R2
R1
i. Cy2BH, 0 °C to rt
   toluene
ii. Me2Zn, !78 °C
R1
R2
ZnMe
O
OPG
Me
EtZnCl (3 equiv)
!30 °C
  48!60 h
R1
R2 OPG
Me
TBS Hn-Bu
H
H
Met-Bu
Mei-Pr
TES Hn-Bu
H
Ht-Bu
Met-Bu
Mei-Pr
88 > 20: 1
81 > 20: 1
83 18 :1
78 > 20: 1
65 > 20: 1
91 > 20: 1
68 > 20: 1
64 > 20: 1
81 > 20: 1
> 20: 1
n-Bu
OTBS
Me
OTBS
Me
OTBS
Me
t-Bu
OTBS
Me
Me
i-Pr
OTBS
Me
Me
n-Bu
OTES
Me
OTES
Me
t-Bu
OTES
Me
t-Bu
OTES
Me
Me
i-Pr
OTES
Me
Me
1
2c,d
3
4e
5e
6
7
8
9e
10e 80
a 2 equiv vinyinc reagent generated relative to ketone.  b dr determined by 1H NMR 
of the unpurified product and refers to the ratio of chelation:Felkin addition products.
c reaction on 5 mmol scale.   d Relative stereochemistry determined by comparison to 
corresponding vinyllithium addition. e 2.5 equiv vinylzinc reagent generated relative to 
ketone.
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
entry alkyneaPG yield (%) drb major product
3.31
3.32
3.33
3.34
3.35
3.36
3.37
3.38
3.39
3.40
HO Me
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Table 3.6 Addition of (E)-vinylzincs to !-phenyl silyloxy ketones 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and trisubstituted vinylzinc reagents to afford chelation products with ! 18:1 dr and 
64"91% yield.  Furthermore, when the reaction in entry 2 was carried out on a 5 mmol 
scale with respect to the ketone, product 3.32 was formed as a single diastereomer in 81% 
yield. 
R2
R1
i. Cy2BH, 0 °C to rt
   toluene
ii. Me2Zn, !78 °C
R1
R2
ZnMe
O
OPG
Ph
EtZnCl (3 equiv)
!30 °C
  48!60h
R1
R2 OPG
Ph
TES H
Hn-Bu
Met-Bu
Me
Men-Bu
Met-Bu
71 > 20: 1
83 > 20: 1
63 > 20: 4
74 > 20: 1
76 > 20: 1
58 > 20: 1
OTES
Ph
n-Bu
OTES
Ph
t-Bu
OTES
Ph
OTBS
Ph
n-Bu
OTBS
Ph
t-Bu
OTES
Ph
1
2
3c
4d
5
6c
MeHO
MeHO
MeHO
MeHO
MeHO
MeHO
entry alkyneaPG yield (%) drb major product
3.41
3.42
3.43
3.44
3.45
3.46
TBS
Me
Me
a 2 equiv vinyzinc reagent generated relative to ketone.  b dr determined by 1H NMR of the 
unpurified product and refers to the ratio of chelation:Felkin addition products.  c 3 equiv 
vinylzinc reagent generated relative to ketone. d Relative stereochemistry determined by 
comparison to corresponding vinyllithium addition (see Appendix A2).
HO Ph
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Next, we explored reaction of vinylzinc reagents with ketones bearing a phenyl 
group at the !-position (Table 3.6).  Reaction of the TBS and TES-protected phenyl-
substituted ketones 3.14 and 3.17 with (E)-di- and trisubstituted vinylzinc reagents 
preceded with moderate to good yield and excellent diastereoselectivity.  Notably, no 
erosion of ee was observed when enantioenriched material was employed (entry 4, see 
Appendix A2).  Unfortunately, the corresponding n-butyl ketone was too unreactive and 
resulted in only trace amounts of product formation at low temperature.  
Given the excellent diastereoselectivties observed in the addition of (E)-vinylzinc 
reagents to !-silyloxy ketones in the presence of EtZnCl, we set out to determine whether 
(Z)-vinylzinc reagents could also be employed.  Synthetic methods to access 
stereodefined (Z)-allylic alcohols are even more challenging than the corresponding (E)-
allylic alcohols.  The (Z)-disubstituted vinylzinc reagents can be prepared according to 
our method.11 As described earlier, hydroboration of 1-bromoalkynes and addition of t-
BuLi as a hydride source initiates a 1,2-metallate to give the (Z)-vinylborane. After 
transmetallation, the (Z)-vinylzinc reagents add to aldehydes in the presence of a Lewis  
 
 
 
 
 
 
Scheme 3.2 Diasteroselective (Z)-vinylation of !-silyloxy ketone  
Br
R1
i. Et2BH, 0 °C to rt
   THF
ii. t-BuLi, !78 °C to rt 
ii. Me2Zn, !78 °C
    toluene
ZnMe
O
OTBS
Ph
EtZnCl (3 equiv)
!30 °C
48 h
OTBS
Ph
R1 R
1 MeHO
R1 = (CH2)4Cl 3.47
dr > 20:1, 58% yield
3.14
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acid.11a As shown in Scheme 3.2, when the (Z)-vinylzinc reagent was reacted with ketone 
3.14 in the presence of 3 equiv EtZnCl, syn-diol 3.47 was furnished in 58% yield with > 
20:1 dr. 
 At this point, evidence for chelation of silyloxy aldehydes and ketones by alkyl 
zinc halide Lewis acids was solely based on the diastereochemical outcome of the 
addition reactions and the observation of increased reaction rates in the presence of 
RZnX.  NMR spectroscopy, rapid injection NMR, and X-ray crystallography were 
utilized by other groups to provide evidence for a chelation pathway.12  In general, most 
of these studies were carried out with ketones, which are more stable in the presence of 
Lewis acids.  We decided to conduct a series of NMR binding studies of TBS-protected 
3-hydroxybutanone (3.7) with varying amounts of EtZnCl.  The 1H and 13C{1H} NMR 
spectra of 3.7 were recorded in CD2Cl2 before any Lewis acid was added as shown in 
Figure 3.2.  Upon addition of 1 equiv EtZnCl, a distinct downfield shift, !, was observed 
for the "-CH-OSi proton.  This is almost double the downfield shift seen for the "’-CH3 
protons.  If ketone 3.7 was bound to the EtZnCl in a monodentate fashion, ! values for 
the " and "’ protons would be expected to be similar.  The fact that "-CH-OSi proton 
experiences a greater ! supports EtZnCl binding both oxygen atoms of the substrate.  
Similarly, when 3 more equiv EtZnCl were added, the "-CH-OSi proton exhibits an 
overall ! twice that of the "’-CH3 protons (! = 0.72 ppm vs ! = 0.36 ppm).  
Significantly, when 4 equiv total of EtZnCl were added, the Me groups on SiMe2 become 
diastereotopic, splitting into two resonances that are 0.017 ppm apart.  In the 13C{1H}  
NMR spectrum, the "-CH#OSi shows a greater downfield shift than "’-CH3 (1.82 ppm 
vs 1.47 ppm, respectively).  These binding studies and the diastereoselectivities of the 
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addition reactions using alkylzinc halides collectively support the possibility of a chelated 
intermediate.    
 
 
 
 
 
 
 
 
 
A 1H NMR spectra in CD2Cl2 
     
 
3.7 
 
 
3.7 + 1 equiv EtZnCl 
 
 
3.7 + 4 equiv EtZnCl 
 
 
 
O
OSi(t-Bu)Me2
EtZnCl (1) 5.0 0.72 0.75 0.34 0.19
EtZnCl (4) 8.8 1.82 1.47 0.72 0.36
C=O (!) "'-C  (!) "-CH-O (!) "'-CH3 (!)LA (equiv )
H
"-C  (!)
"' "
3.7
O
OSi(t-Bu)Me2
H
#1 complex
Zn
Et
Cl O
OSi(t-Bu)Me2
H
Zn
chelate
Cl
R
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B 13C{1H} NMR spectra in CD2Cl2  
 
3.7 
 
 
3.7 + 1 equiv EtZnCl 
 
 
3.7 + 4 equiv EtZnCl 
 
 
Figure 3.2 1H and 13C{1H} binding studies of ketone 3.7 with EtZnCl 
 
 
3.3 Conclusions 
 In summary, we have developed a general method to achieve chelation-controlled 
additions to !-silyloxy ketones.  Dialkylzincs, (E)-di- and trisubstituted vinylzincs, and 
(Z)-trisubstituted vinylzinc reagents react with a variety of !-silyloxy ketones to afford 
chelation products with ! 18:1.  Moreover, enantioenriched ketones can be employed 
 109!
with no erosion of enantiopurity, even at 50 °C.  Preliminary binding studies with EtZnCl 
support the proposed chelation transition state.      
 
 
3.4 Experimental Sections 
General Methods.  All reactions were performed under a nitrogen atmosphere using 
oven-dried glassware and standard Schlenk or vacuum line techniques.  The progress of 
all reactions was monitored by thin-layer chromatography.  Toluene and dichloromethane 
were dried through alumina columns.  Racemic, chiral ketone derivatives were prepared 
by literature method; nucleophilic addition of Grignard or organolithium reagents to 
trans-2-methyl-2-butenal was followed by ozonolysis and protection.13    Enantiopure, 
chiral ketones were prepared from the enantiopure mandelic acid or methyl lactate 
according to literature procedure.14 Alkyl zinc halides were prepared by literature 
methods.15 All chemicals were obtained from Acros, Sigma-Aldrich, or GFS Chemicals 
unless otherwise described.  The 1H NMR and 13C{1H} NMR spectra were obtained 
using a Brüker AM-500 Fourier transform NMR spectrometer at 500 and 125 MHz, 
respectively.  Chemical shifts are reported in units of parts per million (ppm) downfield 
from tetramethylsilane and all coupling constants are reported in hertz.  The infrared 
spectra were obtained using a Perkin-Elmer 1600 series spectrometer.  Thin-layer 
chromatography was carried out on Whatman pre-coated silica gel 60 F-254 plates and 
visualized by ultra-violet light or by staining with ceric ammonium molybdate or 2,4-
dinitrophenylhydrazine stain.  Silica gel (230-400 mesh, Silicycle) was used for air-
flashed chromatography.  Analysis of diastereomeric ratios was performed by gas 
 110!
chromatograpy using a Hewlett-Packard 6990 or Agilent Technologies 7890A GC with a 
Beta-Dex or Chirasil-Dex Column or by 1H NMR of the crude reaction products.  
Analysis of enantiomeric excess was performed using a Hewlett-Packard 1100 series 
HPLC and Chiralcel OD-H or Chiralpak AD-H column.    High-resolution mass spectra 
were measured using a Waters 2695 Separations Module (1S0RR23444).  Relative 
stereochemistry was determined by comparison to literature values or comparison to 
corresponding Grignard or organolithium addition.  Vinyllithium16 reagents were made 
from the corresponding vinyliodides17 according to literature procedure.  
 
General Procedure A: Generation of 1,2-Syn Diols via Alkyl Addition to Chiral 
Ketones. A dry 10 mL Schlenk flask, which was evacuated and backfilled with N2 three 
times, was charged with the alkyl zinc chloride (1.75 mmol, neat solid), dialkylzinc (0.75 
mmol), and toluene (1 mL). The flask was then cooled to !15 °C followed by dropwise 
addition of ketone solution (0.5 mmol in 0.5 mL toluene). The reaction was monitored by 
TLC until completion. The reaction mixture was quenched with saturated aq. NH4Cl (2 
mL) followed by addition of Et2O (5 mL). The organic layer was separated and the 
aqueous solution extracted with Et2O (3 " 10 mL). The combined organic layers were 
successively washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo and purified by column chromatography on silica gel. 
 
General Procedure B: Generation of 1,2-Syn Diols via Alkyl Addition to Chiral 
Ketones.: A dry 10 mL Schlenk flask, which was evacuated and backfilled with N2 three 
times, was charged with the alkyl zinc chloride (2 mmol, neat solid), dialkylzinc (2 
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mmol), and toluene (1 mL). The ketone solution (0.5 mmol in 0.5 mL toluene) was then 
added dropwise followed by heating to 50 °C.  The reaction was monitored by TLC until 
completion. The reaction mixture was quenched with saturated aq. NH4Cl (2 mL) 
followed by addition of Et2O (5 mL). The organic layer was separated and the aqueous 
solution extracted with Et2O (3 ! 10 mL). The combined organic layers were 
successively washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo and purified by column chromatography on silica gel 
 
 (2SR,3SR)-2-(tert-butyldimethylsilyloxy)-3-Methylpentan-3-ol 
(3.8).8 General procedure A was applied to EtZnCl (226 mg, 
1.75mmol), Et2Zn (0.4 mL, 2M in toluene) and 3-((tert-
butyldimethylsilyl)oxy)butan-2-one (100 mg, 0.5 mmol). The crude product was purified 
by flash column chromatography on silica gel (hexanes/EtOAc, 99:1) to afford the title 
compound as an oil (105.2 mg, 91% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): " 0.08 
(s, 3H), 0.09 (s, 3H), 0.92 (m,12H), 1.05 (s, 3H), 1.11 (d, J = 6.3 Hz, 3H), 1.42!1.51 (m, 
2H), 2.22 (s, 1H), 3.68 (q, J = 6.3 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): " !4.7, !4.0, 8.1, 
18.2, 18.3, 20.9, 26.0, 41.4, 73.9, 74.8.  IR (neat): 3575, 3488, 2957, 2932, 2885, 2859, 
1472, 1463, 1389, 1376, 1254, 1107, 1092, 963, 836, 776 cm-1. HRMS calcd for 
C12H28O2NaSi (M+Na)+: 255.1756, found 255.1757. GC (condition 1): t = 13.0 min 
(major), t = 14.7 min (minor). 
 
Me
OTBS
HO Me
(±)
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 (2SR,3SR)-2-(tert-butyldimethylsilyloxy)-3-Methylheptan-3-ol 
(3.10). General procedure A was applied to BuZnCl (276 mg, 
1.75mmol), Bu2Zn (1.50 mL, 1M in pentanes) and 3-((tert-butyldimethylsilyl)oxy)butan-
2-one (100 mg, 0.5 mmol). The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 99:1) to afford the title compound as an 
oil (111.7 mg, 86% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.08 (s, 3H), 0.09 (s, 
3H), 0.90 (m,12H), 1.05 (s, 3H), 1.09 (d, J = 6.3 Hz, 3H), 1.29!1.43 (m, 6H), 2.26 (s, 
1H), 3.66 (q, J = 6.3 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.1, 14.0, 17.9, 18.0, 
20.8, 23.3, 25.6, 25.7, 38.5, 73.9, 74.3. IR (neat): 3575, 3488, 2957, 2933, 2859, 1472, 
1463, 1378, 1255, 1114, 1083, 967, 835, 776 cm-1. HRMS calcd for C14H31OSi (M!OH): 
243.2144, found 243.2143.  GC (condition 1): t = 23.0 min (major) t = 24.0 min (minor). 
 
 (2SR,3SR)-2-(triethylsilyloxy)-3-Methylpentan-3-ol (3.12). General 
procedure A was applied to EtZnCl (226 mg, 1.75mmol), Et2Zn (0.4 
mL, 2M in toluene) and 3-((triethylsilyl)oxy)butan-2-one (100 mg, 0.5 mmol). The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
99:1) to afford the title compound as an oil (111 mg, 96% yield, dr >20:1). 1H NMR (300 
MHz, CDCl3): ! 0.59!0.67 (q, J = 7.8 Hz, 6H), 0.92 (t, J = 7.5 Hz, 3H), 0.98 (t, J = 7.8 
Hz, 9H), 1.04 (s, 3H), 1.11 (d, J = 6.3 Hz, 3H), 1.44!1.49 (q, J = 7.5 Hz, 2H), 2.33 (s, 
1H), 3.66!3.72 (q, J = 6.3 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.4, 7.1, 8.1, 18.4, 
20.5, 31.4, 73.8, 74.7. IR (neat): 3572, 3485, 2959, 2941, 2913, 2879, 1459, 1414, 1377, 
1239, 1109, 1093, 1058, 1006, 961, 914, 745 cm-1. HRMS calcd for C12H28O2NaSi  
(M+Na)+: 255.1756, found 255.1759. GC: t= 19 min (major). 
Me
OTBS
HO Me
(±)
Me
OTES
HO Me
(±)
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 (2SR,3SR)-3-Methyl-2-((triethylsilyl)oxy)heptan-3-ol (3.13). . 
General procedure A was applied to BuZnCl (276 mg, 
1.75mmol), Bu2Zn (1.50 ml, 1M in pentanes) and 3-((triethylsilyl)oxy)butan-2-one  (100 
mg, 0.5 mmol). The crude product was purified by flash column chromatography on 
silica gel (hexanes:toluene, 1:1) to afford the title compound as an oil (101 mg, 78% 
yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.62 (q, J = 7.9 Hz, 6H), 0.91 (t, J = 7.2 
Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H), 1.09 (s, 3H), 1.10 (d, J = 6.4 Hz, 3H), 1.28!1.56 (m, 
6H), 2.35 (s, 1H), 3.68 (q, 6.4 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.4, 7.1, 14.3, 
18.4, 21.0, 23.7, 25.9, 38.8, 74.1, 74.6.  IR (neat): 3442, 2958, 2927, 1463, 1272, 1121, 
1073, 1016, 965 cm-1. HRMS calcd for C14H32O2NaSi  (M+Na)+: 283.2072, found 
283.2061. 
 
 (1SR,2SR)-1-((tert-butyldimethylsilyl)oxy)-2-Methyl-1-
phenylbutan-2-ol(3.15). General procedure A was applied to EtZnCl 
(226 mg, 1.75mmol), Et2Zn (0.4 mL, 2M in toluene) and 1-((tert-
butyldimethylsilyl)oxy)-1-phenylpropan-2-one (139 mg, 0.5 mmol). The crude product 
was purified by flash column chromatography on silica gel (hexanes:EtOAc, 98:2) to 
afford the title compound as an oil (130 mg, 88% yield, dr >20:1).  1H NMR (500 MHz, 
CDCl3): ! !0.27 (s, 3H), 0.04 (s, 3H), 0.90 (s, 9H), 0.92!0.96 (m, 6H), 1.43!1.54 (m, 
2H), 2.30 (s, 1H), 4.46 (s, 1H), 7.24!7.31 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! !5.0, 
!4.3, 8.1, 18.4, 21.0, 26.1, 31.2, 75.3, 81.0, 127.6, 127.8, 128.2, 141.3.  IR (neat): 3588, 
Me
OTES
HO Me
(±)
Ph
OTBS
HO Me
(±)
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3480, 1463, 1258, 1162, 1087, 1066, 1005, 924, 865, 777, 702 cm-1.    HRMS calcd for 
C17H30O2Si  (M+Na)+: 317.1915, found 317.1924.  
 
 (1SR,2SR)-1-((tert-butyldimethylsilyl)oxy)-2-Methyl-1-
phenylhexan-2-ol (3.16).  General procedure A was applied to 
BuZnCl (276 mg, 1.75mmol), Bu2Zn (1.50 ml, 1M in pentanes) 
and 1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-one (139 mg, 0.5 mmol). The 
crude product was purified by flash column chromatography on silica gel 
(hexanes:toluene, 1:1) to afford the title compound as an oil (131 mg, 81% yield, dr 
>20:1). 1H NMR (500 MHz, CDCl3): ! !0.27 (s, 3H), 0.04 (s, 3H), 0.88!0.92 (m, 12H), 
0.96 (s, 3H), 1.26!1.47 (m, 6H), 2.36 (s, 1H), 4.45 (s, 1H), 7.25!7.31 (m, 5H). 1H NMR 
(500 MHz, CDCl3): ! !5.0, !4.3, 14.4, 18.4, 21.7, 23.6, 26.0, 26.1, 38.7, 75.2, 81.2, 
127.6, 127.8, 128.2, 141.3.  IR (neat): 3575, 3479, 2955, 2931, 2859, 1463, 1388, 1361, 
1253, 1093, 1064, 867, 837, 777, 702, 675 cm-1.    HRMS calcd for C17H34O2NaSi  (M + 
Na)+: 345.2228, found 345.2218.   
 
 (1SR,2SR)-2-Methyl-1-phenyl-1-((triethylsilyl)oxy)butan-2-ol 
(3.18). General procedure A was applied to EtZnCl (226 mg, 
1.75mmol), Et2Zn (0.4 mL, 2M in toluene) and 1-phenyl-1-((triethylsilyl)oxy)propan-2-
one (139 mg, 0.5 mmol). The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 97:3) to afford the title compound as an 
oil (125 mg, 85% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.46!0.53 (m, 6H), 
0.86 (t, J = 8.0 Hz, 9H), 0.93 (s, 3H), 0.94 (t, J = 7.5 Hz, 3H), 1.42!1.56 (m, 2H), 2.40 (s, 
Ph
OTBS
HO Me
(±)
Ph
OTES
HO Me
(±)
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1H), 4.48 (s, 1H), 7.24!7.33 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! 5.0, 6.9, 8.1, 21.0, 
32.3, 75.2, 80.8, 127.6, 127.8, 128.1, 141.5.  IR (neat): 3480, 2957, 2912, 1454, 1376, 
1240, 1163, 1089, 1066, 1007, 934 cm-1.    HRMS calcd for C17H30O2Si  (M+Na)+: 
317.1915, found 317.1905. 
 
 (1SR,2SR)-2-Methyl-1-phenyl-1-((triethylsilyl)oxy)hexan-2-ol 
(3.19).  General procedure A was applied to BuZnCl (276 mg, 
1.75mmol), Bu2Zn (1.50 mL, 1M in pentanes) and 1-phenyl-1-((triethylsilyl)oxy)propan-
2-one (139 mg, 0.5 mmol). The crude product was purified by flash column 
chromatography on silica gel (hexanes:toluene, 1:1) to afford the title compound as an oil 
(126 mg, 78% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.49 (qd, J = 7.6 Hz, J = 
3.3 Hz, 6H), 0.86 (t, J = 7.6 Hz, 9H), 0.90 (t, J = 7.6 Hz, 3H), 0.94 (s, 3H), 1.26!1.49 (m, 
6H), 2.45 (s, 1H), 4.47 (s, 1H), 7.25!7.32 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! 5.0, 
6.9, 14.4, 21.6, 23.6, 26.0, 38.7, 75.1, 81.0, 127.6, 127.8, 128.1, 141.5.  IR (neat): 3570, 
3480, 1454, 1413, 1379, 1239, 1155, 1095, 1064, 1007, 856, 808, 742, 702 cm-1.    
HRMS calcd for C19H34O2NaSi  (M+Na)+: 345.2228, found 345.2239. 
 
 (2SR,3SR)-3-Methyl-1-phenyl-2-((triethylsilyl)oxy)pentan-3-ol 
(3.21). General procedure A was applied to EtZnCl (226 mg, 
1.75mmol), Et2Zn (0.4 mL, 2M in toluene) and 4-phenyl-3-((triethylsilyl)oxy)butan-2-
one (140 mg, 0.5 mmol). The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 97:3) to afford the title compound as an 
oil (105 mg, 68% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.28!0.35 (m, 6H), 
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0.83 (t, J = 8.0 Hz, 9H), 0.96 (t, J = 7.5 Hz, 3H), 1.13 (s, 3H), 1.49!1.55 (m, 2H), 2.09 (s, 
1H), 2.56 (dd, J = 8.5 Hz, J = 9.0 Hz, 1H), 2.88 (dd, J = 14.0 Hz, J = 3.5 Hz, 1H), 3.84 
(dd, J = 9.0 Hz, J = 3.5 Hz, 1H), 7.18!7.29 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! 5.3, 
7.2, 8.0, 21.5, 31.6, 39.7, 75.0, 80.3, 126.4, 128.5, 129.8, 140.0.  IR (neat): 3479, 2913, 
1605, 1456, 1377, 1239, 1097, 1006, 949 cm-1. HRMS calcd for C18H32O2NaSi  
(M+Na)+: 331.2072, found 331.2080. 
 
(S)-2-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-Methylpropan-
amide (3.48). The reaction was conducted according to literature 
procedure14b by combining the following reagents: (S)-methyl 2-
hydroxypropanoate (3.7 mL, 39 mmol), N,O-dimethylhydroxylamine hydrochloride (19 
g, 194 mmol), and trimethylaluminum (97 mL, 2M in toluende). The crude product was 
used without further purification.  The resulting compoud, (S)-2-hydroxy-N-methoxy-N-
methylpropanamide (2 g, 15 mmol), was combined with imidazole (1.5 g, 22.5 mmol), 
and tert-butylchlorodimethylsilane  (2.5 g, 16.5 mmol) according to literature 
procedure.14b The crude product was purified by column chromatography on silica gel 
(hexanes:EtOAc, 4:1) to yield the title compound (3.5 g, 95% yield) as an oil.   = 
23.5 (c = 1.5, CHCl3).  1H NMR (500 MHz, CDCl3): ! 0.08 (s, 3H), 0.10 (s, 3H), 0.9 (s, 
9H), 1.36 (d, J = 7.0 Hz, 3H), 3.21 (s, 3H), 3.70 (s, 3H), 4.65!4.70 (m, 1H).  13C{1H} 
(CDCl3, 125 MHz): ! !4.8, !4.5, 18.6, 21.1, 25.9, 26.0, 61.4, 77.2.  IR (neat): 2931, 
1682, 1472, 1388, 1332, 1253, 1156, 1106, 997, 970, 834, 778 cm-1. HRMS calcd for 
C11H26NO3Si  (M+H)+: 248.1683, found 248.1681. 
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 (S)-N-methoxy-N-Methyl-2-((triethylsilyl)oxy)propanamide (3.49).  
The reaction was conducted according to literature procedure14b by 
combining the following reagents: The resulting compoud, (S)-2-
hydroxy-N-methoxy-N-methylpropanamide (1.5 g, 11.3 mmol), was combined with 
imidazole (1.2 g, 17 mmol), and triethylchlorosilane  (2.3 mL, 13.5 mmol). The crude 
product was purified by column chromatography on silica gel (hexanes:EtOAc, 4:1) to 
yield the title compound (2.6 g, 95% yield) as an oil.   = 18.0 (c = 1.4, CHCl3).  1H 
NMR (500 MHz, CDCl3): ! 0.63 (q, J  = 6.7 Hz, 6H), 0.96 (t, J  = 8.1 Hz, 9H), 1.37 (d, J 
= 6.7 Hz, 3H), 3.20 (s, 3H), 3.71 (s, 3H), 4.67!4.71 (m, 1H).  13C{1H} (CDCl3, 125 
MHz): ! 4.9, 6.0, 6.8, 6.9, 21.2, 61.4, 77.2.  IR (neat): 2955, 2877, 1682, 1460, 1415, 
1239, 1155, 1104, 1002, 787, 742 cm-1. HRMS calcd for C11H26NO3Si  (M+H)+: 
248.1683, found 248.1676. 
 
(S)-2-((tert-butyldimethylsilyl)oxy)Heptan-3-one (3.50).  A dry 
25 mL Schlenk flask, which was evacuated and backfilled with 
N2 three times, was charged with (S)-2-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-
methylpropanamide (1.5 g, 6 mmol) and Et2O (15 mL).  After cooling the flask to !78 
°C, n-BuLi (2.9 mL, 2.5M in hexanes) was added slowly.  The reaction was monitored by 
TLC until completion. The reaction mixture was quenched with saturated aq. NH4Cl (2 
mL) followed by addition of Et2O (5 mL). The organic layer was separated and the 
aqueous solution extracted with Et2O (3 " 10 mL). The combined organic layers were 
successively washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo and purified by column chromatography on silica gel 
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(hexanes:EtOAc, 97:3) to yield the title compound (1.26 g, 86% yield) as an oil.   = 
!7.8 (c = 1.0, CHCl3).  1H NMR (500 MHz, CDCl3): ! 0.08 (s, 6H), 0.91 (t, J = 7.5 Hz, 
3H), 0.92 (s, 9H), 1.27 (d, J = 6.9Hz, 3H), 1.31 (s, J  = 7.9 Hz, 2H), 1.54 (q, J = 7.8Hz, 
2H), 2.50!2.64 (m, 2H), 4.13 (q, J = 7.0 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! !4.8, 
!4.5, 14.1, 19.3, 21.1, 22.6, 25.5, 25.9, 36.8, 75.1, 214.6.  IR (neat): 2957, 2932, 2859, 
1719, 1464, 1365, 1257, 1121, 933, 836, 778 cm-1. HRMS calcd for C12H25O2Si  
(M!CH3): 229.1513, found 229.1618. 
 
 (S)-2-((triethylsilyl)oxy)Heptan-3-one (3.51). The reaction was 
conducted according to the procedure above by combining the 
following reagents: (S)-N-methoxy-N-methyl-2-((triethylsilyl)-
oxy)propanamide (1g, 4 mmol) and n-BuLi (2 mL, 2.5M in hexanes).  The crude product 
was purified by column chromatograph on silica gel (hexanes:EtOAc, 97:3) to yield the 
title compound (880 mg, 90% yield)as an oil.   = !7.5 (c = 1.1, CHCl3).  1H NMR 
(500 MHz, CDCl3): ! 0.62 (q, J = 8.1 Hz, 6H), 0.91 (t, J = 7.5 Hz, 3H), 0.96 (t, J =7.9 
Hz, 9H), 1.28 (d, J = 7.0 Hz, 3H), 1.29!1.35 (m, 2H), 1.51!1.57 (m, 2H), 2.53!2.62 (m, 
2H), 4.15 (q, J = 6.9 Hz, 1H).  13C{1H} (CDCl3, 125 MHz): ! 5.0, 6.9, 14.1, 21.2, 22.6, 
25.6, 35.6, 74.9, 214.6.  IR (neat): 2958, 2877, 1719, 1459, 1240, 1171, 1121, 1008, 930, 
744 cm-1. HRMS calcd for C11H23O2Si  (M!C2H5): 215.1246, found 215.1465. 
 
(S)-1-((tert-butyldimethylsilyl)oxy)-1-Phenylhexan-2-one 
(3.52). The reaction was conducted according to the procedure 
Me
OTES
O(!)
Ph
OTBS
O(!)
 119!
above by combining the following reagents: (S)-2-((tert-butyldimethylsilyl)oxy)-N-
methoxy-N-methyl-2-phenylacetamide18 (520mg, 1.68 mmol) and n-BuLi (0.74 mL, 
2.5M in hexanes).  The crude product was purified by column chromatograph on silica 
gel (hexanes:EtOAc, 97:3) to yield the title compound (484 mg, 94% yield) as an oil.  
 = !56.3 (c = 1.2, CHCl3).  1H NMR (500 MHz, CDCl3): ! !0.02 (s, 3H), 0.07 (s, 
3H), 0.79 (t, J = 7.5 Hz, 3H), 0.94 (s, 9H), 1.16 (s, J = 7.5 Hz, 2H), 1.37!1.47 (m, 2H), 
2.39!2.46 (m, 1H), 2.56!2.62 (m, 1H), 5.06 (s, 1H), 7.24!7.42 (m, 5H).  13C{1H} 
(CDCl3, 125 MHz): ! !4.9, !4.7, 13.9, 18.4, 22.4, 25.5, 26.0, 35.8, 81.4, 126.0, 128.1, 
128.6, 139.0, 210.9.  IR (neat): 3097, 3064, 2956, 2859, 1719, 1492, 1471, 1255, 1103, 
1069, 870, 779 cm-1. HRMS calcd for C18H31O2Si  (M+H)+: 307.2094, found 307.2084. 
 
 (2S,3R)-2-((tert-butyldimethylsilyl)oxy)-3-Ethylheptan-3-ol 
(3.23).8  General procedure B was applied to EtZnCl (207 mg, 
1.75mmol), Et2Zn (0.8 mL, 2M in toluene) and (S)-2-((tert-butyldimethyl-
silyl)oxy)heptan-3-one (100 mg, 0.4 mmol). The crude product was purified by flash 
column chromatography on silica gel (hexanes:toluene, 4:1) to afford the title compound 
as an oil (59 mg, 54% yield, dr >20:1).   = 17.7 (c = 0.542, CHCl3).    1H NMR (500 
MHz, CDCl3): ! 0.07 (s, 3H), 0.09 (s, 3H), 0.86 (t, J = 7.5 Hz, 3H), 0.90 (s, 9H), 0.91 (t, 
J = 7.2 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 1.26!1.37 (m, 4H), 1.47!1.54 (m, 4H), 2.13 (s, 
1H), 3.72 (q, J = 6.10 Hz, 1H).  13C{1H} (CDCl3, 125 MHz): ! !4.7, !3.8, 8.1, 14.3, 17.9, 
18.2, 23.8, 25.7, 26.1, 28.7, 33.4, 72.7, 76.0.  IR (neat): 2956, 2859, 1463, 1376, 1255, 
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1099, 974, 834, 775 cm-1. HRMS calcd for C11H25O2Si  (M!C4H9): 217.1751, found 
217.1626. GC (condition 2): t = 37.2 min (major), t = 36.9 min (minor). 
 
 
(2S,3R)-2-((tert-butyldimethylsilyl)oxy)-3-Methylheptan-3-ol 
(3.24). General procedure B was applied to MeZnCl (201 mg, 
1.75mmol), Me2Zn (0.8 mL, 2M in toluene) and (S)-2-((tert-
butyldimethylsilyl)oxy)heptan-3-one (100 mg, 0.4 mmol). The crude product was 
purified by flash column chromatography on silica gel (hexanes:toluene, 4:1) to afford 
the title compound as an oil (84 mg, 81% yield, dr >20:1).  = 10.6 (c = 1.1, CHCl3).    
1H NMR (500 MHz, CDCl3): ! 0.08 (s, 3H), 0.09 (s, 3H), 0.90 (s, 9H), 0.91 (t, J = 7.3 
Hz, 3H), 1.09!1.12 (m, 6H), 1.24!1.41 (M, 6H), 2.17 (s, 1H), 3.62 (q, J = 6.6 Hz, 1H).  
13C{1H} (CDCl3, 125 MHz): ! !4.7, !3.8, 14.3, 18.1, 18.2, 23.7, 23.8, 25.9, 26.1, 36.5, 
74.5, 75.1.  IR (neat): 3478, 2956, 2931, 2859, 1471, 1377, 1255, 1115, 835, 776, 667 
cm-1. HRMS calcd for C14H31OSi  (M!OH): 243.2099, found 243.2133.  GC (condition 
2): t = 26.6 min (major), t = 25.8 min (minor). 
 
 (2S,3R)-3-ethyl-2-((triethylsilyl)oxy)Heptan-3-ol (3.26). General 
procedure B was applied to EtZnCl (207 mg, 1.75mmol), Et2Zn (0.8 
mL, 2M in toluene) and (S)-2-((triethylsilyl)oxy)heptan-3-one (100 
mg, 0.4 mmol). The crude product was purified by flash column chromatography on 
silica gel (hexanes:toluene, 4:1) to afford the title compound as an oil (56 mg, 51% yield, 
dr >20:1).  = 13.1 (c = 1.08, CHCl3).    1H NMR (500 MHz, CDCl3): ! 0.62 (q, J = 
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7.7 Hz, 6H), 0.86 (t, J = 7.4 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 
1.11 (d, J = 6.7 Hz, 3H), 1.25!1.34 (m, 4H), 1.47!1.53 (m, 4H), 2.19 (s, 1H), 3.74 (q, J = 
6.7 Hz, 1H).  13C{1H} (CDCl3, 125 MHz): ! 5.4, 7.1, 8.1, 14.3, 17.9, 23.8, 25.7, 28.6, 
33.3, 72.6, 75.9.  IR (neat): 2957, 2877, 1460, 1377, 1239, 1116, 1006, 946, 791, 744 cm-
1. HRMS calcd for C15H34O2Si  (M!OH): 257.2255, found 257.2285. 
 
(2S,3R)-3-methyl-2-((triethylsilyl)oxy)Heptan-3-ol (3.27). General 
procedure B was applied to MeZnCl (201 mg, 1.75mmol), Me2Zn (0.8 
mL, 2M in toluene) and (S)-2-((triethylsilyl)oxy)heptan-3-one (100 mg, 
0.4 mmol). The crude product was purified by flash column chromatography on silica gel 
(hexanes:toluene, 4:1) to afford the title compound as an oil (90 mg, 86% yield, dr 
>20:1).  = 19.7 (c = 1.1, CHCl3).    1H NMR (500 MHz, CDCl3): ! 0.62 (q, J = 8.2 
Hz, 6H), 0.92 (t, J = 7.4 Hz, 3H), 0.97 (t, J = 7.8 Hz, 9H), 1.11 s, 3H), 1.12 (d, J = 6.7 
Hz, 3H), 1.24!1.51 (m, 6H), 2.25 (s, 1H), 3.65 (q, J = 6.1 Hz, 1H).  13C{1H} (CDCl3, 125 
MHz): ! 5.3, 7.1, 14.3, 18.1, 23.70, 23.73, 25.9, 36.3, 74.5, 75.1.  IR (neat): 3477, 2939, 
2876, 1459, 1377, 1239, 1116, 1008, 980, 782, 726 cm-1. HRMS calcd for C14H31OSi  
(M!OH): 243.2099, found 243.2142. 
 
 (R)-3-((S)-((tert-butyldimethylsilyl)oxy)(phenyl)methyl)Heptan-3-
ol (3.29). General procedure B was applied to EtZnCl (207 mg, 
1.75mmol), Et2Zn (0.8 mL, 2M in toluene) and (S)-1-((tert-
butyldimethylsilyl)oxy)-1-phenylhexan-2-one (123 mg, 0.4 mmol). The crude product 
was purified by flash column chromatography on silica gel (hexanes:toluene, 4:1) to 
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afford the title compound as an oil (75 mg, 56% yield, dr >20:1).  = 40.8 (c = 1.95, 
CHCl3).    1H NMR (500 MHz, CDCl3): ! !0.30 (s, 3H), 0.03 (s, 3H), 0.82 (t, J = 7.7 Hz, 
3H), 0.89 (s, 9H), 0.92 (t, J =  7.5 Hz, 3H), 1.11!1.24 (m, 6H), 1.54!1.66 (m, 2H), 2.23 
(s, 1H), 4.52 (s, 1H), 7.24!7.32 (m, 5H).  13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.2, 8.4, 
14.2, 18.3, 23.5, 25.4, 26.1, 28.6, 33.6, 76.8, 79.1, 127.6, 127.8, 128.4, 141.1.  IR (neat): 
3572, 2956, 2854, 1246, 1388, 1252, 1086, 866, 777, 701 cm-1. HRMS calcd for 
C15H33OSi  (M!OH): 319.2412, found 319.2470. 
 
 (1S,2R)-1-((tert-butyldimethylsilyl)oxy)-2-Methyl-1-phenylhexan-2-
ol (3.30).  General procedure B was applied to MeZnCl (201 mg, 
1.75mmol), Me2Zn (0.8 mL, 2M in toluene) and (S)-2-((tert-
butyldimethylsilyl)oxy)heptan-3-one (99 mg, 0.4 mmol). The crude product was purified 
by flash column chromatography on silica gel (hexanes:toluene, 4:1) to afford the title 
compound as an oil (84 mg, 77% yield, dr >20:1).  = 49.3 (c = 1.993, CHCl3).    1H 
NMR (500 MHz, CDCl3): ! !0.27 (s, 3H), 0.04 (s, 3H), 0.86 (t, J = 7.2 Hz, 3H), 0.90 (s, 
9H), 1.13 (s, 3H), 1.25!1.30 (m, 4H), 1.38!1.44 (m, 2H), 2.09 (s, 1H), 4.46 (s, 1H), 
7.25!7.33 (m, 5H).   13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.3, 14.3, 18.4, 23.4, 23.6, 
25.7, 26.1, 36.7, 75.1, 82.0, 127.6, 127.8, 128.3, 141.1.  IR (neat): 3466, 2955, 2859, 
1463, 1387, 1257, 1092, 867, 777, 702, 673 cm-1. HRMS calcd for C19H33OSi  (M!OH): 
305.2255, found 305.2310. 
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General Procedure C: Generation of (E)-Di- and (E)-Trisubstituted Allylic Alcohols 
via Addition to Chiral Ketones. A dry 10 mL Schlenk flask, which was evacuated under 
vacuum and backfilled with N2 (g) three times, was charged with dicyclohexylborane 
(Cy2BH) (125 mg, 0.7 mmol) and toluene (1.5 mL).  The solution was cooled to 0 °C 
followed by slow addition of alkyne (0.7 mmol).  After 5 min the reaction was warmed to 
room temperature and stirred for an additional 15 min.  The solution was cooled to !78 
°C and dimethylzinc (Me2Zn) (0.4 mL, 2M in toluene) was added.  After stirring at !78 
°C for 30 minutes, the reaction flask was warmed to !30 °C and EtZnCl (1.05 mmol) was 
added under a steady flow of N2 (g).  Immediately thereafter, the ketone (0.35 mmol, in 
0.2 mL toluene) was added.  The reaction mixture stirred at !30 °C and was monitored by 
TLC until completion (usually 36!48  h).  The reaction mixture was quenched with 
saturated aq. NH4Cl (2 mL) and 2N HCl (1 mL) followed by addition of  5 mL Et2O.  
The organic layer was separated and the aqueous layer was extracted successively with 
Et2O (2 " 5 mL).  The combined organic layers were successively washed with aq. 
NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was concentrated in 
vacuo and purified by column chromatography on silica gel 
 
  (2SR,3SR,E)-2-(tert-butyldimethylsilyloxy)-3-Methylnon-4-
en-3-ol (3.31). General procedure C was applied to Cy2BH 
(125 mg, 0.7 mmol), 1-hexyne (81 µL, 0.70 mmol), Me2Zn 
(0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((tert-
butyldimethylsilyl)oxy)butan-2-one (71 mg, 0.35 mmol).  The crude product was purified 
by flash column chromatography on silica gel (hexanes) to afford the title compound as 
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an oil (88 mg, 88% yield, dr >20:1). 1HNMR (300 MHz, CDCl3) ! 0.07(s, 3H), 0.08 (s, 
3H), 0.90 (m,12H), 1.09 (d, J = 6.3 Hz, 3H), 1.17 (s, 3H), 1.31!1.36 (m, 4H), 2.01!2.05 
(m, 2H), 2.43 (s, 1H), 3.62 (q, J = 6.0 Hz, 1H), 5.46 (d, J = 15.6 Hz, 1H), 5.64!5.74 (td, J 
= 15.6 Hz, J = 6.6 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! !4.7, !4.0, 14.2, 18.2, 18.3, 
22.4, 22.5, 26.0, 31.6, 32.3, 74.9, 75.0, 129.9, 134.9. IR (neat) 3563, 3478, 2957, 2930, 
2858, 1471, 1463, 1376, 1362, 1255, 1090, 973, 836, 776, 669 cm-1. HRMS calcd for 
C16H34O2NaSi (M+Na)+: 309.2226, found 303.2229. 
 
 (3SR,4SR,E)-4-(tert-butyldimethylsilyloxy)-1-Cyclopropyl-3-
methylpent-1-en-3-ol (3.32). General procedure C was applied 
to Cy2BH (1.8 g, 5 mmol), cyclopropylacetylene (847 µL, 0.70 
mmol), Me2Zn (5 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((tert-
butyldimethylsilyl)oxy)butan-2-one (1.0 g, 5 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 98:2) to afford the title 
compound as an oil (1.1 g, 81% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.07 (s, 
3H), 0.08 (s, 3H), 0.34!0.38 (m, 2H), 0.67!0.71 (m, 2H), 0.90 (s, 9H), 1.10 (d, J = 6.0 
Hz, 3H), 1.15 (s, 3H), 1.36!1.39 (m, 1H), 2.43 (s, 1H), 3.58!3.65 (q, J = 6.3 Hz, 1H), 
5.19 (dd, J = 15.6 Hz, J = 8.7 Hz, 1H), 5.53 (d, J = 15.6, 1H). 13C{1H} (CDCl3, 125 
MHz): ! !4.6, !4.0, 6.7, 6.8, 13.9, 18.2, 18.3, 22.4, 26.0, 74.8, 74.9, 132.7, 133.4. IR 
(neat) 3558, 3474, 3082, 2956, 2931, 2885, 2859, 1472, 1463, 1255, 1090, 967, 835, 812, 
776 cm-1.  HRMS calcd for C15H30O2NaSi (M+Na)+: 293.1913, found 293.1918.  
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  (3SR,4SR,E)-4-(tert-butyldimethylsilyloxy)-1-
Cyclohexenyl-3-methylpent-1-en-3-ol (3.33).  General 
procedure C was applied to Cy2BH (125 mg, 0.7 mmol), 1-
ethynylcyclohexene (82 µL, 0.70 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 
mg, 1.05 mmol), and 3-((tert-butyldimethylsilyl)oxy)butan-2-one (71 mg, 0.35 mmol). 
The crude product was purified by flash column chromatography on silica gel 
(hexanes:dichloromethane, 99:1) to afford the title compound as an oil (90 mg, 83% 
yield, dr = 18:1). 1H NMR (300 MHz, CDCl3): ! 0.05 (s, 3H), 0.08 (s, 3H), 0.91 (s, 9H), 
1.10 (d, J = 6.3 Hz, 3H), 1.21 (s, 3H), 1.58!1.69 (m, 4H), 2.09!2.13 (m, 4H), 2.49 (s, 
1H), 3.67 (q, J = 6.3 Hz, 1H), 5.54 (d, J = 15.6 Hz, 1H), 5.76 (bs, 1H), 6.29 (d, J = 15.9 
Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.3, 17.9, 18.1, 22.3, 22.4, 22.5, 24.5, 
25.7, 25.8, 74.8, 75.0, 129.1, 130.2, 132.1,135.0. IR (neat) 3557, 3468, 2953, 2929, 2858, 
1649, 1472, 1462, 1448, 1375, 1255, 1090, 970, 835, 776 cm-1. HRMS calcd for 
C18H34O2NaSi (M+Na)+: 333.2226, found 333.2210.   
 
 (2SR,3SR,E)-2-(tert-butyldimethylsilyloxy)-3,4,6,6-
Tetramethylhept-4-en-3-ol (3.34).  General procedure C was 
applied to Cy2BH (157 mg, 0.88 mmol), 4,4-dimethyl-2-pentyne (118 µL, 0.88 mmol), 
Me2Zn (0.50 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((tert-
butyldimethylsilyl)oxy)butan-2-one (71 mg, 0.35 mmol).  The crude product was purified 
by flash column chromatography on silica gel (hexanes:dichloromethane, 99:1) to afford 
the title compound as an oil (82 mg, 78% yield, dr >20:1). 1H NMR (300 MHz, CDCl3): 
! 0.06 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H), 1.08 (d, J = 6.3 Hz, 3H), 1.21 (s, 9H), 1.73 (d, J 
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= 0.9, 3H), 2.49 (s, 1H), 3.89 (q, J = 6.3 Hz, 1H), 5.55 (q, J = 1.2 Hz, 1H). 13C{1H} 
(CDCl3, 125 MHz): ! !4.6, !3.7, 14.1, 18.2, 18.4, 22.4, 26.1, 31.2, 32.2, 72.1, 78.0, 
134.8, 137.6. IR (neat) 3556, 3480, 2956, 2932, 2903, 2859, 1472, 1464, 1375, 1362, 
1255, 1100, 1090, 964, 838, 776 cm-1.  HRMS calcd for C17H36O2NaSi (M+Na)+: 
323.2382, found 323.2369.   
 
 (2SR,3SR,E)-2-(tert-butyldimethylsilyloxy)-3,4,6-Trimethyl-
hept-4-en-3-ol (3.35).  General procedure C was applied to 
Cy2BH (157 mg, 0.88 mmol), 4-dimethyl-2-pentyne (100 µL, 
0.88 mmol), Me2Zn (0.50 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((tert-
butyldimethylsilyl)oxy)butan-2-one (80 mg, 0.35 mmol). The crude product was purified 
by flash column chromatography on silica gel (hexanes:dichloromethane, 99:1) to afford 
the title compound as an oil (65 mg, 65% yield, dr >20:1). 1H NMR (300 MHz, CDCl3): 
! 0.05 (s, 3H), 0.08 (s, 3H), 0.88 (s, 9H), 0.94 (d, J = 5.1 Hz, 3H), 0.96 (d, J = 4.8 Hz, 
3H), 1.07 (d, J = 6.3 Hz, 3H), 1.65 (s, 3H), 2.48 (s, 1H), 2.49!2.54 (m, 1H), 3.74 (q, J = 
6.3 Hz, 1H), 5.33 (d, J = 8.7 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! !4.7, !3.8, 13.2, 
18.2, 18.3, 22.1, 23.1, 23.2, 26.0, 27.3, 71.2, 132.7, 136.4.  IR (neat) 3558, 3479, 2957, 
2931, 2898, 2859, 1464,  1375, 1361, 1313, 1255, 1091, 964, 836, 776 cm-1.  HRMS 
calcd for C16H34O2NaSi (M+Na)+: 309.2226, found 309.2225. 
 
 (2SR,3SR,E)-3-Methyl-2-((triethylsilyl)oxy)non-4-en-3-ol 
(3.36). General procedure C was applied to Cy2BH (125 mg, 0.7 
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mmol), 1-hexyne (81 µL, 0.70 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 
mg, 1.05 mmol), and 3-((triethylsilyl)oxy)butan-2-one (71 mg, 0.35 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
97:3) to afford the title compound as an oil (91 mg, 91% yield, dr >20:1).  1H NMR (500 
MHz, CDCl3): ! 0.61 (q, J = 8.0 Hz, 6H), 0.89 (t, J = 7.0 Hz, 3H), 0.96 (t, J = 7.9, 9H), 
1.09 (d, J = 6.2 Hz, 3H), 1.16 (s, 3H), 1.29!1.37 (m, 4H), 2.03 (q, J = 6.9 Hz, 2H), 2.51 
(s, 1H), 3.63 (q, J = 6.1 Hz, 1H), 5.46 (d, J = 16.1 Hz, 1H), 5.68 (dt, J = 15.8 Hz, J = 7.0 
Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.3, 7.1, 14.2, 18.4, 22.1, 22.5, 31.7, 32.3, 74.9, 
75.0, 130.0, 134.8.  IR (neat): 3563, 3479, 2957, 2932, 2877, 1457, 1377, 1239, 1091, 
1006, 974, 778, 741, 676 cm-1.  HRMS calcd for C16H34O2NaSi (M+Na)+: 309.2228, 
found 309.2235. 
 
 (3SR,4SR,E)-1-Cyclopropyl-3-methyl-4-((triethylsilyl)oxy)-
pent-1-en-3-ol (3.37). General procedure C was applied to 
Cy2BH (125 mg, 0.7 mmol), cyclopropylacetylene (60 µL, 0.70 
mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-
((triethylsilyl)oxy)butan-2-one (71 mg, 0.35 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 98:2) to afford the title 
compound as an oil (64 mg, 68% yield, dr >20:1).  1H NMR (500 MHz, CDCl3): ! 
0.35!0.38 (m, 2H), 0.6 (q, J = 8.0 Hz, 6H), 0.67!0.69 (m, 2H), 0.96 (t, J = 8.0 Hz, 9H), 
1.10 (d, J = 6.0 Hz, 3H), 1.15 (s, 3H), 1.34!1.41 (m, 1H), 2.48 (s, 1H), 3.63 (q, J = 6.0 
Hz, 1H), 5.21 (dd, J = 15.5 Hz, J = 9.0 Hz, 1H), 5.54 (d, J = 15.5 Hz, 1H).  13C{1H} 
(CDCl3, 125 MHz): ! 5.3, 6.7, 6.8, 7.1, 13.9, 18.5, 22.2, 74.9, 132.6, 133.5.  IR (neat): 
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3472, 2956, 1667, 1456, 1377, 1239, 1091, 1017, 966 cm-1.  HRMS calcd for C15H29OSi 
(M!OH): 253.1946, found 253.1983. 
 
 (2SR,3SR,E)-3,6,6-Trimethyl-2-((triethylsilyl)oxy)hept-4-en-
3-ol (3.38). General procedure C was applied to Cy2BH (125 
mg, 0.7 mmol), 3,3-dimethyl-1-butyne (86 µL, 0.70 mmol), Me2Zn (0.35 mL, 2M in 
toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((triethylsilyl)oxy)butan-2-one (71 mg, 
0.35 mmol).  The crude product was purified by flash column chromatography on silica 
gel (hexanes:EtOAc, 98:2) to afford the title compound as an oil (64 mg, 64% yield, dr 
>20:1).  1H NMR (500 MHz, CDCl3): ! 0.61 (q, J = 8.2 Hz, 6H), 0.97 (t, J = 8.6 Hz, 9H), 
1.00 (s, 9H), 1.09 (d, J = 6.3 Hz, 3H), 1.16 (s, 3H), 2.51 (s, 1H), 3.64 (q, J = 6.5 Hz, 1H), 
5.37 (d, J = 15.9 Hz, 1H), 5.70 (d, J = 15.9 Hz, 1H).  13C{1H} (CDCl3, 125 MHz): ! 5.9, 
7.1, 18.4, 22.2, 29.8, 32.9, 74.9, 75.0, 129.7, 140.6.  IR (neat): 3480, 2958, 2877, 1459, 
1363, 1239, 1091, 1007, 978, 787, 739 cm-1.  HRMS calcd for C16H34O2NaSi (M+Na)+: 
309.2228, found 309.2238.    
 
  (2SR,3SR,E)-3,4,6,6-Tetramethyl-2-((triethylsilyl)oxy)hept-
4-en-3-ol (3.39). General procedure C was applied to Cy2BH 
(157 mg, 0.88 mmol), 4,4-dimethyl-2-pentyne (118 µL, 0.88 mmol), Me2Zn (0.50 mL, 
2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-((triethylsilyl)oxy)butan-2-one (71 
mg, 0.35 mmol).  The crude product was purified by flash column chromatography on 
silica gel (hexanes:EtOAc, 99:1) to afford the title compound as an oil (85 mg, 81% 
yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.60 (q, J = 8.3 Hz, 6H), 0.95 (t, J = 8.0 
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Hz, 9H), 1.08 (d, J = 6.3 Hz, 3H), 1.12 (s, 9H), 1.15 (s, 3H), 1.73 (s, 3H), 2.57 (s, 1H), 
3.90 (q, J = 6.8 Hz, 1H), 5.52 (s, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.4, 7.1, 14.1, 18.5, 
22.0, 31.2, 32.2, 72.1, 78.0, 135.0, 137.6.  IR (neat): 3467, 2912, 1647, 1463, 1374, 1311, 
1090, 1006, 962 cm-1.  HRMS calcd for C17H35OSi (M!OH): 283.2416, found 283.2462.  
 
 (2SR,3SR,E)-3,4,6-Trimethyl-2-((triethylsilyl)oxy)hept-4-en-
3-ol (3.40). General procedure C was applied to Cy2BH (157 
mg, 0.88 mmol), 4-dimethyl-2-pentyne (100 µL, 0.88 mmol), 
Me2Zn (0.50 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 3-
((triethylsilyl)oxy)butan-2-one (80 mg, 0.35 mmol). The crude product was purified by 
flash column chromatography on silica gel (hexanes:dichloromethane, 99:1) to afford the 
title compound as an oil (80 mg, 80% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 
0.59 (q, J = 7.6 Hz, 6H), 0.93!0.97 (m, 15H), 1.07 (d, J = 6.3 Hz, 3H), 1.16 (s, 3H), 1.63 
(d, J = 1.3 Hz, 3H), 2.50!2.53 (m, 1H), 2.57 (s, 1H), 3.88 (q, J = 6.5 Hz, 1H), 5.3 (dd, J= 
9.0 Hz, J = 1.3 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 5.3, 7.1, 13.1, 18.4, 21.7, 23.0, 
23.1, 27.3, 72.1, 77.4, 132.9, 136.3.  IR (neat): 3460, 2936, 1638, 1448, 1333, 1303, 
1070, 1083, 974 cm-1.  HRMS calcd for C16H34O2NaSi (M+Na)+: 309.2228, found 
309.2219.    
 
 (1SR,2SR,E)-4-Cyclopropyl-2-methyl-1-phenyl-1-
((triethylsilyl)oxy)but-3-en-2-ol (3.41). General procedure C 
was applied to Cy2BH (125 mg, 0.7 mmol), 
cyclopropylacetylene (60 µL, 0.70 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 
Ph
OTES
HO Me(±)
Me
OTBS
HO Me(±)
i-Pr
Me
 130!
mg, 1.05 mmol), and 1-phenyl-1-((triethylsilyl)oxy)propan-2-one (92 mg, 0.35 mmol).  
The crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 98:2) to afford the title compound as an oil (83 mg, 71% yield, dr 
>20:1). 1H NMR (500 MHz, CDCl3): ! 0.33!0.35 (m, 2H), 0.47!0.52 (m, 6H), 0.66!0.69 
(m, 2H), 0.86 (t, J = 8.2 Hz, 9H), 1.06 (s, 3H), 1.35!1.40 (m, 1H), 2.50 (s, 1H), 4.44 (s, 
1H), 5.13 (dd, J = 15.5 Hz, J = 9.1 Hz, 1H), 5.58 (d, J = 15.5 Hz, 1H), 7.24!7.31 (m, 
5H).  13C{1H} (CDCl3, 125 MHz): ! 5.0, 6.7, 6.7, 6.9, 13.7, 25.6, 75.2, 81.6, 127.6, 
127.7, 128.2, 132.3, 133.3, 141.0.   IR (neat): 3564, 3479, 1667, 1494, 1455, 1414, 1378, 
1310, 1240, 1190, 1159, 1091, 1065, 1006, 978, 856, 811, 743, 701 cm-1.  HRMS calcd 
for C20H32O2NaSi (M+Na)+: 333.2077, found 355.2072. 
 
(1SR,2SR,E)-2-Methyl-1-phenyl-1-((triethylsilyl)oxy)oct-3-
en-2-ol (3.42). General procedure C was applied to Cy2BH (125 
mg, 0.7 mmol), 1-hexyne (81 µL, 0.70 mmol), Me2Zn (0.35 
mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 1-phenyl-1-
((triethylsilyl)oxy)propan-2-one (92 mg, 0.35 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 98:2) to afford the title 
compound as an oil (101 mg, 83% yield, dr >20:1). 1H NMR (500 MHz, CDCl3): ! 0.49 
(qd, J = 7.8 Hz, J = 2.9 Hz, 6H), 0.86 (t, J = 7.9 Hz, 9H), 0.89 (t, J = 6.9 Hz, 3H), 1.08 (s, 
3H), 1.26!1.36 (m, 4H), 2.02 (q, J = 6.9 Hz, 2H), 2.47 (s, 1H), 4.45 (s, 1H), 5.50!5.60 
(m, 2H), 7.23!7.30 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! 5.0, 6.9, 14.2, 22.4, 23.5, 
31.6, 32.2, 75.3, 81.7, 127.6, 127.7, 128.2, 129.8, 134.5, 141.0.  IR (neat) 3562, 3479, 
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2956, 2931, 2876, 1455, 1433, 1377, 1309, 1239, 1174, 1090, 1006, 975, 846, 743 cm-1.  
HRMS calcd for C21H36O2NaSi (M+Na)+: 371.2385, found 371.2380. 
 
 (1SR,2SR,E)-2,3,5,5-Tetramethyl-1-phenyl-1-((triethylsilyl)-
oxy)hex-3-en-2-ol (3.43).  General procedure C was applied to 
Cy2BH (125 mg, 0.7 mmol), 4,4-dimethyl-2-pentyne (141 µL, 
1.05 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 1-
phenyl-1-((triethylsilyl)oxy)propan-2-one (92 mg, 0.35 mmol).  The crude product was 
purified by flash column chromatography on silica gel (hexanes:EtOAc, 98:2) to afford 
the title compound as an oil (80 mg, 63% yield, dr >20:1).  1H NMR (500 MHz, CDCl3): 
! 0.48 (q, J = 8.3 Hz, 6H), 0.86 (t, J = 7.9 Hz, 9H), 0.98 (s, 3H), 1.09 (s, 9H), 1.76 (d, J = 
1.4 Hz, 3H), 2.83 (s, 1H), 4.64 (s, 1H), 5.38 (d, J = 1.3 Hz, 1H), 7.22!7.28 (m, 5H).  
13C{1H} (CDCl3, 125 MHz): ! 5.0, 7.0, 14.6, 22.7, 31.1, 32.2, 78.4, 79.2, 127.4, 127.5, 
128.1, 135.8, 136.8, 141.2.  IR (neat) 2955, 1463, 1362, 1253, 1088, 1062, 863, 837, 777, 
732, 700 cm-1.  HRMS calcd for C22H38O2NaSi (M+Na)+: 385.2539, found 385.2540. 
 
(1SR,2SR,E)-1- ((tert-butyldimethylsilyl)oxy)-4-Cyclopropyl-
2-methyl-1-phenylbut-3-en-2-ol (3.44).  General procedure C 
was applied to Cy2BH (125 mg, 0.7 mmol), cyclopropylacetylene 
(60 µL, 0.70 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 
(S)-1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-one (92 mg, 0.35 mmol).  The 
crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 98:2) to afford the title compound as an oil (86 mg, 74% yield, dr 
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>20:1).  = 25.8 (c = 2.2, CHCl3). 1H NMR (500 MHz, CDCl3): ! !0.24 (s, 3H), 0.03 
(s, 3H), 0.32!0.35 (m, 2H), 0.66!0.69 (m, 2H), 0.89 (s, 9H), 1.06 (s, 3H), 1.34!1.41 (m, 
1H), 2.41 (s, 1H), 4.42 (s, 1H), 5.12 (dd, J = 15.7 Hz, J = 8.8 Hz, 1H), 5.57 (d, J = 15.5 
Hz, 1H), 7.23!7.28 (m, 5H).  13C{1H} (CDCl3, 125 MHz): ! !4.9, !4.4, 6.6 , 6.7, 13.7, 
18.4, 23.8, 26.0, 75.3, 81.7, 127.6, 127.7, 128.3, 132.4, 133.3, 140.8.  IR (neat): 3564, 
3479, 3083, 3065, 3029, 2955, 2930, 2886, 1667, 1472, 1455, 1361, 1253, 1190, 1091, 
1066, 968, 866, 837, 777 cm-1.  HRMS calcd for C20H32O2NaSi (M+Na)+: 355.2072, 
found 355.2074.  HPLC conditions: Chiralpak AD-H, t1 = 12.3 min (major), t2 = 13.3 min 
(hexanes/2-propanol: 99/1, 0.5 mL/min). 
 
 (1SR,2SR,E)-1-((tert-butyldimethylsilyl)oxy)-2-Methyl-1-
phenyloct-3-en-2-ol (3.45).  General procedure C was applied 
to Cy2BH (125 mg, 0.7 mmol), 1-hexyne (81 µL, 0.70 mmol), 
Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 mmol), and 1-((tert-
butyldimethylsilyl)oxy)-1-phenylpropan-2-one (93 mg, 0.35 mmol).  The crude product 
was purified by flash column chromatography on silica gel (hexanes:toluene, 1:1) to 
afford the title compound as an oil (101 mg, 76% yield, dr >20:1). 1H NMR (500 MHz, 
CDCl3): ! !0.28 (s, 3H), 0.03 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H), 0.89 (s, 9H), 1.09 (s, 3H), 
1.26!1.36 (m, 4H), 2.02 (q, J = 6.5 Hz, 2H), 2.37 (s, 1H), 4.43 (s, 1H), 5.50!5.60 (m, 
2H), 7.23!7.28 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.4, 14.2, 18.4, 22.5, 23.8, 
26.0, 31.6, 32.2, 75.4, 81.8, 127.6, 127.7, 128.3, 129.8, 134.5, 140.8.  IR(neat): 3565, 
3480, 3030, 2956, 2858, 1463, 1361, 1252, 1176, 1090, 1066, 975, 938, 868, 837, 777, 
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748, 701, 676, 615 cm-1.  HRMS calcd for C21H36O2NaSi (M+Na)+: 371.2385, found 
370.2392. 
 
 (1SR,2SR,E)-1-((tert-butyldimethylsilyl)oxy)-2,3,5,5-Tetra-
methyl-1-phenylhex-3-en-2-ol (3.46).  General procedure C 
was applied to Cy2BH (125 mg, 0.7 mmol), 4,4-dimethyl-2-
pentyne (141 µL, 1.05 mmol), Me2Zn (0.35 mL, 2M in toluene), EtZnCl (136 mg, 1.05 
mmol), and 1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-one (92 mg, 0.35 mmol).  
The crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 98:2) to afford the title compound as an oil (74 mg, 58% yield, dr 
>20:1).  1H NMR (500 MHz, CDCl3): ! !0.28 (s, 3H), 0.03 (s, 3H), 0.88 (s, 9H), 0.98 (s, 
3H), 1.10 (s, 9H), 1.76 (d, J = 1.4 Hz, 3H), 2.76 (s, 1H), 4.62 (s, 1H), 5.42 (d, J = 1.4 Hz, 
1H), 7.22!7.28 (m, 5H).  13C{1H} (CDCl3, 125 MHz): ! !5.0, !4.3, 14.6, 18.3, 23.0, 
26.1, 31.1, 32.2, 78.4, 79.1, 127.6, 128.2, 135.5, 136.9, 141.1.  IR (neat) 2955, 1454, 
1362, 1239, 1092, 1063, 1004, 853, 700 cm-1.  HRMS calcd for C22H38O2NaSi (M+Na)+: 
385.2539, found 385.2520. 
 
General Procedure D: Generation of (Z)-Disubstituted Allylic Alcohols via Addition 
to Chiral Ketones. A dry 10 mL Schlenk flask, which was evacuated under vacuum and 
backfilled with N2 (g) three times, was charged with diethylborane (0.88 mL, 1M 
toluene) and 1 mL dry THF.  After cooling the flask to 0 °C, the bromoalkyne (0.88 
mmol) was added dropwise and the flask was stirred at room temperature for 20 minutes.  
t!BuLi  (0.51 mL, 1.7 M in pentanes) was added to the flask at !78 °C and stirred for 35 
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minutes, warmed to room temperature and stirred for an additional 40 minutes.  The 
volatiles were then removed under vacuum over 30 minutes and the residue redissolved 
in toluene (2 mL).  Dimethylzinc (0.44 mL, 2M in toluene) was slowly added to the 
reaction mixture at !78 °C and stirred for 30 minutes.  The EtZnCl (136 mg, 1.05 mmol) 
was then added followed by the ketone solution (0.35 mmol, in 0.2 mL toluene). The 
reaction mixture stirred at !30 °C and was monitored by TLC until completion.  The 
reaction mixture was quenched with saturated aq. NH4Cl (2 mL) and 2N HCl (1 mL) 
followed by addition of 5 mL Et2O.  The organic layer was separated and the aqueous 
layer was extracted successively with Et2O (2 " 5 mL).  The combined organic layers 
were successively washed with aq. NaHCO3 and brine, dried over MgSO4, and filtered.  
The filtrate was concentrated in vacuo and purified column chromatography on silica gel. 
 
 (1SR,2SR,Z)-1-((tert-butyldimethylsilyl)oxy)-8-Chloro-2-
methyl-1-phenyloct-3-en-2-ol (3.47).  General procedure D 
was applied to Et2BH (0.88 mL, 1M in hexanes), t-BuLi 
(0.51mL, 1.7 M in pentanes), Me2Zn (0.44 mL, 2M toluene), EtZnCl (136mg, 1.05 
mmol), and 1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-one (93 mg, 0.35 mmol).  
The crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 98:2) to afford the title compound as an oil (78 mg, 58% yield, dr 
>20:1). 1H NMR (500 MHz, CDCl3): ! !0.23 (s, 3H), 0.05 (s, 3H), 0.90 (s, 9H), 1.15 (s, 
3H), 1.47 (q, J = 7.5 Hz, 2H), 1.76 (q, J = 7.8 Hz, 2H), 2.34 (q, J = 7.5 Hz, 2H), 2.42 (s, 
1H), 3.5 (t, J = 6.4 Hz, 2H), 4.52 (s, 1H), 5.35!5.41 (m, 2H), 7.23!7.32 (m, 5H). 13C{1H} 
(CDCl3, 125 MHz): ! !5.0, !4.3, 18.4, 24.5, 26.0, 27.5, 32.4, 45.2, 76.9, 81.8, 127.8, 
Ph
OTBS
HO Me
(±)
Cl
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128.2, 132.2, 133.9, 140.8.  IR (neat): 3564, 2954, 2858, 1728, 1471, 1454, 1361, 1311, 
1258, 1088, 1065, 1006, 938, 865, 837, 778, 703, 671 cm-1.  HRMS calcd for 
C21H35ClO2NaSi (M+Na)+: 405.1995, found 405.1991. 
 
General Procedure E: Determine of Chiral Purity for Additions to Enantioenriched 
Ketones. After the addition following general procedure A or B, the silyl group was 
removed from the crude addition product using tetrabutylammonium fluoride (1M 
solution in THF).  The diol was then purified by flash column chromatography on silica 
gel (hexanes:EtOAc, 85:15) and analyzed by HPLC. 
 
(1S,2R)-2-Methyl-1-phenylhexane-1,2-diol (3.53). = 36.1 (c = 1.8, 
CHCl3).      1H NMR (500 MHz, CDCl3): ! 0.86 (t, J = 6.9 Hz, 3H), 1.20 
(s, 3H), 1.22!1.51 (m, 6H), 1.92 (s, 1H), 2.55 (s, 1H), 4.54 (s, 1H), 
7.27!7.38 (m, 5H). 13C{1H} (CDCl3, 125 MHz): ! 14.3, 23.5, 23.6, 25.6, 36.3, 75.2, 80.9, 
127.8, 128.0, 128.2, 140.7.  IR (neat): 3401, 2956, 2872, 1709, 1604, 1455, 1380, 1220, 
1162, 1087, 1024, 956, 918, 848 cm-1.  HRMS calcd for C13H20O2Na (M+Na)+: 
231.1361, found 231.1362.  HPLC conditions: Chiralcel OD-H, t1 = 31.4 min (major), t2 
= 34.8 min (hexanes/2-propanol: 97/3, 0.5 mL/min). 
 
(1R,2S)-2-Methyl-1-phenylhexane-1,2-diol (3.54).  = !40.6 (c = 
1.8, CHCl3).  This compound was prepared using the same method that 
was used to prepare its enantiomer above. 
 
Ph
OH
HO n-Bu
(+)
Ph
OH
n-Bu OH
(!)
 136!
(1S,2S)-2-Methyl-1-phenylbutane-1,2-diol (3.55). !  = 22.7 (c = 
2.2, CHCl3).      1H NMR (500 MHz, CDCl3): ! 0.96 (t, J = 7.7 Hz, 3H), 
0.99 (s, 3H), 1.50!1.60 (m, 2H), 2.12 (bs, 1H), 2,73 (bs, 1H), 4.52 (s, 1H), 7.26!7.36 (m, 
5H). 13C{1H} (CDCl3, 125 MHz): ! 8.0, 21.0, 31.5, 75.6, 80.0, 127.8, 128.0, 128.2, 
140.8.  IR (neat): 3418, 2978, 1709, 1604, 1463, 1381, 1274, 1165, 1085, 1016, 920, 845 
cm-1. HRMS calcd for C11H16O2 (M+Na)+: 203.1048, found 208.1021.  HPLC conditions: 
Chiralcel OD-H, t1 = 40.2 min, t2 = 48.5 min (major) (hexanes/2-propanol: 97/3, 0.5 
mL/min). 
 
Conditions for Determination of Diastereomeric Ratio by Gas Chromatography for  
(2SR,3SR)-2-(tert-butyldimethylsilyloxy)-3-Methylpentan-3-ol and (2S,3R)-2-((tert-
butyldimethylsilyl)oxy)-3-Ethylheptan-3-ol . 
Condition 1: WCOT fused silica 25m x 0.25mm coating CP CHIRASIL-Dex CB, DF = 
0.25 (oven: 100 °C, flow = 1.6 mL/min). 
! !
!
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Chapter 4. Synthesis of Chiral N-Sulfonyl and N-Phosphinoyl !-Halo Aldimine 
Precursors 
 
4.1 Introduction 
 In recent studies, we have demonstrated that alkylzinc halides and sulfonates 
(RZnX) can coordinate silyl-protected !- and "-hydroxy aldehydes and ketones in a 
bidentate fashion to effectively control diastereofacial selectivity in nucleophilic addition 
reactions.1 Given this unique reactivity, we set out to apply this approach to other 
substrates that do not typically participate in chelation.  !-Halogenated carbonyl 
derivatives are know to react with organometallics reagents according to the Cornforth 
stereoinduction model to yield addition products via a non-chelation pathway.2 Owing to 
the synthetic utility of 1,2-syn haloamines of type 4.2, we aimed to determine whether  
 
  
Scheme 4.1 Route to chelation-controlled additions to !-halo aldimines 
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chelation-controlled additions of organozinc reagents to !-halogenated aldimines via 
transition state 4.3 could be achieved using alkylzinc halide Lewis acids.  Since 
organozinc reagents are less nucleophilic than the analogous Grignard or organolithium 
reagents, it was important that the aldimine starting material, 4.1, contain an electron-
withdrawing group on the nitrogen atom.  Common electron withdrawing groups include 
N-acyl,3 N-sulfonyl,4 N sulfinyl,5 and N-phosphinoyl.6  
 In general, imines derived from aromatic aldehydes and primary amines bearing 
an electron-withdrawing group on nitrogen are stable. The corresponding aliphatic 
aldimines, however, are prone to hydrolysis or self-condensation.  As a result, aliphatic 
aldimines with !-hydrogens are usually generated as needed and immediately trapped to 
preclude these unwanted reaction pathways.4  N-Sulfinyl aldimines are the sole exception 
to this.  In turn, we first focused our attention on developing a facile route to synthesize 
stable, storable precursors of !-halogenated aldimines.  This chapter describes studies 
toward the synthesis of chiral N-sulfonyl and N-phosphinoyl !-halo aldimine precursors.   
  
4.2 Previous Routes to !-Halogenated Aldimines 
 Following early studies by Engerberts and Strating,7 !-amido sulfones have been 
widely utilized in synthesis as stable aldimine precursors.  !-Amido sulfones of type 4.4  
can be prepared in a three-component reaction of an aldehyde, carbamate or sulfonamide, 
and sodium sulfinate in acidic media (Scheme 4.2).7b,c,8 It was also shown that the 
aldimines could be isolated from !-amido sulfones by treatment of 4.4 with mild base.9 
Notably, Chemla and coworkers have applied this two-step approach to furnish N-
! "#"!
sulfonyl aldimines from enolizable, aliphatic aldehydes.10 A similar approach has been 
utilized to store unstable aldehydes as bisulfite adducts. 11     
 
 
 
 
 
 
 
Scheme 4.2 Formation of !-amido sulfones 
 
 !-Halogenated aldimines are versatile intermediates in synthesis and have been 
utilized to access a variety of aza-heterocycles such as azetidines, aziridines, and "-
lactams.12 In particular, De Kimpe and coworkers have made important contributions to 
understanding the reactivity of N-alkyl !-chloro aldimines.13 Their synthesis involved a 
two-step condensation of !,!-disubstituted acetaldehydes with primary amines, followed 
by direct chlorination of the aldimine with N-chlorosuccinimide (Scheme 4.3, route A).14 
Moreover, this method was applied to the synthesis of N-tosyl aldimines.15 In the case of 
enolizable N-alkyl !-chloro aldimines, an alternative approach was needed to preclude 
the formation of !,!-dichlorinated side products.14 Importantly, De Kimple and 
coworkers also investigated routes to access enantioenriched N-alkyl !-chloro aldimines 
containing an enolizble !-hydrogen in efforts toward the synthesis of "-lactams (Scheme 
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4.3, route B).16 The !-lactams were isolated with 82"90% ee from the corresponding 
amino acids.    
 Although #-chloro aldimines bearing an electron-withdrawing group can be 
synthesized directly, they suffer from instability.  Recently, Hayashi and coworkers 
reported a synthesis of N-tosyl #-chloro aldimine precursors that are stable (Scheme 4.3, 
route C).17 However, only the N-tosyl aldimine derived from chloroacetaldehyde was 
studied.  One other example involving #-halogenated amido sulfones derived from urea 
has been reported, but with limited scope with respect to the aldehyde employed (Scheme 
4.3, route C).18   
 Although several important advances in methods for synthesizing #-halogentated 
aldimines have been reported recently (see Scheme 4.3),10,17 there are few routes to 
access #-halo N-sulfonyl aldimines bearing a hydrogen at the #-stereogenic center.  As a 
result, we set out to investigate amido sulfones as stables precursors to these aldimines.  
Moreover, to demonstrate synthetic utility, it was important that enantioenriched #-
chloro aldehydes be compatible with the reaction conditions.   
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Scheme 4.3 Previous routes to !-halogenated aldimines 
 
O
H
R2
R1
N
H
R2
R2
R3
R3NH2
MgSO4
Et2O, rt
N
H
R2
Cl
R3
NCS
CCl4 R1
R1  = alkyl, Ph
R2 = alkyl
R3 = alkyl
O
HO
R1
NH2
1. NaNO2, 6M HCl
    0 °C, 4h
2. LiAlH4 (2 equiv)
3. PCC (3 equiv)
O
H
R1
Cl
4. R2NH2, 
MgSO4
    CH2Cl2, rt
44!50% yield
95% ee
N
O R2
R3O
Cl
R1
HH
60!72% yield
82!90% ee, dr = 9:1 to 16:1 
R1,R2 = alkyl
R3 = Me, Bn, Ph
O
H
R1
R2NH2
ArSO2Na
HCO2H/H2O
 rt 12!24 h
NH
ArO2S
R1
R2
60% yield
Route A: from aliphatic aldehyde via imine formation/chlorination
Route B: from amino acid via formation of enantioenriched chloro aldehyde
Route C: from halo aldehyde via stable amido sulfone precursor
X X
R1 = H, Me
R2 = Ts, 
X = Cl, Br
Ar = Ph, Tol
O
NH2
N
H
R1
Cl
R2
5. R3OCH2COCl
    Et3N, C6H6
This Work
O
H
R1
O
H
R1
X
NH
ArO2S
R1
R2
X
R1 = alkyl, (CH2)nFG
R2 = sulfonyl, phosphinoyl
X = F, Cl, Br
! "##!
4.3 Results and Discussion 
 To test the feasibility of our approach, 2-chlorooctanol was reacted with p-
toluenesulfonamide and p-toluenesulfinic acid sodium salt in aqueous formic acid.  Using 
the reaction conditions reported by Chemla and coworkers10 for non-halogenated 
aldehydes, only 31% conversion to amido sulfone 4.6 was achieved after 12 h, as shown 
in Table 4.1 (entry 1).  Moreover, longer reaction times (24!72 h) did not provide 
synthetically useful yields (entries 2 and 3).  When the reaction was stirred at room 
temperature for 5 days, product 4.6 was afforded in 80% yield.  Ultimately, increasing the 
concentration of the reaction from 0.33 M to 0.67 M improved the yield and decreased 
the reaction time to 72 h (85%, entry 5).  Longer reaction times at 0.67 M did not further 
improve the yield of 4.6 (entry 6). 
 
Table 4.1 Optimization of N-Ts sulfone 4.6 synthesis 
     
 
 
 
 
 
 
 
 
 
O
Cl
n-Hex p-TsNH2, p-TsNa
H2O/HCO2H, rt
NH
Cl
n-Hex
Ts
Ts
entry time (h) yield (%)conditions
1
2
3
4
5
a
a
a
a
b
12 h
24 h
72 h
120 h
6
72 h
120 hb
31
40
54
80
85
86
4.5 4.6
H
a 3  mL of  H2O:HCO2H (1:1) were employed per mmol of 
chloro aldehyde (0.33 M). b 1.5 mL of H2O:HCO2H (1:1) were 
employed per mmol of chloro aldehyde (0.67 M).
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Table 4.2 Synthesis of !-halo N-Ts aldimine precursors in water 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
X
R p-TsNH2,  p-TsNa
H2O/HCO2H (1:1)
48-72 h
NH
X
R
Ts
Ts
entry
1 n-hexyl
2 i-propyl
3 benzyl
4
7
5 OTBDPS
85% (4:1)
75% (>20:1)c
88% (4:1)
90% (12:1)
64% (>20:1)d
R yielda (dr)bproduct
NH
Cl
n-Hex
Ts
Ts
NH
Cl
Ts
Ts
NH
Cl
Ph
Ts
Ts
NH
Cl
Ts
Ts 7
NH
Cl
OTBDPS
Ts
Ts
4.6
4.7
4.8
4.9
4.10
H
X
Cl
Cl
Cl
Cl
Cl
6 n-hexyl 83% (4:1)
NH
Br
n-Hex
Ts
Ts
4.11Br
7 n-hexyl 65% (10:1)
NH
F
n-Hex
Ts
Ts
4.12F
a  1.5 mL of H2O:HCO2H (1:1) were employed per mmol of chloro 
aldehyde (0.67 M) using p-TolSO2Na. b dr determined by analysis of 1H 
NMR spectra. c Reaction conducted on 15 mmol scale. d Major 
diastereomer determined to be syn by X-ray analysis.  Ts = para-
toluenesulfonyl.
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Using the optimized conditions (Table 4.1, entry 5), a variety of aliphatic !-
chloro aldehydes were employed in the reaction, as illustrated in Table 4.2.  Notably, 
functionalized !-chloro aldehydes, including one containing a terminal olefin or silyl-  
protected hydroxyl group, were tolerated under the reaction conditions (entries 4 and 5).  
The !-amido sulfone products were furnished in 64"90% yield.  Scalability is important 
for any practical method.  When the reaction in entry 2 (Table 4.2) was performed on 15 
mmol scale, amido sulfone 4.7 was obtained in 75% yield as a singe diastereomer.    
Additonally, !-bromo and fluoro aldehydes can be employed in the reaction (entries 7 
and 8).  The scale-up reaction of 4.7 was performed by Corinne Rich, a former 
undergraduate student.  Rebecca Platoff, a former undergraduate student, also scaled-up 
several of the reactions in Table 4.2. 
  
Figure 4.1 X-ray crystal structure of amido sulfone 4.10 and proposed transition 
state for observed stereochemistry 
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Next, we turned our attention to determining the stereochemistry of the amido 
sulfone product.  As depicted in Figure 4.1, the relative stereochemistry of 4.10 was 
determined to be syn by X-ray analysis.  The high diastereoselectivity observed in the 
formtion of 4.10 can be rationalized by a hydrogen bonding interaction under aqueous 
conditions between the protonated N-sulfonyl imine and the !-chloro group.  Similar 
diastereofacial selectivity was realized by Petrini and coworkers employing !- 
alkoxyalkyl aldehydes in this three-component reaction.19 Furthermore, they performed 
computational studies and concluded that the conformation lowest in energy displayed a 
favorable electrostatic interaction between the NH and the !-alkoxy or amido group of 
the N-acycylium ion intermediate, which is similar to the transition state depicted in 
Figure 4.1. 
 In recent years, several noteworthy methods have been developed for the 
synthesis of enantioenriched !-chloro aldehydes.20 To show the potential for use of our 
method in complex molecule synthesis, we explored the use of enantioenriched !-chloro 
aldehydes in the reaction.  As shown in Scheme 4.4, when (R)-2-chlorooctonal of 96% ee  
 
 
 
 
 
 
Scheme 4.4 Formation of enantioenriched amido sulfones 
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was employed in the reaction under aqueous conditions, amdio sulfone (!)-4.6 was 
generated with 96% ee in 72% yield.  In contrast to the reaction using racemic aldehyde, 
the product was afforded with > 20:1 dr (4:1 dr using racemic aldehyde).  Similarly, (!)-
4.9 was obtained with no erosion of optical purity. 
 
Table 4.3 Synthesis of "-chloro N-Ts aldimine precursor in organic solvent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some substrates display an unfavorable equilibrium constant toward the iminium 
ion over amido sulfone 4.4 in aqueous media (Scheme 4.2).  For these substrates, we 
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a Reaction conducted in CH2Cl2 under nitrogen atmosphere 
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envisioned performing the reaction in organic sovent.21 As shown in Table 4.3, when the 
reactions were conducted in dichloromethane solvent, comparable yields were obtained  
in most cases.  However, enantioenriched !-chloro aldehydes were not compatible with 
the reaction conditions, showing significant erosion of ee.  An important difference 
between the reaction conditions is that the !-chloro aldehydes are insoluble in the 
aqueous reaction media, and, therefore, do not come in contact with the sodium sulfinate, 
which likely promotes the racemization.  In dichloromethane, however, the diminished ee 
can be attributed to the TolSO2! racemizing the starting aldehyde under homogeneous 
conditions. 
Notably, the corresponding N-Ts !-chloro aldimine can also be isolated upon 
treatment of 4.6 with sodium bicarbonate, as illustrated in Scheme 4.5.  Aldimine 4.13 
was stable at room temperature for several hours and could be employed in other 
reactions.  However, aldimines derived from more functionalized amido sulfones could 
not be isolated with high purity due to facile hydrolysis.      
 
 
 
 
 
Scheme 4.9 Formation of !-chloro aldimine 
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some substrates in Table 4.4.  Several N-sulfonyl sulfone derivatives, including N-Nos, 
Bs, and 2-thienyl, were generated in modest to good yields as illustrated in Table 4.4.  
   
Table 4.4 Synthesis of other !-chloro N-sulfonyl aldimine precursors 
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 ArSO2Na or ArSO2H
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NH
Cl
R1
ArO2S
R2O2S
entry R1 Ar product % yield (dr)a
1 Me p-Tol
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Cl
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O O
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4.14
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4.16
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4.18
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H
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a dr determined by analysis of 1H NMR spectra. b 1.5 mL of H2O:HCO2H (1:1) 
were employed per mmol of chloro aldehyde (0.67 M) using p-TolSO2Na.  c 
Reaction conducted in CH2Cl2 under nitrogen atmosphere using p-TolSO2H
Ms =methanesulfonyl
Bs = para-bromobenzenesulfonyl
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Notably, these sulfonyl protecting groups22 are known to be removed under milder 
conditions than N-Ts,  Moreover, the sulfinic acid group can be altered, showing the 
tunability of these substrates for one-pot reactions. 
N-Phosphinoylimines have received much attention in recent years as versatile 
electrophiles in synthesis.6,24 One advantage to phosphinamides is that removal 
phosphinoyl group can be carried out under mild reaction conditions.  To date, !-chloro 
aldehydes have not been employed in the synthesis of N-phosphinoyl imines.  We 
initially investigated the reaction of 2-chloroisovaleraldehyde with 
diphenylphosphinamide and p-toluenesulfinic acid (Scheme 4.5).  After 48 h at room 
temperature, phosphinamido sulfone 4.19 was generated in 61% yield as a single 
diastereomer.  The reaction was also amenable to other simple alkyl substituted !-chloro 
aldehydes.   
 
 
 
 
 
 
 
 
 
Scheme 4.5 Synthesis of N-phosphinoyl aldimine precursors 
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 We next set out to demonstrate the synthetic utility of the !-chloro aldimine 
precursors in one-pot processes.  Owing to their importance as intermediates in synthesis, 
stereodefined alkynyl aziridines have been the target of many methodology studies.25 We 
envisioned a one-pot reaction in which an excess of the organometallic reagent could be 
used to form the corresponding aldimine in situ and subsequently carry out the 
nucelophilic addition.  Enantioenriched aldimine precursor (+)-4.6 was reacted with 2.2  
equiv lithium TMS-acetylide26 to provide "-chloroamine 4.22 in 85% yield with > 20:1 
dr (Scheme 4.6).  Ring closure under mild reaction conditions gave trans aziridine 4.23 
with 95% ee in 96% yield.  Alternatively, sulfone (+)-4.6 can be treated with NaHCO3 to  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.6 Synthesis of enantioenriched trans alkynyl aziridines 
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isolate aldimine 4.13 in 94% yield followed by nucleophilic addition.  The anti 
stereochemistry of aziridine 4.23 was ascertained by examination of the H1/H2 coupling 
constant (J = 4.5 Hz, see Appendix A3).  The excellent selectivity for the anti 
diasteromer can be rationalized by the Cornforth!Evans model.2 Alkynyl aziridines of 
type 4.23 can be used to access stereodefined aziridine-2-carboxylic acid derivatives.  
Importantly, these building blocks have been used in a straightforward route to amino 
acid and peptide derivatives.27 
 
4.4 Conclusions 
 In summary, a versatile method for the synthesis of chiral N-sulfonyl "-halo 
aldimine precursors has been designed.  Moreover, the scope of the method with respect 
to the nitrogen protecting group was further expanded to include N-phosphinoyl "-chloro 
aldimine adducts.  Readily accessible enantioenriched "-chloro aldehdyes are tolerated 
under the aqueous reaction conditions, displaying no erosion of ee.  Additionally, we 
have demonstrated that these amido sulfone precursors are good substrates for one-pot 
aldimine formation/highly diastereoselective addition reaction to furnish trans alkynyl 
aziridines. 
 
4.5 Experimental Section 
General Methods: Dichloromethane was dried through alumina columns.  Diethylether 
was dried over sodium benzophenone.  Racemic, chiral "-chloro aldehyde derivatives 
were prepared by literature method; reaction of the corresponding aldehyde with N-
! "#$!
chlorosuccinimide and proline.20a Enantioenriched, !-chloro aldehydes were prepared 
using MacMillan’s SOMO catalysis methodology.20b,28 Other chemicals were supplied 
from Acros, Sigma-Aldrich, or GFS Chemicals. Hydrocinnamaldehyde was distilled prior 
to use.  The 1H NMR and 13C{1H} NMR spectra were obtained using a Brüker AM-500 
Fourier transform NMR spectrometer at 500 and 125 MHz, respectively at 22 °C in 
CDCl3 unless stated otherwise.  The 31P NMR spectra were obtained using a Brüker 
DMX-360 Fourier transform NMR spectrometer at 144 MHz.  The 19F NMR spectra 
were obtained using a Brüker DMX-360 Fourier transform NMR spectrometer at 338 
MHz and were unreferenced.  Chemical shifts are reported in units of parts per million 
(ppm) downfield from tetramethylsilane and all coupling constants are reported in hertz.  
The infrared spectra were obtained using a Perkin-Elmer 1600 series spectrometer.  Thin-
layer chromatography was carried out on Whatman pre-coated silica gel 60 F-254 plates 
and visualized by ultra-violet light or by staining with potassium permanganate or 2,4-
dinitrophenylhydrazine stains.  Silica gel (230-400 mesh, Silicycle) was used for air-
flashed chromatography. Diastereomeric ratios were determined by analysis of the 
corresponding 1H NMR spectra.  Analysis of enantiomeric excess was performed using a 
SFC and Chiralcel OD-H or Chiralpak IA column %&!'(!)*+,!-./01!2!)3453667*2892&:!
"";;!.3&/3.!20:!,</&25=29!>?7)!8%5-@0A  High-resolution mass spectra were measured 
using a Waters 2695 Separations Module (1S0RR23444). 
 
General Procedure A: formation of N-Sulfonyl Imine Precursors (aqueous). 
 To a 10 mL round bottom flask was added !-chloro aldehyde (1.5 mmol) followed by 
deionized water (1.2 mL), p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic 
! "##!
acid sodium salt monohydrate (267 mg, 1.5 mmol).  Formic acid (1.2 mL) was 
subsequently added and the reaction mixture was stirred at room temperture for 72 h.  
The resulting solid was filtered through a sintered glass funnel.  The solid was washed 
thoroughly with water (3 x 10 mL) and hexanes (5 x 10 mL).  The solid was then 
collected, dissolved in CH2Cl2 (25 mL) and filtered through celite.  The filtrate was 
concentrated in vacuo and dried under vacuum for several hours.  Most products can be 
used in subsequent reactions without further purification.  Products of higher purity can 
be obtained by recrystallization from EtOAc /hexanes.   
 
General Procedure B: formation of N-Sulfonyl Imine Precursors (CH2Cl2) A dry 10 
mL round bottom flask, which was purged with nitrogen, was charged with p-
toluenesulfonamide (171 mg, 1 mmol), p-toluenesulfinic acid29 (187 mg, 1.2 mmol), !-
chloro aldehyde (1.5 mmol), and CH2Cl2 (4 mL).  MgSO4 was added to the flask and the 
reaction mixture was allowed to stir at room temperature until complete by TLC (24"48 
h).  The product was diluted with dichloromethane (20 mL), filtered through celite, and 
concentrated in vacuo.  The solid product was collected onto a sintered glass filter and 
washed sequentially with hexanes (5 # 10 mL) to remove the excess aldehyde.  Most 
products can be used in subsequent reactions without further purification.  Products of 
higher purity can be obtained by recrystallization from EtOAc /hexanes.    
 
N-((2R)-2-Chloro-1-tosyloctyl)-4-methylbenzenesulfonamide 
(")-(4.6). General Procedure A was applied to (R)-2-
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chlorooctanal (244 mg, 1.5 mmol), p-toluenesulfonamide (171 mg, 1 mmol), and p-
toluenesulfinic acid sodium salt hydrate (267 mg, 1.5 mmol). The title compound was 
obtained as a white solid (340 mg, 72% yield, dr > 20:1, mp = 108!100 °C).   = 
!103.5 (c = 1.0, CHCl3).  Employing racemic 2-chlorooctanal, the title compound was 
obtained as a white solid (85% yield, dr = 4:1).  1H NMR (500 MHz, CDCl3): " 0.88 (t, J 
= 7.1 Hz, 3H), 1.13!1.50 (m, 8H), 1.51!1.62 (m, 2H), 2.44 (s, 6H), 4.71 (t, J = 7.1 Hz, 
1H), 4.79 (d, J = 10.4 Hz, 1H), 5.54 (d, J = 10.3 Hz, 1H), 7.21!7.29 (m, 4H), 7.58 (d, J = 
8.1 Hz, 2H), 7.62 (d, J = 8.4 Hz, 2H). 13C{1H} (CDCl3, 125 MHz): " 14.2, 21.8, 22.0, 
22.7, 26.2, 28.6, 31.6, 36.4, 58.5, 76.0, 127.2, 129.8, 129.9, 130.1, 133.2, 137.8, 144.3, 
145.8. IR (neat): 3275, 2954, 2929, 2859, 1432, 1341, 1322, 1164, 1136, 1083, 908, 814, 
662, 578, 558, 549 cm-1.  HRMS calcd for C16H26ClNO3NaS [M!(SO2Tol)+(MeONa)]+: 
370.1220, found 370.1212. ee = 96% [determined by SFC using Chiralpak IA column , 
7% MeOH/CO2 as eluent at 40 oC and 12 MPa; for major diastereomer t = 4.07 min 
(minor enantiomer), t = 4.62 min (major enantiomer); for minor distereomer t = 5.19 min 
(major enantiomer), t = 5.95 min (minor enantiomer)]. 
 
General Procedure A was applied to (S)-2-chlorooctanal (244 mg, 1.5 mmol), p-
toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid sodium salt hydrate 
(267 mg, 1.5 mmol). The title compound was obtained as a white solid (376 mg, 80% 
yield, dr > 20:1, mp = 108!100 °C).   = +87.4 (c = 1.8, CHCl3).  ee = 96% 
[determined by SFC using Chiralpak IA column , 7% MeOH/CO2 as eluent at 40 oC and 
12 MPa; for major diastereomer t = 4.07 min (major enantiomer), t = 4.62 min (minor 
enantiomer); for minor distereomer t = 5.19 min (minor enantiomer), t = 5.95 min (major 
! "#$!
enantiomer)]. 
 
General Procedure B was applied to 2-chlorooctanal (244 mg, 1.5 mmol), p-
toluenesulfonamide (171 mg, 1 mmol), p-toluenesulfinic acid  (187 mg, 1.2 mmol). The 
title compound (4.6) was obtained as a white solid (315 mg, 67% yield, dr = 2:1). 
 
 
N-(2-Chloro-3-methyl-1-tosylbutyl)-4-methylbenzenesulfonamide 
(4.7).  General Procedure A was applied to 2-chloroisovaleraldehyde (181 
mg, 1.5 mmol), p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid 
sodium salt hydrate (267 mg, 1.5 mmol). The title compound was obtained as a white 
solid  (483 mg, 75% yield, dr > 20:1, mp = 118!120 °C).  1H NMR (500 MHz, CDCl3): ! 
1.07 (d, J = 6.6 Hz, 6H), 1.83!1.89 (m 1H), 2.43 (s, 3H), 2.45 (s, 3H), 4.44 (d, J = 9.4 
Hz, 1H), 5.05 (dd, J = 10.1 Hz, J = 1.2 Hz, 1H), 5.43 (dd, J = 10.2 Hz, J = 1.2 Hz, 1H), 
7.22 (d, J = 8.1 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 7.5 (d, J = 8.3 Hz, 2H), 7.66 (d, J = 8.1 
Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 20.0, 20.2, 21.8, 22.0, 33.1, 65.3, 74.6, 127.3, 
129.7, 129.9, 130.2, 133.1, 137.8, 144.3, 145.8.  IR (neat): 3223, 2967, 2926, 1597, 1446, 
1336, 1314, 1303, 1151, 1130, 1091, 908, 858, 814, 728, 670, 638, 579, 526 cm-1.  
HRMS calcd for C13H20ClNO3NaS [M!(SO2Tol)+(MeONa)] +: 328.0750, found 
328.0742. 
 
General Procedure B was applied to 2-chloroisovaleraldehyde (181 mg, 1.5 mmol), p-
toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid  (187 mg, 1.2 mmol). 
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The title compound (4.7) was obtained as a white solid (356 mg, 83% yield, dr > 20:1). 
 
 
 N-(2-Chloro-3-phenyl-1-tosylpropyl)-4-methylbenzenesulfonamide 
(4.8).  General Procedure A was applied to 2-chlorohydro-
cinnamaldehyde (181 mg, 1.5 mmol), p-toluenesulfonamide (253 mg, 1 mmol), and p-
toluenesulfinic acid sodium salt hydrate (178 mg, 1 mmol). The title compound was 
obtained as a white solid and characterized as a mixture of diastereomers  (419 mg, 88% 
yield, dr = 4:1).  1H NMR (500 MHz, CDCl3) Major: ! 2.41 (s, 3H), 2.44 (s, 3H), 2.91 
(dd, J = 14.5 Hz, J = 8.2 Hz, 1H), 3.06 (dd, J = 14.5 Hz, J = 6.6 Hz, 1H), 4.90 (dd, J = 
10.4 Hz, J = 1.3 Hz, 1H), 4.98 (td, J = 7.2 Hz, J = 1.3 Hz, 1H), 5.62 (d, J = 10.2 Hz, 1H), 
7.18!7.33 (m, 9H), 7.48 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 8.4 Hz, 2H).  13C{1H} (CDCl3, 
125 MHz) Major: ! 21.8, 21.9, 42.4, 58.8, 75.0, 127.3, 127.7, 128.9, 129.6, 129.8, 129.9, 
130.0, 133.0, 135.6, 137.7, 144.4, 145.8.  IR (neat): 3275, 3031, 2930, 1597, 1427, 1332, 
1162, 1131, 1082, 911, 881, 813, 773, 708, 662, 590, 555 cm-1.  HRMS calcd for 
C17H20ClNO3NaS [M!(SO2Tol)+(MeONa)] +: 376.0750, found 376.0688. 
 
General Procedure B was applied to 2-chlorohydrocinnamaldehyde (181 mg, 1.5 mmol), 
p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid  (187 mg, 1.2 mmol). 
The title compound (4.6) was obtained as a white solid (430 mg, 90% yield, dr = 3:1). 
 
N-((2R)-2-Chloro-1-tosylundec-10-en-1-yl)-4-methyl-
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benzenesulfonamide (!)-(4.9).  General Procedure A was applied to (R)-2-chloroundec-
10-enal (304 mg, 1.5 mmol), p-toluenesulfonamide (253 mg, 1 mmol), and p-
toluenesulfinic acid sodium salt hydrate (178 mg, 1 mmol). The title compound was 
obtained as a white solid and characterized as a mixture of diastereomers  (425 mg, 83% 
yield, dr = 12:1).  Employing racemic 2-chloroundec-10-enal, the title compound was 
obtained as a white solid (90% yield, dr = 12:1).    = !64.0 (c = 1.0, CHCl3).  1H 
NMR (500 MHz, CDCl3) Major: " 1.18!1.61 (m, 12H), 2.04 (quartet, J = 6.6 Hz, 2H), 
2.43 (s, 6H), 4.73 (t, J = 6.9 Hz, 1H), 4.80 (d, J = 10.5, 1H), 4.94 (d, J = 11.0 Hz, 1H), 
5.00 (d, J = 17.8 Hz, 1H), 5.53 (d, J = 10.0 Hz, 1H), 5.77!5.85 (m, 1H), 7.23!7.27 (m, 
4H), 7.58 (d, J = 7.8 Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): " 
21.8, 22.0, 26.2, 28.8, 29.0, 29.1, 29.3, 33.9, 36.4, 58.5, 76.0, 114.4, 127.2, 129.8, 129.9, 
130.1, 133.2, 137.9, 139.2, 144.2, 145.8.  IR (neat): 3230, 2922, 2854, 1598, 1450, 1333, 
1315, 1229, 1164, 1149, 1082, 912, 816, 663, 580, 559 cm-1.  HRMS calcd for 
C18H27ClNO2S [M!(SO2Tol)]+: 356.1451, found 356.1439.  ee = 96% [determined by 
SFC using Chiralpak IA column, 7% MeOH/CO2 as eluent at 40oC and 12 MPa; for 
major diastereomer t = 5.17 min (minor enantiomer), t = 6.13 min (major enantiomer); 
for minor distereomer t = 7.32 min (minor enantiomer), t = 7.93 min (major enantiomer)]. 
 
General Procedure B was applied to 2-chloroundec-10-enal (304 mg, 1.5 mmol), p-
toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid  (187 mg, 1.2 mmol). 
The title compound (4.9) was obtained as a white solid (492 mg, 96% yield, dr = 5:1). 
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 N-(3-((tert-Butyldiphenylsilyl)oxy)-2-chloro-1-tosylpropyl)-4-
methylbenzenesulfonamide (4.10).  General Procedure A was 
applied to 3-((tert-butyldiphenylsilyl)oxy)-2-chloropropanal (520 
mg, 1.5 mmol), p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid 
sodium salt hydrate (178 mg, 1 mmol).  The product was also washed with Et2O (3 x 10 
mL).  The title compound was obtained as a white solid  (394 mg, 60% yield, dr > 20:1, 
mp = 130!138 °C).  1H NMR (500 MHz, CDCl3): ! 1.10 (s, 9H), 2.40 (s, 3H), 2.46 (s, 
3H), 3.28 (t, J = 10.4 Hz, 1H), 3.55 (dd, J = 10.7 Hz, J = 5.6 Hz, 1H), 4.64 (ddd, J = 10.1 
Hz, J = 5.8 Hz, J = 1.1 Hz, 1H), 5.41 (dd, J = 10.5 Hz, J = 1.0 Hz, 1H), 5.52 (d, J = 10.5 
Hz, 1H), 7.16 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 7.38!7.49 (m, 6H), 7.57 (dd, 
J = 8.1 Hz, J = 1.5 Hz, 2H), 7.61!7.65 (m, 4H), 7.71 (d, J = 8.4 Hz, 2H).  13C{1H} 
(CDCl3, 125 MHz): ! 19.3, 21.8, 22.0, 27.0, 55.4, 63.6, 71.3, 127.2, 128.1, 128.2, 129.8, 
130.0, 130.1, 130.3, 130.5, 132.5, 132.6, 133.3, 135.7, 135.8, 137.9, 144.1, 145.9.  IR 
(neat): 3275, 3070, 2931, 2858, 1597, 1428, 1344, 1165, 1113, 1083, 909, 814, 736, 704, 
678, 662, 571, 506 cm-1.  HRMS calcd for C27H34ClNO4NaSSi [M!(SO2Tol)+(MeONa)] 
+: 554.1564, found 554.1513. 
 
General Procedure B was applied to 3-((tert-butyldiphenylsilyl)oxy)-2-chloropropanal 
(520 mg, 1.5 mmol), p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid  
(187 mg, 1.2 mmol). The title compound (4.10) was obtained as a white solid (348 mg, 
53% yield, dr >20:1). 
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N-(2-bromo-1-tosyloctyl)-4-methylbenzenesulfonamide 
(4.11).  A was applied to 2-bromooctanal (311 mg, 1.5 mmol), 
p-toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid sodium salt hydrate 
(267 mg, 1.5 mmol). The title compound was obtained as a white solid and characterized 
as a mixture of diastereomers (351 mg, 68% yield, dr = 4:1). 1H NMR (500 MHz, CDCl3) 
Major: ! 0.88 (t, J = 7.8 Hz, 3H), 1.19!1.48 (m, 8H), 1.64 (q, J = 7.7 Hz, 2H), 2.43 (s, 
3H), 2.44 (s, 3H), 4.71 (dd, J = 10.0 Hz, J = 1.1 Hz, 1H), 4.74 (t, J = 7.6 Hz, 1H), 5.54 (d, 
J = 10.2 Hz, 1H), 7.25 (d, J = 7.6 Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.0 Hz, 
4H). 13C{1H} (CDCl3, 125 MHz) Major: ! 14.2, 21.8, 22.0, 22.7, 27.4, 28.5, 31.6, 37.2, 
50.6, 75.6, 127.2, 129.8, 130.0, 130.1, 133.3, 137.9, 144.3, 145.8. IR (neat): 3275, 2928, 
2858, 1597, 1428, 1340, 1321, 1305, 1163, 1137, 1083, 904, 879, 814, 706, 688, 662, 
570, 555 cm-1.  HRMS calcd for C15H23BrNO2S [M!(SO2Tol)]+: 360.0609, found 
360.0617. 
 
N-(2-fluoro-1-tosyloctyl)-4-methylbenzenesulfonamide (4.12). 
A was applied to 2-fluorooctanal (219 mg, 1.5 mmol), p-
toluenesulfonamide (171 mg, 1 mmol), and p-toluenesulfinic acid sodium salt hydrate 
(267 mg, 1.5 mmol). The title compound was obtained as a white solid and characterized 
as a mixture of diastereomers (351 mg, 68% yield, dr = 0:1). 1H NMR (500 MHz, CDCl3) 
Major: ! 0.88 (t, J = 6.8 Hz, 3H), 1.22!1.64 (m, 10H), 2.24 (s, 3H), 2.44 (s, 3H), 4.65 
(dd, J = 25.3 Hz, J = 10.2, 1H), 5.34 (ddd, J = 47.8 Hz, J = 9.0 Hz, J = 3.7Hz, 1H), 5.36 
(d, J = 10.1 Hz, 1H), 7.23 (d, J = 8.1 Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H), 7.55 (d, J = 8.1 
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Hz, 1H), 7.65 (d, J = 8.1 Hz, 2H). 13C{1H} (CDCl3, 125 MHz) Major: ! 14.2, 21.9 (d, JC-
F =16.8 Hz), 22.7, 24.7 (d, J C-F = 4.9 Hz), 28.9, 31.6, 32.0, 32.2, 75.5 (d, JC-F = 18.2 Hz), 
89.9 (d, JC-F = 178.3), 127.2, 129.8, 129.9, 130.0, 132.9, 138.8, 144.2, 145.8. 19F (CDCl3, 
338 MHz): ! !193.7 (m).  IR (neat): 3270, 2956, 2929, 2859, 1448, 1319, 1305, 1163, 
1135, 1083, 1038, 924, 883, 814, 704, 662, 643, 584, 562, 546 cm-1.  HRMS calcd for 
C15H23FNO2S [M!(SO2Tol)]+: 300.1434, found 300.1425. 
 
N-(2-Chloro-3-methyl-1-tosylbutyl)methanesulfonamide (4.14).  
General Procedure A was applied to 2-chloroisovaleraldehyde (181 mg, 
1.5 mmol), methane sulfonamide (95 mg, 1 mmol), and p-toluenesulfinic acid sodium salt 
hydrate (178 mg, 1 mmol). The title compound was obtained as a white solid  (290 mg, 
82% yield, dr = 10:1).  1H NMR (500 MHz, CDCl3): ! 1.07 (s, 6H), 2.05 (m, 1H), 2.48 (s, 
3H), 3.18 (s, 3H), 4.21 (d, J = 7.9 Hz, 1H), 5.02 (d, J = 9.2 Hz, 1H), 5.38 (d, J = 8.7 Hz, 
1H), 7.40 (d, J = 7.4 Hz, 2H), 7.81 (d, J = 7.3 Hz, 2H). 13C{1H} (CDCl3, 125 MHz): ! 
19.6, 20.0, 22.0, 33.5, 43.3, 65.3, 75.2, 130.1, 130.3, 132.9, 146.4.  IR (neat): 3273, 2359, 
1439, 1329, 1284, 1244, 1148, 1130, 1081, 978, 943, 904, 850, 818, 772, 713, 638. 
HRMS cald for  C6H13ClNO2S [(M!SO2Tol)]+, 198.0355, found 198.0472. 
 
4-Bromo-N-(2-chloro-3-methyl-1-tosylbutyl)benzene-
sulfonamide (4.15). General Procedure B was applied to 2-
chloro-3-methylbutanal (482 mg, 4 mmol), 4-bromo-
benzenesulfonamide (472 mg, 2 mmol), and p-toluenesulfinic acid sodium salt hydrate 
(357 mg, 2 mmol). The title compound was obtained as a white solid (643 mg, 65 % 
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yield, dr > 20:1, mp = 133!135 °C decomp.). 1H NMR (500 MHz, CDCl3): ! 1.09 (d, J = 
6.6 Hz, 3H), 1.10 (d, J = 6.6 Hz, 3H), 1.90"2.00 (m, 1H), 2.45 (s, 3H), 4.44 (dd, J = 8.8 
Hz, J = 1.1 Hz, 1H), 5.05 (dd, J = 10.1 Hz, J = 1.2 Hz, 1H), 5.55 (d, J = 10.1 Hz, 1H), 
7.23 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 8.2 Hz, 2H), 7.62 (s, 4H). 13C{1H} (CDCl3, 125 
MHz): ! 19.9, 20.2, 22.0, 33.2, 65.1, 74.6, 128.4, 128.8, 129.9, 132.4, 130.0, 133.0, 
139.7, 146.1.  IR (neat): 3575, 3488, 2957, 2932, 2885, 2859, 1472, 1463, 1389, 1376, 
1254, 1107, 1092, 963, 836, 776 cm-1.  HRMS calcd for C12H28O2Si [M–SO2Tol]+: 
337.9617, found 337.9549. 
 
4-Nitro-N-(2-chloro-3-methyl-1-tosylbutyl)benzenesulfon-
amide (4.16). General Procedure A was applied to 2-chloro-3-
methylbutanal (482 mg, 4 mmol), 4-nitrobenzenesulfonamide 
(472 mg, 2 mmol), and p-toluenesulfinic acid sodium salt hydrate (357 mg, 2 mmol). The 
title compound was obtained as a white solid (387 mg, 42 % yield, dr > 20:1, mp = 
115!120 decomp). 1H NMR (500 MHz, THF-d8): ! 1.87 (d, J = 6.7 Hz, 6H), 2.09!2.19 
(m, 1H), 2.39 (s, 3H), 4.41 (dd, J = 7.1 Hz, J = 3.1 Hz, 1H), 5.11 (dd, J = 10.1 Hz, J = 3.1 
Hz, 1H), 7.23 (d, J = 7.8 Hz, 2H), 7.54 (d, J = 8.1 Hz, 2H), 7.91 (d, J = 8.5 Hz, 2H), 8.29 
( d, J = 8.5 Hz, 2H), 8.46 (d, J = 10.2 Hz, 1H). 13C{1H} (THF-d8, 125 MHz): ! 19.1, 20.7, 
21.7, 33.7, 66.1, 76.2, 124.9, 129.1, 130.6, 130.7, 135.5, 146.4, 148.4, 151.1. IR (neat): 
3193, 2966, 2930, 1537, 1447, 1339, 1316, 1169, 1130, 1080, 856, 741, 602, 574. cm-1. 
HRMS calcd for C11H14ClN2O4S [M–SO2Tol]+: 303.0206, found 303.0211. 
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N-(2-Chloro-3-phenyl-1-tosylpropyl)thiophene-2-sulfonamide 
(4.17).  General Procedure A was applied to 2-chlorohydrocinnam-
aldehyde (181 mg, 1.5 mmol), 2-thiophenesulfonamide (163 mg, 1 
mmol), and p-toluenesulfinic acid sodium salt hydrate (178 mg, 1 mmol). The title 
compound was obtained as a white solid and characterizd as a mixture of diastereomers  
(338 mg, 72% yield, dr = 12:1).  1H NMR (500 MHz, CDCl3) Major: ! 2.43 (s, 3H), 2.91 
(dd, J = 14.2 Hz, J = 8.2 Hz, 1H), 3.07 (dd, J = 14.4 Hz, J = 6.8 Hz, 1H), 4.89 (dd, J = 
10.3 Hz, J = 1.3 Hz, 1H), 4.96 (t, J = 7.4 Hz, 1H), 5.74 (d, J = 10.4 Hz, 1H), 7.07 (dd, J = 
5.1 Hz, J = 3.8 Hz, 1H), 7.18 (d, J = 7.3 Hz, 2H), 7.25!7.34 (m, 6H), 7.56 (d, J = 8.2 Hz, 
2H), 7.62 (dd, J = 5.0 Hz, J = 1.4 Hz, 1H).  13C{1H} (CDCl3, 125 MHz) Major: ! 22.0, 
42.4, 58.7, 75.0, 127.6, 127.7, 129.0, 129.6, 130.0, 130.1, 132.8, 132.9, 133.5, 135.5, 
141.3, 146.0.  IR (neat): 3247, 1596, 1442, 1341, 1313, 1228, 1161, 1127, 1081, 1017, 
982, 913, 854, 813, 721, 701, 680, 599, 578, 543.  HRMS calcd for C14H16ClNO3NaS2 
[M!(SO2Tol)+(MeONa)] +: 368.0158, found 368.0182.  
 
N-(1-((4-(tert-Butyl)phenyl)sulfonyl)-2-chloro-3-methylbutyl)-4-
methylbenzenesulfonamide (4.18). General Procedure B was 
applied to 2-chloro-3-methylbutanal (362 mg, 3 mmol), p-
toluenesulfonamide (343 mg, 2 mmol), and p-tert-butylphenylsulfinic acid sodium salt 
(440 mg, 2 mmol).  The title compound was obtained as a very viscous oil (480 mg, 51% 
yield, dr > 20:1). 1H NMR (500 MHz, CDCl3): ! 1.08 (d, J = 6.6 Hz, 3H), 1.09 (d, J = 6.6 
Hz, 3H), 1.34 (s, 9H), 1.84"1.94 (m, 1H), 2.46 (s, 3H), 4.45 (dd, J = 9.1 Hz, J = 1.3 Hz, 
1H), 5.09 (dd, J = 10.1 Hz, J = 1.4 Hz, 1H), 5.40 (d, J = 10.1 Hz, 1H), 7.31 (d, J = 8.2 
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Hz, 2H), 7.44 (d, J = 8.7 Hz, 2H), 7.54 (d, J = 8.6 Hz, 2H), 7.69 (d, J = 8.2 Hz, 2H). 
13C{1H} (CDCl3, 125 MHz): ! 20.1, 20.2, 21.9, 31.2, 33.1, 35.5, 65.4, 74.7, 126.2, 127.4, 
129.8, 130.0, 133.0, 137.8, 144.3, 158.7. IR (neat): 3270, 2967, 1724, 1596, 1401, 1337, 
1163, 1094, 838, 814, 667, 557 cm-1. HRMS calcd for C12H17ClNO2S [M–p-t-
BuC6H5SO2]+: 274.0669, found 274.0694. 
 
Sodium 4-(tert-butyl)benzenesulfinate hydrate (4.24).  The title 
compound was synthesized according to literature procedure.30 Mp 
> 300 °C.  1H NMR (500 MHz, CD3OD): ! 1.33 (s, 9H), 7.47 (d, J = 8.4 Hz, 2H), 7.58 (d, 
J = 8.4 Hz, 2H). 13C{1H} (CD3OD, 125 MHz): 31.9, 35.7, 125.1, 126.5, 154.0, 154.3. IR 
(neat): 3386, 2961, 2834, 2527, 2208, 1654, 1458, 1395, 1019, 961, 833, 600 cm-1. 
HRMS calcd for C10H13O2S [M–Na]+: 197.0636, found 197.0631.!!
 
General Procedure C: formation of N-phosphinoyl aldimine precursors. A dry 10 
mL round bottom flask, which was purged with nitrogen, was charged with 
diphenylphosphinamide (217 mg, 1 mmol), p-toluenesulfinic acid (234 mg, 1. mmol), !-
chloro aldehdye (1.5 mmol) and dry Et2O (6 mL). The reaction mixture was allowed to 
stir at room temperature until complete by TLC (72 h), upon which the solid product 
precipitated out of solution.  The solid product was collected onto sintered glass filter and 
washed sequentially with Et2O to remove the excess aldehyde.  Most products can be 
used in subsequent reactions without further purification.  Products of higher purity can 
be obtained by recrystallization from EtOAc /hexanes. 
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N-(2-Chloro-3-methyl-1-tosylbutyl)-P,P-diphenylphosphinic amide 
(4.19).  General Procedure C was applied to 2-chloroisovaleraldehyde 
(181 mg, 1.5 mmol), diphenylphosphinamide (217 mg, 1 mmol), and p-
toluenesulfinic acid (187 mg, 1.2 mmol). The title compound was obtained as a white 
solid (292 mg, 61% yield, dr 20 >1, mp = 125!128 °C decomp).  1H NMR (500 MHz, 
CDCl3): ! 0.90 (d, J = 6.5 Hz, 3H), 1.06 (d, J = 6.5 Hz, 3H), 1.96!2.03 (m, 1H), 2.41 (s, 
3H), 4.13 (t, J = 12.0 Hz, 1H), 4.42 (d, J = 9.8 Hz, 1H), 4.84 (t, J = 11.0 Hz, 1H), 7.20 (d, 
J = 8.0 Hz, 2H), 7.38 (td, J = 7.8 Hz, J = 3.2 Hz, 2H), 7.45 (td, J = 7.6 Hz, J = 3.2 Hz, 
2H), 7.50!7.67 (m, 6H), 7.72!7.76 (m, 2H).  13C{1H} (CDCl3, 125 MHz): ! 20.2, 20.7, 
21.9, 33.0, 66.3, 72.7, 128.6 (d, Jc-p = 13.3 Hz), 128.9 (d, Jc-p = 13.0 Hz), 129.7, 130.0, 
131.8 (d, Jc-p = 10.2 Hz), 132.2 (d, Jc-p = 10.2 Hz), 132.4, 132.6, 134.0, 145.  31P NMR 
(144 MHz, CHCl3): !  24.5.  IR (neat): 3180, 3051, 2956, 1595, 1455, 1436, 1305, 1293, 
1194, 1147, 1123, 1110, 1084, 1037, 887, 814, 774, 723, 690, 650, 586, 535.  HRMS 
calcd for C17H20ClNOPS [M!SO2Tol]: 320.0971, found 320.0836. 
 
N-(2-Chloro-3-phenyl-1-tosylpropyl)-P,P-diphenylphosphinic 
amide (4.20).  General Procedure C was applied to 2-chlorohydro-
cinnimaldehyde (253 mg, 1.5 mmol), diphenylphosphinamide (217 
mg, 1 mmol), and p-toluenesulfinic acid (187, 1.2 mmol). The title compound was 
obtained as a white solid and characterized as a mixture of diastereomers (425 mg, 81% 
yield, dr = 1:1).  1H NMR (500 MHz, CDCl3) Diastereomer 1: ! 2.41 (s, 3H), 3.07 (dd, J 
= 14.3 Hz, J = 7.7 Hz, 1H), 3.69 (dd, J = 13.9 Hz, J = 4.6 Hz, 1), 4.08 (dd, J = 11.9 Hz, J 
= 8.2 Hz, 1H), 4.65 (t, J = 10.5 Hz, 1H), 4.93!4.98 (m, 1H), 7.12 (d, J = 6.9 Hz, 2H), 
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7.24!7.69 (m, 17 H). Diastereomer 2: ! 2.47 (s, 3H), 3.16!3.24 (m, 2H), 4.18 (t, J = 11.7 
Hz, 1H), 4.71 (t, J = 11.2 Hz, 1H), 4.93!4.98 (m, 1H), 7.18 (d, J = 7.6 Hz, 2H), 
7.23!7.69 (m, 16H), 7.74 (dd, J = 12.2 Hz, J = 7.6 Hz, 2H). 13C{1H} (CDCl3, 125 MHz) 
Diastereomer 1: ! 21.9, 40.3, 59.4, 73.0, 127.3, 128.6 (d, Jc-p = 12.7 Hz), 128.7 (d, Jc-p = 
12.7), 129.6, 130.0, 132.0, (d, Jc-p = 2.2 Hz), 132.2 (d, Jc-p = 5.0 Hz), 132.7, 133.7, 136.2, 
145.4.  Diastereomer 2: ! 22.0, 42.2, 62.1, 74.3, 127.4, 129.0 (d, Jc-p = 13.2 Hz), 129.7, 
130.0, 132.0 (d, Jc-p = 2.7Hz), 132.3 (d, Jc-p = 6.0 Hz), 132.8, 134.8, 137.0, 145.6. 31P 
NMR (144 MHz, CHCl3): ! 24.6.  IR (neat): 3171, 3060, 1496, 1454, 1437, 1314, 1302, 
1190, 1156, 1126, 1085, 1036, 1010, 815, 750, 726, 697, 589, 575, 546. HRMS calcd for 
C21H25ClNOPS [M!SO2Tol]: 368.0971, found 368.0873. 
 
 !N-(2-Chloro-1-tosylpent-4-en-1-yl)-P,P-diphenylphosphinic 
amide (4.21). General Procedure C was applied to 2-chloropent-4-
enal (178 mg, 1.5 mmol), diphenylphosphinamide (217 mg, 1 
mmol), and benzenesulfinic  acid (171 mg, 1.2 mmol). The title compound was obtained 
as a white solid and characterized as a mixture of diastereomers (313 mg, 68% yield, dr = 
5:1). 1H NMR (500 MHz, CDCl3) Major: ! 2.73!2.79 (m, 1H), 3.01!3.06 (m, 1H), 4.21 
(t, J = 9.6 Hz, 1H), 4.70!4.75 (m, 2H), 5.16 (d, J = 10.5 Hz, 1H), 5.25 (d, J = 17.2 Hz, 
1H), 5.87 (ddt, J = 17.1 Hz, J = 10.4 Hz, J = 6.9 Hz, 1H), 7.34!7.84 (m, 15H). 13C{1H} 
(CDCl3, 125 MHz) Major: !  37.8, 59.4, 75.2, 119.1, 124.9, 128.4 (d, Jc-p = 6.0 Hz), 
128.5 (d, Jc-p = 5.6 Hz), 129.1, 129.4, 131.9 (d, Jc-p = 10.8 Hz), 132.0 (d, Jc-p = 10.7 Hz), 
132.2, 132.4, 133.2, 134.3, 137.2. 31P NMR (144 MHz, CHCl3): !  24.8.  IR (neat): 3061, 
2929, 1676, 1643, 1592, 1438, 1308, 1190, 1161, 1127, 1109, 1082, 998, 922, 750, 727, 
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694, 576, 548, 536.  HRMS calcd for C23H23ClNO3PNaS [M+Na]+: 482.0821, found 
482.0721. 
 
General Procedure D: Formation of !-Chloro Aldimine. A 10 mL round bottom flask 
was charged with !-amido sulfone precursor (1 mmol), 2 mL CH2Cl2, and 2 mL 
saturated sodium bicarbonate solution.  The biphasic mixture was stirred vigourously for 
1h.  The organic layer was separated and the aqueous solution extracted with CH2Cl2 (3 " 
5 mL).  The combined organic layers were successively washed with brine, dried over 
Na2SO4, and filtered.  The filtrate was concentrated in vacuo, diluted with a small amount 
of CH2Cl2 (15 mL), and filtered through a pad of celite.  The filtrant was concentrated in 
vacuo and used without further purification.  
 
(E)-N-(2-Chlorooctylidene)-4-methylbenzenesulfonamide 
(4.13). General Procedure D was applied to N-((2R)-2-chloro-1-
tosyloctyl)-4-methylbenzenesulfonamide (472 mg, 1 mmol).  The title compound was 
obtained as a viscou oil (296 mg, 94% yield).  1H NMR (500 MHz, CDCl3): ! 0.86 (t, J = 
6.9 Hz, 3H), 1.25#1.51 (m, 8H), 1.86#1.99 (m, 2H), 2.45 (s, 3H), 4.45 (quart, J = 6.3 Hz, 
1H), 7.36 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H), 8.38 (d, J = 5.9 Hz, 1H).  13C{1H} 
(CDCl3, 125 MHz) : ! 14.1, 21.9, 22.6, 25.7, 28.6, 31.6, 34.5, 59.7, 128.5, 130.2, 133.9, 
145.5, 172.6.  IR (neat): 3283, 2929, 2859, 1634, 1597, 1456, 1331, 1163, 1091, 814, 
688, 555. HRMS calcd for C15H33ClNO2S [MH]+: 316.1139, found 316.1143.   
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(E)-N-(2-Chloro-3-methylbutylidene)-4-methylbenzenesulfonamide 
(4.25). General Procedure D was applied to N-(2-chloro-3-methyl-1-
tosylbutyl)-4-methylbenzenesulfonamide (429 mg, 1 mmol).  The title 
compound was obtained as a viscous oil (249 mg, 91% yield).  1H NMR (500 MHz, 
CDCl3): ! 1.02 (d,  J = 6.8 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H), 2.21!2.27 (m, 1H), 2.45 (s, 
3H), 4.28 (t, J = 6.5 Hz, 1H), 7.36 (d, J = 8.3 Hz, 2H), 7.82 (d, J = 8.3 Hz, 2H), 8.40 (d, J 
= 6.4 Hz, 1H).  13C{1H} (CDCl3, 125 MHz) : ! 18.2, 19.5, 21.9, 33.2, 65.9, 128.5, 130.2, 
134.0, 145.5, 172.8.  IR (neat): 3282, 2968, 2931, 1636, 1597, 1465, 1329, 1164, 1091, 
1039, 814, 776, 727, 670, 554.  HRMS calcd for C13H20ClNO2NaS [M+CH3OH+Na]+: 
328.0750, found 328.0631.     
 
!""#$%&'$()* : Nucleophilic Addition to "-Chloro Aldimine 
 
 N-((3R,4S)-4-chloro-1-(trimethylsilyl)dec-1-yn-3-yl)-4-
methylbenzenesulfonamide (4.22). A dry 10 mL Schlenk 
flask, which was evacuated and backfilled with N2 three times, was charged with 
trimethylsilyl acetylene (0.44 mmol, 63 µL) and THF (5 mL).  The flask was then cooled 
to !78 °C followed by dropwise addition of n-BuLi (0.22 mL, 2.5 M in hexanes) and 
stirred for 10 minutes. N-((2R)-2-chloro-1-tosyloctyl)-4-methylbenzenesulfonamide (0.2 
mmol, 94 mg) was dissolved in THF (1 mL) and added to the flask dropwise.  The 
reaction was stirred at !78 °C and monitored until completion as determined by TLC 
until completion (15 minutes).31! The reaction mixture was slowly quenched with 
saturated aqueous NH4Cl (4 mL) followed by addition of EtOAc (5 mL). The organic 
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layer was separated and the aqueous solution extracted with EtOAc (3 ! 5 mL).  The 
combined organic layers were successively washed with brine, dried over MgSO4, and 
filtered. The filtrate was concentrated in vacuo and purified by column chromatography 
on silica gel (EtOAc:hexanes, 5:95).      The title compound was obtained as a white solid 
(70 mg, 85% yield, mp = 90!96 °C).  = !77.1 (c = 1.9, CHCl3).  1H NMR (500 
MHz, CDCl3): " 0.01 (s, 9H), 0.89 (t, J = 7.0 Hz, 3H), 1.28!1.39 (m, 7H), 1.47!1.54 (m, 
1H), 1.75!1.80 (m, 2H), 2.44 (s, 3H), 3.96!3.99 (m, 1H), 4.36 (dd, J = 10.1 Hz, J = 3.1 
Hz, 1H), 5.01 (d, J = 10.1 Hz, 1H), 7.32 (d, J = 8.2 Hz, 2H), 7.79 (d, J = 8.4 Hz, 2H). 
13C{1H} (CDCl3, 125 MHz) : " 0.3, 14.2, 21.8, 22.7, 26.4, 28.8, 31.7, 35.3, 51.4, 65.8, 
92.0, 98.6, 127.6, 129.8, 137.5, 143.9.  IR (neat): 3271, 2959, 2940, 1405, 1331, 1250, 
1171, 1094, 1076, 905, 841, 809, 760, 667, 629, 570, 546 cm-1.  HRMS calcd for 
C20H33ClNO2SSi [MH]+: 414.1690, found 414.1692. 
 
Alterative procedure for formation of 4.22 using isolated aldimine.  A dry 10 mL 
Schlenk flask, which was evacuated and backfilled with N2 three times, was charged with 
trimethylsilyl acetylene (0.24 mmol, 34 µL) and THF (5 mL).  The flask was then cooled 
to !78 °C followed by dropwise addition of n-BuLi (0.12 mL, 2.5 M in hexanes) and 
stirred for 10 minutes.  (S)-N-(2-chlorooctylidene)-4-methylbenzenesulfonamide (0.2 
mmol, 63 mg) was dissolved in THF (1 mL) and added to the flask dropwise.  The 
reaction was stirred at !78 °C and monitored by TLC until completion (15 minutes).  The 
rest of the procedure is the same as above. 
 
 
! "#"!
!(2R,3R)-2-hexyl-1-tosyl-3-((trimethylsilyl)ethynyl)-
aziridine (4.23). A 10 mL round bottom flask was 
charged with 4.22 (0.12 mmol, 50 mg) and acetonitrile (3 
mL) followed by K2CO3 (0.36 mmol, 50 mg) in a single portion. The reaction was 
monitored until completion as determined by TLC (12 h).  The acetonitrile was removed 
in vacuo and the product was dissolved in CH2Cl2, washed with brine (2 ! 5 mL), dried 
over MgSO4, and filtered. The filtrate was concentrated in vacuo and purified by column 
chromatography on silica gel (EtOAc:hexanes, 5:95).  The title compound was obtained 
as a viscous oil (44 mg, 96% yield).  = "50.0 (c = 1.9, CHCl3).  1H NMR (500 MHz, 
CDCl3): ! 0.20 (s, 9H), 0.87 (t, J = 7.3 Hz, 3H), 1.21"1.30 (m, 8H), 1.44 (m, 1H), 1.63 
(m, 1H), 2.45 (s, 3H), 2.97 (d, J = 4.5 Hz, 1H), 3.07 (q, J = 6.0 Hz, 1H), 7.33 (d, J = 8.1 
Hz, 2H), 7.89 (d, J = 7.6 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 0.2, 14.2, 21.8, 22.6, 
26.9, 28.9, 30.8, 31.8, 36.2, 48.9, 92.2, 98.4, 128.3, 129.6, 136.7, 144.5.  IR (neat): 2957, 
2928, 2857, 1458, 1336, 1250, 1164, 1092, 906, 845, 815, 761, 708, 675, 642.  HRMS 
calcd for C20H32NO2SSi [MH]+: 378.1923, found 378.2000.  ee = 96% (using 17 from 
aldimine precursor or isolated aldimine), HPLC conditions: AS-H column, 2% 
isopropanol in hexanes, flow = 0.5 mL/min, t1 = 15.8 min (major), t2 = 18.9 min (minor).   
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Chapter 5. Chelation-Controlled Addition of Organozincs to !-Chloro Aldimines 
 
5.1 Introduction 
 
Since Cornforth´s original publication in 1959, the Cornforth model has been used 
to rationalize diastereofacial selectivity in additions to chiral !-halogenated carbonyl and 
imine derivatives.  As depicted in Figure 5.1A for imines, this model is based on the  
 
 
 
Figure 5.1 Stereoinduction models for additions to !-chiral imines 
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minimization of dipole (or electrostatic) interactions by adopting an anti parallel 
orientation of the C=N and C!X bonds.  The stereochemical outcome, however, is the 
same as predicted by the Felkin model. 
 Based on our studies building on these long-standing models, we found that 
alkylzinc halides (RZnX) and sulfonates (RZnO2SRF) are an exceptional class of Lewis 
acids that promoted chelation in additions to !- and "-silyloxy aldehydes and ketones 
(Figure 5.1, transition state B).1  We set out to determine whether this unique reactivity 
could be applied to other substrates that bear even less Lewis basic moieties.  Alkyl 
halides are considerably less Lewis basic than silyl ethers.  However, alkyl halides are 
known to coordinate to transition metals.2  With this thought in mind, we hypothesized 
that alkylzinc halides may effectively coordinate the halogen of chiral !-halo carbonyl or 
imino derivatives to override Cornforth control and afford chelation products.   
To date, we are only aware of three examples of chelation-control in nucleophilic 
additions to "-halogenated carbonyl and imino derivatives.3  In these cases, however, the 
substrate scope with respect to nucleophile was limited to hydride.  The addition of 
carbon-based nucleophiles constitutes an important advance to this methodology.  This 
chapter describes a general method for highly diastereoselective additions of organozinc 
reagents to !-chloro aldimines via chelation.4  Additionally, computational studies are 
presented to further probe the origin of the reversed diastereoselectivity.  All 
computational studies were perfomed by Prof. Per-Ola Norrby at the University of 
Gothenburg.  Importantly, these reactions are the first highly diastereoselective chelation-
controlled C!C bond forming reactions that are halide directed.      
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5.2 Previous Examples of Chelation-Controlled Additions to !-Halogenated 
Carbonyl Derivatives 
 Fuchikami and coworkers reported one early example of chelation control in 
nucleophilic addition of a hydride to an !-halogenated ketone.3a  As illustrated in Table 
5.1, tributyltin hydride was reacted with !-trifluoromethyl ketone 5.1 in the presence of 
several Lewis acids.  When TiCl2(OiPr)2 and MeAlCl2 Lewis acids were employed, the 
expected Cornforth product, 5.3, was obtained with modest dr (Table 5.1, entries 1 and 
2).  On the other hand, when the reaction was conducted in the presence of Et3Al or 
Me3Al, chelation product 5.2 was furnished with 85:15 and 87:13 dr, respectively.  To 
account for the unexpected stereochemical outcome, they proposed that aluminum 
interacts strongly with the trifluoromethyl group of 5.1.  Reductions of other !-
trifluoromethyl ketones were not explored.   
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Table 5.1 Diastereoselective reduction of !-trifluoromethyl ketone by Fuchikami 
 
 
O
Ph
CF3
Me Bu3SnH
Lewis acid
(1.5!2 equiv)
OH
Ph
CF3
Me
OH
Ph
CF3
Me+
5.2
chelation
product
5.3
Felkin/Cornforth
product
5.1
entry dr (5.2: 5.3)
1
Lewis acid
TiCl2(i-Pr)2 28: 72
2 MeAlCl2 36: 64
3 Et3Al 85: 15
4 Me3Al 87:13
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 In 2005, Flowers and coworkers disclosed a highly diastereoselective chelation-
controlled reduction of !-fluoroketones.3b  As shown in Scheme 5.1, lithiumborohydride 
reacted with !-fluoroketone 5.4 in the presence of titanium tetrachloride with excellent 
diastereoselectivity, favoring chelation product 5.5.  Notably, the reaction in the absence 
of TiCl4 narrowly favors the chelation product.  It is likely that lithium of the borohydride 
reagent can also interact with the fluorine atom of ketone 5.4 to form a chelate.  Several 
other acyclic and cyclic ketones were employed in the reaction and modest to good 
diastereoselectivies were observed (5:1 to > 20:1 dr).  Furthermore, Flowers and 
coworkers conducted a series of NMR binding studies to further investigate the 
unexpected diastereostereofacial selectivity of the reactions.  As shown in Scheme 5.1, a 
significant downfield shift was seen in both the 1H and 13C{1H} NMR spectra upon 
addition of 1.25 equiv TiCl4 for the !-CHF and !-CF, respectively.  The 19F NMR 
spectrum exhibited a considerable downfield shift of 12.2 ppm in the presence of TiCl4. 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.1 Diastereoselective reduction of !-fluoro ketones by Flowers 
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Flowers and coworkers also repeated these NMR experiments using less Lewis acidic 
Ti(OiPr)4 and did not see significant downfield shifts in the NMR spectra.  Lastly, 1H and 
13C{1H} NMR experiments were performed with propiophenone and TiCl4 for 
comparison.  As expected in the absence of chelation, they observed much smaller 
downfield shift in both the 1H and 13C{1H} NMR spectra.  Collectively, these 
experiments provided evidence for the proposed chelate intermediate. 
 Davis and coworkers have recently disclosed interesting studies involving 
chelation-controlled additions to !-fluoroimines.3c  As illustrated in Scheme 5.2, ketone 
5.6 was reacted with p-anisidine in the presence of thiourea and molecular sieves to  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.2 Diastereoselective reduction of !-fluoro ketimines by Davis and coworkers 
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generate the aryl !-fluoro ketimine in situ.  They added trichlorosilane subsequently at 
low temperature, which afforded fluoroamine 5.8 with 24:1 dr in 80% yield.  Several 
other ketones were employed in the reaction and yielded chelation products with 4:1 to > 
20:1 dr.  Notably, when the reactions were conducted using either the analogous !-fluoro 
ketone or the ketimine without the !-fluoro group, no reaction was observed.   Davis and 
coworkers proposed that the trichlorosilane can first act a Lewis acid and form a nitrogen 
or fluorine-bound pentacoordinate trigonal bypyramidal complex with the substrate as 
depicted in Figure 5.2.  The silicon can sequentially interact with the nitrogen or fluorine 
in a five-membered chelate in which the silicon complex is octahedral.  This more 
electron rich silicon species can then add hydride in an intramolecular fashion.    
 
 
Figure 5.2 Proposed mechanism of reduction of !-fluoroketimines by Davis  
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To build on this methodology, we aimed to achieve chelation-controlled additions using 
carbon-based nucleophiles.  Rebecca Platoff, a former undergraduate student, contributed 
to the preliminary studies of these additions.  Additionally, we set out to employ 
chlorinated carbonyl and imino derivatives, which can be applied in a variety of 
subsequent transformations.  
 
5.3 Results and Discussion 
5.3.1 Addition of Dialkylzincs to in situ Generated N-Ts !-Chloro Aldimines  
 To determine the feasibility of our approach, we examined the reaction of 
diethylzinc with aldimine precursor 5.10.  We conceived a one-pot reaction in which the 
!-chloro aldimine is formed in situ using an excess of diethylzinc as shown in Scheme 
5.3.  When 5.10 was reacted with diethylzinc in the absence of a Lewis acid, reduction 
product 5.14 was generated and only trace amounts of the desired addition product was  
 
 
 
 
 
Scheme 5.3 In situ generation of !-chloro aldimine 
 
observed (Table 5.2, entry 1).  The formation of 5.14 can be attributed to a facile "-
hydride reduction mechanism.5  On the other hand, when diethylzinc was reacted with 
5.10 in the presence of 1.5 equiv EtZnBr, chelation product 5.12 was afforded with 8:1 dr 
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in 50% yield due to the formation of reduction product 5.14.  Encouraged by this result, 
we next optimized the diastereoselectivity and yield of the reaction.  Lowering the 
reaction temperature to !15 °C yielded 60% of addition product, but with poor 
diastereoselectivity (Table 5.2, entry 3).  Employing 3 equiv EtZnBr and reducing the 
amount of Et2Zn improved the selectivity for the addition pathway (6.8:1, 
addition:reduction) and provided chelation product 5.12 with 11:1 dr (Table 5.2, entry 5).  
Interestingly, performing the reaction with EtZnBr in the absence of Et2Zn yielded only 
addition product, albeit with no diastereoselectivity as shown in entry 6.  Employing 
other zinc-based Lewis acids in the reaction did not improve the diastereoselectivity 
(entries 7 and 8).                  
 
Table 5.2 Optimization of addition product formation and syn-diastereoselectivity 
in the addition of diethylzinc to 5.10 
 
NHTs
Cl
n-Hex
ZnEt2
Lewis Acid
CH2Cl2, 0.12 M
NHTs
Cl
n-Hex
NHTs
Cl
n-Hex+
chelation
(syn)
Cornforth/Felkin
(anti)
NHTs
Cl
n-Hex
Reduction
+
5.10 5.12 5.13 5.14
Ts
1 !
1.0  :  1.5  :  5.0
01.0  :     0  :  5.0 trace addition !
2 EtZnBr 0
1.0  :  1.5  :  5.0EtZnBr –15
1: 1 8: 1
1.5: 1 2: 13
4 EtZnBr 1.0  :  1.5  :  3.0 0 3.5: 1 8: 1
5 EtZnBr 1.0  :  3.0  :  3.0 0 6.8: 1 11: 1
7 1.0  :  3.0  :  3.0 0 6.3: 1 7: 1
8 EtZnONf 1.0  :  3.0  :  3.0 0 1: 1.5 3: 1
EtZnCl
6 EtZnBr 1.0  :  3.0  :     0 0 1: 0 1.5: 1
entry    5.10  :  LA   :  Et2Zn temp (°C) addition:reductiona dr (5.12: 5.13)aLewis Acid (LA)
a Ratios determined by analysis of 1H NMR spectra of unpurified products.
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 The optimized reaction conditions in Table 5.2 (entry 5) were applied to the 
addition of Et2Zn and Me2Zn to other !-chloro aldimine precursors (Table 5.3).  Notably,  
 
 
Table 5.3 Chelation-controlled additions of Et2Zn and Me2Zn to in situ generated !-
chloro aldimines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
entry             aldimine precursor           ZnR2             yield (%)a             drb        product
NHTs
Cl
R2
ZnR2 (3 equiv)
RZnBr (3 equiv)
CH2Cl2, 0 °C
0.12M
NHTs
Cl
R2
R
NHTs
Cl
R2
R+
1c
2
NHTs
Cl
n-Hex
ZnEt2 80c 11:1
ZnMe2 10:183
NHTs
Cl
3c
4d ZnMe2
84
80
>20:1
>20:1
NHTs
Cl
Ph
5
6
ZnEt2
ZnMe2
76
82 20:1
12:1
NHTs
Cl
TBDPSO
7
8
ZnEt2
ZnMe2 85 6:1
NHTs
Cl
9
10
ZnEt2
ZnMe2 68 11:16
69 7:1
a Aldimine generated in-situ from sulfone precursor unless otherwise stated. b dr determined by 
analysis of 1H NMR spectra of the unpurified reaction products and refers to the ratio of 
chelation:Cornforth/Felkin products. c Isolated aldimine can be used and comparable 
diastereoselectivity and yield observed. d Relative product stereochemistry was confirmed by X-ray 
analysis.
60 5:1
chelation Cornforth/Felkin
Ts
Ts
Ts
Ts
Ts
Ts
5.12
5.15
5.16
5.17
5.18
5.19
5.20
5.21
5.22
5.23
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comparable results were observed when the isolated !-chloro aldimine was employed in 
the reaction (Table 5.3, entries 1 and 3).  Additionally, improved yields were achieved 
when Me2Zn was used.  Importantly, the R group on RZnX and R2Zn should be identical 
to preclude a mixture of products.6 The relative stereochemistry of methyl addition 
product 5.17 was confirmed to be by syn by X-ray analysis as illustrated in Figure 5.3.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 X-ray crystal structure of 5.17 
 
 
5.3.2 Addition of Vinylzincs to N-Ts !-Chloro Aldimines 
 
 We next explored the generality of our method with respect to the organozinc 
nucleophile.  To this end, we investigated the addition of vinylzinc reagents to !-chloro 
aldimines.  The allylic amine products of these additions represent versatile intermediates 
in synthesis.7  We envisioned a one-pot reaction in which both the !-chloro aldimine and 
vinylzinc reagent are formed in situ.  The vinylzinc reagents were generated using the 
Srebnik"Oppolzer procedure as shown in Table 5.4.8  To this end, hydroboratin of the 
alkyne and subsequent B to Zn transmetalltion provided the (E)-vinylzinc reagents, which 
were added to the !-halo aldimine precursor.  After screening, we found that performing  
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Table 5.4 One-pot chelation-controlled addition of vinylzinc reagents to !-chloro 
aldimines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R1
i. HBCy2, 0 °C to rt
   CH2Cl2, 
ii. Me2Zn, (7 equiv)
   –78 °C
R2
EtZnBr (2 equiv)
–78 to –45 °C3 equiv
entry
1b,c NHTs
Cl
n-Bu 89c > 20: 1
Ph2 72 > 20: 1
t-Bu3 72 > 20: 1
Mei-Pr
4
70 > 20: 1
NHTs
Cl
n-Hex
Cl(H2C)3
MeMe
NHTs
Cl
Ph
NHTs
Cl
OTBDPS
NHTs
Cl
6
n-Bu
n-Bu
n-Bu
n-Bu
5
6
7
8b,d
9
10
11
70 > 20: 1
ZnMe
R2
R1
NHTs
Cl
R3
NHTs
Cl
R3
R1
R2
83 > 20: 1
69 > 20: 1
79 > 20: 1
77 > 20: 1
81 20: 1
a Comparible diastereoselectivity and yield obtained in the reaction using isolated imine. b Reaction
on 5mmol scale. c dr determined by 1H NMR of the crude reaction products and refers to the ratio 
of chelation:Cornforth/Felkin products. d Reaction carried out using enantioenriched starting material 
with no erosion of ee (see Appendix A4).
> 20: 161
Ts
Ts
Ts
Ts
Ts
Ts
major product
chelation-control
5.24
5.25
5.26
5.27
5.28
5.29
5.30
5.31
5.32
5.33
5.34
aldimine precursor alkyne yield (%) dra product
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the addition of the aldimine precursor at !78 °C followed by warming to !45 °C gave 
optimal yields and diastereoselectivities.  As illustrated in Table 5.4, a variety of terminal 
alkynes can be employed in the reaction, including one bearing a pendent chloro group, 
to yield "-chloroamine products with > 20:1 dr (entries 1!5).  Moreover, internal alkynes 
can be employed to afford (E)-trisubstituted allylic alcohols with > 20:1 dr (Table 
5.4,entries 6 and 7).  The substitution at the #-position of the aldimine precursor can also 
be varied while maintaining high diastereoselectivity for the chelation product (entries 
8!11).  Furthermore, scalability is important for any practical method. When the reaction 
in entry 1 was conducted on a 2g scale, chelation product 5.24 was obtained with > 20:1 
dr in 89% yield.  It is also important to demonstrate the use of enantioenriched aldimines 
for application in small and complex molecule synthesis.  No erosion of ee was observed 
when the reaction in entry 8 was conducted using enantioenriched #-chloro aldimine 
precursor (see Appendix A4 for details).  
 
5.3.3 Applications of syn "-Chloro Allylic Amines  
 We next turned our attention to demonstrating the synthetic utility of the syn "-
chloro allylic amine products.  Chloroamine 5.24 was used to access cis aziridine-2-
carboxaldehyde 5.35 in 83% yield in a two-step sequence (Scheme 5.4).  Importantly, 
aziridine-2-carbonyl derivatives constitute useful intermediates that are know to react 
with organometallic reagents with high diastereoselectivity.9  Additionally, chloroamine 
5.24 was employed in a tandem ring closure/palladium catalyzed allylic substitution 
reaction to furnish amine 5.37 as a 10:1 mixture of diastereomers (Scheme 5.5). 
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Scheme 5.4 Application of syn !-chloro allylic amines to the synthesis of cis 
aziridine-2-carboxaldehydes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.5 Application of syn !-chloro allylic amines to tandem ring 
closure/allylic substitution 
 
To gain insight into the generality of C–X bond participation in chelation-
controlled diastereoselective processes, we tested the reaction of diethylzinc with "-
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diethylzinc in the presence of ethyl zinc bromide, syn bromohydrin 5.38 is generated in 
97% yield with 10:1 dr (Scheme 5.6).  Performing the reaction using !-chloro aldehydes 
afforded chlorohydrins 5.39 and 5.40 with excellent dr (> 20:1).  The chelation-controlled 
products in these reactions indicate that C–X bonds can chelate with different halogens 
and different functional groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.6 Chelation-controlled additions to !-halogenated aldehydes 
 
 
 
5.4 Computational Studies 
 Additions of organozinc reagents to carbonyl derivatives have been studied 
experimentally10 and theoretically11 by many groups.  The commonly accepted 
mechanism involves one zinc moiety that both acts as a Lewis acid to activate the 
substrate and also binds a Lewis basic group to which the dialkylzinc bonds and reacts 
with the carbonyl.  In this case, we proposed that the alkylzinc halide can activate the 
substrate and the halide is available for coordination to the second zinc moiety.  It has 
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 190!
also been widely accepted that the addition of dialkylzincs occur via a four-membered 
ring transition state with the carbonyl.11a Although less common, a 6-membered ring 
transition state has also been shown to be plausible.11b,11k  For that reason, both possible 
transition states were investigated.  As a representative system, we chose to study the 
reaction of N-mesyl-protected !-chloropropanimine, CH3"CHCl"CH=N"SO2Me, with 
dimethylzinc (Me2Zn) and methylzinc chloride (MeZnCl).  Notably, optimization of the 
reactants in the ground state displays a complex between Me2Zn and MeZnCl containing 
a µ-Cl bridge.  In an effort to bring these components into a five-membered chelate 
between the imine nitrogen and the !-chloro moiety, gave a complex in which the 
sulfonyl oxygens coordinate to one zinc atom.  Moreover, this complex lacks the rigidity 
expected for the high diastereoselectivities observed, displaying essentially free rotation 
around the N=C"C"Cl bond.  Interestingly, in contrast to previous studies, the     
         
 Table 5.5 Relative calculated barriers for different additions (kJ mol-1)a       
          
 
 
 
 
six-membered transition state is favored over the four-membered ring transtion state (TS) 
across different levels of theory (Table 5.5).11b,11k,l  The four transition states leading to 
the syn or anti addition products are illustrated in Figures  5.4 and 5.5.  Figure 5.5 
highlights ther difference between the four- and six-membered transition states.  As 
product TS ring size B3LYP/BSI M06/BSII M06/BSIII
anti
anti
syn
syn
4
6
4
6
36
15
22
0
27
14
10
0
17
12
6
0
a Comparison of four- and six-membered ring transition states leading to syn or anti addition 
product. See Figures 5.4 and 5.5 for transition state structures.
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shown in the lowest energy structure leading to the syn addition product, the chelate 
structure with MeZnCl coordinates to the !-Cl group, which restricts the rotation of the 
!-Me group (Figure 5.4A).  Furthermore, in the TS leading to the syn product, the Me 
group is directed away from the reaction center, leading to a favorable addition.  In 
contrast, the Me group is pointed toward the reaction center in the TS leading to the anti 
product (Figure 5.4C and 5.4D).  The significant difference in energy observed for the 
TS’s leading to the syn and anti products support the experimental results.  
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Transition states leading to syn and anti products based on computational 
studies.  (A) 6-membered ring TS leading to syn product, 90% (best TS, M06/II, other 
levels >90%).  (B) 4-Membered ring TS leading to syn product, 9% (ca 6 kJ/mol higher 
than best TS, M06/II).  (C) 6-Membered ring TS leading to anti product, 0.9% (ca 12 
kJ/mol higher than best TS, M06/II).  (D) 4-Membered ring TS leading to anti product, 
0.1% (ca 18 kJ/mol higher than best TS, M06/II).  Structures are drawn in Figure 5.5 and 
highlight the 4- and 6-membered rings. 
! !
! !
A. B.
C. D.
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Figure 5.5  Simplified transition states leading to the syn and anti products.  The 4- and 
6-membered transition states are highlighted in red.  Note that for the purpose of clarity, 
enantiomeric aldimines are used in drawings A,B vs. C,D.  In all cases, the dimethylzinc 
is attacking the imine from the bottom face. 
 
 
 
5.5 Conclusions 
 Substrate control continues to be a widely utilized stategy in asymmetric 
synthesis.  Within this conceptual framework, the models used to rationalize 
diastereofacial selectivity in nucleophilic additions to !-chiral carbonyls and imines have 
been accepted since the 1950’s.  We have achieved a highly diastereoselective method for 
chelation-controlled addition of organozincs to !-chloro aldimines.  The unexpected 
chelation mechanism is supported by computational studies.  Additionally, the synthetic 
utility of the syn "-chloroamines was demonstrated in multi-step and one-pot processes.     
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5.6 Experimental Section 
 
General Methods.  All reactions were performed under a nitrogen atmosphere using 
oven-dried glassware and standard Schlenk or vacuum line techniques.  The progress of 
all reactions was monitored by thin-layer chromatography.  Toluene and dichloromethane 
were dried through alumina columns.  Racemic, chiral !-chloro aldehyde derivatives 
were prepared by literature method; reaction of the corresponding aldehyde with N-
chlorosuccinimide and proline.12 Enantiopure, !-chloro aldehydes were prepared using 
MacMillan’s SOMO catalysis methodology.13 Alkyl zinc halides were prepared by 
literature methods.14 All chemicals were obtained from Acros, Sigma-Aldrich, or GFS 
Chemicals unless otherwise described.  The 1H NMR and 13C{1H} NMR spectra were 
obtained using a Brüker AM-500 Fourier transform NMR spectrometer at 500 and 125 
MHz, respectively.  Chemical shifts are reported in units of parts per million (ppm) 
downfield from tetramethylsilane and all coupling constants are reported in hertz.  The 
infrared spectra were obtained using a Perkin-Elmer 1600 series spectrometer.  Thin-
layer chromatography was carried out on Whatman pre-coated silica gel 60 F-254 plates 
and visualized by ultra-violet light or by staining with ceric ammonium molybdate or p-
anisaldehyde stain.  Silica gel (230-400 mesh, Silicycle) was used for air-flashed 
chromatography.  Analysis of diastereomeric ratios was performed by analysis of 1H 
NMR spectra of unpurified reaction products.  Analysis of enantiomeric excess was 
performed using a Hewlett-Packard 1100 series HPLC and Chiralpak AD-H column.    
High resolution mass spectra were measured using a Waters 2695 Separations Module 
(1S0RR23444).  Relative stereochemistry was determined by comparison to literature 
values, conversion to the corresponding aziridine and analysis of coupling constants, or 
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X-ray analysis.  Analysis of diastereomeric ratios of halohydrins was performed by gas 
chromatograpy using a Hewlett-Packard 6890 GC with a Beta-Dex Column or by 1H 
NMR of the crude reaction products.  The relative stereochemistry was ascertained by 
comparison of the 1H NMR spectra to the corresponding Grignard addition or by 
conversion to the epoxide and analysis of coupling constants.  Coordinates for the 
calculated structures for computational studies are in Appendix A4.   
 
Caution: Care must be taken when handling pyrophoric dialkylzinc reagents. 
 
General Procedure A: Generation of !-Chloro Amines via Alkyl Addition to "-
Chloro Tosyl Aldimines. A dry 10 mL Schlenk flask, which was evacuated and 
backfilled with N2 three times, was charged with the alkyl zinc bromide (0.6 mmol, neat 
solid), dialkylzinc (0.6 mmol), and dichloromethane (1 mL).  The flask was then cooled 
to 0 °C followed by dropwise addition of aldimine solution (0.2 mmol in 0.35 mL 
dichloromethane, 0.12M reaction). The reaction was monitored by TLC until completion.  
The reaction mixture was slowly quenched with saturated 1M HCl (2 mL) followed by 
addition of EtOAc (5 mL). The organic layer was separated and the aqueous solution 
extracted with EtOAc (3 ! 5 mL).  The combined organic layers were successively 
washed with brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo and purified by column chromatography on silica gel.    
 
General Procedure B: Generation of !-Chloro Amines via Alkyl Addition to "-
Chloro Tosyl Aldimines. A dry 10 mL Schlenk flask, which was evacuated and 
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backfilled with N2 three times, was charged with the alkyl zinc bromide (0.6 mmol, neat 
solid), dialkylzinc (0.6 mmol), and dichloromethane (1.35 mL).  The flask was then 
cooled to 0 °C followed by addition of the sulfonamidosulfone precursor as a solid under 
a steady flow of N2 (g) (0.2 mmol, 0.12M reaction). The reaction was monitored by TLC 
until completion.  The reaction mixture was quenched with saturated 1M HCl (2 mL) 
followed by addition of EtOAc (5 mL). The organic layer was separated and the aqueous 
solution extracted with EtOAc (3 ! 5 mL). The combined organic layers were 
successively washed with brine and NaHCO3 (2 x 5 mL), dried over MgSO4, and filtered. 
The filtrate was concentrated in vacuo and purified by column chromatography on silica 
gel. 
 
N-((3S,4S)-4-chlorodecan-3-yl)-4-methylbenzenesulfon-
amide (5.12).  General procedure A was applied to EtZnBr 
(106 mg, 0.6 mmol), Et2Zn (0.3 mL, 2M in dichloromethane) and N-(2-
chlorooctylidene)-4-methylbenzenesulfonamide (63 mg, 0.2 mmol).  The crude product 
was purified by flash column chromatography on silica gel (hexanes:EtOAc, 93:7) to 
afford the title compound a viscous oil (55 mg, 80% yield, dr = 11:1) and characterized as 
a mixture of diastereomers.  1H NMR (500 MHz, CDCl3) Major: " 0.79 (t, J = 7.5Hz, 
3H), 0.88 (t, J = 7.4 Hz, 3H)  1.15–1.67 (m, 2H), 2.42 (s, 3H), 3.35–3.40(m, 1H), 3.93 
(ddd, J =  9.2 Hz, J =  5.0 Hz, J =  2.1 Hz, 1H), 4.61 (d, J =  9.4 Hz, 1H), 7.29 (d, J =  8.1 
Hz, 2H), 7.76 (d, J =  8.3 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): " 10.7, 14.2, 21.7, 22.8, 
26.9, 27.0, 28.9, 31.8, 35.5, 59.4, 65.5, 127.2, 129.8, 139.0, 143.5.  IR (neat): 3280, 2958, 
2930, 2858, 1496, 1425, 1332, 1184, 1162, 1094, 1045, 1005, 912, 815, 774, 729, 707, 
NHTs
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667, 576, 550 cm-1.  HRMS calcd for C17H28ClNO2NaS (M+Na)+: 368.1427, found 
368.1421.  
 
N-((2R,3R)-3-chlorononan-2-yl)-4-methylbenzenesulfonamide 
(5.15).  General procedure B was applied to MeZnBr (96 mg, 0.6 
mmol), Me2Zn (0.3 mL, 2M in dichloromethane) and N-(2-chloro-1-tosyloctyl)-4-
methylbenzenesulfonamide (95 mg, 0.2 mmol).  The crude product was purified by flash 
column chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title compound 
a viscous oil (55 mg, 83% yield, dr = 10:1) and characterized as a mixture of 
diastereomers.  1H NMR (500 MHz, CDCl3) Major: ! 0.88 (t, J = 7.1 Hz, 3H), 1.12 (d, J 
= 6.7 Hz, 3H), 1.17–1.43 (m, 8H), 1.58–1.66 (m, 2H), 2.42 (s, 3H), 3.60–3.64 (m, 1H), 
3.78 (ddd, J = 8.9 Hz, J = 5.1 Hz, J = 2.4 Hz, 1H), 4.67 (d, J = 9.2 Hz, 1H), 7.28 (d, J = 
8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H).   13C{1H} (CDCl3, 125 MHz) Major: ! 14.2, 19.9, 
21.7, 22.7, 26.8, 28.9, 31.8, 35.3, 53.3, 68.0, 127.3, 129.9, 138.6, 143.6.  IR (neat): 3276, 
2955, 2929, 2858, 1455, 1429, 1335, 1164, 1093, 909, 890, 815, 676, 551 cm-1.  HRMS 
calcd for C16H26ClNO2NaS (M+Na)+: 354.1271, found 354.1263.  
 
N-((3R,4R)-4-chloro-5-methylhexan-3-yl)-4-methylbenzenesulfon-
amide (5.16).  General procedure A was applied to EtZnBr (106 mg, 0.6 
mmol), Et2Zn (0.3 (mL, 2M in dichloromethane) and N-(2-chloro-3-methylbutylidene)-4-
methylbenzenesulfonamide (55 mg, 0.2 mmol).  The crude product was purified by flash 
column chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title compound 
a white solid (51.0 mg, 84% yield, dr >20:1, mp = 108!118 °C).  1H NMR (500 MHz, 
NHTs
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CDCl3): ! 0.77 (t, J = 7.5 Hz, 3H), 0.91 (d, J = 6.7 Hz, 3H), 1.04 (d, J = 6.6 Hz, 3H), 
1.43!1.49 (m, 1H), 1.56!1.62 (m, 1H), 1.92!1.99 (m, 1H), 2.43 (s, 3H), 3.60!3.65 (m, 
2H), 4.67 (d, J = 9.4 Hz, 1H), 7.29 (d, J = 8.1 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H).  13C{1H} 
(CDCl3, 125 MHz): ! 10.5, 20.4, 21.0, 21.7, 27.4, 32.0, 56.8, 72.1, 127.1, 129.8, 139.0, 
143.5.  IR (neat): 3273, 2968, 2876, 1597, 1456, 1424, 1324, 1163, 1094, 1027, 992, 924, 
815, 728, 666, 626, 577, 551 cm-1.  HRMS calcd for C14H22ClNO2NaS (M+Na)+: 
326.0958, found 326.0959.  
 
N-((2R,3R)-3-chloro-4-methylpentan-2-yl)-4-methylbenzenesulfon-
amide (5.17). General procedure B was applied to MeZnBr (96 mg, 0.6 
mmol), Me2Zn (0.3 mL, 2M in dichloromethane) and N-(2-chloro-3-
methyl-1-tosylbutyl)-4-methylbenzenesulfonamide (86 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 9:1) 
to afford the title compound a white solid (46.4 mg, 80% yield, dr >20:1, mp = 118!128 
°C).  Clear crystals formed that were suitable for X-ray diffraction study by a slow vapor 
diffusion of hexanes into a chloroform solution of the title compound.  1H NMR (500 
MHz, CDCl3): ! 0.92 (d, J = 6.7 Hz, 3H), 1.03 (d, J = 6.6 Hz, 3H), 1.08 (d, J = 6.6 Hz, 
3H), 1.98!2.05 (m, 1H), 2.43 (s, 3H), 3.47 (dd, J = 8.7 Hz, J = 2.7 Hz, 1H), 3.79!3.85 
(m, 1H), 4.70 (d, J = 9.3 Hz, 1H), 7.30 (d, J = 8.2 Hz, 2H), 7.77 (d, J = 8.3 Hz, 2H).  
13C{1H} (CDCl3, 125 MHz): ! 20.3, 20.4, 20.8, 21.7, 32.2, 51.2, 75.4, 127.2, 129.9, 
138.6, 143.6.  IR (neat): 3261, 2980, 2877, 1599, 1453, 1426, 1332, 1229, 1169, 1153, 
1095, 1042, 955, 902, 837, 816, 727, 676, 605, 557 cm-1.  HRMS calcd for 
C13H20ClNO2NaS (M+Na)+: 312.0801, found 312.0789. 
NHTs
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N-((2R,3R)-2-chloro-1-phenylpentan-3-yl)-4-methylbenzenesulfon-
amide (5.18). General procedure B was applied to EtZnBr (106 mg, 
0.6 mmol), Et2Zn (0.3 mL, 2M in dichloromethane) and N-(2-chloro-3-phenyl-1-
tosylpropyl)-4-methylbenzenesulfonamide (96 mg, 0.2 mmol).  The crude product was 
purified by flash column chromatography on silica gel (hexanes:EtOAc, 9:1) to afford the 
title compound a white solid (55 mg, 76% yield, dr = 11:1) and characterized as a mixture 
of diastereomers.  1H NMR (500 MHz, CDCl3) Major: ! 0.72 (t, J = 7.5 Hz, 3H), 
1.39!1.46 (m, 1H), 1.61!1.68 (m, 1H), 2.42 (s, 3H), 2.92 (dd, J = 14.6 Hz, J = 9.0 Hz, 
1H), 3.05 (dd, J = 14.4 Hz, J = 5.0 Hz, 1H), 3.45!3.51 (m, 1H), 4.18 (ddd, J = 9.0 Hz, J 
= 5.0 Hz, J = 2.0 Hz, 1H), 4.78 (d, J = 9.4 Hz, 1H), 7.14 (d, J = 7.9 Hz, 2H), 7.24!7.32 
(m, 5H), 7.79 (d, J = 8.4 Hz, 2H).  13C{1H} (CDCl3, 125 MHz) Major: ! 10.6, 21.7, 26.5, 
41.5, 59.0, 65.6, 127.0, 127.2, 128.6, 129.4, 130.0, 137.7, 138.6, 143.7.  IR (neat): 3279, 
2969, 2955, 2878, 1598, 1455, 1425, 1326, 1162, 1093, 914, 815, 751, 701, 666, 578, 552 
cm-1.  HRMS calcd for C18H22ClNO2NaS (M+Na)+: 374.0958, found 374.0959. 
 
N-((2R,3R)-3-chloro-4-phenylbutan-2-yl)-4-methylbenzenesulfon-
amide (5.19). General procedure B was applied to MeZnBr (96 mg, 0.6 
mmol), Me2Zn (0.3 mL, 2M in dichloromethane) and N-(2-chloro-3-
phenyl-1-tosylpropyl)-4-methylbenzenesulfonamide (96 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 9:1) 
to afford the title compound a white solid (55 mg, 82% yield, dr = 20:1, mp = 92!124 
°C).  1H NMR (500 MHz, CDCl3): ! 1.06 (d, J = 6.6 Hz, 3H), 2.42 (s, 3H), 2.96 (dd, J = 
14.4 Hz, J = 8.6 Hz, 1H), 3.10 (dd, J = 14.2 Hz, J = 5.6 Hz, 1H), 3.67!3.72 (m, 1H), 4.02 
NHTs
Cl
Ph
(+/!)
NHTs
Cl
Ph
(+/!)
 199!
(td, J = 7.1 Hz, J = 2.1 Hz, 1H), 4.90 (bs, 1H), 7.14 (d, J = 7.5 Hz, 2H), 7.22!7.32 (m, 
5H), 7.80 (d, J = 8.3 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 19.6, 21.7, 41.4, 52.7, 68.2, 
127.0, 127.2, 128.7, 129.5, 130.0, 137.6, 138.3, 143.8.  IR (neat): 3273, 3030, 2979, 
1598, 1430, 1334, 1163, 1093, 972, 936, 815, 752, 701, 678, 579, 552, 528 cm-1.  HRMS 
calcd for C17H20ClNO2NaS (M+Na)+: 360.0801, found 360.0800. 
 
N-((2S,3R)-1-((tert-butyldiphenylsilyl)oxy)-2-chloropentan-3-
yl)-4-methylbenzenesulfonamide (5.20).  General procedure B 
was applied to EtZnBr (106 mg, 0.6 mmol), Et2Zn (0.3 mL, 2M in dichloromethane) and 
N-(3-((tert-butyldiphenylsilyl)oxy)-2-chloro-1-tosylpropyl)-4-methylbenzenesulfonamide 
(131 mg, 0.2 mmol).  The crude product was purified by flash column chromatography 
on silica gel (hexanes:EtOAc, 9:1) to afford the title compound an oil (73 mg, 69% yield, 
dr = 7:1) and characterized as a mixture of diastereomers.  1H NMR (500 MHz, CDCl3) 
Major: ! 0.83 (t, J = 7.3 Hz, 3H), 1.05 (s, 9H), 1.51!1.68 (m, 2H), 2.35 (s, 3H), 
3.56!3.70 (m, 2H), 3.84 (t, J = 7.4 Hz, 1H), 4.78 (d, J = 9.7 Hz, 1H), 7.18 (d, J = 8.0 Hz, 
2H), 7.39 (t, J = 7.5 Hz, 4H), 7.45 (t, J = 7.0 Hz, 2H), 7.57 (t, J = 6.5 Hz, 4H), 7.71 (d, J 
= 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz) Major: ! 10.7, 19.3, 21.7, 26.2, 27.0, 56.2, 
62.4, 65.1, 127.1, 128.0, 128.1, 129.8, 130.1, 130.2, 132,9, 133.0, 135.7, 138.6, 143.5.  IR 
(neat): 3228, 3071, 2962, 2932, 2859, 1599, 1472, 1428, 1331, 1162, 1113, 1022, 910, 
815, 739, 704, 667, 613, 506 cm-1.  HRMS calcd for C28H36ClNO3NaSSi (M+Na)+: 
552.1772, found 552.1778. 
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N-((2R,3S)-4-((tert-butyldiphenylsilyl)oxy)-3-chlorobutan-2-yl)-
4-methylbenzenesulfonamide (5.21).  General procedure B was 
applied to MeZnBr (96 mg, 0.6 mmol), Me2Zn (0.3 mL, 2M in 
dichloromethane) and N-(3-((tert-butyldiphenylsilyl)oxy)-2-chloro-1-tosylpropyl)-4-
methylbenzenesulfonamide (131 mg, 0.2 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 9:1) to afford the title 
compound a white solid (88 mg, 85% yield, dr = 6:1) and characterized as a mixture of 
diastereomers.  1H NMR (500 MHz, CDCl3) Major: ! 1.05 (s, 9H), 1.18 (d, J = 6.6 Hz, 
3H), 2.37 (s, 3H), 3.64 (dd, J = 10.4 Hz, J = 5.7 Hz, 1H), 3.70 (t, J = 7.6 Hz, 1H), 
3.74!3.77 (m, 1H), 3.92!3.96 (m, 1H), 4.83 (d, J = 9.5 Hz, 1H), 7.21 (d, J = 8.2 Hz, 2H), 
7.39 (t, J = 7.0 Hz, 4H), 7.43!7.45 (m, 2H), 7.58!7.60 (m, 4H), 7.73 (d, J = 8.4 Hz, 2H).  
13C{1H} (CDCl3, 125 MHz) Major: ! 19.3, 21.7, 26.9, 27.0, 50.5, 64.8, 64.9, 127.2, 
129.9, 130.0, 130.1, 130.2, 130.3, 132.8, 133.0, 135.6, 135.7, 138.4, 143.6.  IR (neat): 
3274, 2932, 2858, 1598, 1428, 1334, 1164, 1113, 1008, 972, 911, 848, 815, 740, 703, 
614, 593 cm-1.  HRMS calcd for C27H34ClNO3NaSSi (M+Na)+: 538.1615, found 
538.1625. 
 
N-((3R,4R)-4-chlorotridec-12-en-3-yl)-4-methyl-
benzenesulfonamide (5.22).  General procedure B was 
applied to EtZnBr (106 mg, 0.6 mmol), Et2Zn (0.3 mL, 2M in dichloromethane) and N-
(2-chloro-1-tosylundec-10-en-1-yl)-4-methylbenzenesulfonamide (102 mg, 0.2 mmol).  
The crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to afford the title compound an oil (46 mg, 60% yield, dr = 5:1) 
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and characterized as a mixture of diastereomers.  1H NMR (500 MHz, CDCl3) Major: ! 
0.78 (t, J = 7.4 Hz, 3H), 1.15!1.65 (m, 14H), 2.04 (q, J = 7.3 Hz, 2H), 2.42 (s, 3H), 3.37 
(q, J = 7.7 Hz, 1H), 3.91!3.95 (m, 1H), 4.60 (d, J = 9.4 Hz, 1H), 4.94 (d, J = 10.2 Hz, 
1H), 5.00 (d, J = 16.8 Hz, 1H), 5.77!5.85 (m, 1H), 7.29 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 
8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz) Major: ! 10.7, 21.7, 26.9, 27.0, 29.0, 29.1, 
29.2, 29.4, 34.0, 35.5, 59.3, 114.4, 127.2, 129.8, 129.9, 138.8, 139.3, 143.6.  IR (neat): 
3280, 2928, 2856, 1455, 1423, 1332, 1162, 1094, 910, 814, 667, 550 cm-1.  HRMS calcd 
for C20H32ClNO2NaS (M+Na)+: 408.1740, found 408.1735. 
 
N-((2R,3R)-3-chlorododec-11-en-2-yl)-4-methylbenzene-
sulfonamide (5.23).  General procedure B was applied to 
MeZnBr (96 mg, 0.6 mmol), Me2Zn (0.3 mL, 2M in 
dichloromethane) and N-(2-chloro-1-tosylundec-10-en-1-yl)-4-methylbenzenesulfon- 
amide (102 mg, 0.2 mmol).  The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 95:5) to afford the title compound an oil 
(51 mg, 68% yield, dr = 11:1) and characterized as a mixture of diastereomers.  1H NMR 
(500 MHz, CDCl3) Major: ! 1.11 (d, J = 6.6 Hz, 3H), 1.16!1.42 (m, 10H), 1.56!1.68 (m, 
2H), 2.04 (q, J = 7.3 Hz, 2H), 2.42 (s, 3H), 3.58!3.63 (m, 1H), 3.78 (ddd, J = 9.0 Hz, J = 
5.2 Hz, J = 2.4 Hz, 1H), 4.71 (d, J = 9.3 Hz, 1H), 4.93 (d, J = 10.5 Hz, 1H), 5.00 (dq, J = 
17.2 Hz, 1.6 Hz, 1H), 5.81 (ddt, J = 17.2 Hz, J = 10.2 Hz, J = 6.7 Hz, 1H), 7.30 (d, J = 
8.1 Hz, 2H), 7.76 (d, J = 8.3 Hz, 2H).  13C{1H} (CDCl3, 125 MHz) Major: !. 19.9, 21.7, 
26.8, 29.0, 29.1, 29.2, 29.4, 34.0, 35.2, 53.3, 68.0, 114.4, 127.2, 129.9, 138.4, 139.3, 
143.6.  IR (neat): 3277, 2927, 2856, 1640, 1599, 1430, 1336, 1160, 1094, 994, 910, 815, 
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707, 675, 593, 551 cm-1.  HRMS calcd for C27H34ClNO3NaSSi (M+Na)+: 3941584, found 
394.1595. 
 
 (2R,3S)-2-ethyl-3-hexyl-1-tosylaziridine (5.41). N-((3R,4R)-
4-bromodecan-3-yl)-4-methylbenzenesulfonamide (47 mg, 
0.12mmol, generated from procedure B as shown above) was dissolved in 3 mL 
acetonitrile.  Potassium carbonate (33 mg, 0.24 mmol) was then added at room 
temperature and monitored by TLC until completion (~12 h).  The acetonitrile was 
removed in vacuo and the product was dissolved in CH2Cl2 and washed with brine, dried 
over MgSO4, and filtered.  The filtrate was concentrated in vacuo and purified by column 
chromatography on silica gel (hexanes:EtOAc, 95:5) to give the title compound as a 
viscous oil (37 mg, 96% yield).  The product was characterized as a 5:1 mixuture of 
diastereomers.  1H NMR (500 MHz, CDCl3) Major: ! 0.86 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 
7.6 Hz, 3H), 1.17!1.55 (m, 12H), 2.44 (s, 3H), 2.74 (td, J = 7.4 Hz, J = 5.4 Hz, 1H), 2.77 
(td, J = 7.6 Hz, J = 5.4 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.82 (d, J = 8.2 Hz, 2H).  
13C{1H} (CDCl3, 125 MHz): ! 11.8, 14.2, 20.4, 21.8, 22.7, 26.9, 27.5, 29.1, 31.8, 45.7, 
46.8, 128.3, 129.7, 135.8, 144.4.  IR (neat): 2927, 2857, 1460, 1324, 1160, 1092, 931, 
815, 720, 669, 574 cm-1.  HRMS calcd for C17H27NO2NaS (M+Na)+: 332.1678, found 
332.1671.   
 
General Procedure C: Generation of "-Chloro Amines via (E)-Vinylzinc Addition to 
#-Chloro Tosyl Aldimines. A dry 10 mL Schlenk flask, which was evacuated under 
vacuum and backfilled with N2 (g) three times, was charged with dicyclohexylborane 
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(Cy2BH) (107 mg, 0.6 mmol) and dichloromethane (0.7 mL).  The solution was cooled to 
0 °C followed by slow addition of alkyne (0.6 mmol).  After 5 min the reaction was 
warmed to room temperature and stirred for an additional 15 min.  The solution was 
cooled to !78 °C and dimethylzinc (Me2Zn) (0.75 mL, 2M in dichloromethane) was 
added.  After stirring at !78 °C for 30 minutes, EtZnBr (0.4 mmol) was added under a 
steady flow of N2 (g).  Immediately thereafter, the aldimine (0.2 mmol, in 0.2 mL 
dichloromethane) was added.  The reaction mixture was warmed to !40 °C and  
monitored by TLC until completion (usually 4-6 h).  The reaction mixture was slowly 
quenched with saturated 1M HCl (2 mL) followed by addition of  5 mL EtOAc.  The 
organic layer was separated and the aqueous layer was extracted successively with 
EtOAc (2 " 5 mL).  The combined organic layers were successively washed with aq. 
NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was concentrated in 
vacuo and purified by column chromatography on silica gel. 
 
General Procedure D: Generation of #-Chloro Amines via (E)-Vinylzinc Addition to 
$-Chloro Tosyl Aldimines. A dry 10 mL Schlenk flask, which was evacuated under 
vacuum and backfilled with N2 (g) three times, was charged with dicyclohexylborane 
(Cy2BH) (107 mg, 0.6 mmol) and dichloromethane (0.7 mL).  The solution was cooled to 
0 °C followed by slow addition of alkyne (0.6 mmol).  After 5 min the reaction was 
warmed to room temperature and stirred for an additional 15 min.  The solution was 
cooled to !78 °C and dimethylzinc (Me2Zn) (0.75 mL, 2M in dichloromethane) was 
added.  After stirring at !78 °C for 30 minutes, EtZnBr (0.4 mmol) was added under a 
steady flow of N2 (g).  Immediately thereafter, the aldimine precursor (0.2 mmol) was 
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added as a solid under a steady flow of N2 (g).  The reaction mixture was warmed to !45 
°C and monitored by TLC until completion (usually 4-6 h).  The reaction mixture was 
slowly quenched with saturated 1M HCl (2 mL) followed by addition of  5 mL EtOAc.  
The organic layer was separated and the aqueous layer was extracted successively with 
EtOAc (2 " 5 mL).  The combined organic layers were successively washed with aq. 
NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was concentrated in 
vacuo and purified by column chromatography on silica gel. 
 
N-((3R,4R,E)-3-chloro-2-methyldec-5-en-4-yl)-4-methyl-
benzenesulfonamide (5.24). General procedure D was applied to 
Cy2BH (2.67 g, 15.0 mmol), 1-hexyne (1.72 mL, 15.0 mmol), Me2Zn (18.8 mL, 2M in 
dichloromethane), EtZnBr (1.77 g, 10.0 mmol), and N-(2-chloro-3-methyl-1-tosylbutyl)-
4-methylbenzenesulfonamide (2.15 g, 5.0 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 97:3) to afford the title 
compound a white solid (1.59 g, 89% yield, dr >20:1, mp = 78!80 °C). 1H NMR (500 
MHz, CDCl3) ! 0.84 (t, J = 7.4 Hz, 3H), 1.02!1.20 (m, 10H), 1.76 (q, J = 7.2 Hz, 2H), 
2.07!2.14 (m, 1H), 2.41 (s, 3H), 3.55 (dd, J = 8.0 Hz, J = 3.9 Hz, 1H), 4.14 (td, J = 8.1 
Hz, J = 3.7 Hz, 1H), 4.84 (d, J = 8.5 Hz, 1H), 5.12 (dd, J = 15.4 Hz, J = 7.6 Hz, 1H), 5.35 
(dt, J = 15.4 Hz, J = 6.9 Hz, 1H), 7.26 (d, J = 7.7 Hz, 2H), 7.70 (d, J = 8.3 Hz, 2H).  
13C{1H} (CDCl3, 125 MHz): ! 14.1, 19.5, 20.4, 21.7, 22.4, 30.9, 31.8, 31.9, 58.2, 74.5, 
127.2, 127.5, 129.6, 134.9, 138.6, 143.3. IR (neat): 3271, 2960, 2929, 2873, 1434, 1330, 
1162, 1094, 970, 924, 813, 720, 667 cm-1. HRMS calcd for C18H28ClNO2NaS (M+Na)+: 
380.1427, found 380.1420. 
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N-((3R,4R,E)-4-chloro-5-methyl-1-phenylhex-1-en-3-yl)-4-
methylbenzenesulfonamide (5.25).  General procedure D was 
applied to Cy2BH (107 mg, 0.6 mmol), phenylacetylene (66 µL, 0.6 mmol), Me2Zn (0.75 
mL, 2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-methyl-1-
tosylbutyl)-4-methylbenzenesulfonamide (55 mg, 0.2 mmol).  The crude product was 
purified by flash column chromatography on silica gel (hexanes:EtOAc, 93:7) to afford 
the title compound a white solid (54 mg, 72% yield, dr >20:1, mp = 132!136 °C). 1H 
NMR (500 MHz, CDCl3) ! 1.06 (d, J = 6.6 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H), 2.12!2.19 
(m, 1H), 2.21 (s, 3H), 3.66 (dd, J = 8.1 Hz, J = 3.8 Hz, 1H), 4.33 (td, J = 8.2 Hz, J = 3.8 
Hz, 1H), 4.33 (td, J = 8.4 Hz, J = 3.7 Hz, 1H), 5.06 (d, J = 8.6 Hz, 1H), 5.74 (dd, J = 15.8 
Hz, J = 7.8 Hz, 1H), 6.18 (d, J = 15.9 Hz, 1H), 7.03 (d, J = 7.3 Hz, 2H), 7.12 (d, J = 8.1 
Hz, 2H), 7.20!7.25 (m, 3H), 7.69 (d, J = 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 
19.6, 20.4, 21.5, 32.0, 58.5, 74.0, 126.4, 126.6, 127.5, 128.2, 128.5, 129.6, 133.2, 135.9, 
138.2, 143.6. IR (neat): 3270, 2966, 2928, 1599, 1448, 1330, 1162, 1092, 968, 917, 813, 
751, 723, 693, 668, 568, 548 cm-1. HRMS calcd for C20H29ClNO2NaS (M+Na)+: 
400.1140, found 400.1117. 
 
N-((3R,4R,E)-3-chloro-2,7,7-trimethyloct-5-en-4-yl)-4-methyl-
benzenesulfonamide (5.26).  General procedure D was applied to 
Cy2BH (107 mg, 0.6 mmol), 3,3-dimethyl-1-butyne (74 µL, 0.6 mmol), Me2Zn (0.75 mL, 
2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-methyl-1-
tosylbutyl)-4-methylbenzenesulfonamide (55 mg, 0.2 mmol).  The crude product was 
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purified by flash column chromatography on silica gel (hexanes:EtOAc, 95:5) to afford 
the title compound a white solid (51 mg, 72% yield, dr >20:1, mp = 120!122 °C). 1H 
NMR (500 MHz, CDCl3) ! 0.78 (s, 9H), 1.04 (d, J = 6.7 Hz, 3H), 1.06 (d, J = 6.7 Hz, 
3H), 2.12 (oct, J = 6.6 Hz, 1H), 2.39 (s, 3H), 3.55 (dd, J = 7.8 Hz, J = 3.8 Hz, 1H), 4.15 
(td, J = 8.0 Hz, J = 3.39, 1H), 4.86 (d, J = 8.3 Hz, 1H), 5.06 (dd, J = 15.7 Hz, J = 7.5 Hz, 
1H), 5.36 (d, J = 15.6 Hz, 1H), 7.24 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.1 Hz, 2H).   
13C{1H} (CDCl3, 125 MHz): ! 19.5, 20.4, 21.6, 29.2, 32.0, 32.9, 58.3, 74.8, 123.0, 127.5, 
129.7, 138.9, 143.4, 145.2. IR (neat): 3268, 2969, 1449, 1367, 1258, 1164, 1095, 981, 
911, 815, 728, 677, 569, 547 cm-1. HRMS calcd for C18H28ClNO2NaS (M+Na)+: 
380.1427, found 380.1433. 
 
N-((3R,4R,E)-3,9-dichloro-2-methylnon-5-en-4-yl)-4-
methylbenzenesulfonamide (5.27).  General procedure D was 
applied to Cy2BH (107 mg, 0.6 mmol), 5-chloro-1-pentyne (64 µL, 0.6 mmol), Me2Zn 
(0.75 mL, 2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-
methyl-1-tosylbutyl)-4-methylbenzenesulfonamide (55 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
93:7) to afford the title compound a white solid (63 mg, 83% yield, dr >20:1, mp = 90!92 
°C). 1H NMR (500 MHz, CDCl3) ! 1.03 (d, J = 6.5 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H), 
1.58!1.62 (m, 2H), 1.94 (q, J = 7.2 Hz, 2H), 2.06!2.12 (m, 1H), 2.42 (s, 3H), 3.36 (t, J = 
6.6 Hz, 2H), 3.55 (dd, J = 8.1 Hz, J = 3.7 Hz, 1H), 4.17 (td, J = 8.1Hz, J = 3.5 Hz, 1H), 
4.84 (d, J = 8.6 Hz, 1H), 5.21 (dd, J = 15.4 Hz, J = 7.3 Hz, 1H), 5.34 (dt, J = 15.4, J = 6.8 
Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 7.70 (d, J = 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): 
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! 19.7, 20.4, 21.7, 29.2, 31.5, 32.0, 44.2, 57.8, 74.3, 127.4, 129.0, 129.7, 138.5, 143.6. IR 
(neat): 3275, 2963, 1598, 1442, 1330, 1161, 1093, 970, 814, 720, 668 cm-1. HRMS calcd 
for C17H25Cl2NO2NaS (M+Na)+: 400.0881, found 400.0898. 
 
N-((3R,4R,E)-4-chloro-1-(cyclohex-1-en-1-yl)-5-methylhex-1-
en-3-yl)-4-methylbenzenesulfonamide (5.28).  General 
procedure D was applied to Cy2BH (107 mg, 0.6 mmol), 1-
ethynyl-1-cyclohexene (70 µL, 0.6 mmol), Me2Zn (0.75 mL, 2M in dichloromethane), 
EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-methyl-1-tosylbutyl)-4-methylbenzene-
sulfonamide (55 mg, 0.2 mmol).  The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title compound a white 
solid (53 mg, 70% yield, dr >20:1, mp = 78!90 °C).  1H NMR (500 MHz, CDCl3) ! 1.02 
(d, J = 7.1 Hz, 3H), 1.04 (d, J = 7.1 Hz, 3H), 1.52!1.56 (m, 5H), 1.79!1.85 (m, 1H), 
2.08!2.14 (m, 3H), 2.38 (s, 3H), 3.58 (dd, J = 7.4 Hz, J = 4.2 Hz, 1H), 4.18 (td, J = 8.1 
Hz, 2.1 Hz, 1H), 4.85 (d, J = 8.2 Hz, 1H), 5.00 (dd, J = 15.7 Hz, J = 8.1 Hz, 1H), 5.59 (t, 
J = 4.0 Hz, 1H), 5.85 (d, J = 15.7 Hz, 1H), 7.21 (d, J = 8.0 Hz, 2H), 7.66 (d, J = 7.8 Hz, 
2H).  13C{1H} (CDCl3, 125 MHz): ! 19.4, 20.4, 21.7, 22.5, 22.6, 24.3, 26.1, 32.0, 58.8, 
74.4, 122.2, 127.7, 129.5, 131.2, 134.7, 137.1, 138.4, 143.3. IR (neat): 3271, 2928, 1648, 
1599, 1435, 1330, 1092, 967, 917, 813, 728, 667, 554 cm-1.  HRMS calcd for 
C20H28ClNO2NaS (M+Na)+: 404.1427, found 404.1424. 
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N-((3R,4R,E)-3-chloro-2,5,7-trimethyloct-5-en-4-yl)-4-methyl-
benzenesulfonamide (5.29).  General procedure D was applied to 
Cy2BH (107 mg, 0.6 mmol), 4-methyl-2-pentyne (70 µL, 0.6 
mmol), Me2Zn (0.75 mL, 2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-
chloro-3- methyl-1-tosylbutyl)-4-methylbenzenesulfonamide (55 mg, 0.2 mmol).  The 
crude product was purified by flash column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to afford the title compound a white solid (50 mg, 70% yield, dr 
>20:1, mp = 98!102 °C).  1H NMR (500 MHz, CDCl3) ! 0.76 (d, J = 6.7 Hz, 3H), 0.86 
(d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.7 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H), 1.36 (s, 3H), 
1.93!1.99 (m, 1H), 2.28!2.35 ( m, 1H), 2.41 (s, 3H), 3.74 (t, J = 5.0 Hz, 1H), 3.87 (t, J = 
6.4 Hz, 1H), 4.99!5.03 (m, 2H), 7.25 (d, J = 8.3 Hz, 2H), 7.69 (d, J = 8.3 Hz, 2H).  
13C{1H} (CDCl3, 125 MHz): ! 12.2, 17.1, 21.2, 21.7, 22.4, 22.5, 27.1, 30.8, 64.0, 71.8, 
127.7, 128.3, 129.5, 137.8, 138.7, 143.4.  IR (neat): 3280, 2961, 2930, 2870, 1599, 1463, 
1331, 1161, 1095, 919, 814, 667, 570, 548 cm-1.  HRMS calcd for C20H28ClNO2NaS 
(M+Na)+: 380.1427, found 380.1422. 
 
N-((4R,5R,E)-5-chloro-3,6-dimethylhept-2-en-4-yl)-4-methyl-
benzenesulfonamide (5.30).  General procedure D was applied to 
Cy2BH (107 mg, 0.6 mmol), 2-butyne (49 µL, 0.6 mmol), Me2Zn 
(0.75 mL, 2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-
methyl-1-tosylbutyl)-4-methylbenzenesulfonamide (55 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
95:5) to afford the title compound a white solid (45 mg, 69% yield, dr >20:1, mp = 123–
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125 °C).  1H NMR (500 MHz, CDCl3) ! 0.92 (d, J = 6.6 Hz, 3H), 1.00 (d, J = 6.7 Hz, 
3H), 1.29 (s, 3H), 1.41 (d, J = 6.9 Hz, 3H), 1.93 (oct, J = 6.0 Hz, 1H), 2.41 (s, 3H), 3.73 
(dd, J = 7.3 Hz, J = 4.9 Hz, 1H), 3.94 (t, J = 6.4 Hz, 1H), 4.97 (d, J = 5.2 Hz, 1H), 5.31 
(q, J = 7.2 Hz, 1H), 7.24 (d, J = 7.9 Hz, 2H), 7.67 (d, J = 7.8 Hz, 2H).  13C{1H} (CDCl3, 
125 MHz): ! 11.9, 13.3, 17.1, 21.1, 21.7, 30.9, 64.1, 71.6, 125.8, 127.8, 129.3, 134.5, 
138.0, 143.3.  IR (neat): 3258, 2969, 2927, 2872, 1597, 1438, 1329, 1157, 1093, 1063, 
1040, 976, 909, 830, 813, 730, 706, 669, 619, 572, 548, 522, 507 cm-1.  HRMS calcd for 
C16H29ClNO2NaS (M+Na)+: 352.1114., found 352.1105.  
 
N-((7R,8R,E)-8-chlorotetradec-5-en-7-yl)-4-methyl-
benzenesulfonamide (5.31).  General procedure D was 
applied to Cy2BH (107 mg, 0.6 mmol), 1-hexyne (70 µL, 0.6 mmol), Me2Zn (0.75 mL, 
2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-((2R)-2-chloro-1-tosyloctyl)-
4-methylbenzenesulfonamide (94 mg, 0.2 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title 
compound an oil (63 mg, 79% yield, dr >20:1, mp = 74!78 °C).  1H NMR (500 MHz, 
CDCl3) ! 0.84 (t, J = 7.2 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H), 1.08!1.35 (m, 10H), 
1.43!1.48 (m, 2H), 1.73 (q, J = 7.7Hz, 2H), 1.81 (q, J = 6.7 Hz, 2H), 2.41 (s, 3H), 3.84 
(td, J = 6.9 Hz, J = 2.9 Hz, 1H), 3.99 (td, J = 7.9 Hz, J = 2.9 Hz, 1H), 4.79 (d, J = 9.0 Hz, 
1H), 5.21 (dd, J = 15.3 Hz, J = 7.0 Hz, 1H), 5.34 (dt, J = 15.3 Hz, J = 6.7 Hz, 1H), 7.27 
(d, J = 8.3 Hz, 2H), 7.71 (d, J = 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 14.1, 14.2, 
21.2, 22.3, 22.8, 26.6, 28.9, 31.0, 31.8, 31.9, 35.2, 59.7, 67.5, 126.8, 127.4, 129.7, 134.8, 
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138.5, 143.4.  IR (neat): 3274, 2956, 2928, 1431, 1333, 1163, 1094, 969, 814, 707, 677, 
557 cm-1.  HRMS calcd for C21H34ClNO2NaS (M+Na)+: 422.1897, found 422.1913. 
 
Determination of ee for N-((7R,8R,E)-8-chlorotetra-
dec-5-en-7-yl)-4-methylbenzenesulfon-amide.    
(2R,3S)-2-((E)-hex-1-en-1-yl)-3-hexyl-1-tosylaziridine (5.42). N-((7R,8R,E)-8-chloro-
tetradec-5-en-7-yl)-4-methylbenzenesulfonamide (50 mg, 0.12mmol, generated from 
procedure D as shown above) was dissolved in 3 mL acetonitrile.  Potassium carbonate 
(33 mg, 0.24 mmol) was then added at room temperature and monitored by TLC until 
completion (~4 h).  The acetonitrile was removed in vacuo and the product was dissolved 
in CH2Cl2 and washed with brine, dried over MgSO4, and filtered.  The filtrate was 
concentrated in vacuo and purified by column chromatography on silica gel 
(hexanes:EtOAc, 95:5) to give the title compound as a viscous oil (36 mg, 80% yield, 
95% ee).  = !18.0 (c = 2.2, CHCl3).
  1H NMR (500 MHz, CDCl3) ! 0.85 (t, J = 7.2 
Hz, 3H), 0.86 (t, J = 7.2 Hz, 3H), 1.14–1.45 (m, 14H), 2.02 (q, J = 7.6 Hz, 2H), 2.43 (s, 
3H), 2.82 (td, J = 8.1Hz, J = 5.9Hz, 1H), 3.35 (t, J = 7.6 Hz, 1H), 5.21 (ddt, J = 15.3 Hz, 
J = 7.7 Hz, J = 1.5 Hz, 1H), 5.84 (dt, J = 15.3 Hz, J = 6.8 Hz, 1H), 7.31 (d, J = 8.1 Hz, 
2H), 7.82 (d, J = 8.2 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 14.0, 14.2, 21.8, 22.2, 22.6, 
27.1, 27.2, 29.0, 31.2, 31.8, 32.3, 45.9, 46.0, 121.7, 128.0, 129.7, 135.8, 138.6, 144.3.  IR 
(neat): 2956, 2928, 2858, 1599, 1456, 1412, 1379, 1327, 1305, 1291, 1237, 1161, 1093, 
966, 928, 875, 815, 720, 697, 673, 557, 550 cm-1.  HRMS calcd for C21H34NO2S (MH)+: 
364.2310, found 364.2323.  HPLC conditions: AD-H column, 1% IPA/hexanes, flow = 
0.3 mL/min, t1 = 34.2 min, t2 = 38.0 min.      
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N-((2R,3R,E)-2-chloro-1-phenylnon-4-en-3-yl)-4-methyl-
benzenesulfonamide (5.32).  General procedure D was applied to 
Cy2BH (107 mg, 0.6 mmol), 1-hexyne (70 µL, 0.6 mmol), Me2Zn (0.75 mL, 2M in 
dichloromethane), EtZnBr (71 mg, 0.4 mmol), and N-(2-chloro-3-phenyl-1-tosylpropyl)-
4-methylbenzenesulfonamide (96 mg, 0.2 mmol).  The crude product was purified by 
flash column chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title 
compound a white solid (62 mg, 77% yield, dr >20:1, mp = 74!78 °C ).  1H NMR (500 
MHz, CDCl3) ! 0.82 (t, J = 7.1 Hz, 3H), 1.05–1.12 (m, 2H), 1.15 (quint, J = 7.0 Hz, 2H), 
1.77 (q, J = 6.8 Hz, 2H), 2.40 (s, 3H), 3.02 (dd, J = 14.2 Hz, J = 8.1 Hz, 1H), 3.21 (dd, J 
= 14.3 Hz, J = 5.3 Hz, 1H), 4.05–4.10 (m, 2H), 4.90 (d, J = 9.0 Hz, 1H), 5.20 (dd, J = 
15.4 Hz, J = 6.8 H, 1H), 5.29 (dt, J = 15.4 Hz, J = 6.6 Hz, 1H), 7.21 (d, J = 8.3 Hz, 2H), 
7.23–7.31 (m, 5H), 7.72 (d, J = 8.4 Hz, 2H).  13C{1H} (CDCl3, 125 MHz): ! 14.0, 21.6, 
22.3, 31.0, 31.8, 41.5, 59.0, 67.7, 126.5, 127.1, 127.5, 128.7, 129.6, 129.7, 135.1, 137.5, 
138.6, 143.5.  IR (neat): 3273, 2956, 2928, 2871, 1496, 1454, 1431, 1332, 1162, 1094, 
1020, 971, 944, 814, 701, 679, 555 cm-1.  HRMS calcd for C22H28ClNO2NaS (M+Na)+: 
428.1427, found 428.1446. 
 
N-((2S,3R,E)-1-((tert-butyldiphenylsilyl)oxy)-2-
chloronon-4-en-3-yl)-4-methylbenzenesulfonamide 
(5.33).  General procedure D was applied to Cy2BH (107 mg, 0.6 mmol), 1-hexyne (70 
µL, 0.6 mmol), Me2Zn (0.75 mL, 2M in dichloromethane), EtZnBr (71 mg, 0.4 mmol), 
and N-(3-((tert-butyldiphenylsilyl)oxy)-2-chloro-1-tosylpropyl)-4-methylbenzenesulfon-
amide (131 mg, 0.2 mmol).  The crude product was purified by flash column 
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chromatography on silica gel (hexanes:EtOAc, 9:1) to afford the title compound a 
viscous oil (95 mg, 81% yield, dr >20:1).  1H NMR (500 MHz, CDCl3) ! 0.86 (t, J = 7.2 
Hz, 3H), 1.07 (s, 9H), 1.14–1.24 (m, 4H), 1.85 (q, J = 7.2 Hz, 2H), 2.39 (s, 3H), 3.69 (dd, 
J = 10.4 Hz, J = 5.0 Hz, 1H), 3.78–3.86 (m, 2H), 4.35 (t, J =7.4 Hz, 1H), 5.06 (d, J = 9.2 
Hz, 1H), 5.22 (dd, J = 15.3 Hz, J = 7.0 Hz, 1H), 5.50 (dt, J = 15.4 Hz, J = 6.6Hz, 1H), 
7.22 (d, J = 8.2 Hz, 2H), 7.38–7.46 (m, 6H), 7.63 (t, J = 8.9Hz, 4H), 7.70 (d, J = 8.3 Hz, 
2H).  13C{1H} (CDCl3, 125 MHz): ! 14.1, 19.4, 21.7, 22.4, 27.0, 31.0, 31.9, 56.8, 63.9, 
64.8, 125.6, 127.4, 128.0, 128.1, 129.7, 130.2, 132.7, 133.0, 135.4, 135.8, 138.5, 143.4.  
IR (neat): 3272, 3071, 3049, 1463, 1428, 1334, 1163, 1113, 969, 814, 740, 704, 688, 614, 
554, 505 cm-1.  HRMS calcd for C32H42ClNO3NaSSi (M+Na)+: 606.224, found 606.2225. 
 
N-((7R,8R,E)-8-chloroheptadeca-5,16-dien-7-yl)-
4-methylbenzenesulfonamide (5.34).  General 
procedure D was applied to Cy2BH (107 mg, 0.6 mmol), 1-hexyne (70 µL, 0.6 mmol), 
Me2Zn (0.75 mL, 2M in dichloromethane), EtZnBr N-(2-chloro-1-tosylundec-10-en-1-
yl)-4-methylbenzenesulfonamide (102 mg, 0.2 mmol).  The crude product was purified 
by flash column chromatography on silica gel (hexanes:EtOAc, 97:3) to afford the title 
compound a viscous oil (54 mg, 61% yield, dr >20:1).  1H NMR (500 MHz, CDCl3) ! 
0.85 (t, J = 7.3 Hz, 3H), 1.09–1.51 (m, 14H), 1.75 (q, J = 7.6 Hz, 2H), 1.82 (q, J = 7.0 
Hz, 2H), 2.05 (q, J = 7.0 Hz, 2H), 2.42 (s, 3H), 3.84 (td, J = 6.7 Hz, J = 3.2 Hz, 1H),  
4.00 (t, J = 7.9 Hz, 1H), 4.78 (d. J = 9.4 Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 5.00 (d, J = 
17.0 Hz, 1H), 5.22 (dd, J = 15.5 Hz, J = 7.0 Hz, 1H), 5.35 (dt, J = 15.8 Hz, J = 6.7 Hz, 
1H), 5.78–5.86 (m, 1H), 7.27 (d, J = 7.0 Hz, 2H), 7.72 (d, J = 8.5 Hz, 2H).   13C{1H} 
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(CDCl3, 125 MHz): ! 14.1, 21.7, 22.3, 26.6, 29.0, 29., 29.2, 29.5, 31.0, 31.2, 34.0, 35.2, 
59.7, 67.5, 114.4, 126.8, 127.4, 129.7, 134.9.  IR (neat): 3274, 2927, 2856, 1435, 1333, 
1262, 1162, 1094, 970, 910, 814, 707, 677, 557 cm-1.  HRMS calcd for C24H38ClNO2NaS 
(M+Na)+: 462.2210, found 462.2210. 
 
  (2S,3S)-3-isopropyl-1-tosylaziridine-2-carbaldehyde (5.34).  N-
((3R,4R,E)-3-chloro-2-methyldec-5-en-4-yl)-4-methylbenzenesulfon-
amide 5.24 (143mg, 0.4 mmol) was dissolved in 2 mL 
dichloromethane.  Potassium tert-butoxide (90 mg, 0.8 mmol) was then added at room 
temperature and monitored by TLC until completion (~4 h).  The reaction mixture was 
quenched with H2O followed by addition of 5 mL CH2Cl2.  The organic layer was 
separated and the aqueous layer was extracted successively with CH2Cl2 (2 ! 5 mL).  The 
combined organic layers were successively washed with brine, dried over MgSO4, and 
filtered.  The product was concentrated in vacuo and used in the next reaction without 
purification.  The product was dissolved in 5 mL methanol:dichloromethane (1:4) and 
cooled to –78 °C.  Ozone was bubbled through the reaction mixture until a blue color 
persisted.  O2 was bubbled through the reaction for several minutes to remove any excess 
ozone.  Dimethyl sulfide (294 µL, 4 mmol) was added to the reaction at –78 °C and 
allowed to gradually warm to room temperature over several hours.  The solvent and 
excess dimethyl sulfide were removed in vacuo and puried by column chromatography 
(hexanes:EtOAc, 97:3) to give the title compound as a white solid (76 mg, 71% yield, mp 
= 88–92 °C).  1H NMR (500 MHz, CDCl3) ! 0.89 (d, J = 6.5 Hz, 3H), 0.92 (d, J = 6.9 Hz, 
3H), 1.57–1.63 (m, 1H), 2.46 (s, 3H), 2.76 (dd, J = 9.9 Hz, J = 7.5 Hz, 1H), 3.30 (dd, J = 
O
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7.4 Hz, J = 5.1 Hz, 1H), 7.37 (d, J = 8.1 Hz, 2H), 7.84 (d, J = 8.0 Hz, 2H), 9.31 (d, J = 
5.2 Hz, 1H).   13C{1H} (CDCl3, 125 MHz): ! 19.2, 21.0, 21.9, 28.0, 47.1, 52.2, 128.5, 
130.1, 134.0, 145.5, 195.7.  IR (neat): 3499, 2966, 2932, 2875, 1723, 1598, 1468, 1333, 
1164, 1092, 944, 880, 816, 735, 675, 575 cm-1.  HRMS calcd for C13H18NO3S (MH)+: 
268.1007, found 268.1005.    
 
  (E)-dimethyl 2-(9-methyl-8-(4-methylphenylsulfonamido)-
dec-6-en-5-yl)malonate (5.37).  To a microwave vial was added 
N-((3R,4R,E)-3-chloro-2-methyldec-5-en-4-yl)-4-methyl-
benzenesulfonamide 5.24 (72 mg, 0.2 mmol), 1 mL of dry degasses THF and sodium 
hydride (9.6 mg, 0.4 mmol).  The vial was heated to 40 °C under N2(g) until TLC showed 
consumption of the !-chloroamine (~2h).  To a separate schlenk flask was added 
[ClPd(allyl)]2 (3.6 mg, 0.01mmol, 5 mol%) and PPh3 (10.5 mg, 0.04mmol, 20 mol%) in 1 
mL of dry degassed THF at rt under N2(g) and the solution was stirred 30 min.  To this 
catalyst solution was added the aziridine solution at rt and stirred for an additional 45 
min.  In a separate microwave vial was added sodium hydride (16.0 mg, 0.67 mmol) in 3 
mL dry and degassed THF and the reaction cooled to 0 °C.  To this white suspension was 
added dimethylmalonate (69 µL, 0.6 mmol) at 0 °C, which was accompanied by rapid 
evolution of H2.  The reaction soon became clear, after which it was heated to reflux for 
15min.  The dimethyl malonate sodium solution was cooled to rt and cannulated into the 
flask containing the catalyst/aziridine solution at rt.  The reaction mixture was stirred at rt 
until TLC showed complete consumption of the aziridine (4–6h).  The reaction mixture 
was then diluted with EtOAc and quenched with saturated NH4Cl (aq) (5 mL).  The 
O
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organic layer was separated and the aqueous layer was extracted successively with 
EtOAc (2 ! 5 mL).  The combined organic layers were successively washed with brine, 
dried over MgSO4, and filtered.  The filtrate was concentrated in vacuo and purified by 
column chromatography on silica gel (hexanes:EtOAc, 9:1) to give the title compound as 
an oil and mixture of diastereomers (51 mg, 56% yield, dr ~ 10:1).  1H NMR (500 MHz, 
CDCl3) Major: ! 0.79 (d, J = 6.9 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H), 0.85 (t, J = 7.5 Hz, 
3H), 1.02–1.31 (m, 8H), 1.71 (oct, J = 6.6 Hz, 1H), 2.41 (s, 3H), 2.60–2.66 (m, 1H), 3.26 
(d, J = 8.8 Hz, 1H), 3.55 (ddd, J = 15.5 Hz, J = 7.5 Hz, J = 5.3 Hz, 1H), 3.66 (s, 3H), 3.70 
(s, 3H), 4.56 (d, J = 8.0 Hz, 1H), 5.20 (dd, J = 14.9 Hz, J = 9.2 Hz, 1H), 5.30 (dd, J = 
15.1 Hz, J = 7.0 Hz, 1H), 7.27 (d, J = 7.8 Hz, 2H), 7.72 (d, J = 8.2 Hz, 2H).   13C{1H} 
(CDCl3, 125 MHz): ! 14.1, 18.2, 18.3, 21.7, 22.5, 29.2, 32.1, 33.3, 42.8, 52.5, 52.6, 56.7, 
61.1, 127.2, 129.7, 131.1, 132.7, 138.5, 143.2, 168.6, 168.8.  IR (neat): 3291, 2958, 2933, 
2873, 1738, 1435, 1327, 1246, 1161, 1095, 1045, 1026, 975, 917, 815, 707, 667, 569, 549 
cm-1.  HRMS calcd for C23H36NO6S (M+H)+: 476.2083, found 476.2086.         
 
General Procedure E: generation of syn halohydrins via addition to "-halo 
aldehydes. A dry 10 mL Schlenk flask, which was evacuated and backfilled with N2 
three times, was charged with the ethyl zinc bromide (0.3 mmol, 53 mg), diethylzinc (0.6 
mmol), and dichloromethane (1 mL).  The flask was then cooled to 0 °C followed by 
dropwise addition of aldehyde solution (0.2 mmol in 0.35 mL dichloromethane, 0.12M 
reaction). The reaction was monitored by TLC until completion (~10 min).  The reaction 
mixture was slowly quenched with saturated NH4Cl (aq) (2 mL) followed by addition of 
Et2O (5 mL). The organic layer was separated and the aqueous solution extracted with 
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Et2O (3 ! 5 mL).  The combined organic layers were successively washed with brine, 
dried over MgSO4, and filtered. The filtrate was concentrated in vacuo and purified by 
column chromatography on silica gel. 
  
(2R,3R)-2-bromo-1-phenylpentan-3-ol (5.38). General Procedure E 
was applied to EtZnBr (53 mg, 0.3 mmol), Et2Zn (0.3 (mL, 2M in 
dichloromethane), and  2-bromo-3-phenylpropanal  (43 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
93:7) to afford the title compound as an oil (47 mg, 97% yield, dr = 10:1).  1H NMR (500 
MHz, CDCl3): " 0.93 (t, J = 7.3 Hz, 3H), 1.53!1.71 (m, 2H), 1.76 (d, J = 9.4 Hz, 1H), 
3.24 (dd, J = 14.0, J = 7,8 Hz, 1H), 3.29!3.33 (m, 1H), 3.36 (dd, J = 14.1 Hz, J = 7.5 Hz, 
1H), 4.28 (td, J = 7.6 Hz, J = 2.4 Hz, 1H), 7.23!7.33 (m, 5H).  13C{1H} (CDCl3, 125 
MHz): " 10.2, 29.7, 42.5, 64.0, 73.4, 127.1, 128.8, 129.4, 138.6.  IR (neat): 3429, 3086, 
3029, 2966, 2877, 1604, 1496, 1455, 1384, 1236, 1113, 1016, 996, 928, 750, 701, 534 
cm-1.  HRMS calcd for C11H14Br (M!OH)+: 225.1375, found 225.0279.  GC conditions: 
"-Dex column, oven: 140 °C for 10 min then ramp 1 °C/min to 150 °C, flow = 1.4 
mL/min, major diastereomer: t = 20.1. min/t = 20.3 min (enantiomers), minor 
diastereomer: t = 24.4 min/t = 24.8 min (enantiomers). 
 
 (2R,3R)-2-chloro-1-phenylpentan-3-ol (5.39). General Procedure E 
was applied to EtZnBr (53 mg, 0.3 mmol), Et2Zn (0.3 (mL, 2M in 
dichloromethane), and  2-chloro-3-phenylpropanal  (34 mg, 0.2 mmol).  The crude 
product was purified by flash column chromatography on silica gel (hexanes:EtOAc, 
Ph
Br
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93:7) to afford the title compound as an oil (37 mg, 94% yield, dr = 25:1).  1H NMR (500 
MHz, CDCl3): ! 0.94 (t, J = 7.4 Hz, 3H), 1.56!1.71 (m, 2H), 1.84 (d, J = 9.2 Hz, 1H), 
3.10 (dd, J = 14.0 Hz, J = 7.8 Hz, 1H), 3.23 (dd, J = 14.0 Hz, J = 7.2 Hz, 1H), 3.50!3.56 
(m, 1H), 4.13 (td, J = 7.8 Hz, J = 2.5 Hz, 7.24!7.33 (m, 5H). 13C{1H} (CDCl3, 125 
MHz): ! 10.2, 28.3, 41.6, 68.3, 73.7, 127.0, 128.7, 129.6, 137.9.  IR (neat): 3413, 3029, 
2966, 2935, 2878, 1604, 1495, 1455, 1387, 1245, 1181, 1975, 1058, 951, 864, 821, 780, 
756, 702, 614, 562 cm-1.  HRMS calcd for C11H14Cl (M!OH)+: 181.0784, found 
181.0810.  GC conditions: "-Dex column, oven: 140 °C for 10 min then ramp 1 °C/min 
to 150 °C, flow = 1.4 mL/min, major diastereomer: t = 14.7. min/t = 15.2 min 
(enantiomers), minor diastereomer: t = 18.9 min/t = 19.3 min (enantiomers). 
 
(3R,4R)-7-((tert-butyldimethylsilyl)oxy)-4-chloroheptan-3-ol 
(5.40). General Procedure E was applied to EtZnBr (53 mg, 0.3 
mmol), Et2Zn (0.3 (mL, 2M in dichloromethane), and 5-((tert-butyldimethylsilyl)oxy)-2-
chloropentanal (50 mg, 0.2 mmol).  The crude product was purified by flash column 
chromatography on silica gel (hexanes:EtOAc, 93:7) to afford the title compound as an 
oil (32 mg, 83% yield, dr = 20:1).  1H NMR (500 MHz, CDCl3): ! 0.05 (s, 6H), 0.89 (s, 
9H), 0.99 (t, J = 7.6 Hz, 3H), 1.57!1.96 (m, 7H), 3.52!3.57 (m, 1H), 3.65 (td, J = 6.3 Hz, 
J = 4.0 Hz, 1H), 3.98 (dt, J = 9.4 Hz, J = 4.2 Hz, 1H). 13C{1H} (CDCl3, 125 MHz): ! 
!5.1, 10.2, 18.5, 26.2, 27.8, 30.0, 31.7, 62.6, 68.8, 75.6.  IR (neat): 3418, 2930, 2858, 
1471, 1387, 1256, 1104, 1006, 972, 837, 776, 718, 681, 604 cm-1.  HRMS calcd for 
C10H21 (M!Cl)+: 157.1529, found 157.1590.   
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tert-Butyl(3-((2S,3R)-3-ethyloxiran-2-yl)propoxy)dimethyl-
silane (5.43).  Chlorohydrin 5.40 (28 mg,0.1 mmol) was 
dissolved in 1 mL ethanol and KOH (17 mg, 0.3 mmol)  was 
added in one portion at rt.  The reaction was monitored by TLC until completion (~2 h).  
The ethanol was removed in vacuo and the product dissolved in Et2O (10 mL). The 
organic layer was successively washed with brine, dried over MgSO4, and filtered. The 
filtrate was concentrated in vacuo and purified by column chromatography on silica gel 
(hexanes:EtOAc, 93:7) to give the title compound as an oil (23 mg, 95% yield, dr = 
20:1).  1H NMR (500 MHz, CDCl3): ! 0.05 (s, 6H), 0.89 (s, 9H), 1.04 (t, J = 7.47, 3H), 
1.47!1.74 (m, 6H), 2.87 (td, J = 6.5 Hz, J = 4.3 Hz, 1H), 2.94 (td, J = 6.2 Hz, J = 4.4 Hz, 
1H), 3.64 (dt, J = 10.1 Hz, J = 6.5 Hz, 1H), 3.69 (dt, J = 10.2 Hz, J = 6.1 Hz, 1H). 
13C{1H} (CDCl3, 125 MHz): ! !5.1, 10.8, 18.5, 21.3, 24.5, 26.2, 30.0, 57.3, 58.6, 62.9.  
IR (neat): 2956, 2931, 2884, 2858, 1472, 1388, 1256, 1101, 837, 813, 776 cm-1.     HRMS 
calcd for C12H29O2Si (MH)+: 245.1937, found 245.1930. 
 
Computational Studies        
The geometries and frequencies of all four transition states were determined at the 
B3LYP/LACVP* level in Jaguar15.  The B3LYP method16 uses the hybrid 
parameterization of Becke17 together with the functional of Lee, Yang, and Parr.18 The 
LACVP* basis set (in here: BSI) uses 6-31G* for all light elements and the large core 
Hay-Wadt ECP for Zn.19 Frequencies and thermodynamic corrections to the free energy 
were calculated in the gas phase at the same level of theory. A systematic error is 
O
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expected from the use of gas phase corrections, in particular for the entropic contribution, 
but the influence should be minor when limiting the comparison to very similar transition 
states. For each structure, the three lowest frequencies are reported (including the single 
imaginary frequency characteristic of a TS, designated as negative). Solvation energies 
are calculated using the PBF model20 using parameters for benzene.21 To account for 
dispersion and effects of larger basis sets, single point calculations were performed using 
the M06 functional22 together with the cc-PVTZ+ basis set,23 in conjunction with either 
LAV3 (BSII) or TZV*24 (BSIII) for Zn. All reported energies use the "Ultrafine" 
accuracy setting25.  See Appendix A4 for coordinates of calculated structures. 
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Appendix A1. 1H and 13C NMR Spectra Relevant to Chapter 2 
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Figure A1.1 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.20 in CDCl3. 
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Figure A1.2 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.21 in CDCl3. 
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Figure A1.3 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.22 in CDCl3. 
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Figure A1.4 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.23 in CDCl3. 
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Figure A1.5 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.24 in CDCl3. 
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Figure A1.6 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.25 in CDCl3. 
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Figure A1.7 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.26 in CDCl3. 
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Figure A1.8 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.27 in CDCl3. 
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Figure A1.9 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.29 in CDCl3. 
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Figure A1.10 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.30 in CDCl3. 
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Figure A1.11 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.33 in CDCl3. 
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Figure A1.12 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.34 in CDCl3. 
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Figure A1.13 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.35 in CDCl3. 
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Figure A1.14 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.36 in CDCl3. 
 
 
OH
OTBS
Me
(+)
 238 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.15 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.37 in CDCl3. 
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Figure A1.16 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.38 in CDCl3. 
 
OH
OTBS
Me
Cl
 240 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.17 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.39 in CDCl3. 
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Figure A1.18 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.40 in CDCl3. 
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Figure A1.19 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.41 in CDCl3. 
 
OH
OTES
Me
(+)
t-Bu
Me
 243 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.20 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.42 in CDCl3. 
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Figure A1.21 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.43 in CDCl3. 
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Figure A1.22 500 MHz 1H of (S)-O-Mosher ester (2.57) and (R)-O-Mosher ester 
(2.58) in CDCl3. 
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                     (R)-O-Mosher Ester 
 
 
 
 
 
Figure A1.23 500 MHz 1H of (S)-O-Mosher ester (2.59) and (R)-O-Mosher ester 
(2.60) in CDCl3. 
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          (S)-O-Mosher Ester 
 
 
 
 
 
 
 
 
         (R)-O-Mosher Ester 
 
 
 
 
 
 
Figure A1.24 500 MHz 1H of (S)-O-Mosher ester (2.61) and (R)-O-Mosher ester 
(2.62) in CDCl3. 
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              (R)-O-Mosher Ester 
 
 
 
 
 
Figure A1.25 500 MHz 1H of (S)-O-Mosher ester (2.63) and (R)-O-Mosher ester 
(2.64) in CDCl3. 
O
OTBS
Me
O
CF3
Ph
MeO
Cl
O
OTBS
Me
O
CF3
MeO
Ph
Cl
 249 
 
 
 
 
 
                                                (S)-O-Mosher Ester 
 
 
 
 
 
 
 
 
                                                 (R)-O-Mosher Ester 
 
 
 
 
 
 
Figure A1.26 500 MHz 1H of (S)-O-Mosher ester (2.65) and (R)-O-Mosher ester 
(2.66) in CDCl3. 
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       (R)-O-Mosher Ester 
 
 
 
 
 
Figure A1.27 500 MHz 1H of (S)-O-Mosher ester (2.67) and (R)-O-Mosher ester 
(2.68) in CDCl3. 
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Figure A1.28 500 MHz 1H of (S)-O-Mosher ester (2.69) and (R)-O-Mosher ester 
(2.70) in CDCl3. 
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Figure A1.29 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.44 in CDCl3. 
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Figure A1.30 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.46 in CDCl3. 
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Figure A1.31 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.47 in CDCl3. 
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Figure A1.32 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.48 in CDCl3. 
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Figure A1.33 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.49 in CDCl3. 
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Figure A1.34 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.50 in CDCl3. 
Me
OTBSOH
t-Bu
 258 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.35 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.51 in CDCl3. 
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Figure A1.36 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.52 in CDCl3. 
 
 
Figure A1.37 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.53 in CDCl3. 
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Figure A1.38 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.54 in CDCl3. 
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Figure A1.39 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.55 in CDCl3. 
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Figure A1.40 500 MHz 1H and 125 MHz 13C{1H} NMR of 2.56 in CDCl3. 
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Figure A1.41 500 MHz 1H of (S)-O-Mosher ester (2.71) and (R)-O-Mosher ester 
(2.72) in CDCl3. 
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Figure A1.42 500 MHz 1H of (S)-O-Mosher ester (2.73) and (R)-O-Mosher ester 
(2.74) in CDCl3. 
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Figure A1.43 500 MHz 1H of (S)-O-Mosher ester (2.75) and (R)-O-Mosher ester 
(2.76) in CDCl3. 
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Appendix A2. 1H and 13C NMR Spectra Relevant to Chapter 3 
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Figure A2.1 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.8 in CDCl3. 
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Figure A2.2 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.10  in CDCl3. 
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Figure A2.3 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.12 in CDCl3. 
 
Me
OTES
HO Me
(±)
 271 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.4 500 MHz 1H and 125 MHz 13C{1H} NMR of  3.13 in CDCl3 
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Figure A2.5 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.15 in CDCl3 
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Figure A2.6 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.16 in CDCl3 
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Figure A2.7 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.18 in CDCl3 
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Figure A2.8 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.19 in CDCl3 
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Figure A2.9 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.21 in CDCl3 
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Figure A2.10 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.48 in CDCl3 
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Figure A2.11 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.49 in CDCl3 
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Figure A2.12 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.50 in CDCl3 
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Figure A2.13 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.51 in CDCl3 
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Figure A2.14 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.52 in CDCl3 
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Figure A2.15 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.23 in CDCl3 
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Figure A2.16 GC analysis of ethyl addition product 3.23 
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Figure A2.17 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.24 in CDCl3 
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Figure A2.18 GC analysis of methyl addition product 3.24 
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Figure A2.19 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.26 in CDCl3 
 
 
Me
OTES
HO n-Bu
(+)
 287 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.20 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.27 in CDCl3 
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Figure A2.21 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.29 in CDCl3 
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Figure A2.22 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.30 in CDCl3 
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Figure A2.23. 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.31 in CDCl3 
 
 291 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.24 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.32 in CDCl3 
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Figure A2.25 500 MHz 1H NMR in CDCl3 (from vinyllithium addition for 
comparison to 3.32). 
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Figure A2.26 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.33 in CDCl3 
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Figure A2.27. 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.34 in CDCl3 
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Figure A2.28 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.35 in CDCl3 
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Figure A2.29 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.36 in CDCl3 
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Figure A2.30 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.37 in CDCl3 
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Figure A2.31 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.38 in CDCl3 
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Figure A2.32 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.39 in CDCl3 
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Figure A2.33 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.40 in CDCl3 
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Figure A2.34 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.41 in CDCl3 
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Figure A2.35 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.42 in CDCl3 
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Figure A2.36 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.43 in CDCl3 
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Figure A2.37 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.44 in CDCl3 
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Figure A2.37 HPLC analysis of chiral purity of vinyl addition product 3.44 
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Figure A2.38 500 MHz 1H NMR in CDCl3 (from vinyllithium addition for 
comparison to 3.44). 
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Figure A2.39 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.45 in CDCl3 
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Figure A2.40 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.46 in CDCl3 
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Figure A2.41 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.47 in CDCl3 
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Figure A2.42. 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.53 in CDCl3 
 
Ph
OH
HO n-Bu
(+)
 311 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.43.. HPLC analysis of chiral purtiy of methyl addition product 3.53. 
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Figure A2.44.  HPLC analysis of chiral purity of methyl addition product 3.54. 
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Figure A2.45. 500 MHz 1H and 125 MHz 13C{1H} NMR of 3.55 in CDCl3. 
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Figure A2.46. HPLC analysis of chiral purity of ethyl addition product 3.55. 
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Appendix A3. 1H, 13C, 19F, and 31P NMR Spectra Relevant to Chapter 4 
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Figure A3.1 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.6 in CDCl3. 
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Figure A3.2 SFC analysis of enantioenriched 4.6. 
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Figure A3.3 SFC analysis of enantioenriched 4.6. 
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Figure A3.4 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.7 in CDCl3. 
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Figure A3.5 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.8 in CDCl3. 
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Figure A3.6 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.9 in CDCl3. 
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Figure A3.7 HPLC analysis of enantioenriched 4.9. 
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Figure A3.8 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.10 in CDCl3. 
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Figure A3.9 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.11 in CDCl3. 
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Figure A3.10 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.12 in CDCl3. 
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Figure A3.11 338 MHz 19F NMR of 4.12 in CDCl3. 
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Figure A3.12 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.14 in CDCl3. 
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Figure A3.13 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.15 in CDCl3. 
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Figure A3.14 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.16 in CDCl3. 
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Figure A3.15 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.17 in CDCl3. 
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Figure A3.16 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.24 in CD3OD. 
 332 
 
 
 
 
Figure A3.17 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.18 in CDCl3. 
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Figure A3.18 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.19 in CDCl3. 
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Figure A3.19 144 MHz 31P NMR of 4.19 in CDCl3. 
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Figure A3.20 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.20 in CDCl3. 
NH
Cl
Ts Ph
(±)
P
O
Ph
Ph
 336 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.21 144 MHz 31P NMR of 4.20 in CDCl3. 
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Figure A3.22 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.21 in CDCl3. 
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Figure A3.23 144 MHz 31P NMR of 4.21 in CDCl3. 
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Figure A3.24 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.13 in CDCl3. 
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Figure A3.25 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.25 in CDCl3. 
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Figure A3.26 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.22 in CDCl3. 
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Figure A3.27 500 MHz 1H and 125 MHz 13C{1H} NMR of 4.23 in CDCl3. 
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2% (100% solvent C)
alkynyl aziridine (racemate)
AD-H column, 0.5 mL/min
=====================================================================
Injection Date  : 4/16/2012 4:56:57 PM           Seq. Line :   2
Sample Name     : GSIV046                         Location : P1-A-02
Acq. Operator   : Walsh group                          Inj :   1
                                                Inj Volume : 2 µl
Different Inj Volume from Sequence !     Actual Inj Volume : 20 µl
Acq. Method     : C:\HPCHEM\2\METHODS\GS2P05.M
Last changed    : 9/15/2011 1:26:47 PM by Walsh group
Analysis Method : C:\HPCHEM\2\METHODS\GS2P05.M
Last changed    : 4/17/2012 3:14:43 PM by Walsh group
                  (modified after loading)
2.0% IPA  (100%C)
min13 14 15 16 17 18 19 20
mAU
0
50
100
150
200
250
 DAD1 D, Sig=230,16 Ref=360,100 (GSIV046.D)
 1
4.
98
0
 1
7.
82
8
=====================================================================
                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  14.980 BB    0.4989 9779.87793  297.95941  49.5034
   2  17.828 BB    0.6849 9976.10938  219.24413  50.4966
Totals :                  1.97560e4   517.20354
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\GSIV046.D                                           Sample Name: GSIV046
Instrument 2 4/17/2012 3:14:51 PM Walsh group
Page 1 of 1
2% (100% solvent C)
alkynyl aziridine (racemate)
AD-H column, 0.5 mL/min
=====================================================================
Injection Date  : 4/17/2012 1:38:49 PM           Seq. Line :   2
Sample Name     : GSIV052B                        Location : P1-A-02
Acq. Operator   : Walsh group                          Inj :   1
                                                Inj Volume : 2 µl
Different Inj Volume from Sequence !     Actual Inj Volume : 20 µl
Acq. Method     : C:\HPCHEM\2\METHODS\GS2P05.M
Last changed    : 9/15/2011 1:26:47 PM by Walsh group
Analysis Method : C:\HPCHEM\2\METHODS\GS2P05.M
Last changed    : 4/23/2012 3:49:13 PM by Walsh group
                  (modified after loading)
2.0% IPA  (100%C)
min13 14 15 16 17 18 19 20
mAU
0
200
400
600
800
 DAD1 D, Sig=230,16 Ref=360,100 (GSIV052B.D)
  A
rea
: 3
89
23
.6
 1
5.
40
8
 1
8.
51
5
=====================================================================
                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.408 MM    0.6458 3.89236e4  1004.57739  97.8486
   2  18.515 BB    0.6898  855.79767   16.75875   2.1514
Totals :                  3.97794e4  1021.33614
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\GSIV052B.D                                         Sample Name: GSIV052B
Instrument 2 4/23/2012 3:50:03 PM Walsh group
Page 1 of 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.28 HPLC analysis of enantioenriched 4.23. 
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2% (100% solvent C)
alkynyl aziridine, enantioenriched from isolated aldimi
ne
AD-H column, 0.5 mL/min
=====================================================================
Injection Date  : 4/17/2012 6:58:40 PM           Seq. Line :   2
Sample Name     : GSV052A                         Location : P1-A-02
Acq. Operator   : Walsh group                          Inj :   1
                                                Inj Volume : 2 µl
Different Inj Volume from Sequence !     Actual Inj Volume : 20 µl
Method          : C:\HPCHEM\2\METHODS\GS2P05.M
Last changed    : 4/17/2012 6:26:16 PM by Walsh group
2.0% IPA  (100%C)
min13 14 15 16 17 18 19 20
mAU
0
200
400
600
800
 DAD1 D, Sig=230,16 Ref=360,100 (GSV052A.D)
 1
5.
79
1
 1
8.
98
5
=====================================================================
                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   6.190 BB    0.2181   81.68851    5.41182   0.1884
   2   8.779 BP    0.2044   16.69338    1.14320   0.0385
   3   9.385 PB    0.1860   12.71761    1.06002   0.0293
   4  10.981 PB    0.3434  107.73249    4.56399   0.2485
   5  15.791 BB    0.6358 4.20605e4   989.80750  97.0080
   6  18.985 BB    0.7676 1078.42090   19.48780   2.4873
Totals :                  4.33578e4  1021.47432
 Results obtained with enhanced integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\2\DATA\GSV052A.D                                           Sample Name: GSV052A
Instrument 2 4/23/2012 3:47:41 PM Walsh group
Page 1 of 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.29 HPLC analysis of enantioenriched 4.23. 
 
 
Ts
N
TMS (!)
(from isolated aldimine)
 345 
Appendix A4. 1H and 13C NMR Spectra Relevant to Chapter 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 346 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.1 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.12 as a 
mixture of diastereomers. 
NHTs
Cl(+/!)
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Figure A4.2 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.15 
as a mixture of diastereomers. 
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Figure A4.3 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.16. 
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Figure A4.4 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.17 
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Figure A4.5 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.18 as 
mixture of diastereomers. 
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Figure A4.6 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.19 
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Figure A4.7 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.20 as a 
mixture of diastereomers. 
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Figure A4.8 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.21 as a 
mixture of diastereomers. 
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Figure A4.9 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.22 as a 
mixture of diastereomers. 
 355 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.10 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.23 as a 
mixture of diastereomers. 
NHTs
Cl (+/!)
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Figure A4.11 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.41 as a 
mixture of diastereomers. 
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Figure A4.12 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.24 
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Figure A4.13 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.25 
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Figure A4.14 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.26 
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Figure A4.15 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 5.27 
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Figure A4.16 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 5.28 
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Figure A4.17 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.29 
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Figure A4.18 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 5.30 
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Figure A4.19 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.31 
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Figure A4.20 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.42 
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Figure A4.21 HPLC analysis of chiral purity of vinyl addition product 5.42 
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Figure A4.22 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.32 
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Figure A4.23 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.33 
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Figure A4.24 500 MHz 1H and 125 MHz 13C{1H} NMR in CDCl3 of 5.34 
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Figure A4.25 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.35 in CDCl3 
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Figure A4.26 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.37 in CDCl3. 
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Figure A4.27 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.38 in CDCl3 
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Figure A4.28. GC analysis of 5.48 
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Figure A4.29 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.39 in CDCl3 
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Figure A4.30 GC analysis of 5.39 
 
 
 
Ph
Cl
OH
(+/!)
 376 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.31 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.40 in CDCl3 
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Figure A4.32 500 MHz 1H and 125 MHz 13C{1H} NMR of 5.43 in CDCl3 
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Coordinates for calculated structures 
 
Energies are given in Hartree, unless otherwise specified. For each structure is 
reported, in turn: 
E(B3LYP/BSI) 
ZPE (in kJ mol-1), 3 lowest frequencies. 
Ggas (incl. ZPE) 
Ebenzene(B3LYP/BSI) 
Edichloromethane(B3LYP/BSI) 
E(M06/BSII//B3LYP/BSI) 
E(M06/BSII//B3LYP/BSI). 
Cartesian coordinates (in Å) 
Final free energies (in the main article) are obtained by adding dichloromethane 
solvation and thermodynamic contributions to the B3LYP or M06 energies: 
Gtot = E(BSI or BSII or BSIII) + (Ggas - E) + (Edichloromethane - E). 
 
Ground states of the pre- and post-reactive complexes were determined by QRC 
calculations1 from the corresponding transition states. For these, only B3LYP/LACVP* 
energies are reported. All of the pre-reactive complexes are loosely associated and in 
rapid equilibrium with dissociated reactants. In a Curtin-Hammett situation2 they have no 
influence whatsoever on the selectivity of the reaction. The ground states are only 
provided as reference material. 
 
Relative barriers for different additions (kJ mol-1). Comparison of 4- and 6-membering 
ring transition states leading to syn or anti addition products in benzene. 
 
Product TS Ring Size B3LYP/BSI M06/BSII M06/BSIII 
anti 4 37 28 18 
anti 6 16 14 12 
syn 4 23 15 6 
syn 6 0 0 0 
 
 
Relative barriers for different additions (kJ mol-1). Comparison of 4- and 6-membering 
ring transition states leading to syn or anti addition products in dichloromethane. 
 
                                                 
1  J. M. Goodman and M. A. Silva, Tetrahedron Lett. 2003, 44, 8233-8236. 
2  H. Maskill, The Physical Basis of Organic Chemistry, Oxford University Press: Oxford, 1985; E. Clot, 
P.-O. Norrby, in Innovative Catalysis in Organic Synthesis: Oxidation, Hydrogenation, and C-X Bond 
Forming Reactions, Ed: P. Andersson, Wiley-VCH, 2012, 167-191.!
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Product TS Ring Size B3LYP/BSI M06/BSII M06/BSIII 
anti 4 36 27 17 
anti 6 15 14 12 
syn 4 22 15 6 
syn 6 0 0 0 
 
 
4-membered ring TS leading to anti product 
E = -1931.866904 
ZPE = 621.64 kJ/mol, frequencies      -228.31    35.75    38.63 
Ggas = -1931.685019 
Ebenzene = -1931.879033 
Edichloromethane = -1931.866904 
E(M06/BSII//B3LYP/BSI) = -1931.538910 
E(M06/BSII//B3LYP/BSI) = -5359.328281 
 
Coordinates: 
C        0.076788     0.175410    -0.078572 
Cl      -0.001855     1.998200     0.124353 
C        0.920092    -0.189203    -1.292001 
H       -0.967316    -0.091271    -0.286326 
H        0.988549    -1.281112    -1.367406 
H        0.431835     0.182302    -2.197157 
H        1.928112     0.220251    -1.244492 
C        0.337107    -0.544077     1.236135 
H        0.614302    -1.591090     1.105031 
N       -0.431832    -0.234850     2.288675 
S       -1.116001    -1.605563     3.096741 
Zn      -1.077340     1.822725     2.716052 
Cl       1.071778     2.333785     3.694378 
C       -2.920157     2.612445     2.972301 
H       -3.275581     2.457940     3.997678 
H       -2.903171     3.690992     2.781425 
H       -3.639792     2.149410     2.288622 
Zn       2.006040     0.050070     3.303736 
C        2.497625    -1.060639     4.942103 
C        2.729677    -0.047701     1.257177 
H        2.657538     0.877480     0.685940 
H        2.785953    -0.917130     0.602388 
H        3.702281    -0.025175     1.781702 
H        2.102186    -2.080068     4.874262 
H        3.590856    -1.131187     5.006008 
H        2.143234    -0.599977     5.871715 
C       -1.136088    -1.080819     4.814910 
O       -2.504145    -1.699776     2.637378 
 380 
O       -0.210198    -2.750663     2.939913 
H       -1.624714    -1.889327     5.364398 
H       -0.115888    -0.936781     5.171197 
H       -1.728612    -0.167331     4.902161 
 
 
 381 
6-membered ring TS leading to anti product 
E = -1931.874202 
ZPE = 620.36 kJ/mol, frequencies      -240.77    28.68    40.85 
Ggas = -1931.693341 
Ebenzene = -1931.886311 
Edichloromethane = -1931.874202 
E(M06/BSII//B3LYP/BSI) = -1931.543612 
E(M06/BSII//B3LYP/BSI) = -5359.329775 
 
Coordinates: 
C        0.196716    -1.542056    -1.950650 
C        1.198358    -2.099384    -2.951373 
H       -0.579145    -2.293942    -1.768604 
H        1.759176    -2.915052    -2.478738 
H        0.665180    -2.510467    -3.812911 
H        1.905499    -1.346415    -3.297408 
Cl      -0.752691    -0.153796    -2.700556 
C        0.710449    -1.188476    -0.565754 
H        1.565598    -1.780880    -0.247560 
N       -0.179534    -0.771509     0.323278 
S        0.375167    -0.911369     1.921577 
Zn      -1.743392     0.755261    -0.251966 
Cl      -0.265972     2.516326     0.248387 
C       -3.740421     0.420243    -0.210032 
H       -4.177335     0.723981     0.748475 
H       -4.239952     0.992591    -0.999703 
H       -3.965742    -0.641139    -0.367748 
Zn       2.148087     1.496110     0.532036 
C        3.448556     2.803565     1.404038 
C        2.508840     0.348340    -1.347045 
H        1.923371     0.557218    -2.242902 
H        3.055195    -0.591781    -1.453940 
H        3.300469     1.119497    -1.334941 
H        4.392148     2.306248     1.662454 
H        3.680925     3.643915     0.738575 
H        3.022784     3.214683     2.326695 
C       -1.030629    -0.305340     2.852298 
O        0.624858    -2.314343     2.254770 
O        1.493868     0.052492     2.106130 
H       -0.766758    -0.431544     3.905205 
H       -1.179821     0.752632     2.626943 
H       -1.908259    -0.906061     2.606172 
 
 
 382 
4-membered ring TS leading to syn product 
E = -1931.873722 
ZPE = 622.45 kJ/mol, frequencies      -222.42    37.05    42.37     
Ggas = -1931.691276 
Ebenzene = -1931.885184 
Edichloromethane = -1931.873722 
E(M06/BSII//B3LYP/BSI) = -1931.545274 
E(M06/BSII//B3LYP/BSI) = -5359.334278 
 
Coordinates: 
C        0.175795     0.133198    -0.063650 
Cl      -0.126189     1.933803     0.125082 
C        0.361159    -0.560119     1.270306 
H        1.078374     0.070154    -0.667561 
H        0.627894    -1.611986     1.157762 
N       -0.431529    -0.239131     2.305292 
S       -1.151457    -1.596736     3.099638 
Zn      -1.079913     1.812020     2.720443 
Cl       1.107146     2.368690     3.619931 
C       -2.909084     2.590817     3.085280 
H       -3.174075     2.495035     4.144625 
H       -2.928364     3.656230     2.830699 
H       -3.674899     2.078248     2.492959 
Zn       1.993189     0.075413     3.293727 
C        2.489143    -1.043333     4.923995 
C        2.711271    -0.072926     1.230749 
H        2.645856     0.859781     0.668499 
H        2.731868    -0.937530     0.565770 
H        3.689230    -0.080191     1.743884 
H        2.095043    -2.063114     4.850674 
H        3.582360    -1.112863     4.988983 
H        2.132894    -0.588029     5.855609 
C       -1.164382    -1.085689     4.822339 
O       -2.540550    -1.651489     2.634824 
O       -0.276251    -2.765121     2.938623 
H       -1.678117    -1.883666     5.364298 
H       -0.141379    -0.973938     5.182523 
H       -1.730049    -0.155773     4.914257 
C       -1.013540    -0.502205    -0.791588 
H       -1.924354    -0.443406    -0.189624 
H       -1.177074    -0.000074    -1.749088 
H       -0.796664    -1.558960    -0.988300 
 
 383 
6-membered ring TS leading to syn product 
E = -1931.880246 
ZPE = 621.15 kJ/mol, frequencies      -216.97    23.59    39.08     
Ggas = -1931.699114 
Ebenzene = -1931.892196 
Edichloromethane = -1931.880246 
E(M06/BSII//B3LYP/BSI) = -1931.549037 
E(M06/BSII//B3LYP/BSI) = -5359.334616 
 
Coordinates: 
C        0.366209    -1.481340    -1.977987 
Cl      -0.803780    -0.241026    -2.661230 
C        0.754755    -1.164516    -0.554645 
H        1.238744    -1.412655    -2.624667 
H        1.595428    -1.763015    -0.208174 
N       -0.173765    -0.771732     0.307373 
S        0.349405    -0.908365     1.916756 
Zn      -1.732997     0.746670    -0.261157 
Cl      -0.240875     2.519432     0.170075 
C       -3.735371     0.461884    -0.139119 
H       -4.138750     0.857231     0.800401 
H       -4.246069     0.975964    -0.961171 
H       -3.988610    -0.603266    -0.199466 
Zn       2.142740     1.491667     0.526408 
C        3.452714     2.794041     1.390705 
C        2.541049     0.338201    -1.352992 
H        1.965987     0.621995    -2.237019 
H        3.019541    -0.633883    -1.501253 
H        3.383796     1.049544    -1.301005 
H        4.390089     2.290437     1.659547 
H        3.695309     3.623337     0.714939 
H        3.025238     3.220412     2.305812 
C       -1.083549    -0.331460     2.824890 
O        0.621672    -2.305786     2.255209 
O        1.445138     0.078902     2.118561 
H       -0.836809    -0.460713     3.881544 
H       -1.247510     0.725577     2.605371 
H       -1.946964    -0.944096     2.558567 
C       -0.266461    -2.873155    -2.063955 
H       -1.173571    -2.931566    -1.456949 
H       -0.510980    -3.111009    -3.102829 
H        0.446723    -3.620884    -1.696941 
 
 
 
 384 
 
Pre-reactive complexes leading to syn and anti products3 
 
A.                                                            B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C.                                                                D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 4-membered pre-reactive complex leading to anti product  B. 6-membered pre-
reactive complex leading to anti product C. 4-membered pre-reactive complex leading to 
syn product  D. 6-membered pre-reactive complex leading to syn product. 
 
 
                                                 
3 All pictures were created using Molecule for Mac OS X version 2.1, http://www.chemie.uni-
enlargen.de/hommes/molecule/index.html.  
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Pre-reactive complexes 
 
SCF energy: DFT(b3lyp) -1931.90056489835 au 
  C1           -0.0747427101     -0.5972542478     -0.3812547481  
  Cl2           0.8191900331      0.9340543888     -0.0476019920  
  C4            0.8864459978     -1.6966280769     -0.8559258045  
  H5           -0.7882449305     -0.3627297874     -1.1801321146  
  H24           0.3278224653     -2.6095518836     -1.0941779434  
  H25           1.4078393095     -1.3649435061     -1.7568552298  
  H26           1.6255710592     -1.9225941089     -0.0823355281  
  C3           -0.8731268145     -1.0728150929      0.7990441952  
  H6           -1.4914114015     -1.9600474619      0.6075289857  
  N7           -0.8500640413     -0.5175793732      1.9468377850  
  S8           -1.9030451809     -1.2097614790      3.1414151977  
  Zn9          -1.1808253846      1.8472740260      3.1859690182  
  Cl10          0.5975481723      1.4235731139      4.5964519822  
  C11          -2.2066807080      3.1994553443      2.0941278387  
  H12          -2.7058712720      3.9176964954      2.7537522568  
  H13          -1.5340179268      3.7513007810      1.4297003917  
  H14          -2.9716829353      2.7044693821      1.4860547286  
  Zn15          2.8524094864      0.6026881758      2.9521225671  
  C16           2.7288902780     -1.4405967872      3.0941460426  
  C17           3.6002384624      2.4287907400      2.4576571126  
  H18           2.8421380965      3.0613542880      1.9786015923  
  H19           4.4508987541      2.3485738019      1.7682068262  
  H20           3.9461016155      2.9608612783      3.3530510798  
  H21           1.8957700180     -1.8574227924      2.5106532214  
  H22           3.6483747508     -1.9117276481      2.7212003906  
  H23           2.5977331739     -1.7699308623      4.1334755159  
  C24          -0.7465957942     -1.9329758044      4.3034999239  
  O25          -2.4897091663      0.0152828212      3.7398367621  
  O26          -2.7776932467     -2.2396682918      2.5777780725  
  H27          -1.3483993699     -2.2837913054      5.1462913199  
  H28          -0.2337881946     -2.7648457261      3.8174919896  
  H29          -0.0480196904     -1.1521268846      4.6138276835  
 
 386 
SCF energy: DFT(b3lyp) -1931.89330021339 au 
  C1           -0.3277432564     -1.9546014573     -1.9965572986  
  C4            0.9084743155     -2.3314918896     -2.8212883160  
  H5           -1.0963720777     -2.7306484774     -2.0946857483  
  H24           1.3190721057     -3.2795618570     -2.4539424541  
  H25           0.6283276269     -2.4604475325     -3.8694047718  
  H26           1.6761339577     -1.5568566931     -2.7420712760  
  Cl2          -1.0871457448     -0.4443253331     -2.6669061101  
  C3            0.0127939671     -1.8421567396     -0.5368766618  
  H6            0.5595996412     -2.7100236514     -0.1480106602  
  N7           -0.2827635368     -0.8639980228      0.2278886974  
  S8            0.4273012963     -1.0161100016      1.8461086657  
  Zn9          -1.8168220251      0.9225416093     -0.2141752117  
  Cl10         -0.3732822562      2.6267654066      0.1834090508  
  C11          -3.7280895880      0.2794113778     -0.0037469911  
  H12          -4.1746795812      0.6667464017      0.9194134695  
  H13          -4.3440535602      0.6271793688     -0.8407482289  
  H14          -3.7857050627     -0.8155609551      0.0211601491  
  Zn15          2.7333715909      1.7724978004      0.4128947940  
  C16           3.1904690556      2.9928942485      1.9726983370  
  C17           2.8434236176      0.6318439722     -1.2860770085  
  H18           1.9078445863      0.6907062792     -1.8565702772  
  H19           3.0321189909     -0.4198190592     -1.0265130528  
  H20           3.6550319320      0.9544947501     -1.9508099859  
  H21           3.9139512764      2.5184241420      2.6489423450  
  H22           3.6284265873      3.9401771019      1.6330127634  
  H23           2.2950670943      3.2344665169      2.5578766412  
  C24          -0.8348538662     -0.2147287873      2.8348565300  
  O25           0.5094379546     -2.4373577951      2.1896740018  
  O26           1.6326249206     -0.1850102876      1.8418969485  
  H27          -0.5046513353     -0.3113717177      3.8725431774  
  H28          -0.8780478987      0.8393201807      2.5497886667  
  H29          -1.7891363275     -0.7247364942      2.6888267255  
 
 387 
SCF energy: DFT(b3lyp) -1931.89959900985 au 
  C1           -0.0339561886      0.2495961884     -0.4080717615  
  Cl2           0.1159479939      1.9514059093      0.1943097933  
  C3           -0.7479925489     -0.6465093812      0.5616583923  
  H4            0.9946980679     -0.1289860547     -0.4637544772  
  H6           -0.9637376080     -1.6511036054      0.1765177316  
  N7           -1.0853894770     -0.3287470816      1.7495369941  
  S8           -1.9509127030     -1.5771845677      2.6500669558  
  Zn9          -1.2549317343      1.6601313918      2.9813164189  
  Cl10          0.5282549818      1.1953509289      4.3945962815  
  C11          -2.7480337729      2.9756643043      2.6424504424  
  H12          -3.4455193405      2.9794380541      3.4866785415  
  H13          -2.3522490705      3.9893333760      2.5163033155  
  H14          -3.3041101675      2.7056474448      1.7380493201  
  Zn15          3.1401733803      0.2715732113      3.6481525412  
  C16           4.1320962564      0.7535993565      5.3549793463  
  C17           2.8194446173     -0.5222272131      1.7817361321  
  H18           2.6732881044      0.2854278329      1.0518277106  
  H19           1.9340157551     -1.1722643457      1.7557701132  
  H20           3.6757511153     -1.1206204531      1.4454625104  
  H21           3.6544532538      0.2946868202      6.2296347682  
  H22           5.1758785709      0.4152223008      5.3264488283  
  H23           4.1350459731      1.8382647447      5.5181304666  
  C24          -0.6665979939     -2.1931803383      3.7445246114  
  O25          -2.9197623116     -0.7916969376      3.4163446400  
  O26          -2.3675229833     -2.6391818245      1.7307616213  
  H27          -1.1669220379     -2.8743272251      4.4381696212  
  H28           0.0770063664     -2.7272357816      3.1499014649  
  H29          -0.2255584148     -1.3446767370      4.2734227704  
  C29          -0.6906897997      0.2239286103     -1.7913613099  
  H30          -1.7092873760      0.6202679555     -1.7516348260  
  H31          -0.1059864487      0.8254453261     -2.4909497896  
  H32          -0.7266372820     -0.8056007965     -2.1666879282  
 388 
SCF energy: DFT(b3lyp) -1931.89344532132 au 
  C1            0.0107989291     -1.7451385396     -1.9746967207  
  Cl2          -1.2574521464     -0.5868546605     -2.5693851211  
  C3            0.2530643278     -1.6447927268     -0.4973470600  
  H4            0.9429892358     -1.4140471750     -2.4484333056  
  H6            1.0035915946     -2.3624574352     -0.1452696674  
  N7           -0.3008111068     -0.8213787447      0.3062757422  
  S8            0.3887123640     -0.9217666549      1.9366660692  
  Zn9          -1.8931350740      0.9039578900     -0.1878395144  
  Cl10         -0.3510472396      2.5618937761      0.0793120510  
  C11          -3.8340130578      0.3935027968      0.0805892317  
  H12          -4.2491925729      0.8798679288      0.9708072958  
  H13          -4.4355412474      0.7080118332     -0.7798679076  
  H14          -3.9512542870     -0.6906856617      0.1933074353  
  Zn15          2.7642900287      1.6790362271      0.3564334049  
  C16           3.2870694689      2.9486970992      1.8538442397  
  C17           2.8330959526      0.5032069441     -1.3249955927  
  H18           1.9375814229      0.6506784077     -1.9432561736  
  H19           2.9197758418     -0.5633276941     -1.0694557549  
  H20           3.7007287202      0.7488109745     -1.9510339288  
  H21           3.8958098878      2.4350592140      2.6096199028  
  H22           3.8715526920      3.7994389645      1.4808779687  
  H23           2.3998818345      3.3515431860      2.3568257309  
  C24          -0.8411842048     -0.0150656751      2.8711835753  
  O25           0.3985497967     -2.3279573486      2.3399723544  
  O26           1.6372739242     -0.1534294442      1.9131907824  
  H27          -0.5223434976     -0.0747027090      3.9151087763  
  H28          -0.8352340286      1.0238562789      2.5323954922  
  H29          -1.8160699550     -0.4899569793      2.7434494274  
  C29          -0.3336243632     -3.1749796563     -2.4005952733  
  H30          -1.2759955377     -3.5037109622     -1.9534546209  
  H31          -0.4191910398     -3.2300479014     -3.4882117939  
  H32           0.4642692095     -3.8564516498     -2.0831929055  
 
 389 
Post-reactive complexes leading to syn and anti products4 
 
A.      B. 
                 
 
 
 
 
C.      D. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 4-membered post-reactive complex leading to anti product  B. 6-membered post-
reactive complex leading to anti product C. 4-membered post-reactive complex leading 
to syn product  D. 6-membered post-reactive complex leading to syn product. 
 
 
                                                 
4 All pictures were created using Molecule for Mac OS X version 2.1, http://www.chemie.uni-
enlargen.de/hommes/molecule/index.html.  
 390 
 
Post-reactive complexes 
 
SCF energy: DFT(b3lyp) -1931.96451583642 au 
  C1           -0.0083274059     -0.0014465478     -0.0984979730  
  Cl2          -0.1014959046      1.8642672935     -0.0482254341  
  C4            0.4986748185     -0.4202323670     -1.4696749019  
  H5           -1.0456988253     -0.3077276641      0.0386006430  
  H24           0.5431959634     -1.5155313908     -1.5101900808  
  H25          -0.1854131420     -0.0807997340     -2.2519566595  
  H26           1.4939610656     -0.0226539526     -1.6861540434  
  C3            0.8195674605     -0.5068445762      1.1002309832  
  H6            0.8628716523     -1.5967531593      0.9634753430  
  N7            0.1429191584     -0.2283085692      2.4150946027  
  S8           -0.9596631444     -1.4813390406      2.7531577580  
  Zn9          -0.8386948811      1.7431802534      2.5363567066  
  Cl10          1.1623360075      2.4758503361      3.8586229273  
  C11          -2.6952834902      2.4709543121      2.8860462934  
  H12          -2.9499014527      2.4251291145      3.9515870890  
  H13          -2.7486393347      3.5211247262      2.5768225589  
  H14          -3.4468424275      1.9051268291      2.3254489415  
  Zn15          1.6037063350      0.1126814333      3.9953327306  
  C16           2.7351242690     -1.0241687337      5.2256794130  
  C17           2.2643109328      0.0043902909      1.1227141636  
  H18           2.3176910989      1.0721622568      1.3586110903  
  H19           2.7525768379     -0.1471866999      0.1554524797  
  H20           2.8546773499     -0.5609351324      1.8555162165  
  H21           2.7270160477     -2.0705311583      4.9024573300  
  H22           3.7707006530     -0.6658552271      5.2267049269  
  H23           2.3633980206     -0.9769597501      6.2555074469  
  C24          -1.4519075165     -1.0946144963      4.4457628697  
  O25          -2.1519184655     -1.3409694335      1.8962242846  
  O26          -0.2576352616     -2.7750803083      2.7661048335  
  H27          -2.2100101605     -1.8380599716      4.7044560635  
  H28          -0.5987469627     -1.1982823381      5.1209774989  
  H29          -1.8899424409     -0.0948880508      4.4940442084 
 
 391 
SCF energy: DFT(b3lyp) -1931.98270906325 au 
  C1           -0.4382403517     -2.3836686137     -1.8690511733  
  C4           -0.0200109628     -3.5561321331     -2.7465966960  
  H5           -1.3358855466     -2.6338814592     -1.2994519555  
  H24           0.2954836306     -4.3950027761     -2.1131463887  
  H25          -0.8594814288     -3.8907724349     -3.3618790747  
  H26           0.8071025411     -3.2929174331     -3.4110253453  
  Cl2          -0.9801087161     -0.9927284567     -2.9500691957  
  C3            0.6384253037     -1.9022715401     -0.8774763762  
  H6            0.8683690652     -2.8071721829     -0.2878848270  
  N7            0.0040198863     -0.8977702253      0.0015462522  
  S8            0.6412847882     -0.5125596448      1.3950520101  
  Zn9          -1.2357899494      0.8400426882     -0.4035830233  
  Cl10          0.5824228152      2.5728945612     -0.5522551528  
  C11          -3.2199202488      1.1806010234     -0.6094845962  
  H12          -3.5933796889      1.8405229701      0.1814741737  
  H13          -3.4290436313      1.6522514076     -1.5760802492  
  H14          -3.7779162825      0.2378481273     -0.5633865285  
  Zn15          1.5171086230      2.1777890399      1.6241130235  
  C16           2.4167937685      3.2361782763      3.0897368826  
  C17           1.9340238610     -1.4121890697     -1.5382683586  
  H18           1.7420727694     -0.5289580246     -2.1534404406  
  H19           2.3714939911     -2.1934245789     -2.1693215326  
  H20           2.6664186915     -1.1403275940     -0.7748704889  
  H21           2.5949085258      2.5990885237      3.9632100228  
  H22           3.3813216292      3.6266955920      2.7470561298  
  H23           1.7944937965      4.0824221087      3.3991632595  
  C24           0.5314742387     -1.8801544773      2.5662447107  
  O25           2.0772282799     -0.0630979035      1.4124785450  
  O26          -0.2296386876      0.6132290198      1.9080975148  
  H27           0.9439403316     -1.5358803850      3.5164890061  
  H28          -0.5197047461     -2.1549912580      2.6687161164  
  H29           1.1185424487     -2.7193477892      2.1852098383  
 392 
SCF energy: DFT(b3lyp) -1931.98518041849 au 
  C1            1.4986062731     -0.5989157483     -0.0046052580  
  Cl2           2.8108218158      0.5197637524      0.6823189281  
  C3            1.0481522913     -1.5955886267      1.0835165371  
  H4            2.0257997583     -1.1504250810     -0.7871810584  
  H6            0.2157441059     -2.1370968937      0.6085966982  
  N7            0.5671758035     -0.8898191943      2.2846364956  
  S8           -0.9279863578     -1.1393551226      2.7754978632  
  Zn9          -2.1515803693      1.6425938297      3.3401364672  
  Cl10         -0.1435954107      2.6577771845      2.5812406673  
  C11          -4.0951615091      2.0969132476      3.6278548226  
  H12          -4.3161254077      2.2081187932      4.6950318328  
  H13          -4.3509818967      3.0329801081      3.1212713177  
  H14          -4.7275786624      1.2981375293      3.2254382888  
  Zn15          1.4490486359      0.7661862934      3.2339409353  
  C16           2.8031283781      1.0976119436      4.7032992478  
  C17           2.1452015516     -2.6066153353      1.4429942252  
  H18           2.9983716435     -2.1063217770      1.9108533398  
  H19           2.5013155812     -3.1358386608      0.5508689650  
  H20           1.7605412058     -3.3497853949      2.1487450532  
  H21           3.5716761542      0.3158243219      4.7206599139  
  H22           3.2995698674      2.0632665787      4.5562169027  
  H23           2.3140503939      1.1159852117      5.6845438468  
  C24          -1.0589404376     -2.7345981357      3.6121467788  
  O25          -1.1265518181     -0.1229180579      3.8916706847  
  O26          -1.9654462142     -1.1148601678      1.7262400617  
  H27          -2.0828672616     -2.8371302547      3.9780092563  
  H28          -0.8386368607     -3.5230637195      2.8884097582  
  H29          -0.3451145589     -2.7553590876      4.4371741875  
  C29           0.3893446050      0.2536270640     -0.5983529820  
  H30          -0.0898934528      0.8721749260      0.1634126942  
  H31           0.7816148932      0.9052054653     -1.3839170563  
  H32          -0.3710849720     -0.4039002234     -1.0372843918  
 393 
SCF energy: DFT(b3lyp) -1931.98341996433 au 
  C1           -0.3460213302     -2.5150099538     -1.8587614383  
  Cl2          -0.9975554506     -1.1617793664     -2.9266100499  
  C3            0.6823512419     -1.9535570208     -0.8585556473  
  H4            0.1843141550     -3.1672092820     -2.5570679201  
  H6            0.9705969663     -2.8359841724     -0.2602717984  
  N7            0.0097955701     -0.9664553651      0.0094980031  
  S8            0.6332802483     -0.5538362959      1.4003907231  
  Zn9          -1.2224862512      0.7743565297     -0.4315133118  
  Cl10          0.6181798624      2.4816438885     -0.6272202398  
  C11          -3.2001543094      1.1434127986     -0.6469675387  
  H12          -3.5304209751      1.9287568818      0.0416892451  
  H13          -3.4185526608      1.4702663255     -1.6695849077  
  H14          -3.7884509190      0.2403684483     -0.4457468518  
  Zn15          1.5492295006      2.1279925688      1.5576197907  
  C16           2.4739755220      3.2260635649      2.9777063335  
  C17           1.9423870817     -1.4145058543     -1.5500321140  
  H18           1.7052543994     -0.5376904010     -2.1585447082  
  H19           2.3776849717     -2.1846580830     -2.1987056606  
  H20           2.6898211738     -1.1230397314     -0.8087505973  
  H21           2.6830662594      2.6106730540      3.8592888775  
  H22           3.4248085039      3.6184649449      2.5992482628  
  H23           1.8511067315      4.0731468193      3.2844980087  
  C24           0.5047154236     -1.8925997707      2.6016041852  
  O25           2.0731364806     -0.1156767360      1.4187588095  
  O26          -0.2344201188      0.5892709265      1.8796140620  
  H27           0.9111644958     -1.5302508125      3.5476077698  
  H28          -0.5488179939     -2.1584012849      2.7007288723  
  H29           1.0889784093     -2.7436221352      2.2436524250  
  C29          -1.5149508664     -3.2540970239     -1.2236442544  
  H30          -2.0747036358     -2.6004035672     -0.5503401622  
  H31          -2.1946256454     -3.6385826094     -1.9887843998  
  H32          -1.1326322714     -4.1063125178     -0.6465404646  
 
 
 
 
 
 
 
 
 
 
 
 
